"Rank","NCT Number","Title","Acronym","Status","Study Results","Conditions","Interventions","Outcome Measures","Sponsor/Collaborators","Gender","Age","Phases","Enrollment","Funded Bys","Study Type","Study Designs","Other IDs","Start Date","Primary Completion Date","Completion Date","First Posted","Results First Posted","Last Update Posted","Locations","Study Documents","URL"
1,"NCT05958095","Curio Digital Therapy for the Treatment of Post-partum Depression","SuMMER","Active, not recruiting","No Results Available","PostPartum Depression","Device: MamaLift Plus|Device: Digital Sham App","EPDS Score|EPDS Score improvement","Healthcare Innovation Technology Lab|Curio Digital Therapeutics, Inc.","Female","18 Years to 50 Years   (Adult)","Not Applicable","142","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","CU-T-003","April 1, 2023","May 24, 2023","August 15, 2023","July 24, 2023",,"July 24, 2023","Healthcare Innovation and Technology Lab, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT05958095"
2,"NCT05229913","Effects of Esketamine on Postpartum Depression","EEPD","Unknown status","No Results Available","Postpartum Depression","Drug: Esketamine is not added|Drug: Esketamine 0.2mg/kg|Drug: Esketamine 0.4mg/kg|Drug: Esketamine 0.6mg/kg|Drug: Esketamine 0.8mg/kg","Edinburgh Postpartum Depression Scale (EPDS) score|short-form of McGill Pain Questionnaire (SF-MPQ)|Visual analog scale (VAS) for pain","Qinghai University|Qinghai Red Cross Hospital","Female","25 Years to 35 Years   (Adult)","Phase 4","500","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","JMYang|2019-ZJ-930","February 20, 2022","September 30, 2022","June 30, 2023","February 8, 2022",,"February 8, 2022",,,"https://ClinicalTrials.gov/show/NCT05229913"
3,"NCT05077644","Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD)",,"Unknown status","No Results Available","Post-partum Depression","Device: Stella (TM) Mobile Application","Change in level of depression as measured by Edinburgh Postpartum Depression (EPDS)|Proportion of women who reported App use for daily mood, sleep and activities of daily living","Curio Digital Therapeutics, Inc.","Female","18 Years to 50 Years   (Adult)","Not Applicable","65","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CU-T-002","October 1, 2021","December 31, 2021","December 31, 2021","October 14, 2021",,"October 14, 2021","HITLAB, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT05077644"
4,"NCT05299398","Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone",,"Not yet recruiting","No Results Available","Postpartum Depression","Drug: Trazodone|Drug: Placebo","Occurrence of Major depressive episode|Time to occurrence of Major Depressive Episode (MDE)|Hamilton Depression Rating Scale|Edinburgh Postnatal Depression|Blood pressure|Pulse|Body weight|Side effects|Maternal Functioning|Development of mania symptoms|Pill count|Retention rate|Complete blood count (CBC)|Thyroid Stimulating Hormone test|Electrocardiogram QT Interval","Verinder Sharma|Lawson Health Research Institute","Female","18 Years to 45 Years   (Adult)","Phase 1","28","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","120394","September 1, 2022","July 31, 2023","March 31, 2024","March 29, 2022",,"August 11, 2022","Parkwood Institute Mental Health Care Building, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05299398"
5,"NCT04273191","A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)",,"Withdrawn","No Results Available","Postpartum Depression","Drug: Brexanolone","Change from Baseline to Post-Infusion on the 17-item Hamilton Rating Scale for Depression (HAM-D) Total Score|Change from Baseline to Post-Infusion in Functional Connectivity Using Blood Oxygenation Level-Dependent (BOLD) Resting State Functional Magnetic Resonance Imaging (rsfMRI)","Sage Therapeutics","Female","18 Years to 45 Years   (Adult)","Phase 4","0","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","547-EXM-401","February 2020","August 2021","August 2021","February 18, 2020",,"August 18, 2020",,,"https://ClinicalTrials.gov/show/NCT04273191"
6,"NCT02285504","Evaluate SAGE-547 in Female Participants With Severe Postpartum Depression",,"Completed","Has Results","Postpartum Depression","Drug: SAGE-547","Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Treatment Emergent Serious Adverse Events (TESAEs)|Change From Baseline in Clinical Laboratory Measures: Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Gamma Glutamyl Transferase (GGT)|Change From Baseline in Clinical Laboratory Measures: Carbon Dioxide (CO2), Sodium, Potassium and Chloride|Change From Baseline in Clinical Laboratory Measures: Glucose, Total Bilirubin, Calcium, Blood Urea Nitrogen (BUN) and Creatinine|Change From Baseline in Clinical Laboratory Measures: Albumin, Total Protein and Hemoglobin|Change From Baseline in Clinical Laboratory Measure: Hematocrit|Change From Baseline in Clinical Laboratory Measures: Platelet Count, White Blood Cells (WBC), Absolute Lymphocytes, Absolute Neutrophils, Absolute Basophils, Absolute Eosinophils, Absolute Monocytes|Change From Baseline in Clinical Laboratory Measure: Red Blood Cells (RBC)|Change From Baseline in Clinical Laboratory Measure: Mean Corpuscular Volume (MCV)|Change From Baseline in Clinical Laboratory Measure: Mean Corpuscular Hemoglobin (MCH)|Change From Baseline in Clinical Laboratory Measure: Prothrombin Time/International Normalized Ratio (PT/INR)|Change From Baseline in Clinical Laboratory Measure: Potential of Hydrogen (pH)|Change From Baseline in Clinical Laboratory Measure: Specific Gravity|Change From Baseline in Vital Sign: Blood Pressure|Change From Baseline in Vital Sign: Heart Rate|Change From Baseline in Vital Sign: Body Temperature|Change From Baseline in Vital Sign: Respiratory Rate|Change From Baseline in Electrocardiogram (ECG) Parameters: QT Interval, PR Interval, QTc Interval, and QRS Duration|Change From Baseline in Electrocardiogram (ECG) Parameter: Heart Rate|Number of Participants With Physical Examination Findings|Number of Participants With Concomitant Medication Usage|Number of Participants With Suicidal Ideation and Behavior as Assessed by Columbia-Suicide Severity Rating Scale (C-SSRS)|Maximum Plasma Concentration (Cmax) of SAGE-547|Time to Maximum Plasma Concentration (Tmax) of SAGE-547|Area Under the Concentration-Time Curve From Start of the Infusion Until the Time of the Last Sample (AUCall) of SAGE-547|Area Under the Concentration-Time Curve From Time Zero to 60 Hours (AUC0-60) of SAGE-547|Area Under the Concentration-Time Curve in 24 Hours (AUC24) of SAGE-547|Average Drug Concentration in the Plasma at Steady State During a Dosing Interval (Cavg) of SAGE-547|Plasma Clearance (CL) of SAGE-547|Change From Baseline in Hamilton Rating Scale for Depression-17 (HAM-D-17) Total Score|Clinical Global Impression-Improvement (CGI-I) Score","Sage Therapeutics","Female","18 Years to 45 Years   (Adult)","Phase 2","4","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","547-PPD-201","January 7, 2015","June 5, 2015","June 5, 2015","November 7, 2014","December 2, 2021","January 27, 2022","Sage Investigational Site, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02285504"
7,"NCT05826327","Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients",,"Recruiting","No Results Available","Postpartum Depression","Drug: Esketamine|Drug: Sufentanil","Incidence of depression","Women's Hospital School Of Medicine Zhejiang University|Peking University First Hospital|Obstetrics & Gynecology Hospital of Fudan University|Beijing Obstetrics and Gynecology Hospital","Female","18 Years and older   (Adult, Older Adult)","Phase 4","364","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","IRB-20230021-R","May 1, 2023","June 30, 2025","December 31, 2025","April 24, 2023",,"May 30, 2023","Women's hospital, school of medicine, Zhejiang university, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT05826327"
8,"NCT04355091","Emotional Freedom Techniques (EFT) and Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Behavioral: Emotional Freedom Techniques (EFT)","Change from baseline in Edinburgh Postpartum Depression Scale scores at 6 months|Stress Coping Styles Scale|State-Trait Anxiety Inventory","Istanbul University - Cerrahpasa (IUC)","Female","18 Years to 49 Years   (Adult)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","99984023-302.99-","July 1, 2019","September 1, 2019","April 30, 2020","April 21, 2020",,"August 10, 2020","Istanbul University Cerrahpaşa, Istanbul, Eyalet/Yerleşke, Turkey",,"https://ClinicalTrials.gov/show/NCT04355091"
9,"NCT04193462","Relationship-Based Intervention for Post-Partum Depression",,"Recruiting","No Results Available","Post Partum Depression","Other: Post-partum depression- Dyadic psychotherapy-|Other: Post-partum depression- Psycho-educational therapy","Behavioral Assessment of dialogue|Hormonal Assays- Oxytocin","Interdisciplinary Center Herzliya","Female","Child, Adult, Older Adult","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","InterdisciplinaryCH","May 8, 2019","September 2023","October 2023","December 10, 2019",,"May 4, 2022","Interdisciplinary Center, Herzliya, Israel",,"https://ClinicalTrials.gov/show/NCT04193462"
10,"NCT03417960","Accelerated iTBS for Post Partum Depression",,"Recruiting","No Results Available","Post Partum Depression","Device: iTBS","Determine feasibility and tolerability of accelerated iTBS for postpartum depression. The investigators hope to retain >80% of recruited patients (feasibility) and reach a full treatment dose of 120%rMT in >80% of enrolled women (tolerability).|Anti-depressant effect","Medical University of South Carolina","Female","18 Years to 50 Years   (Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Pro00073886","January 24, 2018","May 31, 2024","July 31, 2024","January 31, 2018",,"December 6, 2023","Medical University of South Carolina, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT03417960"
11,"NCT03283254","PREPP: Preventing Postpartum Depression","PREPP","Active, not recruiting","No Results Available","Postpartum Depression (PPD)","Behavioral: Practical Resources for Effective Postpartum Parenting (PREPP)|Behavioral: Enhanced Treatment As Usual (ETAU)","Score on the Edinburgh Postnatal Depression Scale (EPDS)|Score on the Pittsburgh Sleep Quality Index (PSQI)|Score on HRSD-24|Score on the PHQ-9|Hamilton Anxiety Scale (HRSA)|Sleep Efficiency (SEact)|Score on Brief Infant Sleep Questionnaire (BISQ) (baby)|Cry Behavior (baby)|Sleep Behavior (baby)|Total Sleep Time (TSTact) (mother)","Columbia University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years to 45 Years   (Adult)","Not Applicable","216","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","7428|R01HD092062","February 12, 2018","February 28, 2024","February 28, 2024","September 14, 2017",,"February 20, 2024","New York State Psychiatric Institute, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03283254"
12,"NCT04516668","Effect of Tele-consultation in Addition With Psychiatric Follow-up During COVID-19 in Women Who Have Medical History of Post-partum Depression","COVIDDEPERINAT","Unknown status","No Results Available","Post Partum Depression",,"Evaluation of Hospital anxiety and depression scale (HAD)|Evaluation of Edinburgh Postpartum Depression Scale (EPDS)|Evaluation of HAD score in fathers|Evaluation of EPDS in fathers|Study of the relationship between maternals and paternals symptoms|Study of difficuties in child during the quarantine|Risk and protection factors","Assistance Publique - Hôpitaux de Paris","All","18 Years and older   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","APHP200878","November 2020","November 2020","November 2020","August 18, 2020",,"October 6, 2020",,,"https://ClinicalTrials.gov/show/NCT04516668"
13,"NCT02942004","A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)",,"Completed","Has Results","Postpartum Depression","Drug: Placebo|Drug: SAGE-547 60 μg/kg/h|Drug: SAGE-547 90 μg/kg/h","Change From Baseline at 60 Hours in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score|Change From Baseline in HAM-D Total Score at Day 30|Change From Baseline in HAM-D Total Score|Percentage of Participants With HAM-D Response|Percentage of Participants With HAM-D Remission|Change From Baseline in HAM-D Bech 6 Subscale|Change From Baseline in HAM-D Individual Item Scores|Change From Baseline at Key Time Points in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score|Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Change From Baseline in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) Total Score|Percentage of Participants With Treatment-Emergent Adverse Events|Time to Change in Antidepressant Medication","Sage Therapeutics","Female","18 Years to 45 Years   (Adult)","Phase 3","138","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","547-PPD-202 B","August 1, 2016","September 24, 2017","October 19, 2017","October 21, 2016","June 13, 2019","January 28, 2022","Sage Investigational Site, Chandler, Arizona, United States|Sage Investigational Site, Rogers, Arkansas, United States|Sage Investigational Site, Lemon Grove, California, United States|Sage Investigational Site, Orange, California, United States|Sage Investigational Site, Ventura, California, United States|Sage Investigational Site, Gainesville, Florida, United States|Sage Investigational Site, Miami, Florida, United States|Sage Investigational Site, Miramar, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Pensacola, Florida, United States|Sage Investigational Site, Pinellas Park, Florida, United States|Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Hoffman Estates, Illinois, United States|Sage Investigational Site, Wichita, Kansas, United States|Sage Investigational Site, Edgewood, Kentucky, United States|Sage Investigational Site, Owensboro, Kentucky, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Flowood, Mississippi, United States|Sage Investigational Site, Marlton, New Jersey, United States|Sage Investigational Site, Glen Oaks, New York, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Charlotte, North Carolina, United States|Sage Investigational Site, Raleigh, North Carolina, United States|Sage Investigational Site, Columbus, Ohio, United States|Sage Investigational Site, Dayton, Ohio, United States|Sage Investigational Site, Philadelphia, Pennsylvania, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, Richardson, Texas, United States|Sage Investigational Site, San Antonio, Texas, United States|Sage Investigational Site, Orem, Utah, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/04/NCT02942004/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/04/NCT02942004/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02942004"
14,"NCT02942017","A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)",,"Completed","Has Results","Postpartum Depression","Drug: Placebo|Drug: SAGE-547 90 μg/kg/h","Change From Baseline at 60 Hours in 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score|Change From Baseline in HAM-D Total Score at Day 30|Change From Baseline in HAM-D Total Score|Percentage of Participants With HAM-D Response|Percentage of Participants With HAM-D Remission|Change From Baseline in HAM-D Bech 6 Subscale|Change From Baseline in HAM-D Individual Item Scores|Change From Baseline at Key Time Points in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score|Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Change From Baseline in the Generalized Anxiety Disorder 7-Item Scale (GAD-7) Total Score|Percentage of Participants With Treatment Emergent Adverse Event (TEAE)|Time to Change in Antidepressant Medication","Sage Therapeutics","Female","18 Years to 45 Years   (Adult)","Phase 3","108","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","547-PPD-202 C","July 2016","September 17, 2017","October 11, 2017","October 21, 2016","June 13, 2019","January 28, 2022","Sage Investigational Site, Chandler, Arizona, United States|Sage Investigational Site, Rogers, Arkansas, United States|Sage Investigational Site, Lemon Grove, California, United States|Sage Investigational Site, Orange, California, United States|Sage Investigational Site, Ventura, California, United States|Sage Investigational Site, Gainesville, Florida, United States|Sage Investigational Site, Miami, Florida, United States|Sage Investigational Site, Miramar, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Pensacola, Florida, United States|Sage Investigational Site, Pinellas Park, Florida, United States|Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Hoffman Estates, Illinois, United States|Sage Investigational Site, Wichita, Kansas, United States|Sage Investigational Site, Edgewood, Kentucky, United States|Sage Investigational Site, Owensboro, Kentucky, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Flowood, Mississippi, United States|Sage Investigational Site, Marlton, New Jersey, United States|Sage Investigational Site, Glen Oaks, New York, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Charlotte, North Carolina, United States|Sage Investigational Site, Raleigh, North Carolina, United States|Sage Investigational Site, Columbus, Ohio, United States|Sage Investigational Site, Dayton, Ohio, United States|Sage Investigational Site, Philadelphia, Pennsylvania, United States|Sage Investigational Site, Baytown, Texas, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, Richardson, Texas, United States|Sage Investigational Site, San Antonio, Texas, United States|Sage Investigational Site, Orem, Utah, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/17/NCT02942017/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/17/NCT02942017/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02942017"
15,"NCT00782912","Postpartum Anemia and Postpartum Depression","PPADS","Completed","No Results Available","Postpartum Depression",,"Incidence of postpartum depression|Mean Edinburgh Postnatal Depression Scale results|Functional status|Lactation success","Unity Health Toronto","Female","Child, Adult, Older Adult",,"103","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","08-155","November 2008","October 2014","October 2014","October 31, 2008",,"February 22, 2019","St. Michael's Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00782912"
16,"NCT04441879","bBeAMom: Effectiveness of a Cognitive-Behavioral Blended Intervention for Postpartum Depression","bBeAMom","Recruiting","No Results Available","Postpartum Depression","Behavioral: Be a Mom Coping with Depression|Behavioral: Be a Mom","Changes from baseline in depressive symptoms|Changes from baseline in anxiety symptoms|Changes from baseline in quality of life|Changes from baseline in the frequency of negative thoughts|Changes from baseline in marital satisfaction|Changes from baseline in maternal self-efficacy|Changes from baseline in mother-child bonding|Changes from baseline in self-compassion|Changes from baseline in emotional regulation|Changes from baseline in psychological flexibility|Changes from baseline in expectancy for therapy|Therapeutic relationship|Acceptability of the intervention for postpartum women|Usability of the intervention for postpartum women|Feasibility of the online program for postpartum women as measured by number of website logins|Feasibility of the program for postpartum women as measured by website average visit length|Feasibility of the intervention for postpartum women as measured by dropout rate","University of Coimbra|Fundação para a Ciência e a Tecnologia","Female","18 Years to 50 Years   (Adult)","Not Applicable","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","bBeAMom/145563/2019|SFRH/BD/145563/2019","April 1, 2022","November 2023","January 2024","June 22, 2020",,"July 15, 2022","Faculty of Psychology and Education Sciences, University of Coimbra, Coimbra, Portugal",,"https://ClinicalTrials.gov/show/NCT04441879"
17,"NCT02818075","Mobile Phone Based Peer Support to Prevent Postpartum Depression Among Adolescent Mothers",,"Completed","No Results Available","Postpartum Depression","Other: Mobile Phone Based Peer Support|Other: Usual Care","Feasibility as assessed by the Participant Eligibility Assessment Form|Acceptability as assessed by the validated Peer Support Evaluation Inventory|Compliance as assessed by the Activity Log Form|Support strategies as assessed by the Activity Log Form|Edinburgh Postnatal Depression Scale|State-Trait Anxiety Inventory (STAI)|Short Form Social Support Questionnaire (SSQ6)|Health Services Utilization Questionnaire","University of Toronto","Female","16 Years to 24 Years   (Child, Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","32189","April 2016","January 21, 2018","January 21, 2018","June 29, 2016",,"March 19, 2019","University of Toronto, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02818075"
18,"NCT01379781","Behavioral Change in the Mother-Infant Dyad: Preventing Postpartum Depression",,"Completed","Has Results","Postpartum Depression","Behavioral: Behavioral Intervention for PPD","Hamilton Rating Scales of Depression","New York State Psychiatric Institute","Female","18 Years to 35 Years   (Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","#6285","August 2011","February 2014","February 2018","June 23, 2011","August 10, 2015","March 29, 2022","Columbia University Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01379781"
19,"NCT05873569","Preventing Postpartum Depression in Immigrant Latinas",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: Mothers and Babies Virtual Group Intervention","Depressive symptoms|Depressive episodes|Parenting self-efficacy|Parenting responsiveness|Behavioral activation|Decentering|Social support|Mood management|Anxiety symptoms|Perceived stress","Northwestern University|Johns Hopkins University|Palo Alto University","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","300","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STU00217105","October 15, 2023","June 30, 2026","April 30, 2027","May 24, 2023",,"November 1, 2023","Johns Hopkins University School of Medicine, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT05873569"
20,"NCT05055674","The Effects of Motherly on Postpartum Depression",,"Unknown status","No Results Available","Postpartum Depression","Behavioral: Motherly app|Behavioral: COMVC app","Depression symptoms|Anxiety symptoms|Sleep quality|Quality of Life: Physical Health|Quality of Life: Mental Health|Parenting stress|Parental Distress|Parent-child Dysfunctional Interaction|Difficult Child|Attachment|Parenting Competence","University of Sao Paulo","Female","18 Years to 40 Years   (Adult)","Not Applicable","264","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","OR2019-62903","September 2021","March 2022","July 2022","September 24, 2021",,"September 24, 2021",,,"https://ClinicalTrials.gov/show/NCT05055674"
21,"NCT05551195","[Study Evaluating the Efficacy and Safety of a Digital Therapeutic as an Adjunct to TAU in Postpartum Depression]",,"Terminated","No Results Available","Postpartum Depression","Device: WB001|Device: ED001","Hamilton Rating Scale for Depression (HAM-D)|Edinburgh Postpartum Depression Scale (EPDS)|Patient Health Questionnaire (PHQ-9)|Generalized Anxiety Disorder Questionnaire (GAD-7)|Mother-to-Infant Bonding Scale (MIBS)|Clinical Global Impressions Scale - Severity of Illness (CGI-S)|Clinical Global Impressions Scale - Global Improvement (CGI-I)|Patient Global Impression Scale (PGI)|Client Satisfaction Questionnaire (CSQ-8)","Woebot Health|Iqvia Pty Ltd","Female","22 Years to 45 Years   (Adult)","Not Applicable","7","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","WB001-001","November 16, 2022","May 10, 2023","May 10, 2023","September 22, 2022",,"July 19, 2023","Woebot Investigational Site, Lafayette, California, United States|Woebot Investigational Site, Santa Ana, California, United States|Woebot Investigational Site, DeLand, Florida, United States|Woebot Investigational Site, Miami Lakes, Florida, United States|Woebot Investigational Site, Seminole, Florida, United States|Woebot Investigational Site, Decatur, Georgia, United States|Woebot Investigational Site, Glen Oaks, New York, United States|Woebot Investigational Site, Cleveland, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT05551195"
22,"NCT05217251","EEG Alterations of Uterine Contractions in the First Stage of Labor Predicting Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Other: frontal alpha asymmetry in EEG","The incidence of depression in 12 months after childbirth.|The score of pain in 12 months after childbirth","Zhujiang Hospital","Female","18 Years to 45 Years   (Adult)",,"330","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","Maternal EEG monitoring","March 1, 2022","February 2023","December 2024","February 1, 2022",,"March 23, 2022","Zhujiang Hospital, Guanzhou, Guangdong, China",,"https://ClinicalTrials.gov/show/NCT05217251"
23,"NCT06004232","Prenatal Yoga to Prevent Postpartum Depression","PRY-D","Not yet recruiting","No Results Available","Postpartum Depression","Behavioral: Prenatal Yoga to Prevent Postpartum Depression (PRY-D) intervention|Behavioral: Treatment as Usual (TAU)","Edinburgh Postnatal Depression Scale","Henry Ford Health System|National Institute of Mental Health (NIMH)|University of Colorado, Boulder","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R34MH131573","July 2024","March 2026","March 2026","August 22, 2023",,"September 1, 2023",,,"https://ClinicalTrials.gov/show/NCT06004232"
24,"NCT00744328","Postpartum Depression: Transdermal Estradiol Versus Sertraline","E2SERT","Terminated","Has Results","Postpartum Depression","Drug: Transdermal Estradiol|Drug: Sertraline|Other: Placebo","To Test the Efficacy of Estradiol for the Treatment of Postpartum Depression - Percent Change in SIGH-ADS29|Infant Serum Concentrations of Estradiol in 3 Treatment Arms","Northwestern University","Female","18 Years to 45 Years   (Adult)","Phase 4","85","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","R01MH057102","August 2008","September 2013","September 2013","August 29, 2008","October 23, 2014","September 10, 2019","Northwestern University Feinberg School of Medicine; Asher Center for the Study and Treatment of Depressive Disorders, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT00744328"
25,"NCT03024645","Be a Mom: Effectiveness of a Web-based Preventive Intervention for Postpartum Depression","BeAMom","Unknown status","No Results Available","PostPartum Depression","Behavioral: Be A Mom|Other: Treatment as usually (TAU)","Number of women with clinically significant postpartum depressive symptoms (EPDS > 12) at 4 months postpartum|Number of women with clinically significant postpartum depressive symptoms (EPDS > 12) at 12 months postpartum|Changes from baseline in the severity of depressive symptoms|Changes from baseline in anxiety symptoms|Changes from baseline in quality of life|Changes from baseline in dyadic adjustment|Changes from baseline in maternal confidence|Changes from baseline in the frequency of negative automatic thoughts|Changes from baseline in psychological flexibility|Changes from baseline in self-criticism and self-compassion|Changes from baseline in emotional regulation|Acceptability of the program for postpartum women|Feasibility of the program for postpartum women as measured by number of website logins|Feasibility of the program for postpartum women as measured by website average visit length|Feasibility of the program for postpartum women as measured by number of exercises completed|Feasibility of the program for postpartum women as measured by dropout rate.","University of Coimbra","Female","18 Years to 50 Years   (Adult)","Not Applicable","1000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","CINEICC-2-BaM|SFRH/BPD/93996/2013","August 1, 2017","September 1, 2021","December 31, 2021","January 19, 2017",,"April 27, 2021","Ana Fonseca, Coimbra, Portugal",,"https://ClinicalTrials.gov/show/NCT03024645"
26,"NCT05269732","CBT for Postpartum Depression and Infant Emotion Regulation",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: Group Cognitive Behavioural Therapy (CBT)","Infant Temperament|Infant emotion regulation|Maternal Depression|Maternal Anxiety|Brain-to-brain Synchrony (fNIRS)|The Face-to-Face Stillage Paradigm (FFSP)|Parent-Child Early Relational Assessment (PCERA)|Epigenetic Analyses","McMaster University","Female","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","172","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","PIER CBT","June 17, 2022","December 31, 2025","December 31, 2025","March 8, 2022",,"August 29, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05269732"
27,"NCT05997953","Screening of Postpartum Depression in Egyptian Women",,"Recruiting","No Results Available","Postpartum Depression","Other: Edinburgh Postnatal Depression Scale","Number screening positive for possible postpartum depression by Arabic EPDS|Sociodemographic, clinical, and psychosocial predictors of postpartum depression risk","Al-Azhar University","Female","18 Years to 45 Years   (Adult)",,"2000","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","520235","July 1, 2023","June 1, 2024","August 1, 2024","August 18, 2023",,"August 18, 2023","Faculty od Medicine, Department of Obstetrics and Gynecology., Cairo, Cairo., Egypt",,"https://ClinicalTrials.gov/show/NCT05997953"
28,"NCT05766475","In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: ROSE Program: In Person|Behavioral: ROSE Program: Virtual","Symptom Checklist 20 (SCL 20)|Center for Epidemiologic Studies Depression Scale (CES-D)","University of Denver|National Institute of Mental Health (NIMH)|Denver Health Medical Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","900","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","1916994-3|R01MH130976-01","March 13, 2023","June 2027","June 2027","March 13, 2023",,"May 17, 2023","Denver Health Medical Center, Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT05766475"
29,"NCT05585164","Engage & Connect: A Psychotherapy for Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: Engage & Connect","Change in Edinburgh Postnatal Depression Scale (EPDS)|Change in Behavioral Activation for Depression Scale (BADS)|Change in Social Reward Processing on STAR task","Weill Medical College of Cornell University","Female","Child, Adult, Older Adult","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","22-04024696","November 1, 2022","July 2025","July 2027","October 18, 2022",,"October 23, 2023","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT05585164"
30,"NCT05133583","Effect of Laughter Yoga Therapy on Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Other: Laughter yoga","Effect of Laughter Yoga therapy on postpartum Depression","Adiyaman University Research Hospital","Female","19 Years to 60 Years   (Adult)","Not Applicable","104","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","lokman hekim","April 20, 2021","June 2, 2021","September 10, 2021","November 24, 2021",,"November 24, 2021","Didem Simsek Kucukkelepce, Adiyaman, Turkey",,"https://ClinicalTrials.gov/show/NCT05133583"
31,"NCT01482832","Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers","REACH 2","Completed","No Results Available","Postpartum Depression","Behavioral: Interpersonal therapy-based treatment","Diagnosis of depression|Degree of depressive symptoms","Women and Infants Hospital of Rhode Island|National Institute of Mental Health (NIMH)|Pacific Institute for Research and Evaluation|Brown University","Female","12 Years to 19 Years   (Child, Adult)","Not Applicable","250","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R01MH093342","December 2011","December 2017","October 30, 2018","December 1, 2011",,"April 24, 2019","Women & Infants Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT01482832"
32,"NCT06342310","RE104 Safety and Efficacy Study in Postpartum Depression",,"Not yet recruiting","No Results Available","Postpartum Depression","Drug: RE104 for Injection","RE104 30 mg versus RE104 1.5 mg change from baseline in MADRS total score|RE104 30 mg versus RE104 1.5 mg percentage of patients with MADRS response (≥ 50 percent reduction in score from baseline)|RE104 30 mg versus RE104 1.5 mg percentage of patients with MADRS remission (score ≤ to 10)|RE104 30 mg versus RE104 1.5 mg Clinical Global Impression-Improvement (CGI-I)|RE104 30 mg versus RE104 1.5 mg change from baseline in CGI-Severity (CGI-S)|RE104 30 mg versus RE104 1.5 mg changes in total score from baseline in Hamilton Anxiety Rating Scale (HAM-A)|RE104 30 mg versus RE104 1.5 mg incidence of treatment-emergent adverse events (TEAEs) by frequency, severity and seriousness.","Reunion Neuroscience Inc","Female","18 Years to 45 Years   (Adult)","Phase 2","72","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RE104-201-PPD","May 2024","May 2025","June 2025","April 2, 2024",,"April 3, 2024",,,"https://ClinicalTrials.gov/show/NCT06342310"
33,"NCT01658098","Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez",,"Unknown status","No Results Available","Postpartum Depression","Behavioral: edinburgh postpartum depression scale questionary","presence of postpartum depression|sociodemographic characteristics|obstetrical background|medical background","Hospital Universitario Dr. Jose E. Gonzalez","Female","Child, Adult, Older Adult",,"348","Other","Observational","Time Perspective: Prospective","etamez","September 2012","November 2012","February 2013","August 6, 2012",,"August 6, 2012","Hospital Universitario Dr Jose E. Gonzalez, Monterrey, Nuevo Leon, Mexico",,"https://ClinicalTrials.gov/show/NCT01658098"
34,"NCT05772897","Parenting Skills Group for Mothers With Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: Circle of Security Parenting program","Change in methylation of OXTR receptor gene rs53576|Changes in Beck Depression Inventory, Second Edition (BDI-II) Score|Changes Postpartum Depression Screening Scale (PDSS) Score|Changes in Dyadic Adjustment Scale (DAS) Score|Changes in Denver Maternal Stress Assessment Score|Changes in MacArthur Short Form Vocabulary Checklist Score (child)|Changes in Maternal Postnatal Attachment Scale (MPAS) Score|Changes in The Multidimensional Scale of Perceived Social Support (MSPSS) Score|Changes in Carey Infant Temperament Questionnaire (ITQ) Score|Empathy & Theory of Mind Scale (EToMS) Score|Inventory of Callous-Unemotional Traits (ICU) Score","University of Colorado, Denver","Female","18 Years to 50 Years   (Adult)","Not Applicable","750","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","21-2593","August 3, 2023","April 1, 2035","June 1, 2035","March 16, 2023",,"November 30, 2023","University of Colorado Denver, Denver, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT05772897"
35,"NCT05751746","The Effect of Peripartum Magnesium Sulfate Use on the Occurrence of Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Drug: Magnesium sulfate","postpartum depression|postpartum depression severity","Seoul National University Bundang Hospital","Female","18 Years and older   (Adult, Older Adult)",,"108","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","B-2209-780-302","January 30, 2023","December 31, 2023","February 28, 2024","March 2, 2023",,"March 2, 2023","Seoul National University Bundang Hospital, Seongnam-si, Gyeonguido, Korea, Republic of",,"https://ClinicalTrials.gov/show/NCT05751746"
36,"NCT00384943","Study of Home-Based Exercise to Alleviate Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Behavioral: Moderate-intensity Exercise","Change in depressed mood scores immediately following the 3 month intervention and at 3 and 6 months post-treatment,|as measured by the Edinburgh Postnatal Depression Scale and the Hamilton Rating Scale for Depression.|Changes in fatigue levels (measured by the multidimensional fatigue inventory), sleep patterns, anxiety and health status.","McGill University|Fonds de la Recherche en Santé du Québec","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","FRSQ 024018","November 2001",,"November 2004","October 6, 2006",,"October 6, 2006","McGill University Health Centre, Montreal, Quebec, Canada",,"https://ClinicalTrials.gov/show/NCT00384943"
37,"NCT00833469","Escitalopram (Lexapro) for the Treatment of Postpartum Depression","LexaproPPD","Completed","Has Results","Postpartum Depression","Drug: Escitalopram","Change in Clinician-rated Montgomery-Asberg Depression Rating Scale (MADRS)|Change in Edinburgh Postnatal Depression Scale (EPDS)|Change in Beck Anxiety Inventory (BAI)","Massachusetts General Hospital|Forest Laboratories","Female","18 Years to 45 Years   (Adult)","Phase 4","7","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2008-P-001509","January 2009","April 2011","April 2011","February 2, 2009","August 6, 2014","August 6, 2014","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT00833469"
38,"NCT04845347","A Wearable Morning Light Treatment for Postpartum Depression",,"Recruiting","No Results Available","Post Partum Depression","Device: Bright Light Therapy|Device: Dim Light Therapy","Change in score for the Structured interview guide score for the Hamilton Depression Rating Scale - Seasonal Affective Version (SIGH-SAD total score)|Change in Phase angle difference|Edinburgh Postnatal Depression Scale (EPDS) total score|Epworth Sleepiness Scale (ESS) total score|Patient Reported Outcomes Measurement Information System (PROMIS) - Satisfaction with Participation in Social Roles (SPSR) total score|Patient Reported Outcomes Measurement Information System Sleep-related impairment (SRI) total score|Social functioning as measured by the Postpartum Bonding Questionnaire (PBQ) total score","University of Michigan|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HUM00190163|1R01MH121531-01A1","June 23, 2021","May 2025","May 2025","April 14, 2021",,"May 18, 2023","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT04845347"
39,"NCT05937867","A Phase II Study of HS-10353 in Participants With Postpartum Depression",,"Not yet recruiting","No Results Available","Postpartum Depression","Drug: HS-10353 Capsules 30 mg, Oral, QN for 14 days|Drug: HS-10353 Capsules 50 mg, Oral, QN for 14 days|Drug: HS-10353 Capsules matching placebo, 30mg, Oral, QN for 14 days.|Drug: HS-10353 Capsules matching placebo, 50mg, Oral, QN for 14 days","Change from baseline in the HAM-D17 total score at day 15|Change From Baseline in the HAM-D Total Score at Days 3, 8, 21 and 28|Percentage of Participants With HAM-D17 Response|Percentage of Participants With HAM-D17 Remission|Change From Baseline in the Clinical Global Impressions - Severity Scale (CGI-S) Total Score|Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Change From Baseline in Montgomery and Åsberg Depression Rating Scale (MADRS) Total Score|Change From Baseline in Self-Reported Measures of Depressive Symptoms, as Assessed by the Edinburgh Postnatal Depression Scale (EPDS) Total Score|Change From Baseline in Self-Reported Measures of Depressive Symptoms, as Assessed by the 9-item Patient Health Questionnaire (PHQ-9) Score|Change From Baseline in Hamilton Anxiety Rating Scale (HAM-A) Total Score|Change From Baseline in (PWC-20) Total Score|Number of Participants With adverse events (AEs), serious adverse events (SAEs), and adverse events leading to withdrawal from the trial, and association with the investigational drug|Number of Participants With Potentially Clinically Significant Vital Sign Measurements|Number of Participants With Potentially Clinically Significant Laboratory Evaluations","Jiangsu Hansoh Pharmaceutical Co., Ltd.","Female","18 Years to 45 Years   (Adult)","Phase 2","96","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HS-10353-202","August 31, 2023","February 28, 2025","October 31, 2025","July 10, 2023",,"July 10, 2023",,,"https://ClinicalTrials.gov/show/NCT05937867"
40,"NCT01527474","Escitalopram in the Treatment of Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Drug: escitalopram","The primary efficacy assessment will be total score on the Montgomery-Asberg Depression Rating Scale (MADRS).|The Secondary efficacy assessment will be total score on the short form of the Quality of Life Enjoyment and Satisfaction Questionnaire.","BC Women's Hospital & Health Centre","Female","19 Years to 40 Years   (Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SM1562007","April 2008","May 2009","May 2009","February 7, 2012",,"February 10, 2012","Reproductive Mental Health Program, BC Women's Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01527474"
41,"NCT04580901","IPT-G for Mums With Postpartum Depression","OPTIMUM","Unknown status","No Results Available","Postpartum Depression","Behavioral: Group Interpersonal Psychotherapy","Depressive symptoms on Edinburgh Postpartum Depression scale|Depressive symptoms on Patient Health Questionnaire-9 (PHQ-9)|Anxiety|Acceptability|Postpartum bonding|Social Support|Functioning","McMaster University|Hamilton Academic Health Sciences Organization","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","126","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","10612","December 21, 2020","January 2023","March 2023","October 9, 2020",,"March 5, 2021","McMaster Univeristy, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04580901"
42,"NCT05543746","Dynamic Neural Mechanisms of Brexanolone-induced Antidepressant Effects in Postpartum Depression","BRX-PPD","Recruiting","No Results Available","Postpartum Depression","Drug: Brexanolone","Number of successfully analyzed EEG recordings|Number of subjects completing the entire study protocol through the follow-up phase|Number of subjects withdrawn from protocol due to adverse events or participation burden","University of North Carolina, Chapel Hill|Baszucki Brain Research Fund|Sage Therapeutics","Female","18 Years to 45 Years   (Adult)",,"10","Other|Industry","Observational","Observational Model: Case-Only|Time Perspective: Prospective","21-2224","August 5, 2022","March 2024","March 2024","September 16, 2022",,"October 4, 2023","University of North Carolina, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT05543746"
43,"NCT04950868","The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Drug: Quetiapine","Recruitment and retention rate|Blood pressure|Incidence of Treatment-Emergent Adverse Events as assessed by the Systematic Monitoring of Adverse events Related to TreatmentS (SMARTS) score|Maternal functioning will be measured by the Barkin Index of Maternal Functioning (BIMF)|Pulse|Body mass index|Fasting lipid panel test|glycated haemoglobin (HbA1c) tests|Waist circumference|Returned tablet count|Hamilton Depression Rating (HDRS) total score|Edinburgh Postnatal Depression Scale|Generalized Anxiety Disorder 7-item scale|Young Mania Rating Scale","Verinder Sharma|Lawson Health Research Institute","Female","18 Years to 45 Years   (Adult)","Phase 1","30","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","118885","March 18, 2022","March 31, 2023","December 31, 2024","July 6, 2021",,"March 21, 2022","Parkwood Institute, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04950868"
44,"NCT04639752","Remote Peer Support in Prevention of Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: Mom´s Supporting Mom|Behavioral: Enhanced Treatment As Usual","Postpartum depressive symptoms|Postpartum anxiety symptoms|Postpartum health-related quality of life|Cost-effectiveness","National Institute of Mental Health, Czech Republic","Female","18 Years to 45 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","NU21J-09-00064","November 1, 2020","October 31, 2023","April 30, 2024","November 20, 2020",,"April 11, 2022","National Institute of Mental Health, Klecany, Czechia",,"https://ClinicalTrials.gov/show/NCT04639752"
45,"NCT02741206","Preventing Postpartum Depression in Prenatal Care",,"Withdrawn","No Results Available","Post-partum Depression","Behavioral: Bellevue ROSE Intervention|Behavioral: Psycho-education session and usual, Standard of care Control|Behavioral: One Psycho-education session and usual, standard of care Control","Depression severity measured by Patient Health Questionnaire (PHQ-9)|Measure of psycho social risk assessment according to Adapted antenatal Risk Questionnaire (ANRQ)|Measure of perceived social support measured by Multidimensional Scale of Perceived Social Support (MSPSS)|Measure of stress using Perceived Stress Index (PSS)|Parenting Practices and treatment assessed by Parenting Practices and Treatment Questionnaire","NYU Langone Health","Female","18 Years to 45 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Supportive Care","15-01130","June 2016","July 20, 2017","July 20, 2017","April 18, 2016",,"November 22, 2017","New York University School of Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02741206"
46,"NCT00370903","Postpartum Depression and Cesarean Section",,"Completed","No Results Available","Postpartum Depression",,,"Oklahoma State University Center for Health Sciences","Female","15 Years to 43 Years   (Child, Adult)",,"200","Other","Observational","Time Perspective: Retrospective","2005009","August 2006","November 2007","November 2007","September 1, 2006",,"February 4, 2008","Oklahoma State University Center for Health Sciences Houston Parke Clinic, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT00370903"
47,"NCT04011592","Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression",,"Terminated","Has Results","Post Partum Depression","Drug: Ketamine 0.5 mg/kg|Drug: Ketamine 0.2 mg/kg","Change in Depressed Mood as Indicated by Hamilton Depression Rating Scale (HAM-D) Score|Number of Treatment-Emergent Adverse Events|Change in Postnatal Depression as Indicated by Edinburgh Postnatal Depression Scale (EPDS) Scale|Change in Anxiety as Indicated by Generalized Anxiety Disorder 7-Item (GAD-7) Scale|Change in Depression as Indicated by Patient Health Questionnaire (PHQ-9)|Change in Behavioral Suicidal Events (Suicidal Ideation), as Assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS)|Change in Behavioral Suicidal Events (Suicidal Behavior), as Assessed by the Columbia-Suicide Severity Rating Scale (C-SSRS)","The University of Texas Health Science Center, Houston","Female","18 Years to 45 Years   (Adult)","Phase 2","1","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSC-MS-18-0416","March 4, 2019","September 9, 2019","September 9, 2019","July 8, 2019","September 14, 2020","October 19, 2021","The University of Texas Health Science Center at Houston, Houston, Texas, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/92/NCT04011592/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04011592"
48,"NCT03793569","Does Enhancing Maternal Peer Interactions Decrease Rates of Postpartum Depression?",,"Completed","No Results Available","Postpartum Depression","Behavioral: Peer discussion group","Risk of development of postpartum depression|Development of postpartum depression","Milton S. Hershey Medical Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","33","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STUDY00007890","August 27, 2018","July 30, 2019","July 30, 2019","January 4, 2019",,"August 22, 2019","Penn State Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT03793569"
49,"NCT03924492","Expanded Access Protocol of ZULRESSO™ (Brexanolone) Injection for Adult Patients With Postpartum Depression",,"Approved for marketing","No Results Available","Postpartum Depression","Drug: ZULRESSO (brexanolone) injection",,"Sage Therapeutics","Female","18 Years and older   (Adult, Older Adult)",,,"Industry","Expanded Access:Intermediate-size Population",,"547-PPD-401",,,,"April 23, 2019",,"June 28, 2019",,,"https://ClinicalTrials.gov/show/NCT03924492"
50,"NCT05804708","Phase 2 Clinical Trial of GH001 in Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression|Postnatal Depression","Drug: GH001","The anti-depressive effects of GH001 evaluated by the change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) assessed at Day 7","GH Research Ireland Limited","Female","18 Years to 45 Years   (Adult)","Phase 2","15","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","GH001-PPD-203","March 2, 2023","December 2023","December 2023","April 7, 2023",,"November 2, 2023","QPS Netherlands, Groningen, Netherlands|St. Pancras Clinical Research, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05804708"
51,"NCT04129476","Effect of a Cooperative Education Program Based on Precede-Proceed Model During Pregnancy on Postpartum Depression",,"Unknown status","No Results Available","Post Partum Depression","Behavioral: Cooperative Education Program based on Precede-Proceed Model","Postpartum Depression|Predisposing, reinforcing and enabling factors inventory|General health questionnaire (GHQ)","Gonabad University of Medical Sciences","Female","Child, Adult, Older Adult","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","GonabadUMS","November 1, 2019","November 1, 2019","December 1, 2019","October 16, 2019",,"October 16, 2019","Gonabad University of Medical Science, Gonabad, Khorasan Razavi, Iran, Islamic Republic of",,"https://ClinicalTrials.gov/show/NCT04129476"
52,"NCT02191423","Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression",,"Unknown status","No Results Available","Postpartum Depression","Drug: Oxytocin|Drug: placebo|Behavioral: Dyadic psychotherapy","Effect of the administration of oxytocin on cerebral circuit processing|Interactional measures-CIB|Interactional measures-Noldus|Maternal depression symptoms measures- BDI|Maternal depression symptoms measures - EPDS|Maternal anxiety measures-STAI|Physiological measures-Salivary OXT|Maternal thought and action measures","Tel-Aviv Sourasky Medical Center","Female","18 Years to 45 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Diagnostic","TASMC-14-MB-161-CTIL","January 2015","June 2016",,"July 16, 2014",,"July 16, 2014","The Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT02191423"
53,"NCT05209789","Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression","HUGS","Recruiting","No Results Available","Post Partum Depression","Behavioral: HUGS|Behavioral: Playtime","Mother-infant interaction|Mothers' stress","University Hospital, Toulouse","Female","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","104","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","RC31/21/0166","December 18, 2023","December 2026","December 2026","January 27, 2022",,"February 15, 2024","Bordeaux Public Hospital, Bordeaux, France|Havre Public Hospital Maternity, Le Havre, France|Reims Public Hospital Maternity, Reims, France|Rouen Public Hospital Maternity, Rouen, France|Toulouse Child Guidance, Toulouse, France|Toulouse Joseph Ducuing Maternity, Toulouse, France|Toulouse Public Hospital Maternity, Toulouse, France",,"https://ClinicalTrials.gov/show/NCT05209789"
54,"NCT02323152","PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK","PROGEA","Unknown status","No Results Available","Postpartum Depression","Behavioral: psychoeducation|Other: Standard care","Depression Scale|Vulnerable personality|Physical Activity Questionare|Temperament Style","Basque Health Service","Female","18 Years to 60 Years   (Adult)","Not Applicable","135","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","PROGEA","September 2012","September 2016","September 2016","December 23, 2014",,"December 23, 2014",,,"https://ClinicalTrials.gov/show/NCT02323152"
55,"NCT02020148","Can Oxytocin Level Predict Postpartum Depression?",,"Completed","No Results Available","Postpartum Depression",,"Inventory of Depressive Symptomatology, Self-Report (IDS-SR-30)","Northwestern University|Northwestern Memorial Hospital","Female","18 Years and older   (Adult, Older Adult)",,"68","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","00082402","December 2013","June 2015","August 2015","December 24, 2013",,"October 26, 2023","Northwestern Memorial Hospital, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02020148"
56,"NCT01178008","Pilot Study on the Use of Acupuncture for Postpartum Depression",,"Completed","No Results Available","Post-partum Depression","Procedure: Active acupuncture|Procedure: Placebo acupuncture","17-item Hamilton Depression Rating Scale|Hospital Anxiety and Depression Scale (HADS)|Sheehan Disability Scale|Clinical Global Impression Scale|Edinburgh Postnatal Depression Scale","The University of Hong Kong|Kwong Wah Hospital|Hospital Authority, Hong Kong","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","Acup-003","May 2010","December 2011","June 2012","August 9, 2010",,"January 16, 2013","Kwong Wah Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|Tsan Yuk Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT01178008"
57,"NCT06057012","A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)",,"Completed","No Results Available","Severe Postpartum Depression","Drug: BRII-296","Number of Participants With Treatment-emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)|Number of Participants With Adverse Events (AEs) According to Severity|Number of Participants With Change From Baseline in Clinically Significant Vital Sign Parameters|Number of Participants With Abnormal Electrocardiogram (ECG) Parameters|Number of Participants With Change From Baseline in Clinically Significant Clinical Laboratory Evaluations|Number of Participants With Columbia-Suicide Severity Rating Scale (C-SSRS) Responses|Change From Baseline in Glasgow Coma Scale (GCS) Score|Change From Baseline in Stanford Sleepiness Scale (SSS) Score|PK of Brexanolone: Maximum Observed Plasma Concentration (Cmax)|PK of Brexanolone: Time to Reach Cmax (Tmax)|PK of Brexanolone: Area Under the Concentration-time Curve From Time 0 to Last Measurable Concentration (AUC0-last)|PK of Brexanolone: Area Under the Concentration-time Curve From Time 0 to Infinity (AUC0-inf)|PK of Brexanolone: Apparent Terminal Elimination Half-life (t½)|PK of Brexanolone: Apparent Clearance (CL/F)|PK of Brexanolone: Volume of Distribution (Vz/F)|Change From Baseline in Hamilton Depression Rating Scale (HAM-D) Total Score|Number of Participants With HAM-D Response|Number of Participants With HAM-D Remission|Number of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Change From Baseline in Clinical Global Impression - Severity (CGI-S) Response|Change From Baseline in HAM-D Bech-6 Subscale Score|Change From Baseline in HAM-D Individual Item Score|Change From Baseline in Hamilton Anxiety Rating Scale (HAM-A) Total Score","Brii Biosciences Limited","All","18 Years to 45 Years   (Adult)","Phase 2","11","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","BRII-296-002","September 29, 2023","March 13, 2024","March 13, 2024","September 28, 2023",,"March 22, 2024","Cenexel CNR, Sherman Oaks, California, United States|CenExel CNS-Torrance, Torrance, California, United States|Clinical Research Center of Florida, Boynton Beach, Florida, United States|Aventura Clinical Research, LLC, Davie, Florida, United States|South Florida Research Phase I-IV Inc, Miami Springs, Florida, United States|Synexus Clinical Research US, Inc., Atlanta, Georgia, United States|Cenexel ACMR Atlanta Center for Medical Research, Atlanta, Georgia, United States|iResearch Atlanta, LLC, Decatur, Georgia, United States|Research Carolina Elite, Denver, North Carolina, United States|North Texas Clinical Trials, Fort Worth, Texas, United States|Maximos OB/GYN, League City, Texas, United States",,"https://ClinicalTrials.gov/show/NCT06057012"
58,"NCT03665038","A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)",,"Completed","Has Results","Post Partum Depression","Drug: Brexanolone","Number of Participants With Treatment-Emergent Adverse Events (TEAEs)|Area Under the Concentration-Time Curve (AUC) From Time Zero to 60 Hours (AUC0-60)|AUC From Time Zero to Infinity (AUCinf)|Maximum (Peak) Plasma Concentration (Cmax)|Time at Maximum (Peak) Plasma Concentration (Tmax)|Steady-State Drug Concentration in the Plasma During Constant-Rate Infusion (Css)|Average Drug Concentration in Plasma at Steady State During a Dosing Interval (Cavg)|Half-Life of First Elimination Phase of Brexanolone (Thalf)|Clearance of Brexanolone (CL/F)|Steady-State of Volume of Distribution (Vss)","Sage Therapeutics","Female","15 Years to 17 Years   (Child)","Phase 3","28","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","547-PPD-304|2017-004356-34","September 7, 2018","January 8, 2021","January 8, 2021","September 11, 2018","August 11, 2022","August 11, 2022","Sage Investigational Site, Tempe, Arizona, United States|Sage Investigational Site, North Little Rock, Arkansas, United States|Sage Investigational Site, Miramar, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Pensacola, Florida, United States|Sage Investigational Site, Pinellas Park, Florida, United States|Sage Investigational Site, Pompano Beach, Florida, United States|Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Decatur, Georgia, United States|Sage Investigational Site, Edgewood, Kentucky, United States|Sage Investigational Site, Owensboro, Kentucky, United States|Sage Investigational Site, Flowood, Mississippi, United States|Sage Investigational Site, Jackson, Mississippi, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Middleburg Heights, Ohio, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, League City, Texas, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/38/NCT03665038/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/38/NCT03665038/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT03665038"
59,"NCT02682004","Serotonin, Leptin and Adiponectin Level in Patients With Postpartum Depression: Controlled Study",,"Completed","No Results Available","Postpartum Depression","Other: leptin, serotonin and adiponectin level|Other: leptin,serotonin, adiponectin level","Blood level (ng/ml) ELİSA","Zeynep Kamil Maternity and Pediatric Research and Training Hospital","Female","20 Years to 40 Years   (Adult)",,"400","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","51","February 2016","April 2017","May 2017","February 15, 2016",,"March 15, 2022","Zeynep Kamil Maternity and Pediatric Research and Training Hospital, İstanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT02682004"
60,"NCT02978326","A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression",,"Completed","Has Results","Postpartum Depression","Drug: SAGE-217 15/20 mg Oral Solution|Drug: Placebo|Drug: SAGE 217 30 mg Capsules","Parts A and B: Change From Baseline in the 17-Item Hamilton Rating Scale for Depression (HAM-D) Total Score at Day 15|Parts A and B: Change From Baseline in the HAM-D Total Score at Days 3, 8, 21 and 45|Parts A and B: Percentage of Participants With HAM-D Response|Parts A and B: Percentage of Participants With HAM-D Remission|Parts A and B: Change From Baseline in HAM-D Subscales Scores|Parts A and B: Change From Baseline in HAM-D Individual Item Scores|Parts A and B: Change From Baseline in Montgomery and Åsberg Depression Rating Scale (MADRS) Total Score|Parts A and B: Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Parts A and B: Change From Baseline in Hamilton Anxiety Rating Scale (HAM-A) Total Score|Parts A and B: Percentage of Participants With MADRS Response|Parts A and B: Percentage of Participants With MADRS Remission|Parts A and B: Number of Participants With Treatment-Emergent Adverse Events (TEAEs)|Part B: Number of Participants With Potentially Clinically Significant Vital Sign Measurements|Part B: Number of Participants With Potentially Clinically Significant Laboratory Evaluations|Part B: Change From Baseline in Electrocardiogram (ECG) Parameter Heart Rate|Part B: Change From Baseline in ECG Parameters-PR Interval, RR Interval, QRS Duration, QT Interval, QTcF Interval|Part B: Number of Participants With a Response of ""Yes"" to Any Suicidal Ideation or Suicidal Behaviors Item Using the Columbia Suicide Severity Rating Scale (C-SSRS)","Biogen","Female","18 Years to 45 Years   (Adult)","Phase 3","276","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","217-PPD-201","January 4, 2017","November 15, 2018","December 11, 2018","November 30, 2016","December 16, 2021","December 15, 2023","Sage Investigational Site, Little Rock, Arkansas, United States|Sage Investigational Site, Beverly Hills, California, United States|Sage Investigational Site, Oceanside, California, United States|Sage Investigational Site, Wildomar, California, United States|Sage Investigational Site, Washington, District of Columbia, United States|Sage Investigational Site, Aventura, Florida, United States|Sage Investigational Site, Miami, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Pensacola, Florida, United States|Sage Investigational SIte, Pinellas Park, Florida, United States|Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Decatur, Georgia, United States|Sage Investigational Site, Hoffman Estates, Illinois, United States|Sage Investigational Site, Owensboro, Kentucky, United States|Sage Investigational Site, Lake Charles, Louisiana, United States|Sage Investigational Site, New Orleans, Louisiana, United States|Sage Investigational Site, Saint Charles, Missouri, United States|Sage Investigational Site, Las Vegas, Nevada, United States|Sage Investigational Site, Manhasset, New York, United States|Sage Investigational Site, New York, New York, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Raleigh, North Carolina, United States|Sage Investigational Site, Providence, Rhode Island, United States|Sage Investigational Site, Fort Worth, Texas, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, Richardson, Texas, United States|Sage Investigational Site, Orem, Utah, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/26/NCT02978326/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/26/NCT02978326/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02978326"
61,"NCT02862444","A Culturally Appropriate Intervention for Preventing and Reducing Postpartum Depression",,"Unknown status","No Results Available","Postpartum Depression","Other: Culturally Appropriate Intervention","Postpartum depression will be measured by Edinburgh Postnatal Depression Scale (EPDS)","Clalit Health Services|Ben-Gurion University of the Negev","Female","16 Years to 40 Years   (Child, Adult)",,"382","Other","Observational","Time Perspective: Prospective","0004-16-COM2","August 2016","October 2018","October 2018","August 11, 2016",,"August 11, 2016",,,"https://ClinicalTrials.gov/show/NCT02862444"
62,"NCT01386086","Aripiprazole and Resistant Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Drug: aripiprazole","Montgomery Asberg Depression Rating Scale|Udvalg for Kliniske Undersogelser Scale","Lawson Health Research Institute|Bristol-Myers Squibb","Female","18 Years to 45 Years   (Adult)","Phase 3","10","Other|Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CN138-623","June 2011","November 2013","November 2013","June 30, 2011",,"March 17, 2016","Regional Mental Health Care, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT01386086"
63,"NCT01527448","Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II",,"Completed","No Results Available","Postpartum Depression","Drug: Quetiapine XR (seroquel)","The primary efficacy assessment will be total score on the Montgomery-Asberg Depression Rating Scale (MADRS).|To evaluate if Quetiapine XR improves the health relate quality of life of postpartum depression in non-lactating women with Bipolar II Disorder|To evaluate if Quetiapine XR improves satisfaction with medication in postpartum depression in non-lactating women with Bipolar II Disorder.|To evaluate if Quetiapine XR improves sleep quality in postpartum depression in non-lactating women with Bipolar II Disorder.","BC Women's Hospital & Health Centre","Female","19 Years to 40 Years   (Adult)","Not Applicable","26","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","D1443L00032","April 2008","July 2010","July 2010","February 7, 2012",,"February 10, 2012","BC Women's Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01527448"
64,"NCT01762943","Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition",,"Completed","Has Results","Postpartum Depression","Drug: Leuprolide Acetate|Drug: Micronized estradiol|Drug: Progesterone","Blood-oxygen-level-dependent (BOLD) Response During Functional Magnetic Resonance Imaging (fMRI) z Statistic|Change in Inventory of Depression and Anxiety Symptoms (IDAS) Dysphoria Score","University of North Carolina, Chapel Hill|Foundation of Hope, North Carolina|North Carolina Translational and Clinical Sciences Institute|National Institutes of Health (NIH)|National Alliance for Research on Schizophrenia and Depression|National Institute of Mental Health (NIMH)","Female","22 Years to 50 Years   (Adult)","Not Applicable","36","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","12-1758|5R21MH101409","August 2013","October 13, 2016","October 13, 2016","January 8, 2013","October 17, 2017","November 20, 2017","University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01762943"
65,"NCT02057627","Mother-Infant Intervention for Postpartum Depression and Associated Mother-Infant Relationship Dysfunction",,"Completed","No Results Available","Postpartum Depression","Behavioral: Perinatal Dyadic Psychotherapy|Behavioral: Placebo Comparator","Change from baseline on maternal depression diagnosis immediately following the 3 month intervention and at 3 months post-intervention as measured by the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)|Change from baseline in maternal depressive symptom scores immediately following the 3 month intervention and at 3 months post-intervention as measured by the Edinburgh Postnatal Depression Scale|Mother-infant interaction (videotaped and coded) immediately following the 3 month intervention and at 3 months post-intervention|Change from baseline in maternal anxiety diagnosis immediately following the 3 month intervention and at 3 months post-intervention per Structured Clinical Interview for DSM-IV Axis I Disorders (SCID)|Maternal parenting stress immediately following the 3 month intervention and at 3 months post-intervention as measured by the Parenting Stress Index - Short Form (PSI-SF)|Change from baseline in maternal anxiety symptom level immediately following the 3 month intervention and at 3 months post-intervention as measured by the State-Trait Anxiety Inventory - State (STAI-State)","Spaulding Rehabilitation Hospital|Robert Wood Johnson Foundation","Female","Child, Adult, Older Adult","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","1R21HD065156-01","June 2010","July 2012","July 2012","February 7, 2014",,"April 20, 2016","MGH Insiitute of Health Professions, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02057627"
66,"NCT01883479","Effect of Exercise and Wellness Interventions on Preventing Postpartum Depression","HM2","Completed","No Results Available","Postpartum Depression","Behavioral: Exercise|Behavioral: Wellness/Support","Depression|Depressive Symptoms","University of Minnesota|National Institute of Mental Health (NIMH)","Female","21 Years to 45 Years   (Adult)","Not Applicable","450","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R01MH096748","December 2012","May 1, 2017","May 1, 2017","June 21, 2013",,"June 29, 2017","University of Minnesota, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT01883479"
67,"NCT00604604","Postpartum Depression Prevention Trial",,"Completed","No Results Available","Postpartum Depression","Behavioral: Peer support","Structured Clinical Interview for DSM-IV (SCID-I); Edinburgh Postnatal Depression Scale (EPDS)|State Anxiety Inventory (STAI); UCLA Loneliness Scale; Maternal Health Service Utilization and Cost of Care Questionnaire; Peer Support Evaluation Inventory; Peer Volunteer Experience Questionnaire; Peer Volunteer Activity Log","University of Toronto|Canadian Institutes of Health Research (CIHR)","Female","Child, Adult, Older Adult","Not Applicable","702","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","MCT-66874|ISRCTN68337727","August 2004","April 2007","April 2007","January 30, 2008",,"June 3, 2015","Peel Health Department, Mississauga, Ontario, Canada|Halton Region Health Department, Oakville, Ontario, Canada|Ottawa Public Health, Ottawa, Ontario, Canada|York Region Health Services, Richmond Hill, Ontario, Canada|Sudbury & District Health Unit, Sudbury, Ontario, Canada|Toronto Public Health, Toronto, Ontario, Canada|Windsor Essex County Health Unit, Windsor, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT00604604"
68,"NCT01028482","Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline",,"Completed","No Results Available","Postpartum Depression","Drug: Sertraline|Drug: placebo|Other: psychotherapy","depression","Tel-Aviv Sourasky Medical Center","Female","18 Years to 45 Years   (Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","TASMC-09-MB-301-CTIL","March 2008","November 2010","January 2011","December 9, 2009",,"May 10, 2011","Tel Aviv Sourasky Medical Center, Tel Aviv, Israel",,"https://ClinicalTrials.gov/show/NCT01028482"
69,"NCT01328613","A Prospective Study of Postpartum Depression in Women With Major Depression",,"Terminated","No Results Available","Postpartum Depression",,,"National Institute on Aging (NIA)|National Institutes of Health Clinical Center (CC)","Female","18 Years and older   (Adult, Older Adult)",,"85","NIH","Observational","Time Perspective: Other","999908320|08-AG-N320","November 9, 2007",,"September 29, 2014","April 4, 2011",,"December 4, 2019","National Institute of Aging, Clinical Research Unit, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01328613"
70,"NCT01648816","Interaction Between Genetic Factors and Maternal Stressors During Pregnancy in the Risk of Postpartum Depression","IGEDEPP","Completed","No Results Available","Postpartum Depression",,"Depressed subjects at week 8 after delivery (EPDS and DSM I-V criteria for depression)","Assistance Publique - Hôpitaux de Paris","Female","18 Years to 60 Years   (Adult)",,"3338","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","AOM 10056|2010-A01315-35","November 2, 2011","September 4, 2016","July 20, 2017","July 24, 2012",,"September 8, 2023","Louis Mourier Hospital, Colombes, France",,"https://ClinicalTrials.gov/show/NCT01648816"
71,"NCT00961402","The Effect of Exercise on Preventing PostPartum Depression",,"Completed","Has Results","PostPartum Depression","Behavioral: Wellness Control|Behavioral: Exercise Intervention","Structured Clinical Interview for DSM-IV Axis I Disorders|7-Day Physical Activity Recall Interview|Edinburgh Postnatal Depression Scale|PHQ-9","University of Minnesota|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Phase 2","130","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","0903S61462|R21MH085176","September 2009","November 2011","November 2011","August 19, 2009","July 29, 2016","November 18, 2019","University of Minnesota, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT00961402"
72,"NCT00942721","Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Behavioral: Web-based CBT for PPD","Acceptability and feasibility of the Web-based treatment program for women with postpartum depression|Clinical utility of the program in ameliorating postpartum depression symptoms|Women's characteristics that moderate the impact of the program","Oregon Research Institute|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Phase 1","53","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH084931|1R01MH084931-01A1|DSIR 83-ATP","October 2009","April 2013","April 2013","July 21, 2009",,"November 25, 2013","University of Iowa, Iowa City, Iowa, United States|Oregon Research Institute, Eugene, Oregon, United States|University of Melbourne, Heidelberg Heights, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT00942721"
73,"NCT06305325","Coparenting Intervention to Prevent Postpartum Depression",,"Completed","No Results Available","Postpartum Depression|Anxiety","Behavioral: eHealth Antenatal Coparenting Intervention","feasibility-recruitment rate, adherence, and follow-up rate|Acceptability- Participants satisfaction|Depressive Symptoms|anxiety|Coparenting Relationship|Relationship Satisfaction- couple relationship satisfaction to discriminate between distressed and non-distressed relationship.|Postpartum Childcare Stress|Infant Development|partner support","Brock University|University of Toronto","All","18 Years and older   (Adult, Older Adult)","Not Applicable","106","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","35957","September 23, 2018","November 22, 2019","February 22, 2020","March 12, 2024",,"March 12, 2024","Aga Khan University, Karachi, SinDH, Pakistan",,"https://ClinicalTrials.gov/show/NCT06305325"
74,"NCT00548743","Translating Research Into Practice for Postpartum Depression","TRIPPD","Unknown status","No Results Available","Postpartum Depression","Behavioral: Screening and follow up|Behavioral: Usual care","Level of depressive symptoms and level of parenting comfort|Percent eligible women screened and of those screen positive, percent treated and followed according to protocol","Olmsted Medical Center","Female","18 Years to 45 Years   (Adult)","Not Applicable","3000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Screening","5R01HS014744-02","September 2005",,"August 2010","October 24, 2007",,"December 4, 2007","Olmsted Medical Center, Rochester, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT00548743"
75,"NCT02614547","A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression",,"Completed","Has Results","Severe Postpartum Depression","Drug: SAGE-547|Drug: Placebo","Change From Baseline at End of Treatment Period (at 60 Hours) in Hamilton Rating Scale for Depression (HAM-D) Total Score|Percentage of Participants With HAM-D Response|Percentage of Participants With HAM-D Remission|Change From Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Total Score|Percentage of Participants With Clinical Global Impression-Improvement (CGI-I) Response|Change From Baseline in HAM-D Bech 6 Subscale|Change From Baseline to 60 Hours in the HAM-D Individual Item Scores|Change From Baseline in Generalized Anxiety Disorder 7-item Scale (GAD-7) Total Score|Number of Participants With Treatment-Emergent Adverse Events (TEAEs)","Sage Therapeutics","Female","18 Years to 45 Years   (Adult)","Phase 2","21","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","547-PPD-202 A","December 15, 2015","June 22, 2016","June 22, 2016","November 25, 2015","September 13, 2021","January 27, 2022","Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Worcester, Massachusetts, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02614547"
76,"NCT05038085","Postpartum Depression and Maternal Attachment",,"Unknown status","No Results Available","Postpartum Depression|Progressive Muscle Relaxation","Behavioral: progressive muscle relaxation exercise","The Edinburgh Postpartum Depression Scale (EPDS), Prenatal Attachment Scale (PAS)|The EPDS, The Postpartum Attachment Scale (PPAS)","Gazi University","Female","18 Years to 35 Years   (Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","2021 - 175","October 25, 2021","April 8, 2022","June 2022","September 8, 2021",,"April 14, 2022","Gazi University, Ankara, Çankaya, Turkey",,"https://ClinicalTrials.gov/show/NCT05038085"
77,"NCT06136520","The Effect of Baby Massage Training Given to Pregnant Women on Maternal Attachment and Postpartum Depression",,"Recruiting","No Results Available","Baby Massage|Postpartum Depression","Behavioral: Baby massage","the Maternal Attachment Scale (mother-baby bonding scale)|The Edinburgh Postpartum Depression Scale","Istanbul University - Cerrahpasa (IUC)","Female","18 Years to 35 Years   (Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","2023/132","October 26, 2023","June 1, 2024","July 30, 2024","November 18, 2023",,"November 18, 2023","Betül Uncu, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT06136520"
78,"NCT00298311","Effect of Home-Based Peer Support on Maternal-Infant Interaction and Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Behavioral: mci guidance peer support","maternal-infant interaction|cognitive development|social development|salivary cortisol|depressive symptomatology|social support","Canadian Research Institute for Social Policy|Women's Health Research Unit|Social Support Research Program|University Health Network, Toronto|Edmonton Mental Health Services|Canadian Mental Health Association|Pediatric Rehabilitation Services|Department of Health and Wellness, NB","Female","Child, Adult, Older Adult","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Health Services Research","PPD MOD","November 2005","February 2009","July 2010","March 2, 2006",,"August 7, 2017",,,"https://ClinicalTrials.gov/show/NCT00298311"
79,"NCT05693792","A Six-Month Prospective Follow-Up Study of WB001",,"Withdrawn","No Results Available","Postpartum Depression","Other: Observational","Hamilton Rating Scale for Depression (HAM-D)|Patient Health Questionnaire (PHQ-9)|Edinburgh Postpartum Depression Scale (EPDS)|Generalized Anxiety Disorder Questionnaire (GAD-7)|Mother-to-Infant Bonding Scale (MIBS)|Patient Global Impression scale (PGI)|Columbia-Suicide Severity Rating Scale (C-SSRS)","Woebot Health","Female","22 Years to 45 Years   (Adult)",,"0","Industry","Observational","Observational Model: Cohort|Time Perspective: Prospective","WB001-002","February 1, 2023","June 8, 2024","June 8, 2024","January 23, 2023",,"May 6, 2023",,,"https://ClinicalTrials.gov/show/NCT05693792"
80,"NCT04278456","Postpartum Depression",,"Unknown status","No Results Available","Postpartum Depression|Melatonin","Behavioral: postpartum depression","edinburgh depression scale","Erzincan University","Female","18 Years to 45 Years   (Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","EBYU 88","March 21, 2020","May 21, 2020","July 21, 2020","February 20, 2020",,"February 20, 2020","Erzincan Byu, Erzincan, Turkey",,"https://ClinicalTrials.gov/show/NCT04278456"
81,"NCT05753176","Online 1-Day CBT-Based Workshops for Preventing Postpartum Depression",,"Recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety","Behavioral: Online 1-Day Cognitive Behavioural Therapy-Based Workshop","EPDS score as a continuous outcome (Total EPDS) and an EPDS score of 13 or more at 2-months postpartum (T3) will serve as co-primary outcomes.|Maternal Anxiety (Generalized Anxiety Disorder 7-Item Scale (GAD-7))|Maternal Social Support (MSPSS)|Maternal Perceived Stress (Perceived Stress Scale (PSS))|Problems with the Mother-Infant Relationship (Postpartum Bonding Questionnaire (PBQ))|Infant Temperament (Infant Behaviour Questionnaire-Revised (IBQ-R))","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","408","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","RCT1-day CBT to prevent PPD","November 10, 2022","March 10, 2025","March 10, 2025","March 3, 2023",,"December 18, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05753176"
82,"NCT00560027","Case Management Study for Postpartum Depression and Intimate Partner Violence",,"Completed","No Results Available","Postpartum Depression|Intimate Partner Violence","Other: Case Management by Family Support Counselor (not RCT)","Positive screens for PPD and/or IPV|Healthcare utilization over 2 years (acute care, emergency and well visits)","Johns Hopkins University|Leonard & Helen R. Stulman Charitable Foundation","Female","Child, Adult, Older Adult","Not Applicable","173","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Screening","20064046","July 2010","June 2013","June 2013","November 19, 2007",,"May 28, 2015","Harriet Lane Clinic, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00560027"
83,"NCT05044455","Online Peer-Delivered Group CBT for PPD",,"Active, not recruiting","No Results Available","Postpartum Depression","Behavioral: Cognitive Behavioural Therapy (CBT)","Edinburgh Postnatal Depression Scale (EPDS)|MINI International Neuropsychiatric Interview|GAD-7|Multidimensional Scale of Perceived Social Support (MSPSS)|The Postpartum Bonding Questionnaire (PBQ)|Infant Behavior Questionnaire-Revised Very Short Form (IBQ-R)|EQ-5D-5L|Healthcare Resource Utilization Questionnaire","McMaster University|Canadian Institutes of Health Research (CIHR)","Female","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","167","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","OnlinePeerCBT","March 28, 2022","January 2024","October 2024","September 14, 2021",,"April 6, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05044455"
84,"NCT02355067","Social Media Intervention for Postpartum Depression",,"Completed","Has Results","Postpartum Depression|Parenting","Behavioral: Social Media Intervention|Behavioral: Traditional In-Person Intervention","Attendance|Acceptability|Beck Depression Inventory (BDI-II)|Parenting Sense of Competency (PSOC) Scale","Children's Hospital of Philadelphia|The Oscar G. & Elsa S. Mayer Family Foundation|University of Pennsylvania","Female","15 Years and older   (Child, Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","14-011491","January 2015","November 3, 2017","November 3, 2017","February 4, 2015","October 2, 2019","March 9, 2021","The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/67/NCT02355067/ICF_000.pdf|""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/67/NCT02355067/Prot_SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02355067"
85,"NCT01912833","Study of Exposure to Stress, Postpartum Mood, Adverse Life Events, and Hormonal Function Among Latinas (SEPAH Latina)","SEPAH","Completed","No Results Available","Postpartum Depression",,"Postpartum depression","University of North Carolina, Chapel Hill","Female","18 Years to 45 Years   (Adult)",,"34","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","13-0788","August 2013","September 2014","September 2014","July 31, 2013",,"December 8, 2014","University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01912833"
86,"NCT03596879","Insomnia and Rumination in Late Pregnancy and the Risk for Postpartum Depression","PPD","Completed","No Results Available","Insomnia|Post Partum Depression","Behavioral: dCBTI|Behavioral: Sleep Education","Improvement in Sleep - Insomnia Severity Index|Prevention of Postpartum Depression Symptoms - Edinburg Postnatal Depression Scale (EPDS)","Henry Ford Health System","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","91","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","12204","July 18, 2018","July 31, 2019","July 31, 2019","July 24, 2018",,"December 5, 2019","Henry Ford Medical Center, Novi, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03596879"
87,"NCT05595512","Postpartum Depression",,"Completed","No Results Available","Development of Depression Postpartum","Behavioral: Naser Al-Husban","Postpartum depression symptoms","University of Jordan","Female","18 Years to 49 Years   (Adult)",,"73","Other","Observational","Observational Model: Other|Time Perspective: Retrospective","JUH obstetrics","January 30, 2014","March 30, 2021","April 30, 2021","October 27, 2022",,"October 27, 2022",,,"https://ClinicalTrials.gov/show/NCT05595512"
88,"NCT05186272","mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression",,"Enrolling by invitation","No Results Available","Post Partum Depression|Perinatal Depression","Behavioral: Stress reduction program 'A'|Behavioral: Stress reduction program 'B'","Patient Health Questionnaire-9|Perceived Stress Scale|Generalized Anxiety Disorder 7-item scale|Promis Sleep Disturbance - Short Form 6a","Kaiser Permanente","Female","18 Years to 99 Years   (Adult, Older Adult)","Phase 3","600","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","1693692","June 14, 2022","March 1, 2025","March 1, 2025","January 11, 2022",,"April 26, 2023","Kaiser Permanente Northern California, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT05186272"
89,"NCT04860661","Esketamine on Postpartum Depression in Cesarean Section Women","EKET","Recruiting","No Results Available","Esketamine|Postpartum Depression","Drug: Esketamine|Drug: Normal saline","Edinburgh Postnatal Depression Scale(EPDS） scores|Visual Analogue Scale/Score (VAS) score|total number of PCA compressions|total volume of PCA","Ailin Luo|The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School|Central South University|The First Affiliated Hospital of Anhui Medical University|The First Affiliated Hospital of University of South China|Guangdong Women and Children Hospital|Third Affiliated Hospital of Zhengzhou University|First Affiliated Hospital of Guangxi Medical University|Dalian Municipal Central Hospital|Jining First People's Hospital|Maternal and Child Health Hospital of Hubei Province|Tongji Hospital","Female","18 Years to 40 Years   (Adult)","Not Applicable","1248","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","EKET","May 1, 2021","December 31, 2023","December 31, 2023","April 27, 2021",,"July 5, 2023","Tongji Hospital, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT04860661"
90,"NCT03638687","Neuroimaging Epigenetics of Prospective Postpartum Depression Biomarkers",,"Completed","No Results Available","Post Partum Depression|Bipolar Disorder",,"Epigenetic Analysis|Brain Imaging","Johns Hopkins University|National Institute of Mental Health (NIMH)","Female","18 Years to 65 Years   (Adult, Older Adult)",,"80","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB00038271|R01MH104262","May 2014","October 2019","August 2020","August 20, 2018",,"September 22, 2020","Johns Hopkins East Baltimore Medical Campus, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT03638687"
91,"NCT04073043","Telephone Coaching Intervention for Postpartum Depression and Anxiety",,"Completed","No Results Available","Postpartum Depression|Anxiety","Behavioral: Telephone Coaching","Edinburgh Postnatal Depression Scale (EPDS)|Generalized Anxiety Disorder-7 (GAD-7)|Questions on usability & acceptability|Barkin Index of Maternal Functioning (BIMF)|Parental Stress Questionnaire (PARSS)|Client Satisfaction Questionnaire (CSQ-8)|Questionnaire on Use of services for mental health problems|Acceptability of Coaching Questionnaire|Coach logs and records|Coach exit interview","McGill University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","52","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","SMHC-18-25","August 12, 2019","April 26, 2021","April 26, 2021","August 28, 2019",,"April 6, 2022","St. Mary's Hospital Centre, Montreal, Quebec, Canada","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/43/NCT04073043/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04073043"
92,"NCT06348316","Early Half Swaddling and Kangaroo Care Practices on Maternal Sleep Quality and Postpartum Depression in Term Babies",,"Recruiting","No Results Available","Mothers|Postpartum Depression","Other: Half swaddle|Other: Kangaroo care","Mother sleep quality evaluated using the Pittsburgh Sleep Quality Index (PSQI)|Postpartum depression evaluated using the Edinburgh Postnatal Depression Scale (EPDS)","Trakya University","Female","18 Years to 49 Years   (Adult)","Not Applicable","136","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Other","TÜTF-GOBAEK 2023/45","September 30, 2023","April 2, 2024","July 30, 2024","April 4, 2024",,"April 4, 2024","Trakya University, Edirne, Turkey",,"https://ClinicalTrials.gov/show/NCT06348316"
93,"NCT05225025","A Pilot Trial of the Reach Out, Stay Strong, Essentials for Mothers of Newborns (ROSE) Postpartum Depression Prevention Intervention in Pregnant Patients Admitted to Strong Hospital",,"Completed","No Results Available","Postpartum Depression|Postpartum Anxiety","Behavioral: ROSE|Other: Standard of Care","Subject-reported in-hospital distress|Subject-reported depressive symptom severity|Subject-reported anxiety symptom severity|Clinical diagnosis of depression","University of Rochester|Mae Stone Goode Foundation","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","45","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","STUDY00005941","July 5, 2021","May 2, 2022","May 2, 2022","February 4, 2022",,"June 13, 2022","Strong Hospital, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT05225025"
94,"NCT04414696","Postpartum Wellness","POW","Completed","No Results Available","Postpartum Depression","Behavioral: Exercise intervention","Depression symptoms|Physical Activity|Depressive symptoms","Kaiser Permanente","Female","18 Years to 45 Years   (Adult)","Not Applicable","134","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","1548855","November 19, 2020","December 13, 2022","May 1, 2023","June 4, 2020",,"November 7, 2023","Division of Research, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT04414696"
95,"NCT06221280","Effects of Nerve Blocks on Pain After Caesarean Section and Postpartum Depression",,"Enrolling by invitation","No Results Available","Postoperative Pain|Cesarean Section|Postpartum Depression","Procedure: Nerve block","Pain (VAS score)|Postpartum depression (Edinnburg Depression Scale)","Kahramanmaras Sutcu Imam University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2023/10-02","November 1, 2023","May 1, 2024","July 1, 2024","January 24, 2024",,"January 24, 2024","KahramanmarasSIU, Kahramanmaraş, Turkey",,"https://ClinicalTrials.gov/show/NCT06221280"
96,"NCT03654261","1-Day CBT Workshops for PPD",,"Completed","No Results Available","Postpartum Depression","Behavioral: Cognitive Behavioural Therapy","Edinburgh Postnatal Depression Scale (EPDS)|Beck Depression Inventory-II|Generalized Anxiety Disorder-7 (GAD-7)|Postpartum Bonding Questionnaire|Client Satisfaction Questionnaire|Healthcare Utilization|Infant Behaviour Questionnaire-Revised (Very short form)|Strengths and Difficulties Questionnaire|Early Childhood Behaviour Questionnaire (very short form)|EQ-5D","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","461","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","1Day-CBT","January 1, 2018","August 17, 2020","October 1, 2020","August 31, 2018",,"May 25, 2022","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03654261"
97,"NCT03709004","Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression",,"Withdrawn","No Results Available","Breastfeeding|Postpartum Depression","Other: Pacifier","Infant Feeding - Breastfeeding Status|Infant Feeding - Breastfeeding Duration|Pacifier Use","University of California, Davis|Benedictine University|Yale University","All","12 Hours to 45 Years   (Child, Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","1132743","September 25, 2019","September 25, 2019","September 25, 2019","October 17, 2018",,"September 27, 2019","University of California Medical Center, Sacramento, California, United States",,"https://ClinicalTrials.gov/show/NCT03709004"
98,"NCT03285139","Peer Administered CBT for PPD","PL-CBT","Completed","No Results Available","Postpartum Depression","Behavioral: Cognitive Behavioural Therapy","Edinburgh Postnatal Depression Scale|Postpartum Bonding Questionnaire|Social Provisions Scale|CCHS Maternal Healthcare Utilization|Adult Adolescent Parenting Inventory|Cognitive Therapy Awareness Scale|Therapist Evaluation Checklist|EQ-5D|Generalized Anxiety Disorder-7|Mini International Neuropsychiatric Interview - Current Major Depressive Disorder","McMaster University|Kids Can Fly Brantford","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","73","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","PL CBT","January 3, 2018","February 28, 2020","February 28, 2020","September 15, 2017",,"March 23, 2022","Kids Can Fly, Brantford, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03285139"
99,"NCT06131255","DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study"")",,"Not yet recruiting","No Results Available","Post-partum Depression","Drug: Citalopram","Evaluate the citalopram effect on white matter morphology|Evaluate the citalopram effect on gray matter morphology|To evaluate the efficacy of citalopram on the clinical symptomatology of the PPD patients through the use of clinical scales","Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","Female","18 Years to 40 Years   (Adult)",,"15","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","DRACULA 1","January 1, 2024","December 1, 2025","April 30, 2026","November 14, 2023",,"November 14, 2023","Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, MI, Italy",,"https://ClinicalTrials.gov/show/NCT06131255"
100,"NCT00277108","Lexapro in the Treatment of Patients With Postpartum Depression",,"Completed","No Results Available","Postpartum Depression","Drug: Escitalopram (Lexapro)","The primary outcome measure will be remission of major depression, defined as a score of 12 or less on the Montgomery-Asberg Depression Scale.|A score of 7 or less on the Hamilton Depression Scale (21 item) will be used as a secondary measure of remission.","University of Rochester|Forest Laboratories","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","20","Other|Industry","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","LXP-MD80","February 2004","April 2007","April 2007","January 13, 2006",,"November 6, 2008","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT00277108"
101,"NCT05046405","Home-based Transcranial Direct Current Stimulation in Postpartum Depression: the Feasibility Study and Pilot Study","4MUMs","Not yet recruiting","No Results Available","Postnatal Depression","Device: Transcranial Direct Current Stimulation","Feasibility of the intervention - Number of completed tDCS applications|Change from Baseline on the feasibility of the intervention according to patients.|Change across treatment and follow-up time points on the feasibility of the intervention - Compliance with symptom monitoring|Change across treatment and follow-up time points on the feasibility of the assessment procedures - Compliance with outcomes assessment visits|Change from baseline depressive symptoms.|Change from Baseline on the feasibility of the intervention according to Health Providers|Feasibility of the intervention - tDCS Adverse Effects|Feasibility of the intervention -Health Technology Users' Satisfaction Survey|Change from Baseline on the feasibility of the assessment procedures - Acceptability of outcomes assessment visits by women|Change from Baseline on the feasibility of the assessment procedures - Acceptability of outcomes assessment visits (newborn-infants)|Estimate of recruitment|Estimate of retention|Estimate of dropouts|Change from Baseline in Clinical Status according to depressive symptoms.|Change from Baseline in Clinical Status according to anxiety symptoms|Change from Baseline in Clinical Status according to difficulties in emotion regulation.|Change from Baseline in Clinical Status according to Sleep quality|Change from Baseline in Clinical Status according to Ruminative Thinking|Infant and Toddler Development|Change from Baseline in bonding quality in mother-baby dyad.|Change from Baseline in parental stress.|Quality of Life according to the EuroQol five dimensions, five level questionnaire - EQ-5D-5L|Mother epigenetic biomarkers (collected during at-home visits)|Mother genetic biomarkers (collected during at-home visits)|Quantification of neuroinflammatory biomarkers of mothers (collected during at-home visits)|Baby epigenetic biomarkers (collected during at-home visits)|Quantification of neuroinflamatory biomarkers of babies (collected during at-home visits)|Baby genetic biomarkers (collected during at-home visits)","Ana Ganho Ávila|Centro Hospitalar e Universitário de Coimbra, E.P.E.|University of Coimbra","Female","18 Years to 45 Years   (Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","2020.02059.CEECIND|PTDC/PSI-GER/3110/2021","October 2, 2022","January 31, 2024","September 30, 2026","September 16, 2021",,"September 16, 2021",,,"https://ClinicalTrials.gov/show/NCT05046405"
102,"NCT00816725","Effectiveness of a Web-based Prevention Program for Postpartum Depression",,"Completed","No Results Available","Depression|Postpartum Depression","Behavioral: Mothers and babies Internet course and PPD informational brochure","Edinburgh Postnatal Depression Scale (EPDS)|Center for Epidemiologic Studies-Depression (CES-D) Scale","University of California, San Francisco|National Institute of Mental Health (NIMH)","Female","18 Years to 60 Years   (Adult)","Not Applicable","1000","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","F32MH077371|5A|DATR AK-TAIF","January 2009","June 2013","June 2013","January 5, 2009",,"April 11, 2014","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT00816725"
103,"NCT04913584","Peer Administered Online CBT for PPD","PL-OCBT","Completed","No Results Available","Postpartum Depression","Behavioral: Cognitive Behavioural Therapy","Edinburgh Postnatal Depression Scale|Postpartum Bonding Questionnaire|Social Provisions Scale|Canadian Community Health Survey Maternal Healthcare Utilization|Adult Adolescent Parenting Inventory|EuroQol-5D|Generalized Anxiety Disorder-7|Mini International Neuropsychiatric Interview - Current Major Depressive Disorder|Parenting Stress Index (Short-Form)|Infant Behavior Questionnaire-Revised|Ages and Stages Questionnaire","McMaster University|Kids Can Fly","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","183","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","PL OCBT","August 25, 2020","February 22, 2022","February 22, 2022","June 4, 2021",,"April 19, 2022","Kids Can Fly, Brantford, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04913584"
104,"NCT04437342","Postpartum Depression in the Covid-19 Pandemic and the Impact of Anaesthesia",,"Completed","No Results Available","Postpartum Depression|Psychological Stress|Maternal Distress","Other: PHQ-9 (Patient Health Questionnaire) Depression Scale|Other: GAD-7 (General Anxiety Disorder) scale|Other: 38 questions questionnaire|Other: EPDS (Edinburgh Postnatal Depression Scale)","Correlation between the Covid-19 pandemic and postpartum depression with EPDS scale (Edinburgh postnatal depression scale)|Correlation between the Covid-19 pandemic, postpartum depression and type of anaesthesia (general, epidural, spinal, combined, epidural analgesia for vaginal delivery)|Correlation between the Covid-19 pandemic, postpartum depression and postpartum pain","General and Maternity Hospital of Athens Elena Venizelou|National and Kapodistrian University of Athens|Alexandra Hospital, Athens, Greece|University of Ioannina|Larissa University Hospital","Female","18 Years and older   (Adult, Older Adult)",,"330","Other","Observational","Observational Model: Other|Time Perspective: Prospective","Covid-19 Postpartum depression","June 30, 2020","August 30, 2020","October 27, 2020","June 18, 2020",,"January 6, 2021","""Elena Venizelou"" General and Maternity Hospital of Athens, Athens, Attica, Greece|Aretaieio University Hospital, Athens, Attica, Greece|Alexandra Genaral Hospital Athens, Athens, Greece|University of Ioannina Health Science, Ioannina, Greece|University of Ioannina, Medical School, Ioannina, Greece|University of Thessaly Medical School, Larisa, Greece",,"https://ClinicalTrials.gov/show/NCT04437342"
105,"NCT02726659","Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression",,"Terminated","No Results Available","Bipolar Disorder|Postpartum Depression","Drug: Celecoxib|Drug: Placebo","Hamilton Rating Scale for Depression (HAM-D)|Montgomery Asberg Depression Scale|Udvalg for Kliniske Undersogelser Scale|Edinburgh Postnatal Depression Scale (EPDS)|Clinical Global Impression Scale (CGI)","Lawson Health Research Institute","Female","18 Years to 45 Years   (Adult)","Phase 3","1","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment","107775","May 2016","January 16, 2019","January 16, 2019","April 4, 2016",,"January 20, 2022","Parkwood Institute, Mental Health Care Buildling, London, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02726659"
106,"NCT02272387","Is Vitamin D Insufficiency and Deficiency Associated With Antepartum and Postpartum Depression?",,"Terminated","No Results Available","Depression|Postpartum Depression","Dietary Supplement: Vitamin D3 (Cholecalciferol)|Other: Placebo","Antepartum and Postpartum Depressive symptoms|Maternal morbidities|Fetal morbidities","St. Luke's-Roosevelt Hospital Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","151","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","13-0223","October 2014","April 14, 2016","April 14, 2016","October 22, 2014",,"August 24, 2017","Mount Sinai Roosevelt Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02272387"
107,"NCT01935375","Multidisciplinary Model of Nurse Midwife",,"Completed","No Results Available","Postpartum Depression","Behavioral: CNM Interpersonal Psychotherapy|Behavioral: Treatment as Usual","Hamilton Rating Scale for depression|Global Assessment of functioning|Dyadic Adjustment Scale|Social Support Questionnaire|Client Satisfaction Questionnaire|Edinburgh Postnatal Depression Scale","Drexel University","Female","16 Years to 45 Years   (Child, Adult)","Not Applicable","61","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","18981","July 2010","June 2014","June 2014","September 5, 2013",,"August 7, 2015","Drexel University, Phila, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT01935375"
108,"NCT05700760","The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention","ROSES-II","Recruiting","No Results Available","Postpartum Depression","Behavioral: ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns)|Behavioral: Enhanced Care as Usual (CAU)","SCID-5 Major Depressive Episode|SF-12","Michigan State University|Pacific Institute for Research and Evaluation|Henry Ford Health System|Butler Hospital","Female","18 Years and older   (Adult, Older Adult)","Phase 3","2320","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R01MH130948|STUDY00007607","June 5, 2023","December 31, 2027","December 31, 2027","January 26, 2023",,"August 1, 2023","Michigan State University, Flint, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT05700760"
109,"NCT04769700","Post-partum Depression, Breastfeeding Adherence and Fear in COVID-19",,"Completed","No Results Available","Breast Feeding, Exclusive|Post Partum Depression|Covid19","Behavioral: Edinburgh Postnatal Depression Scale|Behavioral: Breast Feeding Adherence|Behavioral: Fear of Covid-19 Scale","Post-Partum Depression Frequency|Breast Feeding Adherence and behavior.|Fear of Covid-19 severity","Instituto Mexicano del Seguro Social","Female","18 Years and older   (Adult, Older Adult)",,"250","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","Lactancia1","January 1, 2021","June 1, 2021","June 1, 2021","February 24, 2021",,"October 2, 2023","Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico",,"https://ClinicalTrials.gov/show/NCT04769700"
110,"NCT04427410","The Relationship Between Oxytocin Level and Postpartum Depression",,"Completed","No Results Available","Oxytocin Deficiency|Postpartum Depression|Prenatal Stress","Diagnostic Test: Salivary test","Oxytocin levels","Cukurova University|Ayseren Cevik","Female","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","TYL-2019-12476","July 20, 2019","October 20, 2019","February 20, 2020","June 11, 2020",,"June 11, 2020","Cukurova University, Adana, Saricam, Turkey",,"https://ClinicalTrials.gov/show/NCT04427410"
111,"NCT05518162","Treatment of Post-partum Depression Using an Behavioral Intervention Called ROSE (Reach Out, Stay Strong, Essentials for Mothers of Newborns) Delivered Using an Electronic App",,"Recruiting","No Results Available","Post-partum Depression","Device: InBloom|Behavioral: ROSE","proportion of participants with post-partum depression assessed using the Mini International Neuropsychiatric Interview (MINI)|mean depression severity measured using Patient Health Questionnaire (PHQ-9)|Return on Investment (ROI)","University of Rochester|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","152","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","RSRB00007456|R44MH112216","July 17, 2023","July 1, 2025","July 1, 2025","August 26, 2022",,"September 28, 2023","University of Rochester Medical Center, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT05518162"
112,"NCT04576754","Pivotal Test: WB001",,"Completed","No Results Available","Postpartum Depression","Device: WB001|Device: Educational","Hamilton Depression Rating Scale for Depression (HAMD)|Clinical Characteristic Questions|The Edinburgh Postnatal Depression Scale (EPDS)|The Patient Health Questionnaire (PHQ-8)|Generalized Anxiety Disorder 2-item scale (GAD-2)|The Mother-to-Infant Bonding Scale (MIB)|Patient-Reported Outcomes Measurement Information System (PROMIS)|The Mental Health Self-Efficacy Scale (MHSES)|The Client Satisfaction Questionnaire (CSQ-8)","Woebot Health","Female","18 Years to 45 Years   (Adult)","Not Applicable","83","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","Woebot Labs Inc. - 0030","November 12, 2020","June 14, 2021","August 20, 2021","October 6, 2020",,"November 14, 2022","Woebot Labs Inc, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT04576754"
113,"NCT03927378","Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression",,"Completed","No Results Available","Prenatal Depression|Ketamine|Postpartum Depression","Drug: S-ketamine|Drug: Placebo","The incidence of depression at 42 days after childbirth.|Maternal depression score at 7 days postpartum.|Maternal depression score at 42 days postpartum.|Maternal depression severity at 42 days postpartum.|Intensity of pain at 1, 7, and 42 days postpartum.|Maternal breast feeding at 1, 7, and 42 days postpartum.|Length of hospital stay after giving birth.|Incidence of maternal complications within 42 days postpartum.|Incidence of neonatal diseases within 42 days.","Peking University First Hospital|Peking University International Hospital|Hunan Provincial Maternal and Child Health Care Hospital|Women's Hospital of Nanjing Medical University|Women's Hospital School Of Medicine Zhejiang University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","364","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2018[224]","June 19, 2020","August 3, 2022","August 3, 2022","April 25, 2019",,"April 4, 2023","Peking University First Hospital, Beijing, Beijing, China|Beijing Tiantan Hospital, Beijing, Beijing, China|Peking University International Hospital, Beijing, Beijing, China|Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China|Huaian Maternal and Child Health Care Hospital, Huaian, Jiangsu, China|Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China|Women's Hospital School Of Medicine Zhejiang University, Hanzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT03927378"
114,"NCT02813174","Personality Style and Self Compassion in Postpartum Depression: An Online Prevention Study",,"Completed","No Results Available","Postpartum Depression","Behavioral: Compassionate Mind Training from Compassion-Focused Therapy","Edinburgh Postnatal Depression Scale|Vulnerable Personality Style Questionnaire|Self Compassion Scale|Mini-markers|Postpartum Depression Predictors Inventory - Revised","i4Health","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","228","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","16-018-H","June 2016","May 9, 2017","May 9, 2017","June 24, 2016",,"August 21, 2017","Palo Alto University, Palo Alto, California, United States",,"https://ClinicalTrials.gov/show/NCT02813174"
115,"NCT06273423","Feasibility Evaluation of a Dance Fitness Program",,"Not yet recruiting","No Results Available","Postpartum Depression","Other: OULA, Mind-body Physical Activity","Feasibility and acceptability|Changes in postpartum depression|Changes in postpartum anxiety","Montana State University","Female","20 Years to 39 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","OULA for Postpartum Depression","October 2024","May 2025","June 2025","February 22, 2024",,"February 22, 2024",,,"https://ClinicalTrials.gov/show/NCT06273423"
116,"NCT04227704","Ketamine to Prevent PPD After Cesarean","PoCKet","Completed","Has Results","Postpartum Depression","Drug: Ketamine 50 MG/ML|Drug: Control","The Prevalence of Postpartum Depression in the Study Population, as Defined as EPDS Greater Than 10 Out of 30|Percentage of Eligible Patients Consenting to Participation|Percentage of Patients With a Complete Dataset|Number of Patients in Study Arms Experiencing One or More Severe Side Effects|Dose of Opiate Analgesics Administered|Dose of Ketorolac Administered (mg)|Prevalence of Intraoperative Hypotension|Maximum Intraoperative Pain (NRS)|Adverse Effects|Plasma Concentrations of Ketamine|Total Opiate Consumption in Morphine Equivalents|Surgical Site Pain: Numerical Rating Scale (NRS 0-10)|Edinburgh Postpartum Depression Scale (EPDS)|Apgar Scores|Admission to NICU|The Number of Participants Achieving Breastfeeding Success|Prevalence of Intraoperative Hypertension|Prevalence of Intraoperative Bradycardia|Prevalence of Intraoperative Tachycardia|Postpartum Anxiety","Washington University School of Medicine","Female","18 Years to 45 Years   (Adult)","Phase 3","25","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","201910191","November 12, 2020","August 9, 2021","August 9, 2021","January 14, 2020","January 26, 2023","January 26, 2023","Washington University in St. Louis, Saint Louis, Missouri, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/04/NCT04227704/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/04/NCT04227704/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04227704"
117,"NCT04485000","Online 1-Day CBT-Based Workshops for PPD",,"Completed","No Results Available","Postpartum Depression","Behavioral: Online 1-Day Cognitive Behavioural Therapy (CBT)-Based Workshop","Edinburgh Postnatal Depression Scale (EPDS)|Cost-effectiveness: Costs of service|Cost-effectiveness: Quality-Adjusted Life Year (QALY)","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","403","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","ONLINE1DAYCBT","April 20, 2020","January 30, 2021","January 30, 2021","July 24, 2020",,"February 16, 2021","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04485000"
118,"NCT05622305","Public Health Nurse-Delivered 1-Day CBT Workshops for PPD",,"Recruiting","No Results Available","Postpartum Depression","Behavioral: 1-Day Cognitive Behavioural Therapy-Based Workshop","Edinburgh Postnatal Depression Scale (EPDS)|Generalized Anxiety Disorder 7-Item Scale|Multidimensional Scale of Perceived Social Support (MSPSS)|Parenting Stress Index (PSI-SF)|Postpartum Bonding Questionnaire (PBQ|Infant Behavior Questionnaire-Revised Very Short Form (IBQ-R)|EQ-5D-5L|Healthcare Resource Utilization Questionnaire|Mini International Neuropsychiatric Interview - Major Depressive Disorder Module|Mini International Neuropsychiatric Interview - Generalized Anxiety Disorder Module","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","447","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PHN1DayCBT","October 11, 2022","December 31, 2024","December 31, 2024","November 18, 2022",,"March 13, 2024","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05622305"
119,"NCT04928742","Online PHN CBT for PPD",,"Completed","No Results Available","Postpartum Depression","Behavioral: Group Cognitive Behavioural Therapy (CBT)","Maternal Depressive Symptoms|Anxiety|Mother-Infant Bonding|Social Support|Relationship with Partner|Infant Temperament|Cost Effectiveness - costs|Cost Effectiveness - QALY|Maternal Major Depressive Disorder","McMaster University","Female","18 Years to 99 Years   (Adult, Older Adult)","Not Applicable","159","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","OnlinePHNCBT","March 30, 2020","March 2, 2022","March 2, 2022","June 16, 2021",,"July 25, 2022","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04928742"
120,"NCT03791021","Early Diagnosis of PPD Through Self-portraits","ppd","Completed","No Results Available","Postpartum Depression","Diagnostic Test: draw a person (DAP)|Diagnostic Test: Edinburgh Postnatal Depression Scale (EPDS)|Diagnostic Test: Beck Depression Inventory- II (BDI-II)|Diagnostic Test: Traumatic Events Questionnaire (TEQ)","development of a reliable projective tool for prediction of PPD","Sheba Medical Center|University of Haifa","Female","18 Years to 40 Years   (Adult)",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","5651-18-SMC","January 1, 2019","June 1, 2020","June 1, 2020","January 2, 2019",,"June 9, 2020","Aya Mohr Sasson, Ramat -Gan, Please Select, Israel",,"https://ClinicalTrials.gov/show/NCT03791021"
121,"NCT05040581","1 Day Workshops for Preventing PPD: A Pilot Study",,"Completed","No Results Available","Postpartum Depression","Behavioral: 1-Day CBT-Based Workshop for Preventing PPD","Acceptability of developed treatment manual|Feasibility of recruiting 15 mothers into a pilot workshop|Feasibility of recruiting 60 participants into pilot RCT in 6 months|Proportion of eligible participants who enroll in study|Proportion of participants in experimental arm who complete intervention|Proportion of participants who complete all outcome measures|Estimate of treatment effect and variance of primary outcome for later RCT - Major Depressive Disorder|Estimate of treatment effect and variance of primary outcome for later RCT - Depressive Symptoms","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","37","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1DayPrev","June 1, 2022","December 31, 2022","December 31, 2022","September 10, 2021",,"March 2, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05040581"
122,"NCT04934488","Online Peer-Delivered 1-Day CBT Workshops for PPD",,"Completed","No Results Available","Postpartum Depression","Behavioral: Online Peer-Delivered 1-Day CBT-Based Workshop","Depression|Cost-Effectiveness - Costs|Cost-Effectiveness - Quality Adjusted Life Year|Anxiety|Mother-Infant Bonding|Social Support|Partner Relationship Quality|Parenting stress|Infant Temperament|Client Satisfaction","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","404","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","Peer1DayCBT","June 7, 2021","February 18, 2022","February 18, 2022","June 22, 2021",,"February 27, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04934488"
123,"NCT05314361","Public Health Nurse-Delivered 1-Day CBT Workshops Pilot",,"Completed","No Results Available","Postpartum Depression","Behavioral: 1-Day Cognitive Behavioural Therapy-Based Workshop","Number of participants recruited in recruitment period|Number of participants who complete all data collection procedures|Number of participants who complete study (retention)|Number of participants who complete the intervention (adherence)|Estimate Treatment effect - Edinburgh Postnatal Depression Scale (EPDS)","McMaster University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","119","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","PHN1DayCBTPilot","March 18, 2022","April 1, 2023","April 1, 2023","April 6, 2022",,"August 25, 2023","McMaster University, Hamilton, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05314361"
124,"NCT04940585","ROSE in Sunset Park",,"Active, not recruiting","No Results Available","Post Partum Depression","Other: ROSE Program","Acceptability of the ROSE intervention|Change in level of postpartum depression|Change in the level of self-efficacy|Change in perceived social support|Change in perception of stress","NYU Langone Health","Female","18 Years to 100 Years   (Adult, Older Adult)","Not Applicable","51","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","19-01961","March 4, 2021","February 28, 2024","February 28, 2024","June 25, 2021",,"November 9, 2023","NYU Langone Health, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04940585"
125,"NCT00795652","Mom: Managing Our Mood, Part of The Family Help Program","MOM","Completed","No Results Available","Postpartum Depression","Behavioral: Distance Treatment for postpartum depression","Diagnosis with SCID (Semi-structured diagnostic interview)|Edinburgh Postnatal Depression Scale|Sheehan Disability Scale|Satisfaction measure, designed by the investigator|Beck Depression Inventory-II","IWK Health Centre|Canadian Institutes of Health Research (CIHR)","Female","19 Years and older   (Adult, Older Adult)","Phase 2","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","3556","May 2006","February 2010","February 2010","November 21, 2008",,"September 2, 2016","IWK Health Centre, Halifax, Nova Scotia, Canada",,"https://ClinicalTrials.gov/show/NCT00795652"
126,"NCT02738021","Managing PPD at Gouverneur",,"Withdrawn","No Results Available","Post-Partum Depression","Behavioral: STRONG","Patient Health Questionnaire-9 (PHQ-9)|Maternal Depression Management Inventory","NYU Langone Health","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","15-00416","March 1, 2016","October 2017","October 2017","April 14, 2016",,"December 6, 2017",,,"https://ClinicalTrials.gov/show/NCT02738021"
127,"NCT01967394","Social Media, Teen Moms and PPD",,"Completed","No Results Available","Postpartum Depression","Other: Use of internet based social marketing intervention|Other: No use of social media","Effectiveness of Social Marketing Intervention|Number of teens seeking depression treatment","University of Louisville|National Institute of Nursing Research (NINR)","Female","13 Years to 21 Years   (Child, Adult)","Not Applicable","287","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Outcomes Assessor)","1R15NR013563-01A1|R15NR013563","June 2013","December 2015","December 2015","October 22, 2013",,"December 29, 2015","Three Rivers, Carrollton, Kentucky, United States|Hands Program of Kenton County (Young Families of Children, Inc), Covington, Kentucky, United States|Lincoln Trail Health Department, Elizabethtown, Kentucky, United States|St. Joseph Hospital, Lexington, Kentucky, United States|University of Louisville Hospital, Louisville, Kentucky, United States|Hands Program of Boone and Campbell Counties (Every Child Succeeds), Newport, Kentucky, United States|Three Rivers Health Department, Owensboro, Kentucky, United States|Lake Cumberland Health Department, Somerset, Kentucky, United States",,"https://ClinicalTrials.gov/show/NCT01967394"
128,"NCT03499756","Couple-based Interpersonal Psychotherapy on Postnatal Depression and Family Sense of Coherence",,"Completed","No Results Available","Postnatal Depression","Behavioral: Couple-based interpersonal psychotherapy","Edinburgh Postnatal Depression Scale|Family Sense of Coherence Scale (Short Form)|Dyadic Adjustment Scale","The Hong Kong Polytechnic University","All","18 Years to 60 Years   (Adult)","Not Applicable","455","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","PolyU 156082/17H","May 30, 2019","December 31, 2022","December 31, 2022","April 17, 2018",,"May 10, 2023","Queen Elizabeth Hospital, Kowloon, Hong Kong",,"https://ClinicalTrials.gov/show/NCT03499756"
129,"NCT00617045","Duloxetine for the Treatment of Postpartum Depression","DuloxPPD","Withdrawn","No Results Available","Postpartum Depression|Major Depressive Disorder","Drug: duloxetine","Change in depression severity compared to baseline scores on the IDS-C between the two subject groups.","Yale University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HIC0609001827-Lilly-Duloxetine|F1J-US-X043","July 2007","December 2012","May 2013","February 15, 2008",,"June 17, 2016","Perinatal & Postpartum Research Program 142 Temple ST Suite 301, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT00617045"
130,"NCT03346551","Postnatal Depression, Attachment and Self-defining Memories","PNDattachMEMO","Unknown status","No Results Available","Postnatal Depression","Behavioral: Evaluation of the quality attachment : ""Adult Attachment Narratives"" and ""CaMir scale""|Behavioral: Evaluation of the self-defining memories : ""Specific Questionnaire during an interview""","Quality attachment|First Self-defining memory|Second Self-defining memory|Third Self-defining memory","CHU de Reims","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","PA17012","October 13, 2017","November 13, 2019","December 13, 2019","November 17, 2017",,"November 13, 2018","Damien JOLLY, Reims, France",,"https://ClinicalTrials.gov/show/NCT03346551"
131,"NCT05891717","Comparative Effect of Training on Postpartum Depression",,"Completed","No Results Available","Postnatal Depression|Self Efficacy","Other: Resistance training|Other: Flexibility training","Exercise self efficacy|Epidemiological studies Depression scale|MAPP-QOL ( Maternal Postpartum Quality Life Questionnaire)","Riphah International University","Female","20 Years to 40 Years   (Adult)","Not Applicable","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","REC/RCR & AHS/23/0509","November 20, 2022","July 13, 2023","August 1, 2023","June 7, 2023",,"December 27, 2023","Jinnah Hospital, Lahore, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05891717"
132,"NCT04347499","Culturally Adapted CBT Based Guided Self-Help in Patients With Postnatal Depression",,"Completed","No Results Available","Postnatal Depression","Other: CaCBT based guided self help using Khushi aur Khatoon Manual","Edinburgh Postnatal Depression Scale (EPDS)|Bradford Somatic Inventory (BSI)|World Health Organisation Disability Assessment Schedule (WHODAS 2.0)","Peshawar Medical College|Pakistan Association of Cognitive Therapists","Female","18 Years to 45 Years   (Adult)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","CBT PND KHI","August 5, 2019","February 2, 2020","November 1, 2020","April 15, 2020",,"November 8, 2022","Zainab Panjwani Hospital, Karachi, Pakistan",,"https://ClinicalTrials.gov/show/NCT04347499"
133,"NCT01507649","Effect of a Telephone-based Intervention on Postnatal Depression",,"Completed","No Results Available","Postnatal Depression","Behavioral: telephone-based cognitive-behavioral intervention","Change in depressive symptoms|Change in quality of life","The University of Hong Kong","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","397","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","09101031","July 2012","December 2014","December 2014","January 11, 2012",,"December 2, 2015","The University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT01507649"
134,"NCT04442529","Mothers and Babies Qatar (MB-Q): A Postpartum Depression Intervention","MB","Unknown status","No Results Available","Postpartum Depression|Anxiety|Diabetes","Behavioral: Mothers and Babies (MB)","Depressive symptoms|Anxiety symptoms|Perceived stress|Behavioral Activation|Mood Regulation|Social Support|Decentering Thoughts|Diabetes self-management|Religious Coping- major life stressors|Mothers and Babies Skill Utilization","Sidra Medicine|Northwestern University","Female","18 Years to 50 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2019-0004","May 1, 2021","October 31, 2021","October 31, 2022","June 22, 2020",,"April 21, 2021",,,"https://ClinicalTrials.gov/show/NCT04442529"
135,"NCT01002027","Three Model Care Pathways for Postnatal Depression",,"Completed","No Results Available","Postnatal Depression","Behavioral: CBT-Counselling","Clinical Depression Score","University of Melbourne|Beyondblue (The National Depression Initiative)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","68","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","H2005/01895","November 2004","February 2007","February 2007","October 27, 2009",,"October 27, 2009","Austin Health, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT01002027"
136,"NCT06285916","A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression","NuMom","Not yet recruiting","No Results Available","Depression, Postpartum|Postpartum Depression|Post-partum Depression|Postnatal Depression|Post-Natal Depression","Drug: NORA520 Dose 1|Drug: NORA520 Dose 2|Drug: Placebo","Incidence, severity, and causality of AEs, SAEs, and AESIs|Change from baseline in HAM-D17 total score compared to placebo|Change from baseline in HAM-D17 total score|HAM-D17 response|HAM-D17 remission|Change from baseline in HAM-D17 subscale and individual item scores|Change from baseline in Clinical Global Impression - Severity (CGI-S) score|Clinical Global Impression - Improvement (CGI-I) scale positive response|Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) total score|Change from baseline in Hamilton Anxiety Rating Scale (HAM-A) total score|Change from baseline in Edinburgh Postnatal Depression Scale (EPDS) total score|Number of patients who start any new antidepressant or anti-anxiety medication","Gerbera Therapeutics, Inc.","Female","18 Years to 45 Years   (Adult)","Phase 2","90","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","NORA520-PT-US-1a","February 2024","February 2026","March 2026","February 29, 2024",,"February 29, 2024","Gerbera site, Canoga Park, California, United States|Gerbera sites, Miami Gardens, Florida, United States|Gerbera site, Orlando, Florida, United States|Gerbera site, Saint Petersburg, Florida, United States|Gerbera site, League City, Texas, United States|Gerbera site, Richardson, Texas, United States",,"https://ClinicalTrials.gov/show/NCT06285916"
137,"NCT00518830","Treatment of Postnatal Depression for Low-Income Mothers in Primary Care in Santiago, Chile","DPP","Completed","No Results Available","Postnatal Depression","Other: multi-component intervention|Other: Usual care","EPDS|four dimensions of the Short Form-36 (SF-36) Questionnaire: mental health; emotional role; social functioning; and vitality(34) and significant clinical improvement.","Fondo Nacional de Desarrollo Científico y Tecnológico, Chile","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","230","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","1040434","March 2004",,"July 2006","August 21, 2007",,"August 21, 2007",,,"https://ClinicalTrials.gov/show/NCT00518830"
138,"NCT04487171","Screening for Postpartum Depression and Associated Risk Factors Among Women Who Deliver in Four Hospital in France During the COVID-19 Epidemic","COVIE-19/20","Recruiting","No Results Available","Postpartum Depression|Covid19|Prevalence|Social Distance","Other: Questionnaire","Variation of prevalence of clinically-significant post-partum depressive symptoms","Centre Hospitalier Universitaire, Amiens|Centre Hospitalier de Beauvais|Central Hospital Saint Quentin|Centre Hospitalier Compiègne","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","248","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Other","PI2020_843_0049","July 21, 2020","July 2023","August 2023","July 27, 2020",,"March 22, 2023","CHU Amiens, Amiens, France",,"https://ClinicalTrials.gov/show/NCT04487171"
139,"NCT04745494","Studies of Mothers With Postnatal Depression",,"Completed","No Results Available","Postnatal Depression","Other: OT administration|Other: Placebo administration","Change in maternal mood|Change in maternal mindmindedness|Change in mother-infant interactional style|Change in maternal OT|Change in infant OT|Maternal gaze during interaction with her infant","University College, London","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","16/0679","May 12, 2017","March 15, 2020","January 30, 2021","February 9, 2021",,"February 9, 2021","University College London, London, UK, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04745494"
140,"NCT05148260","Tackling Postnatal Depression: Culturally Adapted Learning Through Play Plus (LTP+) Intervention for British Mothers of African and Caribbean Origin",,"Not yet recruiting","No Results Available","Postnatal Depression","Behavioral: Learning Through Play plus (LTP+)|Behavioral: Psychoeducation","Change in postnatal depression is being assessed|Change in postnatal anxiety is being assessed|Change in social support is being assessed|Change in health-related quality of life is being assessed|Change in service satisfaction is being assessed|Change in child physio-emotional development is being assessed|Change in parenting knowledge of child development is being assessed","Nottingham Trent University","Female","18 Years to 60 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","0000-0001-5034-0335b","September 1, 2023","August 30, 2026","August 30, 2026","December 8, 2021",,"November 18, 2022",,,"https://ClinicalTrials.gov/show/NCT05148260"
141,"NCT04834622","Community Singing Interventions for Postnatal Depression: a Hybrid Type II Effectiveness-implementation Trial","SHAPER-PND","Recruiting","No Results Available","Postnatal Depression","Behavioral: Melodies for Mums|Behavioral: Control Community Sessions","To assess the effectiveness of group singing interventions on symptoms of postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS)|To assess the acceptability of the intervention using the Acceptability of Intervention Measure (AIM)|To assess whether singing improves (changes) further aspects of mental health, including depression using the Hamilton Depression Rating Scale (HDRS).|To assess whether singing improves (changes) further aspects of mental health, including depression using the Beck Depression Inventory (BDI).|To assess whether singing improves (changes) further aspects of mental health, including stress using the Perceived Stress Scale (PSS)|To assess whether singing improves (changes) further aspects of mental health, including wellbeing using the Office for National Statistics Wellbeing Scale (ONS):|To assess whether singing improves (changes) further aspects of mental health, including anxiety, using the State-Trait Anxiety Scale (STAI)|To ascertain whether singing improves the observed mother-infant interaction using the Crittenden CARE-Index (CCI)|To ascertain whether singing improves the perceived mother-infant relationship using the Maternal Postpartum Attachment Scale (MPAS)|To ascertain whether singing improves the perceived mother-infant relationship using the Parent Reflective Functioning Questionnaire (PRFQ)|To ascertain whether singing improves social support and reduces loneliness using the UCLA Loneliness Scale|To ascertain whether singing improves social support and reduces loneliness using the Multidimensional Scale of Perceived Social Support (MSPSS)|To identify whether there are biological mechanisms underpinning the psychological outcomes assessed using changes in measurements in stress hormones, including hair cortisol, diurnal cortisol and salivary cytokines|To identify whether there are biological mechanisms underpinning the psychological outcomes assessed using changes in measurements in salivary oxytocin|To identify how the singing sessions affect the lived experience of mothers with PND using focus groups|To explore the phenomenology of PND and how singing intersects with PND among women with particular risk factors for PND (traumatic birth, adverse childhood experiences, and social isolation/loneliness) using semi-structured interviews|To assess the acceptability of the intervention using the Intervention Measure (AIM)|To assess reasons for perceived acceptability of the intervention using semi-structured interviews|To assess uptake/reach of the intervention using recruitment rate records|To assess the appropriateness of the intervention using Intervention Appropriateness Measure (IAM)|To assess the appropriateness of the intervention using semi-structured interviews|To assess the feasibility of the intervention using the Feasibility of Intervention Measure (FIM)|To assess the feasibility of the intervention using semi-structured interviews|To assess intervention adherence and attrition rates using attendance data (rates and drop out reasons)|To assess the adoption of the intervention using participants and stakeholder enrollment rates|To assess the cost effectiveness of the intervention using the 5-level EQ-5D version (EQ5D-5L)|To assess the cost effectiveness of the intervention using the Adult Service Use Schedule (AD-SUS)|To assess the cost effectiveness of the intervention using implementation activity logs (to estimate implementation costs).|To assess factors affecting the sustainability and scalability of the intervention using the NOMAD Scale:|To assess factors affecting the sustainability and scalability of the intervention using semi-structured interviews","King's College London|University College, London","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","219425/Z/19/Z-PND|278445","September 1, 2021","December 2023","December 2023","April 8, 2021",,"March 8, 2023","Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Rd, Brixton, London SE5 9RT, London, United Kingdom","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/22/NCT04834622/Prot_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/22/NCT04834622/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04834622"
142,"NCT03336541","Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression",,"Completed","No Results Available","Perinatal Depression|Ketamine|Cesarean Delivery|Postpartum Depression","Drug: Ketamine|Drug: Placebo","The score of postpartum depression at 48 hous after childbirth.|Time of first breast feeding.|The proportion of neonates with breast feeding.|Duration of neonatal sleep within 24 hours after delivery.|Length of stay in hospital after delivery.|The score of postpartum depression at 42 days after delivery.|Incidence of postpartum depression at 42 days after delivery.|Incidence of maternal complications with 42 days after delivery.|Incidence of neonatal complications with 42 days after delivery.","Peking University First Hospital","Female","18 Years to 45 Years   (Adult)","Phase 4","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2017[36]","November 23, 2017","May 14, 2018","June 25, 2018","November 8, 2017",,"December 13, 2021","Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital, Beijing, Beijing, China",,"https://ClinicalTrials.gov/show/NCT03336541"
143,"NCT03196726","Behavioural Interventions for Postnatal Depression: a RCT Study",,"Completed","No Results Available","Postnatal Depression","Behavioral: Brief Cognitive Behavioral Therapy|Behavioral: standard management based on Clinical Practice Guideline","changes in depression level","Ministry of Health, Malaysia","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","NMRR-15-2404-26677","March 2, 2017","October 30, 2018","December 31, 2018","June 23, 2017",,"April 1, 2019","Klinik Kesihatan Seksyen 7,, Shah Alam, Selangor, Malaysia|Klinik Kesihatan Kuala Lumpur, Kuala Lumpur, W.P. Kuala Lumpur, Malaysia|Klinik Kesihatan Sg Besi, Kuala Lumpur, WP Kuala Lumpur, Malaysia|Klinik Kesihatan Presint 11, Putrajaya, WP Putrajaya, Malaysia|Klinik Kesihatan Presint 9, Putrajaya, WP Putrajaya, Malaysia|Klinik Kesihatan Presint 18, Putrajaya, WP Putraya, Malaysia",,"https://ClinicalTrials.gov/show/NCT03196726"
144,"NCT03763435","The Effects of Pregnancy Classes and Contributing Factors to Postpartum Depression",,"Unknown status","No Results Available","Postpartum Depression|Sleep Disorder|Breast Feeding|Self Esteem","Behavioral: Antenatal pregnancy classes","Postpartum Depression|Genital self-image|sleep disorders|breast-feeding|socio-economic-demographical features","Bartin State Hospital","Female","Child, Adult, Older Adult",,"400","Other","Observational","Observational Model: Case-Control|Time Perspective: Cross-Sectional","Bartin2018-3","December 7, 2018","June 15, 2019","July 15, 2019","December 4, 2018",,"April 23, 2019","Bartin State Hospital, Bartin, Turkey",,"https://ClinicalTrials.gov/show/NCT03763435"
145,"NCT04644081","LTP+CaCBT for Treating Postnatal Depression and Improving Child Wellbeing in Jos Nigeria","LTP+CaCBT","Unknown status","No Results Available","Postnatal Depression","Behavioral: LTP|Behavioral: CaCBT|Drug: TAU","Change in postnatal depression is being assessed|Change in postnatal anxiety is being assessed|Change in health is being assessed|Change in social support is being assessed|Change in health-related quality of life is being assessed|Change in service satisfaction is being assessed|Change in child physio-emotional development is being assessed|Change in parenting knowledge of child development is being assessed","Nottingham Trent University|University of Manchester|Teesside University|Sheffield Hallam University|University of Jos","Female","18 Years to 60 Years   (Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","0000-0001-5034-0335","September 1, 2021","August 31, 2022","December 30, 2022","November 25, 2020",,"March 25, 2021",,,"https://ClinicalTrials.gov/show/NCT04644081"
146,"NCT06237569","Dose Low Dose Ketamine in Casesarian",,"Not yet recruiting","No Results Available","Postoperative Pain|Postpartum Depression","Drug: Application of ketamine and midazolam or ketamine alone to patients undergoing cesarean section under spinal anesthesia","postpartum depression|intraoperative complications|postoperative pain","Inonu University","Female","18 Years to 45 Years   (Adult)",,"150","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","inonu Caesarean","June 1, 2024","August 1, 2024","September 1, 2024","February 1, 2024",,"February 1, 2024","Inonu universitesi, Malatya, Turkey",,"https://ClinicalTrials.gov/show/NCT06237569"
147,"NCT06208852","Virtual Patient Navigation During a Pandemic",,"Recruiting","No Results Available","Post-partum Depression","Other: Virtual Navigator Program","Intervention: Changes in mental health engagement|Qualitative: Barriers and facilitators to virtual and in-person mental health services|Intervention: Changes in depressive symptoms|Intervention: Changes in mental health service use|Intervention: Changes in perceived social support|Intervention: Satisfaction with the virtual patient navigator","Children's Hospital of Philadelphia|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","40","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Screening","19-016174-B|R61MH118405|19-016174","June 29, 2023","November 18, 2025","November 18, 2025","January 17, 2024",,"January 17, 2024","Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT06208852"
148,"NCT01423331","An Evaluation and Factor Analysis for Maternal Mental Health",,"Unknown status","No Results Available","Postpartum Depression",,,"Shin Kong Wu Ho-Su Memorial Hospital|Department of Health, Executive Yuan, R.O.C. (Taiwan)","Female","20 Years and older   (Adult, Older Adult)",,"200","Other","Observational",,"20110409R","August 2011","December 2012","December 2012","August 25, 2011",,"August 25, 2011",,,"https://ClinicalTrials.gov/show/NCT01423331"
149,"NCT00059228","Clinical Trial of Estrogen for Postpartum Depression",,"Terminated","Has Results","Postpartum Depression|Depression","Drug: 17beta Estradiol|Drug: Placebos","Beck Depression Inventory","National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)","Female","20 Years to 45 Years   (Adult)","Phase 2","12","NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","030161|03-M-0161","April 17, 2003","November 15, 2016","November 15, 2016","April 22, 2003","June 13, 2018","June 13, 2018","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00059228"
150,"NCT00056901","Screening Evaluation for Women With Postpartum Depression",,"Terminated","No Results Available","Postpartum Depression|Depression",,,"National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)","Female","20 Years to 45 Years   (Adult)",,"68","NIH","Observational",,"030138|03-M-0138","March 25, 2003",,"December 24, 2017","March 26, 2003",,"February 14, 2018","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00056901"
151,"NCT03777046","Maternal Mental Health in the Hospital Setting","MMH","Completed","No Results Available","Post Partum Depression","Behavioral: Standard of Care (SOC)|Behavioral: SOC with Psychology Therapy (CBT)","Difference in PPD score","Michelle Lopez|Baylor College of Medicine","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","545","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H44040","January 24, 2019","March 13, 2020","May 22, 2020","December 17, 2018",,"February 14, 2023","Texas Children's Hospital - Women's Pavilion, Houston, Texas, United States|Texas Children's Hospital, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT03777046"
152,"NCT02133963","Determining Relationships Among Maternity Stress & Sleep","DREAMSS","Completed","No Results Available","Postpartum Depression|Depression",,"Feasibility of the study protocol during the prenatal phase. Feasibility will be defined by the successful completion of enrollment and stress testing lab visits in 13 out of the 15 participants designed per group.|Feasibility with respect to the ability to retain participants / avoid attrition, which will be defined as having at least 90% of participants who completed the prenatal phase of the study, also complete one of the postpartum phone interviews.|The investigators will test for group differences, between women with or without depression histories, in stress reactivity of cortisol [calculated using area under the curve (AUC)] to a mild psychosocial stressor paradigm.|The investigators will test for group differences, between women with or without depression histories, in stress reactivity of adrenocorticotropic hormone ACTH [calculated using area under the curve (AUC)] to a mild psychosocial stressor paradigm.|The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal depressive symptoms using the Endinburgh Postnatal Depression Scale (EPDS).|The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal anxious symptoms using the Spielberger State-Trait Anxiety Inventory (STAI), trait version.|The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in recent stressful life events (last 6 months) using the Life Events Scale (LES).|The investigators will use a two-group t-test, or a Mann-Whitney-Wilcoxon test for non-normal distributions, to test for group differences in prenatal sleep quality (past 30 days) using the Pittsburgh Sleep Quality Index (PSQI).","University of North Carolina, Chapel Hill|North Carolina Translational and Clinical Sciences Institute","Female","18 Years to 45 Years   (Adult)",,"17","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","13-3229","May 2014","May 2015","May 2015","May 8, 2014",,"May 19, 2015","UNC Chapel Hill, Chapel Hill, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT02133963"
153,"NCT06048263","The Perinatal Synergistic Multi-component Intervention to alLeviate dEpressive Symptoms. A Case Series","SMILES","Not yet recruiting","No Results Available","Postpartum Depression","Behavioral: interpersonal psychotherapy (IPT)|Drug: Ketamine","Depressive symptoms|P30 (TMS-evoked potential)|N45 (TMS-evoked potential)|P60 (TMS-evoked potential)|N100 (TMS-evoked potential)|Cortical evoked activity (CEA)|Anxiety|Psychosocial stress|Post-Traumatic Stress Disorder (PTSD)|Obstetric Quality of Recovery|Number of participants who successfully breastfeed their newborn baby|Adverse effects - sedation|Adverse effects - Blurred vision|Adverse effects - diplopia|Adverse effects - dizziness|Adverse effects - euphoria|Adverse effects - amnesia|Adverse effects - hallucinations|Adverse effects - nystamus|Antidepressant treatment","Washington University School of Medicine","Female","Child, Adult, Older Adult","Phase 2|Phase 3","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","202306156","May 1, 2024","April 1, 2025","April 1, 2025","September 21, 2023",,"March 27, 2024","Barnes-Jewish Hospital, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT06048263"
154,"NCT01407783","Systems of Care for New Moms: Integrating Depression Treatment","NUMOMS","Completed","No Results Available","Post-partum Depression","Behavioral: Problem Solving Tools (PST)","PHQ-9|BDI-II|Qualitative Interview","Washington University School of Medicine|Nurses for Newborns Foundation","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","29","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","5R34MH083085-02","August 2008","May 2013","May 2013","August 2, 2011",,"May 11, 2018","Washington University and Nurses for Newborns Foundations, Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT01407783"
155,"NCT04617132","Online MBI for Families Affected by PPDA",,"Active, not recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety","Behavioral: MBCT/MBSR","Feasibility|Acceptance & Satisfaction|Relationship & Interactions|PHQ-9|GAD-7","British Columbia Children's Hospital","All","19 Years and older   (Adult, Older Adult)",,"40","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","H20-01884","October 20, 2020","September 2023","September 2023","November 5, 2020",,"February 14, 2023","Reproductive Mental Health Program, BC Children's Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT04617132"
156,"NCT06042972","Risk of Maternal Depression From 1 Year to 4 Years Postpartum in Yvelines","DeTaPoP","Recruiting","No Results Available","Post Partum Depression","Other: Questionnaire including Edinburgh postnatal depression scale, Patient Health Questionnaire 2 and background variables","Edinburgh Postnatal Depression Scale and Patient Health Questionnaire 2","Centre Médical Porte Verte","Female","18 Years to 65 Years   (Adult, Older Adult)",,"800","Other","Observational","Observational Model: Other|Time Perspective: Prospective","2023-A01411-44","September 30, 2023","October 30, 2024","October 30, 2024","September 21, 2023",,"March 19, 2024","Hôpital de la Porte Verte, Versailles, Île-de-France, France",,"https://ClinicalTrials.gov/show/NCT06042972"
157,"NCT04685148","Maternal Mental Health Trial","MAMA","Recruiting","No Results Available","Major Depressive Disorder|Postpartum Depression","Drug: Transdermal patch estradiol|Drug: Transdermal patch placebo","Number of participants with Major Depression Disorder|EPDS Depressive symptoms|HamD6 Depressive symptoms|Maternal mental wellbeing|Maternal anxiety|Parental stress|Parental reflective capacity|Parental competences|Proportion of women who exclusively breastfeed their infants|Predictive value of composite gene transcription and DNA methylation marker for estrogen sensitivity|Maternal sleep quality|Maternal attachment to unborn child|Cold cognitive function|Hot cognitive function|Socio-emotional infant development|Infant development (Bayley-III)|Cortisol dynamics Cortisol dynamics|Cortisol evening Cortisol dynamics|Hair cortisol level Cortisol dynamics|Epigenetic markers relevant for infant HPA axis|Estradiol level|Change in estradiol level|Progesterone level|Change in progesterone level|Allopregnanolone level|Change in allopregnanolone level|Negative bias in responses to infant vocalisations and video","Vibe G Frøkjær, MD, PhD|Herlev Hospital|Hvidovre University Hospital|Rigshospitalet, Denmark","Female","18 Years to 45 Years   (Adult)","Phase 1|Phase 2","220","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2020-001592-33","February 3, 2021","December 31, 2026","December 31, 2030","December 28, 2020",,"September 23, 2021","Neurobiology Researc hUnit, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT04685148"
158,"NCT04135612","The Impact of a Daily Smartphone-based Communication Among Postpartum Women on Breastfeeding Rates",,"Completed","No Results Available","Breast Feeding, Exclusive|Post Partum Depression","Other: Smartphone based communication","breastfeeding rates","Wolfson Medical Center","Female","18 Years to 50 Years   (Adult)","Not Applicable","224","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","0026-19-WOMC","October 30, 2019","September 1, 2020","September 1, 2020","October 22, 2019",,"February 17, 2021","Wolfson medical center, Holon, Israel|Wolfson medical center, H̱olon, Israel",,"https://ClinicalTrials.gov/show/NCT04135612"
159,"NCT06301087","Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App",,"Completed","No Results Available","Development, Child|Postnatal Depression","Device: Web Application","Time to neurodevelopment desorder diagnostic|User's satisfaction|Relevance of the neurodevelopmental desorder notification|Rate of mothers'postnal depression|Time of mothers'postnatal depression","Weprom|Kelindi","All","up to 10 Years   (Child)",,"55618","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","WP-2024-01","May 1, 2022","February 8, 2024","February 8, 2024","March 8, 2024",,"March 15, 2024","ILC, Le Mans, France",,"https://ClinicalTrials.gov/show/NCT06301087"
160,"NCT04857593","Online Singing Interventions for Postnatal Depression in Times of Social Isolation: a Single Arm Study","SHAPER-PNDO","Recruiting","No Results Available","Postnatal Depression|Social Isolation","Behavioral: Melodies for Mums","To assess the effectiveness of online group singing interventions on symptoms of postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS)|To assess whether online singing improves (changes) further aspects of mental health, including depression using the Hamilton Depression Rating Scale (HDRS)|To assess whether online singing improves (changes) further aspects of mental health, including depression using the Beck Depression Inventory (BDI).|To assess whether online singing improves (changes) further aspects of mental health, including stress using the Perceived Stress Scale (PSS)|To assess whether online singing improves (changes) further aspects of mental health, including wellbeing using the Office for National Statistics Wellbeing Scale (ONS):|To assess whether online singing improves (changes) further aspects of mental health, including anxiety, using the State-Trait Anxiety Scale (STAI)|To ascertain whether online singing improves the observed mother-infant interaction using the Crittenden CARE-Index (CCI)|To ascertain whether online singing improves the perceived mother-infant relationship using the Maternal Postpartum Attachment Scale (MPAS)|To ascertain whether online singing improves the perceived mother-infant relationship using the Parent Reflective Functioning Questionnaire (PRFQ)|To ascertain whether online singing improves social support and reduces loneliness using the UCLA Loneliness Scale|To ascertain whether online singing improves social support and reduces loneliness using the Multidimensional Scale of Perceived Social Support (MSPSS)|To identify whether there are biological mechanisms underpinning the psychological outcomes assessed using changes in measurements in stress hormones, including diurnal cortisol and salivary cytokines|To identify whether there are biological mechanisms underpinning the psychological outcomes assessed using changes in measurements in salivary oxytocin|To identify how the online singing sessions affect the lived experience of mothers with PND using focus groups|To explore the phenomenology of PND and how singing intersects with PND among women with particular risk factors for PND (traumatic birth, adverse childhood experiences, and social isolation/loneliness) using semi-structured interviews","King's College London|University College, London","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","219425/Z/19/Z-PNDO","January 4, 2021","March 31, 2022","September 30, 2022","April 23, 2021",,"May 10, 2022","Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Rd, Brixton, London SE5 9RT, London, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/93/NCT04857593/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04857593"
161,"NCT06046456","Prenatal Affective Cognitive Training to Reduce the Risk of Postpartum Depression (PACT)","PACT","Recruiting","No Results Available","Postpartum Depression|Emotional Regulation|Cognitive Function 1, Social|Pregnancy Related|Mother-Child Relations","Other: Prenatal Affective CogntiiveTraining","Post partum depression|Affective cognition","Mental Health Services in the Capital Region, Denmark|University of Copenhagen","Female","18 Years to 50 Years   (Adult)","Not Applicable","146","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R7-A182","January 10, 2023","July 2024","July 2024","September 21, 2023",,"September 28, 2023","Mental Health Services in The Capital Region of Denmark, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT06046456"
162,"NCT00565032","Postpartum Thyroid Measures and Mood",,"Completed","No Results Available","Postpartum Depression",,"Numerical score on the Edinburgh Postnatal Depression Scale","Oklahoma State University Center for Health Sciences","Female","18 Years to 50 Years   (Adult)",,"75","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","9899015","January 2000",,"August 2001","November 29, 2007",,"January 28, 2010","Oklahoma State University Center for Health Sciences Houston Park Obstetrics Clinic, Tulsa, Oklahoma, United States",,"https://ClinicalTrials.gov/show/NCT00565032"
163,"NCT06250933","The Meleis Theory on Postpartum Depression, Breastfeeding, and Maternal Self-Efficacy in Women Experiencing Preterm Birth",,"Recruiting","No Results Available","Premature Birth|Theory, Double Bind|Postpartum Depression|Breast Feeding|Self Efficacy","Other: Postpartum Maternal Care and Premature Infant Care Training","Postpartum Depression|Maternal Self-Efficacy|Breastfeeding Self-Efficacy","Bilecik Seyh Edebali Universitesi","Female","Child, Adult, Older Adult","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","SBU-AKSOYGUVENC1","January 10, 2024","March 27, 2024","June 26, 2024","February 9, 2024",,"February 9, 2024","Rahime AKSOY BULGURCU, Bilecik, Gülümbe, Turkey",,"https://ClinicalTrials.gov/show/NCT06250933"
164,"NCT06253676","Sensing Technologies for Maternal Depression Treatment in Low-Resource Settings","StandStrong","Not yet recruiting","No Results Available","Post Partum Depression","Behavioral: Problem Management Plus (PM+)","Patient Health Questionnaire-9 (PHQ-9)|Psychological Outcome Profiles Questionnaire (PSYCHLOPS)|Generalized Anxiety Disorder-7 (GAD-7)|World Health Organization Disability Assessment Schedule (WHODAS)","George Washington University|Transcultural Psychosocial Organization Nepal|University of Witwatersrand, South Africa|Yale University|Duke University","Female","15 Years to 39 Years   (Child, Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","R33MH126877","April 2024","February 2026","August 2026","February 12, 2024",,"February 12, 2024","Transcultural Psychosocial Organization Nepal, Kathmandu, Nepal",,"https://ClinicalTrials.gov/show/NCT06253676"
165,"NCT05173285","Brief Internet-Based Acceptance and Commitment Therapy Intervention for Parents in the Postpartum",,"Completed","No Results Available","Postpartum Depression","Diagnostic Test: Baseline Assessment|Behavioral: Brief Online ACT Intervention|Diagnostic Test: Post-Intervention Assessment (i.e. between 4-6 weeks after baseline assessment)|Diagnostic Test: Follow-up Assessment (i.e. between 8-12 weeks after baseline assessment)","Change in Depression on The Edinburgh Postnatal Depression Scale from Baseline to Post Intervention (i.e. between week 4-6 after baseline assessment)|Change in Depression on The Edinburgh Postnatal Depression Scale from Baseline to Follow-up (i.e. between week 8-12 after baseline assessment)|Change in Wellbeing Score on The Flourishing Scale from Baseline to Post Intervention (i.e. between week 4-6 after baseline assessment)|Change in Wellbeing Score on The Flourishing Scale from Baseline to Follow Up (i.e. between week 8-12 weeks after baseline assessment)","Hannah Palma Carlos|Royal Holloway University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","138","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","27112020","June 3, 2020","March 28, 2022","March 28, 2022","December 29, 2021",,"May 16, 2022","Royal Holloway University of London, Egham, Surrey, United Kingdom",,"https://ClinicalTrials.gov/show/NCT05173285"
166,"NCT05845840","A Study of BRII-297 in Healthy Adult Subjects",,"Completed","No Results Available","Postpartum Depression","Drug: BRII-297|Drug: Placebo","Number of participants with adverse events receiving BRII-297 compared to placebo|Number of participants with abnormal clinical vital signs|Number of participants with abnormal clinically significant 12-lead electrocardiogram (ECG) readings|Number of participants with abnormal clinically significant clinical laboratory results|Number of participants with abnormal S-STS - Sheehan Suicidality Tracking Scale (self-report) results|Number of participants with abnormal SSS - Stanford Sleepiness Scale (self-report) results|PK of BRII-279 and brexanolone: Maximum observed plasma drug concentration Cmax|PK of BRII-279 and brexanolone: Time to maximum observed plasma drug concentration (Tmax)|PK of BRII-279 and brexanolone: Area under the curve from time 0 to last measurable concentration (AUClast)|PK of BRII-279 and brexanolone: Area under the curve from time 0 to infinity (AUC0-inf)|PK of BRII-279 and brexanolone: Terminal elimination half-life (T ½)|PK of BRII-279 and brexanolone: Apparent clearance after extravascular administration (CL/F)|PK of BRII-279 and brexanolone: Apparent volume of distribution (Vz/F)","Brii Biosciences Limited","All","18 Years to 50 Years   (Adult)","Phase 1","41","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","BRII-297-001","May 15, 2023","November 21, 2023","January 17, 2024","May 6, 2023",,"January 18, 2024","CMAX, Adelaide, South Australia, Australia",,"https://ClinicalTrials.gov/show/NCT05845840"
167,"NCT04813341","Effectiveness of Mat Pilates and Aerobic Training on Fatigue and Depression",,"Completed","No Results Available","Post Partum Depression","Other: Pilates training|Other: Aerobic Training","Multidimensional Fatigue Inventory|Edinburgh Postnatal Depression Scale","Riphah International University","Female","18 Years to 35 Years   (Adult)","Not Applicable","26","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","REC/00844 Rida Fatima","September 18, 2020","August 30, 2021","August 30, 2021","March 24, 2021",,"September 23, 2021","Anmol Hospital Phalia, Jhelum, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT04813341"
168,"NCT00804739","Perinatal Depression Treatment in a Pediatric Setting- Pilot Phase","MITT","Completed","No Results Available","Postpartum Depression","Other: Mother-Infant Treatment Team","Treatment Engagement|Treatment Adherence|Treatment Response|Treatment Remission|Maternal functional assessment|Maternal healthcare utilization|Infant healthcare utilization","University of Rochester|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","30","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","1R34MH082141-01","January 2009","January 2012","January 2012","December 9, 2008",,"February 27, 2012","University of Rochester, Rochester, New York, United States",,"https://ClinicalTrials.gov/show/NCT00804739"
169,"NCT04663243","Effectiveness of Thinking Healthy Program for Prevention of Antenatal Depression","PAD","Completed","No Results Available","Post Partum Depression","Behavioral: Thinking healthy Program sessions designed for antenatal period","Assessment of antenatal depression|Assessment of postpartum depression after 6 sessions of Thinking Healthy Program","University of the Punjab","Female","18 Years to 45 Years   (Adult)","Not Applicable","22","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","THP in clinical settings","July 3, 2020","January 29, 2021","April 29, 2021","December 10, 2020",,"September 23, 2021","Sheikh Zayed Hospital, Lahore, Punjab, Pakistan","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/43/NCT04663243/Prot_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/43/NCT04663243/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04663243"
170,"NCT05059600","A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting",,"Completed","Has Results","Postpartum Depression","Drug: ZULRESSO®","Percentage of Participants With At Least One Treatment-Emergent Adverse Event (TEAE) Leading to Dose Interruption/Discontinuation|Percentage of Participants With Nonadherence With the Safe-Use Conditions for Administration of ZULRESSO®|Number of Use-Related Issues Related to the Home Administration of ZULRESSO®|Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)|Percentage of Participants With Medication Error","Sage Therapeutics","Female","18 Years and older   (Adult, Older Adult)","Phase 4","52","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","547-PPD-404","October 8, 2021","July 14, 2022","July 14, 2022","September 28, 2021","July 19, 2023","July 19, 2023","Sage Investigational Site, Culver City, California, United States|Virtual Site (recruiting nationwide), Culver City, California, United States|Sage Investigational Site, Miramar, Florida, United States|Sage Investigational Site, Pompano Beach, Florida, United States|Sage Investigational Site, New York, New York, United States|Sage Investigational Site, League City, Texas, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/00/NCT05059600/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/00/NCT05059600/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT05059600"
171,"NCT04442503","A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)",,"Completed","Has Results","Depression, Postpartum","Drug: SAGE-217|Drug: Placebo","Change From Baseline (CFB) in the 17-item Hamilton Rating Scale for Depression (HAM-D) Total Score at Day 15|Change From Baseline in the 17-item HAM-D Total Score|Change From Baseline in Clinical Global Impressions - Severity Scale (CGI-S) Score|Percentage of Participants With HAM-D Response|Percentage of Participants With HAM-D Remission|Percentage of Participants With Clinical Global Impression - Improvement (CGI-I) Response|Change From Baseline in Hamilton Rating Scale for Anxiety (HAM-A) Total Score|Change From Baseline in the Montgomery Åsberg Depression Rating Scale (MADRS) Total Score|Change From Baseline in HAM-D Subscale|Change From Baseline in Self-Reported Measures of Depressive Symptoms, as Assessed by the Edinburgh Postnatal Depression Scale (EPDS) Total Score|Change From Baseline in Self-Reported Measures of Depressive Symptoms, as Assessed by the 9-item Patient Health Questionnaire (PHQ-9) Score|Percentage of Participants With at Least One Treatment-Emergent Adverse Event (TEAE)","Biogen","Female","18 Years to 45 Years   (Adult)","Phase 3","200","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","217-PPD-301|2020-001424-34","June 8, 2020","March 15, 2022","April 12, 2022","June 22, 2020","June 22, 2023","November 30, 2023","Sage Investigational Site, Scottsdale, Arizona, United States|Sage Investigational Site, Bentonville, Arkansas, United States|Sage Investigational Site, Anaheim, California, United States|Sage Investigational Site, Bellflower, California, United States|Sage Investigational Site, Beverly Hills, California, United States|Sage Investigational Site, Costa Mesa, California, United States|Sage Investigational Site, Imperial, California, United States|Sage Investigational Site, Lemon Grove, California, United States|Sage Investigational Site, Norwalk, California, United States|Sage Investigational Site, Oceanside, California, United States|Sage Investigational Site, Orange, California, United States|Sage Investigational Site, Orange, California, United States|Sage Investigational Site, Redlands, California, United States|Sage Investigational Site, San Bernardino, California, United States|Sage Investigational Site, Sherman Oaks, California, United States|Sage Investigational Site, Torrance, California, United States|Sage Investigational Site, Aurora, Colorado, United States|Sage Investigational Site, Norwich, Connecticut, United States|Sage Investigational Site, Boynton Beach, Florida, United States|Sage Investigational Site, Hialeah, Florida, United States|Sage Investigational Site, Jacksonville, Florida, United States|Sage Investigational Site, Miami Springs, Florida, United States|Sage Investigational Site, Miami, Florida, United States|Sage Investigational Site, Miramar, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Orlando, Florida, United States|Sage Investigational Site, Pensacola, Florida, United States|Sage Investigational Site, Pinellas Park, Florida, United States|Sage Investigational Site, Pompano Beach, Florida, United States|Sage Investigational Site, Alpharetta, Georgia, United States|Sage Investigational Site, Atlanta, Georgia, United States|Sage Investigational Site, Decatur, Georgia, United States|Sage Investigational Site, Savannah, Georgia, United States|Sage Investigational Site, Idaho Falls, Idaho, United States|Sage Investigational Site, Hoffman Estates, Illinois, United States|Sage Investigational Site, Lincolnwood, Illinois, United States|Sage Investigational Site, Wichita, Kansas, United States|Sage Investigational Site, New Orleans, Louisiana, United States|Sage Investigational Site, Boston, Massachusetts, United States|Sage Investigational Site, Detroit, Michigan, United States|Sage Investigational Site, Flowood, Mississippi, United States|Sage Investigational Site, Saint Charles, Missouri, United States|Sage Investigational Site, Saint Louis, Missouri, United States|Sage Investigational Site, Saint Louis, Missouri, United States|Sage Investigational Site, Las Vegas, Nevada, United States|Sage Investigational Site, Marlton, New Jersey, United States|Sage Investigational Site, Brooklyn, New York, United States|Sage Investigational Site, Glen Oaks, New York, United States|Sage Investigational Site, New York, New York, United States|Sage Investigational Site, Chapel Hill, North Carolina, United States|Sage Investigational Site, Charlotte, North Carolina, United States|Sage Investigational Site, Denver, North Carolina, United States|Sage Investigational Site, Beachwood, Ohio, United States|Sage Investigational Site, Mayfield Heights, Ohio, United States|Sage Investigational SIte, North Canton, Ohio, United States|Sage Investigational Site, Oklahoma City, Oklahoma, United States|Sage Investigational Site, Allentown, Pennsylvania, United States|Sage Investigational Site, Moosic, Pennsylvania, United States|Sage Investigational Site, Providence, Rhode Island, United States|Sage Investigational site, Charleston, South Carolina, United States|Sage Investigational Site, Dallas, Texas, United States|Sage Investigational Site, Fort Worth, Texas, United States|Sage Investigational Site, Houston, Texas, United States|Sage Investigational Site, League City, Texas, United States|Sage Investigational Site, Richardson, Texas, United States|Sage Investigational Site, San Antonio, Texas, United States|Sage Investigational Site, North Chesterfield, Virginia, United States|Sage Investigational Site, Bellevue, Washington, United States|Sage Investigational Site, Barcelona, Spain|Sage Investigational Site, Barcelona, Spain|Sage Investigational Site, Barcelona, Spain|Sage Investigational Site, Collado-Villalba, Spain|Sage Investigational Site, Madrid, Spain|Sage Investigational Site, Oviedo, Spain|Sage Investigational Site, Sabadell, Spain|Sage Investigational Site, Valladolid, Spain|Sage Investigational Site, Vigo, Spain|Sage Investigational Site, Runwell, Essex, United Kingdom|Sage Investigational Site, Preston, Lancashire, United Kingdom|Sage Investigational Site, Morpeth, Northumberland, United Kingdom|Sage Investigational Site, Headington, Oxford, United Kingdom|Sage Investigational Site, Maidstone, United Kingdom","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/03/NCT04442503/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/03/NCT04442503/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT04442503"
172,"NCT04818047","Adaptation and Pilot Testing of Web and Mobile Interface for the VID-KIDS Intervention","VID-KIDS","Completed","No Results Available","Post Partum Depression","Behavioral: VID-KIDS Intervention Program","Nursing Child Assessment Satellite Training (NCAST) assessment scale will be used to evaluate Mother-Infant (M-I) interactions","University of Calgary|Alberta Health services","Female","16 Years to 49 Years   (Child, Adult)","Not Applicable","20","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CHREB-Ethics ID #: REB16-1811","March 15, 2021","December 31, 2022","December 31, 2022","March 26, 2021",,"May 12, 2023","University of Calgary, Calgary, Alberta, Canada|Maternal Newborn Child and Youth Strategic Clinical Network, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT04818047"
173,"NCT00001481","The Role of Hormones in Postpartum Mood Disorders",,"Recruiting","No Results Available","Postpartum Depression","Drug: Estradiol|Other: Placebo|Drug: Progesterone","Outcome measures will include mood, behavioral, and hormonal parameters as well as response to o-CRH.","National Institute of Mental Health (NIMH)|National Institutes of Health Clinical Center (CC)","Female","18 Years to 50 Years   (Adult)","Phase 2","100","NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Basic Science","950097|95-M-0097","April 26, 1996","May 13, 2025","June 13, 2025","November 4, 1999",,"March 27, 2024","National Institutes of Health Clinical Center, Bethesda, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00001481"
174,"NCT04138368","The Effect of Early Dyadic Psychotherapy for Mothers Suffering From PPD on Oxytocin Level and on Childrens' Emotional Development",,"Unknown status","No Results Available","Postpartum Depression","Behavioral: dyadic psychotherapeutic intervention|Behavioral: supportive intervention","the dyadic psychotherapy reinforce mother-child bonding and attachment, over and above the standard supportive care.|the dyadic psychotherapy will prevent the development of emotional psychopathology of the child","HaEmek Medical Center, Israel","All","3 Months and older   (Child, Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","EMC-0057-19","January 1, 2020","December 2021","December 2021","October 24, 2019",,"March 18, 2020","Ilanir shchori, Afula, Israel",,"https://ClinicalTrials.gov/show/NCT04138368"
175,"NCT04506489","Access to Maternity and Risk Factors in a Non-consultant Population (PROXIMA)",,"Unknown status","No Results Available","Post Partum Depression","Other: Psychological investigation","Self questionnaire : health, Anxiety, Postnatal, Body Satisfaction, , Bartholomew, RelationShip, Social , Perinatal, Family Relationship , parental stress, dyadic alliance, Parental Bonding , Prenatal attachment , birth experience","Centre Hospitalier Universitaire de Besancon","Female","25 Years to 45 Years   (Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","P/2019/434","July 1, 2019","January 1, 2021","January 1, 2021","August 10, 2020",,"August 10, 2020","Mathilde Pointurier, Besançon, Franche Comté, France",,"https://ClinicalTrials.gov/show/NCT04506489"
176,"NCT04366817","Psychological Impact of the Lockdown on Patients Giving Birth During the COVID-19 Epidemic Short Title : Isolement and Childbirth: Psychological Impact","COVMUM","Completed","No Results Available","Post Partum Depression","Behavioral: psychological assessment","Proportion of patients with postpartum depression defined by an EPDS score >12|Socio-demographic data|Occurrence of a maternal or fetal pathology in a previous pregnancy|Pregnant maternal pathology (hypertension, diabetes, threat of premature delivery)|Presence of psycological maternal risk factor|Dyadic adjustment scale 16 (DAS-16)|Perinatal post traumatic stress disorder questionnaire (PPQ scale)|Mother to infant bonding scale (MIBS) autoquestionnaire|Measure Qualitative Interviews by Grounded theory","Assistance Publique - Hôpitaux de Paris","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","287","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","APHP200471","April 27, 2020","February 17, 2021","February 17, 2021","April 29, 2020",,"June 30, 2022","Service médecine foetale-Hôpital Trousseau, Paris, France",,"https://ClinicalTrials.gov/show/NCT04366817"
177,"NCT04348929","Birth Experience During COVID-19 Confinement","CONFINE","Completed","No Results Available","Postpartum Depression","Other: Self-administered questionnaires","""Labor Agentry Scale questionnaire"" score in immediate post-partum (duration of hospital stay)|""Labor Agentry Scale questionnaire"" score at two months after birth|Edinburg Postnatale Depression Scale questionnaire"" score at two months after birth|""Impact of Event Scale - Revised questionnaire"" score at two months after birth|Breastfeeding statement at two months after birth|""SF-12 Quality of life questionnaire"" score at two months after birth|""SF-12 Quality of life questionnaire"" score in immediate post-partum|Diagnosis of post-natal depression (made by a specialist)","Central Hospital, Nancy, France","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","927","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","2020-A00881-38","April 16, 2020","July 21, 2023","July 21, 2023","April 16, 2020",,"February 8, 2024","Centre Hospitalier Régional Universitaire de Nancy, Nancy, France",,"https://ClinicalTrials.gov/show/NCT04348929"
178,"NCT03052374","Video-Feedback Interaction Guidance for Improving Interactions Between Depressed Mothers and Their Infants (""VID-KIDS"")","VID-KIDS","Active, not recruiting","No Results Available","Post Partum Depression","Behavioral: VID-KIDS Intervention Program","NCAST assessment scale will be used to evaluate Mother-Infant (M-I) interactions","University of Calgary|Alberta Health services","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","REB-Ethics ID #: REB16-1811","May 1, 2017","December 31, 2022","March 31, 2024","February 14, 2017",,"May 12, 2023","Maternal Newborn Child and Youth Strategic Clinical Network, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03052374"
179,"NCT03221556","Improving Outcomes for Low-Income Mothers With Depression",,"Completed","No Results Available","Post Partum Depression","Behavioral: Engagement-Focused Care Coordination|Behavioral: Problem Solving Education (PSE)","Depression Symptoms|Anxiety Symptoms|Parenting behaviors|Child Behavior|Engagement and Retention with Mental Health Services|Coping with Stress|Behavioral Activation for Depression","Boston Medical Center|Patient-Centered Outcomes Research Institute|Boston University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","231","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","H-36434|AD-1603-34662","February 5, 2018","June 16, 2020","June 16, 2020","July 18, 2017",,"January 12, 2021","Boston Medical Center, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03221556"
180,"NCT00276900","Sertraline for the Prevention of Recurrent Postpartum Depression",,"Completed","No Results Available","Depression","Drug: Sertraline","Depressive symptoms (measured at Weeks 24 and 52 postpartum)|Functioning (measured at Weeks 24 and 52 postpartum)","University of Pittsburgh|National Institute of Mental Health (NIMH)","Female","18 Years to 45 Years   (Adult)","Phase 3","300","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double|Primary Purpose: Prevention","R01MH053735|DSIR 83-ATP","December 2003","August 2006","August 2006","January 13, 2006",,"October 7, 2013","Women's Behavioral HealthCare Program, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00276900"
181,"NCT04414943","Low-dose S-ketamine in Women With Prenatal Depression",,"Completed","No Results Available","Prenatal Depression|Ketamine|Postpartum Depression","Drug: S-ketamine|Drug: Placebo","The incidence of depression at 42 days postpartum.|Maternal depression score at 7 days postpartum.|Maternal depression score at 42 days postpartum.|Maternal depression severity at 42 days postpartum.|Intensity of pain at 1, 7, and 42 days postpartum.|Maternal breast feeding at 1, 7, and 42 days postpartum.|Length of hospital stay after giving birth.|Incidence of maternal complications within 42 days postpartum.|Incidence of neonatal diseases within 42 days.","Peking University First Hospital|Peking University International Hospital|Hunan Provincial Maternal and Child Health Care Hospital|Women's Hospital of Nanjing Medical University|Women's Hospital School Of Medicine Zhejiang University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","364","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2019[336]","June 19, 2020","August 3, 2022","August 3, 2022","June 4, 2020",,"April 4, 2023","Peking University First Hospital, Beijing, Beijing, China|Beijing Tiantan Hospital, Beijing, Beijing, China|Peking University International Hospital, Beijing, Beijing, China|Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China|Huaian Maternal and Child Health Care Hospital, Huaian, Jiangsu, China|Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China|Women's Hospital School Of Medicine Zhejiang University, Hangzhou, Zhejiang, China",,"https://ClinicalTrials.gov/show/NCT04414943"
182,"NCT00282776","Identification and Therapy of Postpartum Depression",,"Completed","No Results Available","Depression","Behavioral: Care Management for Postpartum Depression|Behavioral: TAU","Depressive symptoms, social functioning, and health|Preferences for depression treatment","University of Pittsburgh|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Phase 3","628","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","R01MH071825|DSIR 82-SEMS","August 2006","March 2012","March 2012","January 27, 2006",,"October 7, 2013","Women's Behavioral HealthCARE Program, Suite 410, 3501 Forbes Ave, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00282776"
183,"NCT01312883","Mothers Avoiding Depression Through Empowerment Intervention Trial","MADE IT","Completed","No Results Available","Postpartum Depression","Behavioral: Behavioral education intervention","The primary outcome measure is to evaluate the effectiveness in a randomized controlled trial of a patient education intervention to reduce depressive symptoms among Black and Hispanic postpartum women.|Breastfeeding continuation rate and Physical functioning","Icahn School of Medicine at Mount Sinai|National Institute on Minority Health and Health Disparities (NIMHD)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","540","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","2P60MD000270-06|P60MD000270","September 2007","September 2010","October 2010","March 11, 2011",,"March 11, 2011","Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01312883"
184,"NCT03460756","A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression",,"Completed","Has Results","Depressive Disorder|Depression|Depression, Postpartum|Behavioral Symptoms|Mood Disorders|Mental Disorder|Pregnancy Complications|Postpartum Blues|PPD|Postpartum Disorder","Drug: Ganaxolone|Drug: Placebo","Change From Baseline in Hamilton Depression Rating Scale 17-item Version (HAMD17) Through Treatment|Change From Baseline in Hamilton Depression Rating Scale 17-item Version Post Treatment|Number of Participants With Response to Hamilton Depression Rating Scale 17 Item (HAMD17)|Number of Participants With Hamilton Depression Rating Scale 17-item Remission|Change From Baseline in Edinburgh Postnatal Depression Scale (EPDS) Total Score|Change From Baseline in Spielberger State-Trait Anxiety Inventory, 6-item Version|Number of Participants With Clinical Global Impression-Improvement","Marinus Pharmaceuticals","Female","18 Years to 48 Years   (Adult)","Phase 2","84","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","1042-PPD-2003","December 28, 2017","July 5, 2019","July 5, 2019","March 9, 2018","January 30, 2023","August 18, 2023","Marinus Research Site, Glendale, California, United States|Marinus Research Site, Lemon Grove, California, United States|Marinus Research Site, Long Beach, California, United States|Marinus Research Site, Oceanside, California, United States|Marinus Research Site, Panorama City, California, United States|Marinus Research Site, San Bernardino, California, United States|Marinus Research Site, San Marcos, California, United States|Marinus Research Site, Ventura, California, United States|Marinus Research Site, Gainesville, Florida, United States|Marinus Research Site, Hollywood, Florida, United States|Marinus Research Site, Jacksonville, Florida, United States|Marinus Research Site, North Miami, Florida, United States|Marinus Research Site, Atlanta, Georgia, United States|Marinus Research Site, Atlanta, Georgia, United States|Marinus Research Site, Decatur, Georgia, United States|Marinus Research Site, Marietta, Georgia, United States|Marinus Research Site, Idaho Falls, Idaho, United States|Marinus Research Site, Hoffman Estates, Illinois, United States|Marinus Research Site, Leawood, Kansas, United States|Marinus Research Site, Wichita, Kansas, United States|Marinus Research Site, Flowood, Mississippi, United States|Marinus Research Site, Las Vegas, Nevada, United States|Marinus Research Site, Albuquerque, New Mexico, United States|Marinus Research Site, Raleigh, North Carolina, United States|Marinus Research Site, Englewood, Ohio, United States|Marinus Research Site, Downingtown, Pennsylvania, United States|Marinus Research Site, Media, Pennsylvania, United States|Marinus Research Site, Houston, Texas, United States|Marinus Research Site, Irving, Texas, United States|Marinus Research Site, League City, Texas, United States|Marinus Research Site, San Antonio, Texas, United States|Marinus Research Site, Orem, Utah, United States|Marinus Research Site, Richmond, Virginia, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/56/NCT03460756/Prot_002.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/56/NCT03460756/SAP_003.pdf","https://ClinicalTrials.gov/show/NCT03460756"
185,"NCT03228394","A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression",,"Completed","Has Results","Depression|Depressive Disorder|Depression, Postpartum|Behavioral Symptoms|Mood Disorders|Mental Disorders|Puerperal Disorders|Pregnancy Complications|Postpartum|PPD","Drug: Ganaxolone|Drug: Placebo","Change From Baseline in Hamilton Depression Rating Scale 17-item Version (HAMD17) Total Score|Change From Baseline in HAMD17 Total Score at Indicated Time Points|Number of Participants With HAMD17 Response|Number of Participants With HAMD17 Remission|Change From Baseline in Edinburgh Postnatal Depression Scale (EPDS) Total Score|Change From Baseline in Spielberger State-Trait Anxiety Inventory 6-item Version (STAI6) Total Score|Number of Participants With Response to Clinical Global Impression-Improvement (CGI-I) Scale","Marinus Pharmaceuticals","Female","18 Years to 45 Years   (Adult)","Phase 2","91","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","1042-PPD-2002","June 27, 2017","May 10, 2019","May 10, 2020","July 24, 2017","February 8, 2023","July 19, 2023","Marinus Research Site, Little Rock, Arkansas, United States|Marinus Research Site, Costa Mesa, California, United States|Marinus Research Site, Lemon Grove, California, United States|Marinus Research Site, San Diego, California, United States|Marinus Research Site, Jacksonville, Florida, United States|Marinus Research Site, Atlanta, Georgia, United States|Marinus Research Site, Decatur, Georgia, United States|Marinus Research Site, Leawood, Kansas, United States|Marinus Research Site, Overland Park, Kansas, United States|Marinus Research Site, New York, New York, United States|Marinus Research Site, Dayton, Ohio, United States|Marinus Research Site, Houston, Texas, United States|Marinus Research Site, Irving, Texas, United States|Marinus Research Site, Orem, Utah, United States|Marinus Research Site, Salt Lake City, Utah, United States|Marinus Research Site, Richmond, Virginia, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/94/NCT03228394/Prot_002.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/94/NCT03228394/SAP_003.pdf","https://ClinicalTrials.gov/show/NCT03228394"
186,"NCT01838889","Exploratory Trial of a Group Psychological Intervention for Postnatal Depression in British Mother's of South Asian Origin","ROSHNI-D","Completed","No Results Available","Depression, Postpartum|Postnatal Depression in British South Asian Women","Behavioral: Culturally adapted psychological intervention (Positive Health Programme)","Edinburgh Post Natal Depression Scale (EPDS; Cox et al 1987)|EuroQoL-5 Dimensions (EQ-5D)|The Parenting Stress Index (PSI)|Multidimensional Scale of Perceived Social Support (MSPSS)|Dyadic Adjustment Scale (DAS)|Home Inventory (HI)|Hamilton Rating Scale for Depression (HRSD)|Client Service Receipt Inventory (CSRI)","Lancashire Care NHS Foundation Trust|University of Manchester","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","83","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","47847|PB-PG-1208-18087","March 2011","August 2013","October 2013","April 24, 2013",,"December 8, 2014","Primary Care; Mother and Baby Clinics, Borough of Blackburn with Darwen; Burnley; Preston; Manchester, Lancashire, Greater Manchester, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01838889"
187,"NCT05894681","Psychoeducation in Preventing Postpartum Depression According to Watson",,"Active, not recruiting","No Results Available","Pregnancy Related","Other: THE EFFECT OF WATSON MODEL-BASED PSYCOEDUCATIONAL INTERVENTIONS ON PREVENTION OF POSTPARTITION DEPRESS","Patient Satisfaction Evaluation Form According to Watson Improvement Processes|Edinburgh Postpartum Depression Scale|Multidimensional Scale of Perceived Social Support|Personal Information Form","Yasemin Ozhuner|Eskisehir Osmangazi University","Female","20 Weeks to 32 Weeks   (Child)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","YASEMİN ÖZHÜNER","October 1, 2022","February 16, 2023","January 20, 2024","June 8, 2023",,"January 25, 2024","Eskisehir Osmangazi University, Eskişehir, Odunpazarı, Turkey",,"https://ClinicalTrials.gov/show/NCT05894681"
188,"NCT02532504","Change Your Life With Seven Sheets of Paper","CREATOR","Completed","No Results Available","Postnatal Depression","Other: CBT","Edinburgh Postnatal Depression Scale (EPDS)|Patient health Questionnaire-9|World Health Organization Quality of Life","Pakistan Institute of Living and Learning","Female","18 Years to 45 Years   (Adult)","Phase 2","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)","CREATOR001","August 2015","March 2016","March 2016","August 25, 2015",,"January 16, 2017","Orangi Town, Karachi, Pakistan",,"https://ClinicalTrials.gov/show/NCT02532504"
189,"NCT04332146","Mindfulness-based Intervention for Postnatal Depression",,"Unknown status","No Results Available","Postnatal Depression","Behavioral: Mindfulness-based program (MBI-p-R)|Behavioral: Booklet-based psychoeducation","Change from Baseline Depression at 8 weeks|Change from 8 weeks Depression at 3 months|Change from Baseline Anxiety at 8 weeks|Change from 8 weeks Anxiety at 3 months|Change from Baseline Stress at 8 weeks|Change from 8 weeks Stress at 3 months|Change from Baseline Executive Function at 8 weeks|Change from 8 weeks Executive Function at 3 months|Change from Baseline Attention at 8 weeks|Change from 8 weeks Attention at 3 months|Change from Baseline Working Memory at 8 weeks|Change from 8 weeks Working Memory at 3 months|Change from Baseline Visual-Motor Coordination at 8 weeks|Change from 8 weeks Visual-Motor Coordination at 3 months|Change from Baseline Role Functioning at 8 weeks|Change from 8 weeks Role Functioning at 3 months|Change from Baseline Quality of Life at 8 weeks|Change from 8 weeks Quality of Life at 3 months|Change from Baseline Sleep Quality at 8 weeks|Change from 8 weeks Sleep Quality at 3 months|Change from Baseline Mindfulness Levels at 8 weeks|Change from 8 weeks Mindfulness Levels at 3 months","The University of Hong Kong","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","UW17-431","September 1, 2019","July 2020","September 2021","April 2, 2020",,"April 2, 2020","Queen Mary Hospital, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT04332146"
190,"NCT04183582","Behavioural Activation (BA) for Postnatal Depression in Blackpool","BA","Unknown status","No Results Available","Postnatal Depression","Behavioral: Behavioural Activation","Patient Health Questionnaire (PHQ9)|Generalised Anxiety Disorder Questionnaire (GAD7)|Parental Stress Scale (PSS)|Maternal Infant Responsiveness Instrument (MIRI)|Behavioural Activation for DEpression Scale (BADS)|Snaith-Hamilton Pleasure Scale (SHAPS)|Ages and Stages Questionnaire (ASQ)","National Society for the Prevention of Cruelty to Children","Female","18 Years to 50 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","BBS001","December 2019","September 2020","September 2021","December 3, 2019",,"December 3, 2019","Centre for Early Child Development, Blackpool, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04183582"
191,"NCT05813782","The Effect of Baby Massage on Postpartum Depression and Maternal Attachment",,"Recruiting","No Results Available","Depression, Postpartum|Maternal Behavior|Attachment","Behavioral: Baby Massage","Postpartum depression|Maternal attachment","Tokat Gaziosmanpasa University|TC Erciyes University","Female","19 Years to 35 Years   (Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","22-KAEK-084","September 3, 2022","May 15, 2023","August 15, 2023","April 14, 2023",,"April 14, 2023","Tokat Gaziosmanpaşa University, Tokat, Turkey",,"https://ClinicalTrials.gov/show/NCT05813782"
192,"NCT01463202","Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression","DEPO-ABCD","Completed","Has Results","Contraception|Postpartum Depression|Lactation","Drug: Depot medroxyprogesterone acetate","Duration of Breastfeeding Among Women Who Plan to Breastfeed Their Infants After Postpartum or Delayed (4-6 Weeks Postpartum) Initiation of DMPA|Rates of Use of Highly Effective Contraception (Defined as DMPA, IUD, Implant, Sterilization, or Lactational Amenorrhea) After Postpartum or Delayed Initiation of DMPA|Rates of Postpartum Depression After Postpartum or Delayed Initiation of DMPA|Exclusivity of Breastfeeding Among Women Who Plan to Breastfeed Their Infants After Postpartum or Delayed (4-6 Weeks Postpartum) Initiation of DMPA","Beatrice Chen|Society of Family Planning|University of Pittsburgh","Female","18 Years and older   (Adult, Older Adult)","Phase 4","184","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","SFP5-1","November 2011","February 13, 2017","October 16, 2017","November 1, 2011","March 13, 2018","August 31, 2018","Center for Family Planning Research, Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/02/NCT01463202/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT01463202"
193,"NCT02823418","Neuraxial Labor Analgesia and the Incidence of Postpartum Depression",,"Completed","No Results Available","Parturition|Analgesia, Obstetrical|Depression, Postpartum","Procedure: No neuraxial labor analgesia|Procedure: Neuraxial labor analgesia","The incidence of postpartum depression|The mode of delivery|Neonatal Apgar score|Status of baby feeding|Severity of pain|Persistent pain|Persistent pain affecting daily life","Peking University First Hospital|Beijing Obstetrics and Gynecology Hospital|Beijing Haidian Maternal and Child Health Hospital","Female","18 Years to 34 Years   (Adult)",,"599","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2014[712]|ChiCTR-OCH-14004888","August 1, 2014","May 29, 2015","April 25, 2017","July 6, 2016",,"July 26, 2021",,,"https://ClinicalTrials.gov/show/NCT02823418"
194,"NCT05275413","mHealth Intervention to Reduce Maternal Postnatal Depression and Promote Family Health",,"Recruiting","No Results Available","Postnatal Depression|Quality of Life|Family Relations","Behavioral: family-based mHealth Intervention|Behavioral: mother-only mHealth Intervention|Other: Health education","Postnatal depression symptoms|Perceived social support levels of expectant mothers|Anxiety and stress levels of all participants|Health-related quality of life (QoL) of all participants|Perceived family cohesion levels of all participants","The Hong Kong Polytechnic University|Kwong Wah Hospital|The University of Hong Kong|University of Glasgow|Tsan Yuk Hospital, Hong Kong","All","Child, Adult, Older Adult","Not Applicable","1578","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","KC/KE-20-0119/ER-2","June 16, 2022","June 30, 2023","December 31, 2023","March 11, 2022",,"August 22, 2022","Kwong Wah Hospital, Hong Kong, Hong Kong|Tsan Yuk Hospital, Hong Kong, Hong Kong","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/13/NCT05275413/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT05275413"
195,"NCT00228033","Effectiveness of Supplemental Calcium in Preventing Postpartum Depression",,"Completed","No Results Available","Depression|Depression, Postpartum","Drug: Elemental calcium (as carbonate)","Score on Edinburgh Postnatal Depression Scale; measured at Weeks 6 and 12 after childbirth|Symptoms of depression; measured throughout the study with a standard psychiatric interview|Calcium effects on depression; measured througout pregnancy","Oregon Health and Science University|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Phase 4","238","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Prevention","R21MH063242|DAHBR AD-D","April 2002","December 2005","August 2007","September 28, 2005",,"March 20, 2014","Oregon Health & Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT00228033"
196,"NCT04923698","Effect of Yoga on Postpartum Depression",,"Completed","No Results Available","Yoga","Other: yoga training","BMI assessment|Zung self-rating depression scale","Cairo University",,"Child, Adult, Older Adult","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","Cairo Un110","January 24, 2019","March 30, 2020","March 30, 2020","June 11, 2021",,"June 11, 2021","Ghada Ebrahim Elrefaye, Giza, Egypt",,"https://ClinicalTrials.gov/show/NCT04923698"
197,"NCT01452321","Repetitive Transcranial Magnetic Stimulation in Postpartum Depression","rTMSPPD","Completed","No Results Available","Depression, Postpartum","Procedure: repetitive transcranial magnetic stimulation (rTMS)","Hamilton Depression Rating Scale (HDRS)|Battery of Neuropsychological Tests and Social Adjustment Scale","University of Sao Paulo General Hospital","Female","18 Years to 36 Years   (Adult)","Phase 2","14","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","0588/07","August 2007","July 2008","September 2009","October 14, 2011",,"October 14, 2011","Department and Institute of Psychiatry, General Hospital, University of Sao Paulo medical school, São Paulo, Brazil",,"https://ClinicalTrials.gov/show/NCT01452321"
198,"NCT01309516","Randomised Control Trial of a Complex Intervention for Postnatal Depression",,"Completed","No Results Available","Postnatal Depression|Depression, Postpartum","Behavioral: Complex Intervention","Depression|Postnatal Depression|Infants' weight|Infants' height|Social Support|health related quality of life|Maternal Attachment","Pakistan Institute of Living and Learning|Dow University of Health Sciences|University of Manchester","Female","18 Years and older   (Adult, Older Adult)","Phase 2","107","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","pill110409","May 2009","December 2010","May 2011","March 7, 2011",,"September 22, 2015","Civil hospital, Karachi, Sindh, Pakistan|Abbasi Shaheed hospital Karachi, Karachi, Sindh, Pakistan",,"https://ClinicalTrials.gov/show/NCT01309516"
199,"NCT04146025","Nurtured in Nature",,"Completed","No Results Available","Postpartum Depression|Pregnancy Related|Environmental Exposure","Behavioral: Nature Coach Intervention","Green space use|Prevention of postpartum depression|Improvement in general well-being","University of Pennsylvania","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","36","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","833693","September 12, 2019","February 24, 2020","March 27, 2020","October 31, 2019",,"November 24, 2020","University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04146025"
200,"NCT04847362","The Effect of Tele-Health Education Provided in the Postpartum Period in the Covid 19 Pandemic",,"Unknown status","No Results Available","Postpartum Depression|Anxiety State","Behavioral: Experimental","postpartum depression|postpartum mother-baby attachment|anxiety state","Saglik Bilimleri Universitesi","Female","18 Years to 35 Years   (Adult)","Not Applicable","74","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","11.04.2021-27076","April 11, 2021","November 22, 2021","January 30, 2022","April 19, 2021",,"November 23, 2021","Zeynep Kamil Women's and Children's Diseases Training and Research Hospital, İstanbul, Turkey|Saglık Bilimleri Universitesi, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04847362"
201,"NCT03415321","Development of Postnatal Mobile Support Application",,"Completed","No Results Available","Postpartum Depression|Postnatal Complication|Nurse's Role","Device: Postpartum Mobile Support Application","Edinburgh Postnatal Depression Scale|State-Trait Anxiety Inventory","Necmettin Erbakan University","Female","20 Years to 55 Years   (Adult)","Not Applicable","124","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","NecmettinEU","April 4, 2019","July 30, 2019","February 20, 2020","January 30, 2018",,"June 23, 2020","Necmettin Erbakan University, Konya, Turkey",,"https://ClinicalTrials.gov/show/NCT03415321"
202,"NCT05295069","Can Postpartum Depression Be Prevented With Care",,"Completed","No Results Available","Sleep Quality, Depression, Postnatal Care, Single-Blind Method, Fatigue, Social Support","Behavioral: A nursing care program was applied for the intervention group under the guidance of Levine's conservation model.","Visual Analogue Scale to Evaluate Fatigue Severity Scores|Edinburgh Postpartum Depression Scale Scores|The Postpartum Support Scale Scores|the Postpartum Sleep Quality Scale Scores|The Postpartum Physical Symptom Severity Scale Scores","Ataturk University","Female","18 Years to 35 Years   (Adult)","Not Applicable","112","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","AtaturkU-GulsenEryilmaz-001","July 1, 2019","April 1, 2020","March 9, 2021","March 24, 2022",,"March 24, 2022","AtaturkU, Erzurum, Turkey",,"https://ClinicalTrials.gov/show/NCT05295069"
203,"NCT05784116","Immune/Inflammatory Biomarkers in Postpartum Depression","PPDINFLAME","Recruiting","No Results Available","Depression, Postpartum",,"Peripheral inflammation|Postpartum depression|Multimodal MRI","IRCCS San Raffaele|Ministry of Health, Italy","Female","18 Years to 45 Years   (Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","RF-2019-12371066","April 1, 2022","November 24, 2024","November 24, 2024","March 24, 2023",,"March 24, 2023","Ospedale San Raffaele, Milano, Italy",,"https://ClinicalTrials.gov/show/NCT05784116"
204,"NCT02505984","Preventing Postpartum Depression With Intranasal Oxytocin","IN-OXT","Completed","No Results Available","Depression, Postpartum|Anxiety","Drug: Oxytocin|Drug: Placebo","Treatment effect on mother-infant bonding|Change in depression symptoms|Change in anxiety symptoms|Child development","Massachusetts General Hospital|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years to 50 Years   (Adult)","Phase 2","56","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2015P001100|224421|225686|1R21HD090396-01A1","October 2015","May 2023","May 2023","July 22, 2015",,"May 6, 2023","Massachusetts General Hosptial, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT02505984"
205,"NCT06355375","Exercise in Pregnancy and Risk of Postpartum Depression",,"Recruiting","No Results Available","Depression|Pregnancy Related","Behavioral: exercise in pregnancy","edinburgh depression scale|Postpartum depression|preterm birth","Federico II University","Female","20 Years to 40 Years   (Adult)","Not Applicable","398","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","02.24","March 22, 2024","January 1, 2025","December 1, 2025","April 9, 2024",,"April 9, 2024","Gabriele Saccone, Naples, Italy",,"https://ClinicalTrials.gov/show/NCT06355375"
206,"NCT02559986","Follow up of Mothers Suspected of Postpartum Depression",,"Completed","No Results Available","Depression, Postpartum","Other: telephone interview","Rate at which mothers sought treatment for suspected PD|Factors associated with help seeking behavior","Indiana University","Female","18 Years and older   (Adult, Older Adult)",,"73","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","1111007501","January 2012","December 2014","December 2014","September 25, 2015",,"September 25, 2015",,,"https://ClinicalTrials.gov/show/NCT02559986"
207,"NCT05907213","Ketamine Tolerated Dose for Postpartum Depression and Pain After Cesarean Delivery",,"Recruiting","No Results Available","Pain, Postoperative|Depression, Postpartum","Drug: Ketamine (Ketalar) Dose Level 1|Drug: Ketamine (Ketalar) Dose Level 2|Drug: Ketamine (Ketalar) Dose Level 3|Drug: Ketamine (Ketalar) Dose Level 4","Maximum Tolerated Dose of ketamine|Patient reported acceptability of any reported side effects","Grace Lim, MD, MS|National Institute of Mental Health (NIMH)|University of Pittsburgh","Female","18 Years and older   (Adult, Older Adult)","Phase 1","12","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Other","STUDY22100018|1R01MH134538-01","September 25, 2023","December 2025","July 2026","June 18, 2023",,"February 13, 2024","Magee Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT05907213"
208,"NCT00051246","Group Therapy for Postpartum Depression",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Mother-Infant Group Psychotherapy|Behavioral: Interpersonal Psychotherapy","Reduction of depression as measured by the Hamilton Rating Scale for Depression (HRSD)|Improvement in parent-infant interactions as measured by the Early Relational Assessment (ERA)","University of Wisconsin, Madison|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","147","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","R01MH062054","January 2002","July 2008","July 2008","January 8, 2003",,"January 24, 2014","University of Wisconsin Dept. of Psychiatry, Madison, Wisconsin, United States",,"https://ClinicalTrials.gov/show/NCT00051246"
209,"NCT06070168","Determining the Effect of Telephone Counseling Service Provided to Primiparous Mothers on Postpartum Depression",,"Completed","No Results Available","Depression, Postpartum","Other: Telephone Counseling","Change in postpartum depression","Ondokuz Mayıs University","Female","18 Years to 60 Years   (Adult)","Not Applicable","110","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2021/485","October 7, 2023","March 3, 2024","March 3, 2024","October 6, 2023",,"April 3, 2024","Ondokuz Mayis University, Samsun, Atakum, Turkey|Ondokuz Mayis University, Samsun, Turkey",,"https://ClinicalTrials.gov/show/NCT06070168"
210,"NCT05444179","Nutrition and Physical Activity Intervention on Psychosocial Well-Being of Postpartum Mothers",,"Not yet recruiting","No Results Available","Postpartum Depression|Lifestyle, Healthy","Behavioral: Mommies can Eat & Exercise with No Stress (MomEENS)","Edinburgh Postnatal Depression Scale|Perceived Stress Scale (PSS)|Postpartum Sleep Quality Scale (PSQS)|Positive Affect Balance Scale (PABS)|Multiple Pass 24-Hour Diet Recall|International Physical Activity Questionnaire- Short Form|Body weight measurement|Height measurement|Waist circumference measurement|Blood Pressure Assessment|Breastfeeding Self-Efficacy -Short Form (BSES-SF)","Universiti Teknologi Mara|Universiti Sains Islam Malaysia","Female","19 Years to 40 Years   (Adult)","Not Applicable","32","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","MiChild Group","August 1, 2022","October 1, 2022","December 30, 2022","July 5, 2022",,"July 5, 2022","Universiti Teknologi MARA, Shah Alam, Selangor, Malaysia","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/79/NCT05444179/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/79/NCT05444179/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT05444179"
211,"NCT05400382","Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression","MaMiDaPP","Not yet recruiting","No Results Available","Depression, Unipolar|Pain, Postoperative","Behavioral: Mindfulness","Postpartum depression|Post-operative pain","University of Illinois at Urbana-Champaign|University of Pittsburgh Medical Center|Southern Illinois University|Arrowhead Regional Medical Center|Northwestern University Feinberg School of Medicine","Female","18 Years to 45 Years   (Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MaMiDaPP","July 1, 2023","March 31, 2026","March 31, 2026","June 1, 2022",,"June 1, 2022",,,"https://ClinicalTrials.gov/show/NCT05400382"
212,"NCT04043533","The Effect of an Exercise Program in Reducing the Severity of Postpartum Depression in Women",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Exercises","Effect of exercise","Didem Kucukkelepce|Adiyaman University Research Hospital","Female","19 Years to 40 Years   (Adult)","Not Applicable","80","Other","Interventional","Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","AdıyamanUniversty","September 1, 2017","February 15, 2018","June 15, 2018","August 2, 2019",,"August 2, 2019","Didem Şimşek Küçükkelepçe, Adi̇yaman, Turkey",,"https://ClinicalTrials.gov/show/NCT04043533"
213,"NCT02843022","Effectiveness of a Web-based Nursing Intervention in the Reduction of Postpartum Depression and Parenting Stress.",,"Completed","No Results Available","Depression, Postpartum","Behavioral: standardized electronic messages|Behavioral: nurse phone call if requested|Behavioral: Staff nurse phone follow-up","postpartum depression symptoms|breastfeeding outcomes|patient satisfaction/experience|Parenting stress","Saint Anselm College|Catholic Medical Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","683","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","NURS2015-3","November 2015","February 2018","February 2018","July 25, 2016",,"April 23, 2018","Catholic Medical Center, Manchester, New Hampshire, United States",,"https://ClinicalTrials.gov/show/NCT02843022"
214,"NCT02769858","The Effects of Light Therapy on Circadian Rhythms, Sleep, and Mood in Postpartum Depression",,"Completed","Has Results","Depression, Postpartum","Device: Light therapy","Change From Baseline Score of the Hamilton Depression Rating Scale-Seasonal Affective Version (SIGH-SAD) at 5 Weeks|Change From Baseline Score of the Edinburgh Postnatal Depression Scale (EPDS) at 5 Weeks|Change From Baseline Time of Dim Light Melatonin Onset (DLMO) at 5 Weeks","University of Michigan","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","10","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","G016030","June 2015","December 2016","December 2016","May 12, 2016","December 19, 2017","April 22, 2021","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02769858"
215,"NCT03309163","Effect of Tramadol in Prevention of Postpartum Depression","ETPPD","Completed","No Results Available","Caesarean Section","Drug: Tramadol|Drug: Hydromorphone|Drug: Ropivacaine (Epidural analgesia)","The incidence of postpartum depression|EPDS scores|GAD-7 scores|QoR-15 scores|Pain intensity|Norepinephrine and serotonin levels in the blood","Xinqiao Hospital of Chongqing","Female","20 Years to 40 Years   (Adult)","Phase 4","1230","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","ETPPD Trail","October 9, 2017","June 13, 2019","August 13, 2019","October 13, 2017",,"August 14, 2019","Xinqiao Hospital, Third Military Medical University, Chongqing, Chongqing, China",,"https://ClinicalTrials.gov/show/NCT03309163"
216,"NCT05356026","Online Postpartum Follow-up on Depression and Postpartum Adaptation",,"Completed","No Results Available","Postpartum Depression|Postpartum Adaptation","Other: Online postpartum follow-up","Postpartum depression|Postpartum adaptation","Gazi University","Female","18 Years to 35 Years   (Adult)","Not Applicable","62","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2020/93","March 10, 2021","August 20, 2021","September 28, 2021","May 2, 2022",,"May 2, 2022","Gazi University, Ankara, Turkey",,"https://ClinicalTrials.gov/show/NCT05356026"
217,"NCT00436150","Interpersonal Therapy-Based Treatment to Prevent Postpartum Depression in Adolescent Mothers",,"Completed","No Results Available","Depression","Behavioral: Interpersonal therapy-based treatment|Behavioral: Standard care","Postpartum depression diagnosis|Degree of depressive symptoms|Prenatal distress|Social support","Women and Infants Hospital of Rhode Island|National Institute of Mental Health (NIMH)","Female","12 Years to 18 Years   (Child, Adult)","Not Applicable","106","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","R34MH077588|DSIR 84-CTP","February 2007","September 2009","September 2009","February 16, 2007",,"March 12, 2013","Women & Infants Hospital of Rhode Island, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00436150"
218,"NCT02235064","Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression",,"Terminated","Has Results","Depression, Postpartum","Drug: Sertraline|Drug: Placebo","Number of Participants With Development of Postpartum Depression up to 12 Weeks Following Discharge From Hospital|Number of Participants With Adverse Reaction to Treatment Agent up to 12 Weeks Following Discharge From Hospital|Reported Infant Weight at 4 Weeks Following Delivery|Number of Participants With Perceived Infant Sleeping Difficulty at 4 Weeks Postpartum|Number of Participants With Perceived Infant Feeding Difficulties 4 Weeks Postpartum|Reported Infant Weight at 8 Weeks Following Delivery|Reported Infant Weight at 12 Weeks Following Delivery|Number of Participants With Perceived Infant Sleeping Difficulty at 8 Weeks Postpartum|Number of Participants With Perceived Infant Sleeping Difficulty at 12 Weeks Postpartum|Number of Participants With Perceived Infant Feeding Difficulties 8 Weeks Postpartum|Number of Participants With Perceived Infant Feeding Difficulties 12 Weeks Postpartum","The Cooper Health System","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","2","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","CUH IRB#: 14-078","July 2014","July 2015","July 2015","September 9, 2014","April 10, 2017","March 29, 2018","Cooper University Hospital, Camden, New Jersey, United States",,"https://ClinicalTrials.gov/show/NCT02235064"
219,"NCT05196152","MomMoodBooster VA Program","Perinatal MMB","Active, not recruiting","No Results Available","Perinatal Depression|Postpartum Depression","Behavioral: MomMoodBooster|Behavioral: Phone Coaching","Change in Depressive Symptoms|Change in Behavioral Activation|Change in Negative Automatic Thoughts|Change in Anxiety Symptoms|Change in Dyadic Adjustment","University of Iowa|US Department of Veterans Affairs","Female","18 Years to 50 Years   (Adult)","Not Applicable","200","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","202102537|202104724","March 3, 2022","December 30, 2023","September 30, 2024","January 19, 2022",,"October 26, 2023","University of Iowa, Iowa City, Iowa, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/52/NCT05196152/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT05196152"
220,"NCT05206552","The Correlation Between Maternal Infant Bonding, Pain and Postpartum Depression",,"Recruiting","No Results Available","Maternal Care Patterns","Other: Questionnaire","Pain verbal numerical score after labor and maternal infant bonding.|Pain verbal numerical score after labor and postpartum depression","Rabin Medical Center","Female","18 Months and older   (Child, Adult, Older Adult)",,"200","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","0514-21","January 25, 2022","January 25, 2023","July 25, 2023","January 25, 2022",,"September 21, 2022","Beilinson hospital, Petach tikvah, Israel",,"https://ClinicalTrials.gov/show/NCT05206552"
221,"NCT01527786","Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine",,"Completed","No Results Available","Depression","Drug: Desvenlafaxine","Sheehan Disability Scale (SDS)|Montgomery-Asberg Depression Rating Scale (MADRS), the Hamilton Rating Scale- Anxiety (HAM-A), the Yale-Brown Obsessive Compulsive Scale (YBOCS), the Panic Disorder Severity Scale (PDSS), and the Penn Sate Worry Questionnaire (PSWQ).","BC Women's Hospital & Health Centre","Female","19 Years to 45 Years   (Adult)","Phase 3","25","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PRISTIQ IOP # 3151A1-44","November 2010","February 2014","February 2014","February 7, 2012",,"January 28, 2015","BC Women's Hospital, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT01527786"
222,"NCT03267563","Minimum Intervention to Maintain a Postpartum Depression Prevention Program in Clinics Serving Low-income Women","ROSE","Active, not recruiting","No Results Available","Depression, Postpartum","Behavioral: EIAU|Behavioral: LICF|Behavioral: HICF","Sustainment of core program elements|Total length of time any ROSE services were offered|Health impact: Postpartum depression (PPD) rates over time at each clinic|ROSE Intervention reach|Cost-effectiveness","Michigan State University|Butler Hospital|Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)|Palo Alto Veterans Institute for Research|University of Rochester|University of Massachusetts, Worcester|Pacific Institute for Research and Evaluation","All","18 Years and older   (Adult, Older Adult)","Not Applicable","800","Other","Interventional","Allocation: Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","MichiganSUROSE","June 12, 2018","October 31, 2023","December 31, 2023","August 30, 2017",,"December 15, 2022","Michigan State University, Flint, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03267563"
223,"NCT02495350","The Correlation Between Prelabor Analgesic Plan and Actual Labor Analgesia With Satisfaction, Postpartum Depression, and Breast Feeding Success",,"Completed","No Results Available","Depression, Postpartum","Other: Questionarie","Assessment of postpartum depression using Edinborough Postnatal Depression scale|Assessment of breast feeding duration in women undergoing vaginal deliveries|Increases in labor satisfaction defined as a vas (visual analog scale) satisfaction over 7 in women undergoing vaginal deliveries","Rabin Medical Center","Female","18 Years to 55 Years   (Adult)",,"1954","Other","Observational","Observational Model: Other|Time Perspective: Prospective","0666-14-RMC","June 2015","August 2016","September 2016","July 13, 2015",,"November 17, 2017","Beilinson hospital, Petach tikvah, Israel",,"https://ClinicalTrials.gov/show/NCT02495350"
224,"NCT02210702","Oral Contraceptive Ethinyl Estradiol Dose Effect on Postpartum Depression and Sexual Functioning Scales",,"Unknown status","No Results Available","Postpartum Depressive Mood|Postpartum Sexual Function","Drug: Ethinyl Estradiol 35mcg/Norethindrone 1mg|Drug: Ethinyl Estradiol 20mcg/Norethindrone 1mg","Change in Edinburgh Postnatal Depression Scale at baseline, 3 weeks postpartum and 6 weeks pospartum|Change in Arizona Sexual Experiences Scale scores at baseline, 3 weeks postpartum, and 6-7 weeks postpartum|Change in Brief Index of Sexual Functioning for Women scores at baseline, week 3 postpartum, and week 6-7 postpartum|Time to First Coitus|Urine Pregnancy Test","The Jones Institute","Female","18 Years to 45 Years   (Adult)","Phase 4","33","Other","Interventional","Allocation: Randomized|Intervention Model: Single Group Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Prevention","14-06-FB-0118-HOSP","July 2014","January 2015",,"August 7, 2014",,"August 7, 2014","Sentara Norfolk General Hospital, Norfolk, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT02210702"
225,"NCT00602355","Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression",,"Completed","Has Results","Depression, Postpartum","Drug: Sertraline|Drug: Placebo|Behavioral: Interpersonal psychotherapy (IPT)|Behavioral: Clinical management|Behavioral: Mothercrafting","Hamilton Depression Rating Scale (HAM-D)|Depression Illness Severity Based on Beck Depression Inventory (BDI)|Global Illness Severity Based on Clinical Global Impression (CGI) Scale|Social Functioning Based on Postpartum Adjustment Questionnaire (PPAQ)|Hamilton Anxiety Rating Scale (HARS)","Women and Infants Hospital of Rhode Island|National Institute of Mental Health (NIMH)","Female","18 Years to 50 Years   (Adult)","Phase 2","162","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","R01MH074919|R01MH074636|DSIR 83-ATP","February 2008","July 2014","July 2014","January 28, 2008","September 21, 2016","September 21, 2016","University of Iowa, Iowa City, Iowa, United States|Women and Infants Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00602355"
226,"NCT03088319","Post-natal Depression and Chronic Stress","serene","Completed","No Results Available","Depression, Postpartum",,"post natal depression|allostatic load as a composite index including blood GABA, BDNF and 8iso-Prostaglandins and capillary cortisol + heart rate variability index","Institut de Recherche Biomedicale des Armees","Female","18 Years to 40 Years   (Adult)",,"100","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2016-A00887-44","April 11, 2017","October 11, 2019","October 11, 2019","March 23, 2017",,"February 12, 2020","Marion Trousselard, Brétigny-sur-Orge, Not In US/Canada, France",,"https://ClinicalTrials.gov/show/NCT03088319"
227,"NCT03022526","CSE v. Epidural for Postpartum Depression","COPE","Completed","Has Results","Depression, Postpartum|Labor Pain","Procedure: CSE|Procedure: Epidural|Drug: Bupivacaine / fentaNYL","Edinburgh Postnatal Depression Score (EPDS)|Pain Score on Average (BPI - Short Form)|Perceived Stress (PSS)|Number of Participants Currently Breastfeeding at 2 Days Postpartum (Yes/No)|Number of Participants Currently Breastfeeding at 6 Weeks Postpartum (Yes/No)|Number of Participants Currently Breastfeeding at 3 Months Postpartum (Yes/No)|Parent-Infant Attachment (MPAS)|Child Development (ASQ-3) Personal Social Score|Parenting Self-efficacy (PMP-SE)|Parenting Self-Efficacy (PMP-SE)","Grace Lim, MD, MS|University of Pittsburgh","Female","18 Years to 50 Years   (Adult)","Not Applicable","61","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","PRO16060602","January 2017","December 31, 2019","December 31, 2019","January 16, 2017","August 10, 2020","August 19, 2020","Magee Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/26/NCT03022526/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03022526"
228,"NCT05423093","Virtual Group Psychoeducational Discussions With Spanish-Speaking Mothers of Infants in Pediatric Primary Care",,"Recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety","Behavioral: Single-Session Virtual Group Psychoeducational Session about Postpartum Depression","Satisfaction as assessed by the Intervention Satisfaction Survey|Acceptability of intervention Measure|Intervention Appropriateness Measure (IAM)|Acceptability of the Intervention as assessed by the Intervention Appropriateness Measure|Feasibility of Intervention Measure|Change in mental health care stigma as assessed by the Stigma Concerns about Mental Health Care (SCMHC) scale|Change in Depression Stigma as assessed by the Adapted Personal Stigma Scale (PSS)|Change in Postpartum Depression Knowledge as assessed by Adapted Postpartum Depression Knowledge Measure|Change in Intention to disclose if developed postpartum depression symptoms as assessed by questionnaire|Intention to seek primary care as assessed by questionnaire|Mental health utilization as assessed by the Mental Health Service Utilization|Psychosocial Resource Utilization as assessed by questionnaire","Johns Hopkins University|National Institute of Mental Health (NIMH)","Female","16 Years to 99 Years   (Child, Adult, Older Adult)","Not Applicable","32","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","IRB00170216|1K23MH118431-01A1","June 9, 2022","November 30, 2023","September 9, 2024","June 21, 2022",,"December 5, 2023","Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT05423093"
229,"NCT06049433","Maternal Mental Health Access - MaMa","MaMa","Recruiting","No Results Available","Postpartum Depression|Perinatal Depression","Behavioral: Maternal Mental Health Access for Postpartum Depression- Prevention and UPLIFT- intervention|Behavioral: On-Demand + Discussion board (DB)|Behavioral: Arm 2|Behavioral: On Demand (OD) + Video Conference (VC)|Behavioral: Arm 3","Implementation outcome; Feasibility and acceptability|Sociocultural Determinants and Behavior","University of Utah|National Institute of Nursing Research (NINR)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","120","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","00159109|RF1NR020841","April 4, 2023","June 30, 2025","September 30, 2025","September 22, 2023",,"September 22, 2023","University of Utah, Salt Lake City, Utah, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/33/NCT06049433/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT06049433"
230,"NCT06276647","Improving Health Outcomes and Equity by Targeting Postpartum Mothers at Highest Risk","HOME","Recruiting","No Results Available","Maternal Behavior|Postpartum Depression","Behavioral: HOME","Emergency Department (ED) Visits and Readmissions|Ability to Obtain Needed Services|Depressive Symptoms","University of Pennsylvania|National Institutes of Health (NIH)|Columbia University|National Institute on Minority Health and Health Disparities (NIMHD)","Female","18 Years to 55 Years   (Adult)","Not Applicable","214","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","850584|R01MD016029","February 20, 2024","February 15, 2025","May 31, 2025","February 26, 2024",,"March 1, 2024","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT06276647"
231,"NCT06148831","Carrying for the Culture",,"Recruiting","No Results Available","Postpartum Depression|Breast Feeding","Device: Infant Carrier","Depression Scale Score of Each Participant|Number of Weeks of Lactation of Each Participant|Proportion of Parents who Exclusively Breastfed their Infant|Lactation Frequency of Each Participant|Cultural Models of Infant Care Score of Each Participant|Average Crying Frequency of Infant|Participant Breastfeeding Self-Efficacy Score|Participant Ability to Access Human Milk Score|Participant Responsiveness to Infant Feeding Cues Score|Mother to Infant Bonding Scale Score","Nurturely","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","400","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","23","January 8, 2024","December 2027","December 2028","November 28, 2023",,"March 22, 2024","Nurturely, Eugene, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT06148831"
232,"NCT05676918","Maternal Well-being in the Postnatal Stage","BIEMAT","Recruiting","No Results Available","Postpartum Depression|Postpartum Disorder","Behavioral: Positive Psychology Intervention|Behavioral: Cognitive Behavior Therapy","Postpartum depression change|Positive and Negative Affect change|Satisfaction with life change (SWLS). Scores range from 5 to 35, where higher scores mean a better outcome.|Beliefs about pregnancy change|Psychological well-being change|Maternal filial bond in the postpartum change|Maternal self-efficacy change","Universidad Complutense de Madrid|Universidad Pontificia de Salamanca","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","98","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","UCM-UPS-WELLBEING","January 16, 2023","June 2024","June 2024","January 9, 2023",,"June 7, 2023","Covadonga Chaves Vélez, Madrid, Pozuelo De Alarcón, Spain",,"https://ClinicalTrials.gov/show/NCT05676918"
233,"NCT05852314","A Problem-Solving Intervention for Women With Suicidal Ideation During Postnatal Period in Pakistan",,"Recruiting","No Results Available","Postnatal Depression","Behavioral: Culturally Adapted Manual Assisted Therapy (CMAP-SI)","System Usability Scale|Beck Scale for Suicidal Ideation (BSS) (Beck et al., 1988)|Suicide Attempt and Self-Harm (SASH) (Eylem, 2011)|Edinburgh postnatal depression scale (EPDS) (Cox et al., 1987)|Beck Depression Inventory (BDI) (Beck et al., 1961)|Life Events Checklist (Husain et al., 2000)|Oslo- 3 Social Support Scale (O3SSS) (Dalgard, 2009)|Euro Quol (EQ-5D) (Rabin & Charro, 2001)","Pakistan Institute of Living and Learning","Female","16 Years to 44 Years   (Child, Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","CMAP- PND","July 10, 2023","June 2024","June 2024","May 10, 2023",,"August 29, 2023","Benazir Bhutto Hospital, Rawalpindi, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT05852314"
234,"NCT03715218","Impact of Mothers Touch Program to Improve Maternal Health After Birth",,"Completed","No Results Available","Post Partum Depression|Quality of Life","Other: Mothers Touch Program|Other: Usual Care Program","Change in Post-natal depression|Change in Quality of Life","NMP Medical Research Institute|Warwick Research Services|Mothers Touch Foundation, India","Female","18 Years to 35 Years   (Adult)","Not Applicable","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","NMP 0146","January 21, 2018","May 15, 2018","August 12, 2018","October 23, 2018",,"October 23, 2018","NMP Medical Reserach Institute, Jaipur, Rajasthan, India",,"https://ClinicalTrials.gov/show/NCT03715218"
235,"NCT04821544","Maternal Stress on Human Milk and Infant Outcomes",,"Recruiting","No Results Available","Postpartum Depression|Preterm Labor","Behavioral: Mindfulness-based intervention (with a focus on self-compassion; MBSC)","Maternal Stress - Biomarker Change|Maternal Stress - Psychometric Measure Change|Maternal Self-compassion - Biomarker Change|Maternal Self-compassion - Psychometric Measure Change|Human Milk Proteins & Peptides Change|Maternal Metabolomic & Transcriptomic Changes|Infant Metabolomic & Transcriptomic Changes","University of Idaho|Oregon Health and Science University|Oregon State University|National Institute of General Medical Sciences (NIGMS)|Kootenai Health","Female","18 Years to 50 Years   (Adult)","Not Applicable","500","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","20-024|5U54GM104944-08","May 1, 2021","June 30, 2025","June 30, 2025","March 29, 2021",,"September 6, 2023","Kootenai Health, Coeur d'Alene, Idaho, United States|Oregon Health & Science University, Portland, Oregon, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/44/NCT04821544/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT04821544"
236,"NCT04998565","Add-on Effectiveness of EA or TENS in Early Postpartum Breast Engorgement","ETBEG","Terminated","No Results Available","Breast Engorgement in Puerperium|Post Partum Depression","Other: Routine care|Procedure: Electrical Acupuncture|Procedure: Transcutaneous Electrical Nerve Stimulation","Severity Index (0-19)|EPDS|BSES-SF","China Medical University Hospital","Female","18 Years to 50 Years   (Adult)","Not Applicable","2","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","CMUH106-REC1-101","September 12, 2017","June 30, 2018","July 31, 2019","August 10, 2021",,"August 10, 2021","China Medical University Hospital, Taichung, Taiwan",,"https://ClinicalTrials.gov/show/NCT04998565"
237,"NCT03470675","Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries",,"Active, not recruiting","No Results Available","Pain|Postpartum Depression","Drug: Epidural saline + IV saline|Drug: Epidural morphine 3 mg + IV saline|Drug: Epidural morphine 3 mg + IV ketamine 0.3 mg/kg","Perineal pain in postpartum patients 1 week after obstetric anal sphincter injuries.|Perineal Pain|Presence of postpartum depression|Assessment of maternal-infant bonding|Medoc Pathway Device Score|Maternal quality of life|Female sexual function|Promis 29 profile|Brief Pain Inventory (Short Form) Modified","Northwestern University","Female","18 Years and older   (Adult, Older Adult)","Phase 4","67","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","STU00206016","June 27, 2018","May 30, 2024","June 30, 2024","March 20, 2018",,"October 27, 2023","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03470675"
238,"NCT03420755","Integrating Text Messages Into the Mothers and Babies Course",,"Completed","No Results Available","Perinatal Depression|Postpartum Depression","Behavioral: Mothers and Babies 1-on-1|Behavioral: Mothers and Babies Plus Text","Text messages read by HV clients|Home Visitor Adherence to MB-TXT protocol|Client completion of personal projects|Client perceived utility and comprehension of text messages|Depressive Symptoms|Cognitive Structuring|Behavioral Activation|Social Support|Mood regulation|Mothers and Babies Skill Utilization","Northwestern University|National Institute on Minority Health and Health Disparities (NIMHD)","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","63","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STU00203918-A|1R21MD011320-01","June 7, 2017","February 28, 2019","March 31, 2019","February 5, 2018",,"November 15, 2019","Northwestern University, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT03420755"
239,"NCT02979444","Comparing the Effectiveness of Clinicians and Paraprofessionals to Reduce Disparities in Perinatal Depression",,"Completed","Has Results","Perinatal Depression|PostPartum Depression","Behavioral: Mothers and Babies Groups","The Change in QIDS-16 Scores From Baseline to 24 Weeks Postpartum|The Change in the Behavioral Activation Scale From Baseline to 24-weeks Postpartum|The Change in the Negative Mood Regulation Scale|The Change in the MOS Social Support Survey From Baseline to 24-Weeks Postpartum|The Change in the Experiences Questionnaire From Baseline to 24-Weeks Postpartum","Northwestern University","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","874","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STU00203761","August 2016","August 5, 2019","August 13, 2020","December 1, 2016","April 13, 2020","October 5, 2020","Northwestern University, Chicago, Illinois, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/44/NCT02979444/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/44/NCT02979444/SAP_001.pdf","https://ClinicalTrials.gov/show/NCT02979444"
240,"NCT05215028","Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study","MALO_2","Completed","No Results Available","Child Development Disorder|Post Partum Depression","Device: web-application","impact on neurodevelopmental disorders detection|impact on hearing disorders|impact on visual disorders|impact on mandatory or recommended vaccines|impact on postnatal depression","Weprom|Kelindi","All","up to 3 Years   (Child)",,"4346","Other|Industry","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","WP-2022-02","November 11, 2021","January 7, 2022","January 7, 2022","January 31, 2022",,"January 31, 2022","ILC, Le Mans, France",,"https://ClinicalTrials.gov/show/NCT05215028"
241,"NCT01744041","Mommy-Baby Treatment for Perinatal Depression",,"Completed","Has Results","Depressive Disorder, Major|Postpartum Depression","Behavioral: Dyadic Interpersonal Psychotherapy|Other: Enhanced Treatment as Usual","Change in Edinburgh Depression Scale From Baseline","Washington University School of Medicine|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","42","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","201203136|K23MH090245","November 2012","January 31, 2017","January 31, 2017","December 6, 2012","January 11, 2022","January 11, 2022","Washington University School of Medicine, Saint Louis, Missouri, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/41/NCT01744041/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT01744041"
242,"NCT00361478","Effect of the 'Mother and Baby' Program on Well-Being",,"Completed","No Results Available","Postnatal Depression","Behavioral: Exercise and education|Behavioral: Education","Affect Balance Scale|Edinburgh Postnatal Depression Scale|Exercise level","University of Melbourne","Female","18 Years to 45 Years   (Adult)","Phase 3","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","07/2004","July 2005","August 2006","August 2006","August 8, 2006",,"August 13, 2008","The Angliss Hospital, Ferntree Gully, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT00361478"
243,"NCT01217658","Measuring and Reducing Excessive Infant Crying","UTHealth THB","Completed","No Results Available","Infant Colic|Postpartum Depression","Behavioral: The Happiest Baby on The Block|Behavioral: AAP Infant Colic counseling","Mean night-time crying|Mean sleep duration|Maternal Depression, Anxiety and Somatization|Salivary Biomarkers","The University of Texas Health Science Center, Houston|National Institutes of Health (NIH)|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","3 Weeks to 5 Weeks   (Child)","Not Applicable","28","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSC-MS-10-0392|K23HD065872","January 2011","September 2015","September 2015","October 8, 2010",,"December 8, 2015","University of Texas Health Science Center at Houston, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT01217658"
244,"NCT04279093","Digital Assessment of Well-being in New Parents","DAWN-P","Completed","No Results Available","Postnatal Depression","Other: No intervention, but participants will use a smartphone app daily to complete the EPDS","Percentage of app based EPDS (Edinburgh Postnatal Depression Scale) assessments completed during the app-use phase|Percentage of eligible individuals recruited to the study|Dropout rate - percentage of participants who consent to take part in the study dropping out during the app use phase|Percentage of participants completing at least a third of app-based assessments|Percentage of participants completing at least half of app-based assessments|Transcripts from qualitative interviews with parents who have used the screening app regarding acceptability of the app|abridged Mobile App Rating Scale|Edinburgh Postnatal Depression Scale - app-based version|Edinburgh Postnatal Depression Scale - paper version|Number of adverse events occurring during the app-use phase of the study|Qualitative interview data on participants' experience of using the app.|Demographic questionnaire|BMI (from casenotes)|past psychiatric history as reported in casenotes (any history of major depression, previously prescribed psychiatric medication, previously referred for talking therapy)|Answers to mental health screening questions at booking appointment (NICE, 2014: section 1.5.4)|Details of current childbirth (mode of delivery, live/still birth, any major obstetric complications)|parity (total number of pregnancies reaching viable gestational age)","Emily Eisner|Manchester University NHS Foundation Trust|Manchester Academic Health Science Centre","All","18 Years and older   (Adult, Older Adult)",,"23","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","274007","April 14, 2020","September 9, 2020","September 9, 2020","February 20, 2020",,"May 2, 2022","University of Manchester, Manchester, Greater Manchester, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/93/NCT04279093/Prot_SAP_002.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/93/NCT04279093/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04279093"
245,"NCT04565730","Different Anesthesia Methods on Development of Postnatal Depression After Cesarean Delivery",,"Completed","No Results Available","Pregnancy Related","Other: Grup I= General anesthesia group|Other: Grup II= Spinal anesthesia group","Development of postnatal depression","Medipol University","Female","18 Years to 50 Years   (Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","Medipol Hospital 16","October 27, 2020","July 30, 2023","August 10, 2023","September 25, 2020",,"August 14, 2023","Istanbul Medipol University Hospital, Istanbul, Bagcilar, Turkey",,"https://ClinicalTrials.gov/show/NCT04565730"
246,"NCT06253390","New Cognitive Treatment for Peripartum Depression","MCT-DPP","Recruiting","No Results Available","Postnatal Depression","Behavioral: Metacognitive training|Behavioral: control","EPDS score","CHU de Reims","Female","18 Years to 45 Years   (Adult)","Not Applicable","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","PO23063*","January 10, 2024","June 2028","December 2028","February 12, 2024",,"February 12, 2024","Chu Reims, Reims, France",,"https://ClinicalTrials.gov/show/NCT06253390"
247,"NCT00251342","Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale",,"Unknown status","No Results Available","Depression, Postpartum","Procedure: Edinburgh Postnatal Depression Scale","Mother's mental health at 6 months postpartum, as measured on the EPDS and General Health Questionnaire-12 (GHQ-12), both being self-report questionnaires.|Mother's parenting stress (measured by the Parenting Stress Index, a self-report questionnaire)|Marital relationship satisfaction (measured by the Chinese Kansas Marital Satisfaction Scale, a self-report questionnaire)|Marital status and employment status (both father and mother, where applicable) at 6 and 18 months postpartum|Child health measures, including weight at 6 and 18 months, number of hospitalizations and visits to doctors within the first 6 and 18 months as reported by mother|Mother's mental health outcome (EPDS and GHQ scores) at 18 months postpartum","Chinese University of Hong Kong|Hong Kong Department of Health|The University of Hong Kong","Female","Child, Adult, Older Adult","Phase 2|Phase 3","460","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double|Primary Purpose: Diagnostic","CRE-2005.224-T|CUHK_CCT00019","October 2005",,"January 2008","November 10, 2005",,"April 5, 2007","Maternal and Child Health Centres, Department of Health, Hong Kong, China",,"https://ClinicalTrials.gov/show/NCT00251342"
248,"NCT04820920","Online LTP+CaCBT for Treating Depression in British Mothers of African/Caribbean Heritage",,"Unknown status","No Results Available","Postnatal Depression","Behavioral: LTP|Behavioral: CaCBT|Behavioral: Psychoeducation","Change in postnatal depression is being assessed|Change in postnatal anxiety is being assessed|Change in health is being assessed|Change in social support is being assessed|Change in health-related quality of life is being assessed|Change in service satisfaction is being assessed|Change in child physio-emotional development is being assessed|Change in parenting knowledge of child development is being assessed","Nottingham Trent University|University of Manchester|Teesside University|Sheffield Hallam University","Female","18 Years to 60 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","0000-0001-5034-0335a","September 14, 2021","April 30, 2023","August 30, 2023","March 29, 2021",,"November 24, 2021","Nottingham Trent University, Nottingham, England, United Kingdom",,"https://ClinicalTrials.gov/show/NCT04820920"
249,"NCT04368208","Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression","DEPRECOVID","Completed","No Results Available","Postnatal Depression","Other: Assessment of postnatal depression using the the Edinburgh questionnaire between 4 and 6 weeks after delivery","Report postnatal depression between 4 of 6 weeks during the covid 19 pandemia|Report factors associated with postnatal depression between 4 of 6 weeks during the covid 19 pandemia|Describe the experience and the satisfaction about delivery during the covid 19 pandemia","Poitiers University Hospital","Female","18 Years to 50 Years   (Adult)",,"501","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2020-A01065-34","April 29, 2020","October 21, 2020","November 27, 2020","April 29, 2020",,"January 26, 2021","Bertrand GACHON, Poitiers, France",,"https://ClinicalTrials.gov/show/NCT04368208"
250,"NCT05382884","The SUPPORT Study: Effectiveness and Usability of a Web-Enabled Resource for Postpartum Mental Health","SUPPORT","Completed","No Results Available","Postpartum Depression|Postpartum Anxiety|Postnatal Depression|Perinatal Disorder|Perinatal Depression|Postpartum Disorder","Other: Postpartumcare.ca (Web-Enabled Intervention)","Change from Baseline Postpartum Depression at 4 weeks and 6 weeks, evaluated using the Edinburgh Postnatal Depression Scale (EPDS).|Change from Baseline Postpartum Anxiety at 4 weeks and 6 weeks, evaluated using the Perinatal Anxiety Screening Scale (PASS).|Website usability, as evaluated using the System Usability Scale (SUS)|Website satisfaction, evaluated using the Patient Global Impression of Change (PGIC) questionnaire|Website satisfaction, evaluated using the user-perceived web quality instrument|Website satisfaction, evaluated using the Patient Education Materials Assessment Tool (PEMAT)|Website metrics including average time on page, average session duration, returning visitors, and number of pages visited per session.","University of British Columbia|Women's Health Research Institute of British Columbia|Canadian Institutes of Health Research (CIHR)","All","19 Years and older   (Adult, Older Adult)","Phase 2","103","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","H21-03407","April 20, 2022","April 1, 2023","May 1, 2023","May 19, 2022",,"May 10, 2023","Women's Heath Research Institute, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT05382884"
251,"NCT02526407","The Impact of Creative Interventions on Symptoms of Postnatal Depression",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Singing|Behavioral: Group play","Postnatal depression|Mental wellbeing|Self-esteem|Social functioning|Inflammatory immune response","Royal College of Music|Chelsea and Westminster NHS Foundation Trust|Imperial College London","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","153","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","SATB2015","October 19, 2015","July 31, 2016","September 30, 2016","August 18, 2015",,"April 13, 2017","Chelsea and Westminster Hospital, London, United Kingdom|Centre for Performance Science, Royal College of Music, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02526407"
252,"NCT00681668","Quetiapine in Postpartum Depression",,"Terminated","Has Results","Postpartum Depressive Disorder","Drug: Quetiapine","The Change in the Hamilton Rating Scale for Depression (HAM-D)|Change in Efficacy Scales: Clinical Global Impression (CGI), Montgomery Asberg Depression Rating Scale (MADRS), Brief Psychiatric Rating Scale (BPRS)|Change in Functional Outcome: Global Assessment of Functioning (GAF), Parental Bonding Questionnaire (PBQ)|Electrocardiogram (ECG), Vital Signs, Laboratory","AstraZeneca","Female","18 Years to 39 Years   (Adult)","Phase 2","5","Industry","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","D1449L00023","August 2007","October 2008","October 2008","May 21, 2008","September 17, 2010","December 21, 2010","Research Site, Herten, Westfalen-Lippe, Germany",,"https://ClinicalTrials.gov/show/NCT00681668"
253,"NCT04017442","Neuraxial Preservative Free Morphine for Normal Spontaneous Vaginal Delivery",,"Completed","No Results Available","Postpartum Pain|Postpartum Depression|Opioid Consumption","Drug: Preservative Free Morphine|Drug: Saline","Opioid Consumption|Pain Score|Obstetric Quality of Recovery Score (OBSQ10)|Edinburgh Postnatal Depression Scale (EPDS)|Number of participants with breast feeding success","Icahn School of Medicine at Mount Sinai","Female","18 Years and older   (Adult, Older Adult)","Phase 4","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","GCO 18-2789","October 19, 2019","August 31, 2023","August 31, 2023","July 12, 2019",,"September 21, 2023","Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT04017442"
254,"NCT03836430","The Impact of a Newborn Behavioral Intervention on the Mental Health of Mothers With Late Pre-Term Infants","BabyAMOR","Completed","No Results Available","Postpartum Depression|Preterm Infant|Infant Development","Behavioral: Newborn Behavioral Observation-Family Wellness (NBO-FW)","Maternal postpartum depression|Maternal parenting stress|Parenting confidence|Positive Parenting Quality|Safe sleep practices|Breastfeeding|Participation in well child visits","Brigham and Women's Hospital|Child Trends","Female","18 Years to 50 Years   (Adult)","Not Applicable","208","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","2018P001771","August 1, 2019","May 5, 2022","May 5, 2022","February 11, 2019",,"August 17, 2022","Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT03836430"
255,"NCT05285215","Integrated Psychological Program for Management of Postnatal Depression and Persistent Postpartum Pain After Childbirth","CODEPAD-II","Recruiting","No Results Available","Depression, Postpartum","Procedure: Integrated psychological program (IPP)","The incidence of postnatal depression in both groups|The incidence of persistent postpartum pain (PPP) in both groups|Breastfeeding self-efficacy in both groups|Postpartum bonding in both groups|Health status in both groups","KK Women's and Children's Hospital","Female","21 Years to 50 Years   (Adult)","Not Applicable","1480","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","CSAINV21jun-0008","April 18, 2022","December 31, 2025","December 31, 2026","March 17, 2022",,"August 9, 2023","KK Women's and Children's Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT05285215"
256,"NCT02526433","The Impact of Creative Interventions on Symptoms of Postnatal Depression (Cohort Study)",,"Completed","No Results Available","Depression, Postpartum",,"Depression|Mental wellbeing|Social functioning|Self-esteem|Further questions assessing health and wellbeing including perceived health, health service utilisation, mother-infant bond and creative participation","Royal College of Music|Imperial College London","Female","18 Years and older   (Adult, Older Adult)",,"2558","Other","Observational","Observational Model: Case-Only|Time Perspective: Cross-Sectional","SATB2015b","October 19, 2015","January 31, 2017","January 31, 2017","August 18, 2015",,"April 13, 2017","Centre for Performance Science, Royal College of Music, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT02526433"
257,"NCT05698394","Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth",,"Active, not recruiting","No Results Available","Prenatal Depression|Ketamine|Postpartum Depression","Drug: Esketamine|Drug: Placebo","Incidence maternal depression at 2 years postpartum|PHQ-9 scores and incidence of moderate-severe depression in women at 2 years postpartum.|Incidence of chronic pain in women at 2 years postpartum|Incidence of developmental delay in offspring at 2 years of age","Peking University First Hospital","Female","18 Years and older   (Adult, Older Adult)","Phase 4","364","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2022-562","June 19, 2020","August 2024","November 2024","January 26, 2023",,"January 26, 2023","Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China|Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China|Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China|Peking University First Hospital, Beijing, China",,"https://ClinicalTrials.gov/show/NCT05698394"
258,"NCT05643898","""Mamá, te Entiendo"" App-based Intervention for Reducing Depressive Symptoms in Postpartum Women",,"Not yet recruiting","No Results Available","Minor Depressive Disorder|Major Depressive Disorder|Post Partum Depression","Behavioral: Mamá, te entiendo (Mom, I get you)","Intervention's acceptability by credibility/expectancy|Satisfaction with the intervention|Participants' adherence to the intervention|Participants' usability of the intervention|Participants' adherence to the homework exercises|Engagement with the intervention|Intervention's acceptability by participant's experience|Resources needed to complete the intervention|Change in depression diagnosis|Change in depressive symptoms|Change in postpartum depressive symptoms|Change in perceived social support|Change in mother-infant bonding|Change in satisfaction and self-efficacy regarding motherhood|Mental Healthcare Services Use from T0 to T1|Mental Healthcare Services Use from T1 to T2","Pontificia Universidad Catolica de Chile|Agencia Nacional de Investigación y Desarrollo|Instituto Milenio para Investigación en Depresión y Personalidad","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","66","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","210824004","March 1, 2023","November 1, 2023","November 1, 2023","December 9, 2022",,"December 9, 2022",,,"https://ClinicalTrials.gov/show/NCT05643898"
259,"NCT02213601","Efficacy of Yoga for Postpartum Depression",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Yoga","Change from baseline in depression on the 17-item Hamilton Depression Rating Scale (HDRS) at week 8|Change from baseline in panic symptoms on the Inventory of Depression and Anxiety Symptoms Panic Scale (IDAS) at week 8|Change from baseline in social anxiety symptoms on the Inventory of Depression and Anxiety Symptoms Social Anxiety Scale (IDAS) at week 8|Change from baseline in traumatic intrusion symptoms on the Inventory of Depression and Anxiety Symptoms Traumatic Intrusions Scale (IDAS) at week 8|Change from baseline in health-related quality of life symptoms on the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) at week 8","University of Iowa","Female","18 Years to 45 Years   (Adult)","Not Applicable","57","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","201105725","June 2011","October 2012",,"August 11, 2014",,"August 11, 2014","University of Iowa, Iowa City, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT02213601"
260,"NCT04045132","Social Media-Based Parenting Program for Women With Postpartum Depressive Symptoms",,"Completed","Has Results","Postpartum Depression|Parenting|Parent-Child Relations","Behavioral: Social Media-Based Parenting Program|Behavioral: MoodGym","The Parent Child Early Relational Assessment (PCERA)|The Edinburgh Postnatal Depression Scale (EPDS)|The Beck Depression Inventory (BDI-II)|The Parenting Sense of Competence Scale (PSOC)|The Parenting Stress Index-Short Form (PSI-SF)|The National Comorbidity Survey (NCS)|Multi-dimensional Scale of Perceived Social Support (MSPSS)|Therapeutic Factors Inventory (TFI-8)|Acceptability Survey|MoodGym Acceptability Survey","Children's Hospital of Philadelphia|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","19-016174|R61MH118405|19-016174-B","December 17, 2019","October 7, 2021","October 7, 2021","August 5, 2019","February 11, 2022","December 27, 2023","Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/32/NCT04045132/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/32/NCT04045132/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04045132"
261,"NCT05800509","Gestational Diabetes and Perinatal Depression: an Intervention Program",,"Not yet recruiting","No Results Available","Gestational Diabetes Mellitus|Postpartum Depression|Perinatal Depression","Behavioral: Clips Intervention|Device: Structured Questionnaire Only","Number and percentage of participants with interventional health education as accessed by the questionnaire of EPDS change from baseline within the period from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the self-drafted questionnaire of social support change from baseline within the period from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the questionnaire of PPAQ change from baseline within the period from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the self-drafted questionnaire of habit of diet change from baseline within the period from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the medical record of maternal body weight in kilograms change from baseline of pre-pregnancy within the 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the medical record of maternal BMI in kg/m^2 change from baseline of pre-pregnancy within the 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the questionnaire of knowledge and self-management of gestational diabetes mellitus change from baseline from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the self-drafted questionnaire of health belief change from baseline within the period from 22nd week of pregnancy to 6 months after delivery.|Number and percentage of participants with interventional health education as accessed by the medical record of their perinatal complications.|Number and percentage of participants with interventional health education as accessed by the medical record of their infants' body weight in kilograms.","National Taiwan University Hospital|Mackay Memorial Hospital|Taiwan Adventist Hospital|Taipei Veterans General Hospital, Taiwan","All","20 Years and older   (Adult, Older Adult)","Not Applicable","226","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Supportive Care","202103014RINC","April 2023","July 2024","July 2024","April 5, 2023",,"April 5, 2023",,,"https://ClinicalTrials.gov/show/NCT05800509"
262,"NCT06275217","Mindful Yoga for Postpartum Depression",,"Recruiting","No Results Available","Mood Disorders","Behavioral: Mindfulness-based yoga program|Other: Psychoeducation","Edinburgh Postnatal Depression Scale|Depression Anxiety Stress Scale-Depression|Depression Anxiety Stress Scale-Anxiety|Depression Anxiety Stress Scale-Stress|Pittsburgh Sleep Quality Index|36 Item-Short Form Health Survey Questionnaire|Five Facet Mindfulness Questionnaire|Pregnancy Symptom Inventory|Cortisol concentration level|Physical fitness|Balance","The Hong Kong Polytechnic University","Female","18 Years to 60 Years   (Adult)","Not Applicable","198","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Outcomes Assessor)|Primary Purpose: Treatment","HMRF17182481","January 8, 2021","July 15, 2025","December 31, 2025","February 23, 2024",,"February 23, 2024","The Hong Kong Polytechnic University, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT06275217"
263,"NCT02010840","The Effect of a Father Inclusive Psychoeducation Program on Postnatal Depression",,"Unknown status","No Results Available","Pregnancy","Behavioral: Psychoeducation program","Edinburgh Postnatal Depression Scale|Dyadic Adjustment Scale|Medical Outcomes Study Short Form 12-item Health Survey","The University of Hong Kong|Education Bureau, The Government of the Hong Kong Special Administrative Region","All","18 Years and older   (Adult, Older Adult)","Not Applicable","1152","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","748113","July 2014","November 2016","November 2016","December 13, 2013",,"December 2, 2015","The University of Hong Kong, Hong Kong, Hong Kong",,"https://ClinicalTrials.gov/show/NCT02010840"
264,"NCT05830266","Mother-infant Bonding in the Brain: a Mindfulness-based Intervention",,"Recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety|Parental Stress","Behavioral: ""Mindful with your Baby"" group-based therapist-guided intervention|Behavioral: ""Mindful with your baby"" self-guided online intervention","Change from baseline postpartum depressive symptoms|Change from baseline postpartum anxiety symptoms|Change from baseline parental stress|Change from baseline mother-infant bonding|Change from baseline neural synchrony between mother and infant (EEG outcome 1)|Change from baseline neural synchrony between mother and infant (EEG outcome 2)|Change from baseline postpartum-specific anxiety|Change from baseline worry|Change from baseline mindfulness skills|Change from baseline self-compassion|Change from baseline bonding|Change from baseline infant temperament|Change from baseline mindful parenting|Change from baseline parenting self-efficacy|Change from baseline personal goal","Tilburg University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","222-2022-166","July 1, 2023","May 2024","August 2024","April 26, 2023",,"April 10, 2024","Tilburg University, Tilburg, North Brabant, Netherlands",,"https://ClinicalTrials.gov/show/NCT05830266"
265,"NCT02122393","A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression",,"Completed","No Results Available","Depression|Anxiety","Drug: Sertraline|Behavioral: Cognitive Behavioural Therapy","Beck Depression Inventory|Beck Anxiety Inventory|Parenting Stress Index","University of Melbourne|Pfizer","Female","18 Years to 40 Years   (Adult)","Phase 3","45","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","H2001/01263","April 2002","April 2005","April 2005","April 24, 2014",,"April 29, 2014","Austin Health, Melbourne, Victoria, Australia",,"https://ClinicalTrials.gov/show/NCT02122393"
266,"NCT01453114","Cognitive-Behavioral Therapy (CBT) in Women Discontinuing Antidepressant for Pregnancy",,"Completed","No Results Available","Depression|Postpartum Depression|Antenatal Depression","Behavioral: Cognitive Behavioral Therapy","Relapse|Depression severity","Massachusetts General Hospital","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","15","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2008P002161","November 2008","July 2012","July 2012","October 17, 2011",,"April 7, 2015","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT01453114"
267,"NCT02053649","Integrated Chronotherapy for Perinatal Depression",,"Completed","No Results Available","Depression|Major Depressive Disorder|Postpartum Depression","Behavioral: Triple Chronotherapy|Other: Usual Care","Change in Depression Score|Sleep/Circadian Behavior","Rhode Island Hospital|The Depressive and Bipolar Disorder Alternative Treatment Foundation|National Institute of Mental Health (NIMH)","Female","18 Years to 40 Years   (Adult)","Not Applicable","24","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","540053-2|1R34MH104377-01A1","January 2014","January 15, 2019","February 28, 2019","February 4, 2014",,"May 29, 2019","Miriam Hospital Women's Medicine Collaborative, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT02053649"
268,"NCT04925765","Virtual Reality Biofeedback for Postpartum Anxiety and Depression","VITALISE","Completed","No Results Available","Anxiety and Depression|Postpartum Depression|Pregnancy Related","Device: Flowly (TMC-CP01)","Post-Session Feasibility and Acceptability|State-Trait Anxiety Inventory (STAI)|Edinburgh Postnatal depression scale (EPDS)","Grace Lim, MD, MS|University of Pittsburgh","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","8","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STUDY21040063","September 1, 2021","September 30, 2021","October 15, 2021","June 14, 2021",,"February 4, 2022","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04925765"
269,"NCT01646463","Pilot Trial of CenteringPregnancy With Mindfulness Skills",,"Completed","No Results Available","Premature Birth|Low Birth Weight|Postpartum Depression","Behavioral: CenteringPregnancy|Behavioral: CenteringPregnancy with Mindfulness Skills","preterm birth|birth weight|postpartum depression|change in and level of perceived stress|change in and type(s) of coping|change in and level of mindfulness|change in and level of positive and negative emotion|change in and level of pregnancy-related anxiety|change in and level of depressive mood|change in and levels of salivary cortisol|change in and level of adrenocorticotropic hormone (ACTH)|change in and levels of corticotropin releasing hormone (CRH)|change in and levels of blood pressure","University of California, San Francisco","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","49","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","K01AT005270","January 2011","May 3, 2017","May 3, 2017","July 20, 2012",,"February 17, 2020","University of California, San Francisco, San Francisco, California, United States",,"https://ClinicalTrials.gov/show/NCT01646463"
270,"NCT03949465","rTMS for Peripartum Depression",,"Withdrawn","No Results Available","Postpartum Depression|Antepartum Depression|Peripartum Depression","Device: Transcranial Magnetic Stimulator","Change in Montgomery-Asberg Depression Rating Scale (MADRS) scores|Rate of Clinical Remission of Depressive Symptoms|Rate of Clinical Response in Depressive Symptoms|Perinatal Anxiety Symptoms|Anxiety Symptoms|Antenatal Maternal Attachment|Postnatal Maternal Attachment|Quick Inventory of Depressive Symptomatology- Self-report (QIDS-SR)","University of Calgary","Female","18 Years to 40 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","REB18-1175","May 18, 2023","May 18, 2023","May 18, 2023","May 14, 2019",,"September 13, 2023","University of Calgary, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT03949465"
271,"NCT06277661","The Mom and Infant Outcomes (MOMI) Study",,"Not yet recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety|Cardiometabolic Syndrome","Behavioral: MOMI PODS|Behavioral: Enhanced Usual Care (EUC)","Change in Life's Essential 8 (LE8) Composite Score|Change in Patient Health Questionnaire-9 (PHQ-9) Score|Change in Generalized Anxiety Disorder-7 (GAD-7) Score","Ohio State University","Female","Child, Adult, Older Adult","Not Applicable","384","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2023H0305","May 1, 2024","June 30, 2027","May 30, 2028","February 26, 2024",,"April 9, 2024","The Ohio State University, Columbus, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT06277661"
272,"NCT04297956","Survey on Patients After Childbearth Following Bariatric Surgery","SPOtMom","Unknown status","No Results Available","Bariatric Surgery Status in Childbirth|Puerperal Depression",,"Number of patients with prevalence of symptoms of depression or anxiety assessed by questionnaires and structured clinical interview (SCID)|Number of patients with prevalence of symptoms of depression or anxiety assessed by questionnaires and structured clinical interview|Number of patients with prevalence of symptoms of depression assessed by structured clinical interview|Mean change of body weight from baseline|Status of nutritional deficiencies and therapy adherence|Adverse events in pregnancy and child development","Wuerzburg University Hospital","Female","18 Years and older   (Adult, Older Adult)",,"70","Other","Observational","Observational Model: Cohort|Time Perspective: Retrospective","spot_mom","February 5, 2020","February 2023","February 2023","March 6, 2020",,"February 1, 2022","University Hospital, Würzburg, Bavaria, Germany|Sana Adipositaszentrum Offenbach, Offenbach am Main, Hessen, Germany|Uniklinikum Aachen, Klinik für Allgemein-, Viszeral-und Transplantationschirurgie, Aachen, Nordrhein-Westfalen, Germany|Sana Adipositaszentrum NRW, Remscheid, Nordrhein-Westfalen, Germany|Adipositaszentrum Westküstenklinium Heide, Heide, Schleswig-Holstein, Germany",,"https://ClinicalTrials.gov/show/NCT04297956"
273,"NCT05097586","RCT of At-Home tDCS for Depression in Pregnancy",,"Recruiting","No Results Available","Major Depression|Pregnancy|Postpartum Depression","Device: active tDCS|Other: workbook|Device: sham tDCS","Depressive symptoms post treatment|Remission of depression|Depressive symptoms|Self-reported depressive symptoms|Self-reported anxiety symptoms|Maternal Quality of Life (QoL)|Health Service Use: Health System Costs|Health Service Use: Productivity Loss|Health Service Use: Participant Cost|Dyadic Relationship|Maternal Birth Outcomes|Neonatal Birth Outcomes|Maternal Child Relationship|Infant Temperament|Child Development","Women's College Hospital|Centre for Addiction and Mental Health|Sunnybrook Health Sciences Centre","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","156","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","CTO Project ID: 3263","November 8, 2021","January 2024","October 2026","October 28, 2021",,"April 26, 2023","Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada|Women's College Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT05097586"
274,"NCT04741776","A Pilot Randomized Trial of Video-based Family Therapy for Depressed Home Visited Mothers",,"Completed","No Results Available","Perinatal Depression|Postpartum Depression|Family Conflict","Behavioral: Resilience Enhancement Skills Training|Behavioral: Problem-Solving Individual Therapy","Beck Depression Inventory-Second Edition|Perceived Hostility Survey (Ages 18 + and Ages 8-17)|Multidimensional Scale of Perceived Social Support - Family subscale|Emotion Regulation Questionnaire-Cognitive Reappraisal scale (Adult version, and Children and Adolescents version)|Maternal school enrollment/job attainment","Dartmouth-Hitchcock Medical Center|National Institute of Mental Health (NIMH)","All","15 Years and older   (Child, Adult, Older Adult)","Not Applicable","166","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","D21065|1R34MH124951","April 22, 2021","June 1, 2023","November 14, 2023","February 5, 2021",,"December 18, 2023","Dartmouth-Hitchcock Clinic, Lebanon, New Hampshire, United States",,"https://ClinicalTrials.gov/show/NCT04741776"
275,"NCT03703219","Impact of Mothers Touch Program on Women's Psychological Functioning",,"Completed","No Results Available","Psychological Distress|Post Partum Depression|Mood","Other: Mothers Touch Program","Post Natal Depression|General well being|Parent-Infant Relationship|Maternal Confidence","NMP Medical Research Institute|Warwick Research Services|Mothers Touch Foundation, India","Female","18 Years to 35 Years   (Adult)",,"110","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","NMP 0143","April 12, 2018","July 15, 2018","September 6, 2018","October 11, 2018",,"October 22, 2018","NMP Medical Reserach Institute, Jaipur, Rajasthan, India",,"https://ClinicalTrials.gov/show/NCT03703219"
276,"NCT03427528","Development, Feasibility and Acceptability of Fathers and Babies (FAB): A Pilot Study",,"Completed","Has Results","Perinatal Depression|Postpartum Depression|Depression","Behavioral: Fathers and Babies (FAB)|Behavioral: MB 1-on-1 plus TXT","Change in Depressive Symptoms|Change in Anxiety|Change in Perceived Stress|Change in Social Support Effectiveness|Instrumental Social Support Support Survey (Cyranowski et al., 2013).|Emotional Support Support (Cyranowski et al., 2013)","Northwestern University|National Institute on Minority Health and Health Disparities (NIMHD)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STU00203918-B|1R21MD011320-01","February 15, 2018","September 4, 2020","September 4, 2020","February 9, 2018","July 18, 2022","July 18, 2022","Northwestern University, Chicago, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/28/NCT03427528/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/28/NCT03427528/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT03427528"
277,"NCT02121496","Social Circumstances, Parenting Techniques, and Infant Development",,"Completed","No Results Available","Postpartum Depression|Infant Development|Rhythm; Sleep","Behavioral: Resources for Postpartum Parenting","Change in maternal mood and prevalence/severity of postpartum depression.|The effect of behavioral intervention for infants on infant development|The effect of behavioral intervention on infant sleep and fuss behavior","New York State Psychiatric Institute|The Robin Hood Foundation","Female","18 Years to 45 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","#6889","March 2014","December 2019","December 2019","April 23, 2014",,"January 28, 2020","Columbia University Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02121496"
278,"NCT03809572","Mindfulness Based Cognitive Therapy (MBCT) During Pregnancy",,"Terminated","No Results Available","Maternal Psychological Distress|Postpartum Depression|Prenatal Stress","Behavioral: Mindfulness Based Cognitive Therapy","Center for Epidemiologic Studies Depression Scale - Revised (CESD-R)|Emotion Regulation Questionnaire (ERQ)|Stroop Task|Brain activation during an emotion regulation task|Brain activation during the Stroop task|Rate of Postpartum Depression|Infant Behavior Questionnaire - Revised (IBQ-R)","Oregon Health and Science University","Female","21 Years to 45 Years   (Adult)","Not Applicable","56","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","1R21AT010292-01","March 22, 2019","October 1, 2020","March 8, 2021","January 18, 2019",,"December 20, 2021","Oregon Health and Science University, Portland, Oregon, United States",,"https://ClinicalTrials.gov/show/NCT03809572"
279,"NCT02387424","Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depressive Relapse/Recurrence",,"Completed","No Results Available","Postpartum Depression|Pregnancy|Depression","Behavioral: MBCT-PD|Behavioral: OAR","Engagement (class attendance)|Client Satisfaction (CSQ-8)|MBCT-PD Adherence Scale (MBCT-PD-AS)|Change in Depressive Relapse Status: Longitudinal Interval Follow-up Evaluation (LIFE)|Change in Edinburgh Postpartum Depression Scale (EPDS)","University of Colorado, Boulder|Emory University|Kaiser Permanente|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","86","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","13-0353-02|R34MH083866","July 2010","May 2013","May 2013","March 13, 2015",,"April 6, 2020","University of Colorado Boulder, Boulder, Colorado, United States|Kaiser Permanente Colorado, Denver, Colorado, United States|Emory University, Atlanta, Georgia, United States|Kaiser Permanente, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT02387424"
280,"NCT05887115","Nurse Family Partnership for Women With Previous Live Births",,"Recruiting","No Results Available","Pregnancy, High Risk|Child Development|Post Partum Depression","Behavioral: Nurse Family Partnership","Presence of Pregnancy-related hypertension|Change in maternal tobacco use by cotinine|Change in self reported maternal tobacco use|Index child language development measured by the Bayley IV language subscale|Index child language development measured by the MacArthur Bates CDI (Communicative Development Inventories)|Number of participants with infection during pregnancy based on medical record review|Number of infants born with weight less than 2500 grams per medical record review|Number of infants born less than 34 weeks gestation per medical record review|Change in self-reported maternal substance use|Initiation and continuation of any breastfeeding per maternal report|Percentage of well-child visits attended for index child per medical record review|Index child immunization use per medical record review|Index child emergency room visits for serious preventable injuries and sentinel injuries for child abuse.|Index child hospitalization for injuries|Change in quality of home environment measured by the HOME (Home Observation Measurement of the Environment) Inventory short form|Change in quality of home environment measured by the CHAOS (Confusion, Hubbub and Order Scale) Scale|Mother-child interaction measured by the Dyadic Assessment of Naturalistic Caregiver-child Experiences (DANCE)|Child's developmental index measured by Bayley IV developmental assessment|Index child's social and emotional development based on Bayley IV socio-emotional subscale|Index child's social and emotional development measured by the Child Behavior Checklist (CBCL) (maternal report)|Change in maternal perceived stress measured by Perceived Stress Scale (maternal report)","University of Colorado, Denver|Nationwide Children's Hospital|University of Rochester","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","880","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Investigator)|Primary Purpose: Health Services Research","20-0470","March 31, 2023","February 28, 2026","February 28, 2027","June 2, 2023",,"June 2, 2023","Nationwide Children's Hospital, Columbus, Ohio, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/15/NCT05887115/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT05887115"
281,"NCT04167709","CHS Nurses Clinical Competence in Detecting Signs of PPD in Non-Native Speaking Immigrant Mothers'",,"Completed","No Results Available","Depression, Postpartum","Other: Education in clinical competence in detecting signs of postpartum depression in immigrant mothers","Clinical Cultural Competence Training Questionnaire|General Self Efficacy scale|mothers offered to participate in screening|mothers participating in screening|screening with help of interpreter|mothers offered follow-up after screening","Lund University|Region Skane|Föreningen Mjölkdroppen Helsingborg","All","25 Years to 67 Years   (Adult, Older Adult)","Not Applicable","40","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2018/1063","June 9, 2019","May 13, 2020","March 31, 2021","November 19, 2019",,"September 5, 2021","Lund University, Lund, Scania, Sweden",,"https://ClinicalTrials.gov/show/NCT04167709"
282,"NCT02391870","The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression",,"Completed","No Results Available","Pregnancy|Depression|Postpartum Depression","Behavioral: MBCT-PD","Engagement|Client Satisfaction|MBCT-PD Adherence Scale (MBCT-PD-AS)|Depressive Relapse Status: Longitudinal Interval Follow-up Evaluation (LIFE)|Change in Edinburgh Postpartum Depression Scale (EPDS)","University of Colorado, Boulder|Emory University|Kaiser Permanente|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","49","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","13-0353-01|R34MH083866","November 2008","March 2011","March 2011","March 18, 2015",,"April 6, 2020","University of Colorado Boulder, Boulder, Colorado, United States|Kaiser Permanente Colorado, Denver, Colorado, United States|Emory University, Atlanta, Georgia, United States|Kaiser Permanente, Atlanta, Georgia, United States",,"https://ClinicalTrials.gov/show/NCT02391870"
283,"NCT01977326","Task Sharing Counseling Intervention by Community Health Workers for Prenatal Depression in South Africa","AFFIRM-SA","Completed","No Results Available","Moderate Depression|Clinical Depression|Postpartum Depression","Behavioral: basic counselling by lay-health workers|Other: Enhanced usual care","Hamilton depression rating Scale (HAM-D)|Edinburgh Postnatal depression scale (EPDS)|Mini International Psychiatric Interview 2.0.0 (MINI) Major depression|Multidimensional Scale of Perceived Social Support (MSPSS)|WHO Disability Assessment Schedule (WHO-DAS) 12 item version 2.0|Health services utilisation questionnaire|Cape Town Functional Assessment Instrument for Maternal Depression|Obstetric and Infant outcome measures (head circumference, weight, height, feeding, diarrhoea, respiratory tract infections, immunisation","University of Cape Town|National Institute of Mental Health (NIMH)","Female","18 Years to 45 Years   (Adult)","Not Applicable","4205","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Treatment","5U19MH095699-02|1U19MH095699","October 2013","June 2016","June 2016","November 6, 2013",,"October 28, 2016","Michael Mapongwana Clinic, Cape Town, Western Cape, South Africa|Site B Clinic, Cape Town, Western Cape, South Africa",,"https://ClinicalTrials.gov/show/NCT01977326"
284,"NCT04376021","Proyecto BEBE: The Effect of Babywearing Education on Breastfeeding Exclusivity",,"Completed","No Results Available","Breastfeeding, Exclusive|Mother-Infant Interaction|Postpartum Depression","Behavioral: Babywearing","Proportion of infant feeds coming from breastmilk versus formula|Score on Edinburgh Postnatal Depression Scale (EPDS)|Score on the Mother-Infant Bonding Questionnaire|Score on the Proximal Care Beliefs Questionnaire","Nurturely|Project Concern International","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","101","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","28","February 6, 2018","June 26, 2019","June 26, 2019","May 6, 2020",,"May 12, 2020","Project Concern International, San Diego, California, United States",,"https://ClinicalTrials.gov/show/NCT04376021"
285,"NCT04108533","Lactation Achievement With Texts at Home","LATcH","Completed","No Results Available","Breastfeeding|Breastfeeding, Exclusive|Postpartum Depression","Behavioral: Text-Based Support","Exclusivity|Any Breastfeeding|Duration|Formula|Compliance|Mood","University of Pennsylvania","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","124","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","833824","January 6, 2020","January 20, 2021","March 30, 2021","September 30, 2019",,"September 2, 2021","Hospital of the University Of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04108533"
286,"NCT03887910","Northwell Health Visits: A Family Connects Pilot Implementation at Northwell Health",,"Completed","No Results Available","Unspecified Child Maltreatment, Suspected|Unspecified Child Maltreatment, Confirmed|Postpartum Depression","Other: Enhanced Intervention|Other: Intervention","Child Emergency Room Presentation Rates|Mother Emergency Room Presentation Rates|Child Hospital Admissions|Mother Hospital Admissions|Mother Postnatal Well-Care Compliance Rates|Child Postnatal Well-Care Compliance Rates|Mother Mental Health - Anxiety Rates|Mother Mental Health - Depression Rates|Family Connections to Community Services/Resources|Mother parenting behaviors|Mother alcohol and other drug abuse|Family Violence","Northwell Health","All","Child, Adult, Older Adult","Not Applicable","840","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Other","18-0328","January 9, 2019","January 1, 2022","October 31, 2022","March 25, 2019",,"April 4, 2023","Northwell Health, Manhasset, New York, United States",,"https://ClinicalTrials.gov/show/NCT03887910"
287,"NCT02373709","Sequence Variations of Genes in the Estrogen Pathway and Perinatal Depression",,"Active, not recruiting","No Results Available","Postnatal Depression|Genetic Predisposition",,"Perinatal depression","KK Women's and Children's Hospital|National University Hospital, Singapore","Female","21 Years to 35 Years   (Adult)",,"750","Other","Observational","Observational Model: Case-Control|Time Perspective: Retrospective","2010/539/F","October 2010","December 2023","December 2025","February 27, 2015",,"October 5, 2021","KK Women's and Children's Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT02373709"
288,"NCT04741971","Whether Probiotics Use in Neonate and Infant Improve Their Mother's Life Quality",,"Not yet recruiting","No Results Available","Postpartum Depression|Quality of Life|Functional Gastrointestinal Disorders|Probiotics","Dietary Supplement: Probiotics group|Dietary Supplement: Non-probiotics group","Maternal Sleep Quality|Maternal quality of life|Maternal risk of postnatal depression|Neonate and infant' condition of functional gastrointestinal disorders|Neonate and infant' diaper dermatitis|Neonate and infant' atopic dermatitis","Buddhist Tzu Chi General Hospital","All","1 Day to 50 Years   (Child, Adult)","Not Applicable","220","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","P00001711","February 18, 2021","December 31, 2024","December 31, 2024","February 5, 2021",,"February 5, 2021",,"""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/71/NCT04741971/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT04741971"
289,"NCT04264520","Initial Intervention Efficacy for an Online PTSD Intervention for Pregnant Women",,"Terminated","No Results Available","Perinatal Problems|Post Traumatic Stress Disorder|Post Partum Depression","Behavioral: PTSD Psychoeducation + Skills Intervention","PTSD Checklist for DSM-5 (PCL-5) Total Scores|Baby's Weight at Birth in Pounds/Ounces|Total Gestation Length in Weeks|Baby's APGAR Score at Birth","Medical University of South Carolina|MUSC Specialized Center of Research Excellence","Female","18 Years to 40 Years   (Adult)","Not Applicable","5","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","00096405","June 5, 2020","April 23, 2021","April 23, 2021","February 11, 2020",,"September 28, 2021","Medical University of South Carolina Institute of Psychiatry, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT04264520"
290,"NCT02142972","Low Back Pain and Depression: Cohort Study",,"Completed","No Results Available","Low Back Pain|Pelvic Pain|Depression",,"Post-Partum Depression|Pain Scores in the visual analogue scale|Low back pain disability|Pain drawing area","Universidad Rey Juan Carlos","Female","18 Years to 45 Years   (Adult)",,"236","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2011/28","October 2011","February 2014","May 2014","May 20, 2014",,"May 20, 2014",,,"https://ClinicalTrials.gov/show/NCT02142972"
291,"NCT00373750","Cradling Our Future Through Family Strengthening Study",,"Completed","No Results Available","Substance Abuse|Post-partum Depression|Depression","Procedure: Family Spirit Intervention","Increase in parental competence at nine intervals over 39 month study period|Differences in social and emotional competence, and internalizing, externalizing and regulatory problems for children between ages 12-36 months|Moderators and mediators of intervention response for mothers and children.|Increase in maternal outcomes at nine intervals over 39 month study period|Improved childhood outcomes at nine intervals over 39 month study period","Johns Hopkins Bloomberg School of Public Health|National Institute on Drug Abuse (NIDA)","Female","12 Years to 19 Years   (Child, Adult)","Not Applicable","322","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","1R01DA019042-01A1","June 2006","December 2010","December 2010","September 8, 2006",,"January 12, 2015","Johns Hopkins Center for American Indian Health, Fort Defiance, Arizona, United States|Johns Hopkins Center for American Indian Health, San Carlos, Arizona, United States|Johns Hopkins Center for American Indian Health, Tuba City, Arizona, United States|Johns Hopkins Center for American Indian Health, Whiteriver, Arizona, United States|Johns Hopkins Center for American Indian Health, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00373750"
292,"NCT00053651","Prevention of Postpartum Depression in Low-Income Women",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Survival Skills for Moms with New Babies",,"Butler Hospital|National Institute of Mental Health (NIMH)","Female","18 Years to 45 Years   (Adult)","Phase 1","250","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R21MH061555|DSIR AT-AS","September 2001",,,"February 5, 2003",,"August 22, 2013","Women and Infants Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00053651"
293,"NCT02538497","The Northern Babies Longitudinal Study",,"Completed","No Results Available","Depression, Postpartum","Behavioral: The Newborn Behavioral Observation (NBO)|Behavioral: Routine care","Levels of postpartum depression|Parental reflective functioning|Bonding between parent and child|Parent-child interaction|Parental stress|A composite measure of the infant´s temperament|Infants social withdrawal behaviour|Infant cognitive, communicative and motor development|Heart rate variability","University of Tromso|Public Health Sisters in the Tromsø municipality|University Hospital of North Norway","All","Child, Adult, Older Adult","Not Applicable","350","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2015/614REK nord","November 2015","December 2018","December 2018","September 2, 2015",,"May 17, 2019","UiT The Arctic University of Norway, Tromso, Norway",,"https://ClinicalTrials.gov/show/NCT02538497"
294,"NCT03039530","Group CBT for PPD in the Public Health Setting",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Group Cognitive Behavioral Therapy|Behavioral: Postnatal Care As Usual","Edinburgh Postnatal Depression Scale (EPDS)|Mini International Neuropsychiatric Interview - Current Major Depressive Disorder|Penn State Worry Questionnaire (PSWQ)|Postpartum Bonding Questionnaire|Parent-Child Early Relational Assessment|Social Provisions Scale|Ages and Stages Questionnaires - Third Edition|Maternal & Infant Healthcare Utilization|Infant Behaviour Questionnaire-Revised|Face-to-Face Still Face Paradigm|Parasympathetic Nervous System Functioning: Heart Rate Variability|Salivary Cortisol|Corticolimbic Brain Function: EEG-Based Frontal Lobe Asymmetry (via MUSE Headband)","McMaster University|Niagara Region Public Health","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","141","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","PH CBT","April 1, 2017","January 1, 2021","January 1, 2021","February 1, 2017",,"April 19, 2021","Niagara Region Public Health, Thorold, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03039530"
295,"NCT04396509","Effects of Type of Delivery Mode and Gestational Age on Maternal Bonding",,"Completed","No Results Available","Mother-Infant Interaction|Postnatal Depression|Postpartum Anxiety","Behavioral: Maternal Attachment Inventory Score","Compare mother-infant bond (MIB) scores between the vaginal delivery and the C-section (C/S) groups.|evaluate the correlations between the MIB scores and their sociodemographic data.","Kanuni Sultan Suleyman Training and Research Hospital","Female","18 Years to 45 Years   (Adult)",,"200","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","mai-nsd-c/s","June 1, 2018","June 1, 2019","June 10, 2019","May 20, 2020",,"May 21, 2020","Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04396509"
296,"NCT02497677","Copenhagen Infant Mental Health Project: Enhancing Parental Sensitivity and Attachment (CIMHP)","CIMHP","Active, not recruiting","No Results Available","Infant Social Withdrawal|Maternal Postnatal Depression","Behavioral: Circle of Security -Parenting|Behavioral: Care as Usual","Maternal sensitivity|Infant-mother attachment quality|Infant Social withdrawal|Infants socio-emotional development - maternal and partner's report|Infant cognitive and language development|Maternal Depressive Symptoms|Maternal overall psychological distress|Maternal depression diagnosis|Maternal Attachment|Family Functioning, reported by mother and partner|Parental Reflective Functioning, reported by mother and partner|Parental Stress, reported by mother and partner|Number of extra homes visits by the health nurse","University of Copenhagen|University of Aarhus","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","314","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","UCPH 2015-10","July 2015","July 2020","December 2024","July 14, 2015",,"November 18, 2023","UCPH Babylab, University of Copenhagen, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT02497677"
297,"NCT05110456","To Evaluate the Effectiveness of a Virtual and Telephone Intervention for the Prevention of Postpartum Depression in Women at Risk",,"Active, not recruiting","No Results Available","Depression, Postpartum","Behavioral: Telephone support","Change from baseline at 3 month postpartum depressive symptoms: The Edinburgh Perinatal/Postnatal Depression Scale (EPDS)|Depressive symptoms: The Edinburgh Postnatal Depression Scale (EPDS)|Change from baseline in Generalized Anxiety Disorder questionnaire (GAD-7) score|Anxiety related to pregnancy: Pregnancy-specific anxiety scale (PRAQ-R2)|Stress: Perceived Stress Scale (PSS)|Well-being: WHO-5 (World Health Organization) index|Self-efficacy: General Self-Efficacy scale (GSE)|Self-compassion: Self-Compassion Scale (SCS)|Sleep: Pittsburgh Sleep Quality Index (PSQI)|Social Adjustment: Social Adjustment Scale - Self-report (SAS-SR)|Marital satisfaction: Short Form of the Dyadic Adjustment Scale (DAS-7)|Co-parenting: Co-parenting Relationship Scale (CRS)|Social support: Social Provisions|Parenting practices: Parenting Cognitions and Behaviors Scale|Change from 3 months post-partum at 6 month post partum child social, emotional and cognitive development: Ages and stages questionnaire 3rd edition (ASQ-3)|Child's temperament: Difficult Temperament Scale|Personality disorders symptoms: Personality Inventory for DSM-5 Brief Form (PID-5 BF)|Gender roles: Bem Sex Role Inventory (BSRI)","St. Justine's Hospital|Canadian Medical Association|Hewitt Foundation","Female","14 Years and older   (Child, Adult, Older Adult)","Not Applicable","510","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2021-3210","November 9, 2021","August 30, 2024","August 30, 2025","November 8, 2021",,"November 2, 2023","St. Justine hospital, Montréal, Quebec, Canada","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/56/NCT05110456/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT05110456"
298,"NCT00951717","Using a Preparation and Education Intervention to Reduce Postpartum Depression Among New Mothers (The MADE IT 2 Study)",,"Completed","No Results Available","Depression, Postpartum|Depression","Behavioral: Behavioral education intervention","Depressive symptoms|Breastfeeding continuation rate|Physical functioning","Icahn School of Medicine at Mount Sinai|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","590","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","05-1062|R01MH077683|DSIR 83-ATP","July 2009","October 2010","October 2010","August 4, 2009",,"November 22, 2011","Mount Sinai Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00951717"
299,"NCT01175603","Preventing Postpartum Depression in African American Home Visiting Clients",,"Completed","No Results Available","Depression","Behavioral: Mothers and Babies Course (Adapted for Baltimore Home Visiting Programs)","Depressive symptoms|Depressive Symptoms|Depressive episodes|Depressive Episodes","Johns Hopkins University|Abell Foundation","Female","14 Years to 50 Years   (Child, Adult)","Phase 2","82","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","JHMI ICTR 2009|ICTR 2009","October 2009","October 2010","October 2010","August 5, 2010",,"April 7, 2016","People's Community Health Center, Baltimore, Maryland, United States|DRUM Healthy Families, Baltimore, Maryland, United States|Maternal and Infant Nursing Program, Baltimore, Maryland, United States|Sinai Hospital Perinatal Depression Outreach Program, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT01175603"
300,"NCT05657886","Half Swaddle and Kangaroo Care in Preterm on Breastfeeding, Infant Attachment, Sleep Quality and Depression of Mothers",,"Completed","No Results Available","Kangaroo Care","Other: Half swaddle|Other: Kangaroo care","breastfeeding evaluated using the Breastfeeding Self-Efficacy Scale-Short Form|breastfeeding evaluated using the Latch Breastfeeding Diagnosis Measurement Form|breastfeeding evaluated using the Perception of Insufficient Milk Questionnaire (PIMQ)|mother infant attachment evaluated using the Mother-to-Infant Bonding Scale (MIBS)|mother sleep quality evaluated using the Pittsburgh Sleep Quality Index (PSQI)|postpartum depression evaluated using the Edinburgh Postnatal Depression Scale (EPDS)","Trakya University","Female","18 Years to 49 Years   (Adult)","Not Applicable","160","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","2020/P0226","July 5, 2020","January 5, 2021","March 2, 2022","December 20, 2022",,"December 22, 2022","Turkey, Trakya University, Edirne, Turkey",,"https://ClinicalTrials.gov/show/NCT05657886"
301,"NCT06042166","A Postpartum Adaptation Study of the Connecting and Reflecting Experience Parenting Program","PMAD-CARE","Not yet recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety|Parenting Stress|Parent Child Relationships","Behavioral: Connecting and Reflecting Experience (CARE) Program","Change from Baseline to Post-Treatment in Postpartum Anxiety Score|Change from Baseline to Post-Treatment in Postpartum Depression Score|Change from Baseline to Post-Treatment in Parenting Stress Score|Change from Baseline to Post-Treatment in Parental Reflective Functioning|Change from Baseline to Post-Treatment in Parent-Infant Bonding|Post-treatment rating of treatment acceptability and feasibility|Change from Session 1 to Session 12 in Therapeutic Group Processes|Change from Baseline to Post-Treatment in Infant Temperament","Montefiore Medical Center|American Psychological Foundation","Female","18 Years to 70 Years   (Adult, Older Adult)","Not Applicable","21","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2023-15124","May 2024","December 2025","December 2025","September 18, 2023",,"November 7, 2023","Montefiore Medical Center, Bronx, New York, United States",,"https://ClinicalTrials.gov/show/NCT06042166"
302,"NCT05400161","Social Media-Based Parenting Program for Women With Postpartum Depressive Symptoms: Impact on Child Development",,"Recruiting","No Results Available","Postpartum Depression|Parenting|Parent-Child Relations|Child Development","Behavioral: MoodGym|Behavioral: Social Media-Based Parenting Program","Changes in parent-child interactions|Changes in severity of depressive symptoms|Changes in parenting competence|Changes in parenting stress|Prior mental health service use|Social support|Therapy group cohesion|Acceptability of the parenting program|Acceptability of the online depression treatment program|Child Development","Children's Hospital of Philadelphia|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","90","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","22-019784|R33MH118405","November 18, 2022","May 31, 2025","May 31, 2025","June 1, 2022",,"September 13, 2023","Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT05400161"
303,"NCT05830955","The Effect of Lullaby and Breastmilk Smell on Preterm Newborns",,"Completed","No Results Available","Preterm|Infant, Premature, Diseases|Postpartum Depression|Mother-Infant Interaction","Other: Lullaby group|Other: Breast milk group|Other: Control group","Heart Rate change|Oxygen Saturation change|Respiration Rate change|Body Temperature change|Comfort level change|Maternal Attachment|Postpartum Depression","Mustafa Kemal University|Istanbul University - Cerrahpasa (IUC)|Yuzuncu Yıl University|Van Training and Research Hospital","All","35 Weeks to 37 Weeks   (Child)","Not Applicable","57","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","Hatay Mustafa Kemal University","May 15, 2023","March 4, 2024","March 5, 2024","April 26, 2023",,"March 6, 2024","Van Training and Research Hospital, Van, Turkey",,"https://ClinicalTrials.gov/show/NCT05830955"
304,"NCT04183946","Willkommen Mutterglück: Online CBT for Pregnant and Postpartum Women With Depression and Anxiety",,"Unknown status","No Results Available","Prenatal Anxiety|Generalized Anxiety|Postpartum Depression|Major Depressive Disorder","Behavioral: Online Cognitive Behavioural Therapy","Change of depressive symptoms at four measuring points from baseline to follow up|Change of anxiety symptoms at four measuring points from baseline to follow up|Change of severity of depressive symptoms at four measuring points from baseline to follow up|Change of depression symptoms from baseline until follow-up|Participant's satisfaction with the program and it's usability|Program's evaluation of feasibility with prenatal and postpartum women","University of Zurich|Ambulatorium für kognitive Verhaltenstherapie und Verhaltensmedizin - UZH|Lamprecht AG","Female","18 Years to 45 Years   (Adult)","Not Applicable","300","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Willkommen Mutterglück Program","June 2020","January 2022","January 2024","December 3, 2019",,"December 3, 2019","University of Zurich, Department of Psychology - Clinical Psychology and Psychotherapy, Zürich, Switzerland",,"https://ClinicalTrials.gov/show/NCT04183946"
305,"NCT06293274","The Importance of Discharge Education for Mommy Blues",,"Recruiting","No Results Available","Postpartum Sadness","Procedure: Discharge training","Motherhood Sadness Scale|Edinburgh Postnatal Depression Scale - EPDS","Kocaeli University","Female","18 Years to 45 Years   (Adult)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","sdilek5","January 1, 2024","March 30, 2024","May 30, 2024","March 5, 2024",,"March 22, 2024","Kocaeli University, Kocaeli, Turkey",,"https://ClinicalTrials.gov/show/NCT06293274"
306,"NCT05503056","Art Therapy in Obstetric Patients",,"Active, not recruiting","No Results Available","Pregnancy Related|Depression","Other: art therapy|Other: nothing","changes in Edinburgh Postnatal Depression Scale scores|change in maternal-infant bonding scores|utilization of behavioral health/psychology/psychiatry services during pregnancy and postpartum|use of psychiatry medications during and after pregnancy|obstetrical complications (postpartum hemorrhage, OASIS, ICU admission)|gestational age at time of delivery|mode of delivery|reason for delivery (iatrogenic vs spontaneous)|birth weight|APGAR scores|NICU admissions|delivery complications (shoulder dystocia, low birth weight)","Medstar Health Research Institute","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","20223247","September 1, 2022","August 30, 2023","June 30, 2024","August 16, 2022",,"January 5, 2024","Washington Hospital Center, Washington, District of Columbia, United States",,"https://ClinicalTrials.gov/show/NCT05503056"
307,"NCT06144294","Whole-Body Hyperthermia for Mood and Anxiety Disorders",,"Not yet recruiting","No Results Available","Postpartum Depression|Mood Disorders|Anxiety Disorders|Postpartum Anxiety","Other: Whole-Body Hyperthermia|Diagnostic Test: fMRI","Percent change in EEG amplitude.|Percent change in EEG frequency.|Mean change from baseline in inflammatory activity as measured by pro-inflammatory cytokines.|Mean change in average 24-hour core temperature.|Individualized precision functional brain maps.","Weill Medical College of Cornell University","All","18 Years to 50 Years   (Adult)","Not Applicable","240","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","23-01025619","June 2024","June 2028","June 2029","November 22, 2023",,"February 22, 2024","Weill Cornell Medicine, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT06144294"
308,"NCT04933708","LaPPS: Labor Podcast for Patient Satisfaction","LaPPS","Completed","No Results Available","Labor Onset and Length Abnormalities|Pregnancy Related","Behavioral: Labor Podcast","Labor Agentry Scale|Birth Satisfaction|Edinburgh Postpartum Depression Scale","University of Pennsylvania","Female","18 Years to 50 Years   (Adult)","Not Applicable","201","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Treatment","848622","July 1, 2021","July 1, 2022","July 1, 2022","June 22, 2021",,"October 7, 2022","Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT04933708"
309,"NCT05588089","The Effect of Baby Care Training Given to Fathers After Birth","Babycare","Completed","No Results Available","Mothers|Fathers","Other: Training group","Edinburgh Postpartum Depression Scale|Postpartum Quality of Life Scale","Hitit University","All","18 Years to 45 Years   (Adult)","Not Applicable","64","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Participant)|Primary Purpose: Health Services Research","Hitituniversity","February 4, 2022","June 28, 2022","September 27, 2022","October 20, 2022",,"October 20, 2022","Fatma Yıldırım, Çorum, Turkey",,"https://ClinicalTrials.gov/show/NCT05588089"
310,"NCT06282419","The Effect of Visual and Audio Stimulus Offered to Father-to-be",,"Recruiting","No Results Available","Ultrasonography Prenatal","Other: USE OF MOBILE ULTRASOUND|Other: ultrasound image taken from the internet","Introductory Information Form (For Women)|Spouse Support Scale Perceived by Women During Early Postpartum Period|Breastfeeding Self-Efficacy Scale-Short Form|Breastfeeding Adaptation Scale|Edinburgh Postpartum Depression Scale|Introductory Information Form (For Men)|Fathers' Breastfeeding Attitude and Participation Scale|Edinburgh Postpartum Depression Scale for Men","Ataturk University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","132","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","B.30.2.ATA.0.01.00/542","August 21, 2023","March 31, 2024","December 31, 2025","February 28, 2024",,"March 1, 2024","Atatürk University, Erzurum, Turkey",,"https://ClinicalTrials.gov/show/NCT06282419"
311,"NCT04350333","Efficacy of Digital CBT-I Intervention During Pregnancy",,"Unknown status","No Results Available","Insomnia in Pregnancy","Behavioral: CBT-I|Behavioral: Assertive communication training","Depression|Anxiety|Sleep pattern (sleep onset latency; total sleep time; wake after sleep onset; sleep efficiency)|insomnia symptoms|Emotion regulation","University of Rome G. Marconi","Female","19 Years to 40 Years   (Adult)","Not Applicable","114","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Prevention","UMarconi","May 1, 2021","December 31, 2021","December 31, 2021","April 17, 2020",,"April 27, 2021",,,"https://ClinicalTrials.gov/show/NCT04350333"
312,"NCT03167905","CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)","CODEPAD","Active, not recruiting","No Results Available","Depression, Postpartum|Analgesia, Obstetrical|Anesthesia, Obstetrical","Device: Epidural delivery system|Drug: Entonox|Drug: Meperidine|Drug: Ultiva|Drug: Fentanyl|Drug: Ropivacaine","The incidence of major postnatal depression in both groups|The incidence of (clinically significant, probable) postnatal depression in both groups|The incidence of acquiring post-delivery persistent pain in both groups|Pain vulnerability in both groups (1)|Pain vulnerability in both groups (2)|Pain vulnerability in both groups (3)|Psychological vulnerability in both groups (1)|Psychological vulnerability in both groups (2)|Psychological vulnerability in both groups (3)|Pain severity in both groups|Preferences for labor analgesia|Preferences for epidural analgesia|Chinese version of Angle Labor Pain Questionnaire (A-LPQ)","KK Women's and Children's Hospital","Female","21 Years to 50 Years   (Adult)","Phase 2|Phase 3","881","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","2017/2090","June 15, 2017","July 19, 2021","December 31, 2025","May 30, 2017",,"January 5, 2024","KK Women's and Children's Hospital, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT03167905"
313,"NCT03803189","Proactive, Personalized Postpartum Mental Healthcare","P3MH","Completed","No Results Available","Postpartum Depression|Postpartum Blues|Postpartum Anxiety|Postpartum Mood Disorder","Behavioral: Usual care plus eToolkit","Change in Edinburgh Postpartum Depression Scale (EPDS) Score|Time to treatment initiation","Women's College Hospital|Canadian Institutes of Health Research (CIHR)|Michael Garron Hospital","All","18 Years and older   (Adult, Older Adult)","Not Applicable","130","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","2018-0099-B|PCG-155463","March 14, 2019","April 24, 2021","April 24, 2021","January 14, 2019",,"October 5, 2021","South East Toronto Family Health Team, Toronto, Ontario, Canada|Women's College Hospital Family Practice Health Centre, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03803189"
314,"NCT04296734","Prenatal Depression Prevention Effects on Parenting and Young Child Self-Regulation and Functioning","EPIC","Recruiting","No Results Available","Postpartum Depression|Child Development|Parenting|Child Self-Regulation","Behavioral: Mothers and Babies","Maternal depressive symptoms|Parenting outcomes ) of parenting self-efficacy (SE) and Parenting Hostile Reactive Behavior (HRB)|Child self-regulation outcomes|Maternal mental health and cognitive-behavioral skills|Parenting outcomes of parental positive affect, sensitive responsiveness, and verbalizations","Northwestern University|Ann & Robert H Lurie Children's Hospital of Chicago|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Months and older   (Child, Adult, Older Adult)",,"1287","Other|NIH","Observational","Observational Model: Case-Control|Time Perspective: Prospective","HD097215|GRANT12740559|1R01HD097215-01A1","November 14, 2019","January 31, 2024","May 31, 2024","March 5, 2020",,"May 6, 2023","Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT04296734"
315,"NCT05484999","The Maternal Well-Being Study","MWB","Active, not recruiting","No Results Available","Postpartum Depression|Postpartum Anxiety|Weight Retention, Postpartum|Nutritional and Metabolic Diseases","Other: Meals|Other: Meals + Social Support|Other: Control","% of meals delivered to and consumed by subjects|perception of the nutritious home delivered meal program|% of Edinburgh postnatal depression scale score >15 at 12 weeks postpartum","Texas Tech University Health Sciences Center","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","84","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Prevention","A22-4290","May 16, 2022","June 30, 2024","December 30, 2024","August 2, 2022",,"February 13, 2024","Texas Tech University Health Sciences Center, Amarillo, Texas, United States",,"https://ClinicalTrials.gov/show/NCT05484999"
316,"NCT04087317","Vaginal Postpartum Pain Management Protocol Comparison",,"Completed","No Results Available","Pain|Post Partum Depression|Opioid Use|Breast Feeding","Drug: Paracetamol 1000 Mg Oral Tablet|Drug: Ibuprofen 400Mg Tab|Drug: Ibuprofen 400 mg|Drug: MIR","Visual analog scale (VAS) score difference in the 24 first hours.|Amount of additional analgesia requirements.|Total analgesia requirements.|Breastfeeding rate.|Treatments side effects.|Visual analog scale (VAS) score difference up to maternal discharge.","Rambam Health Care Campus","Female","18 Years to 45 Years   (Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","Rambam Health Care Center.","June 1, 2020","June 30, 2022","July 30, 2022","September 12, 2019",,"January 3, 2024","Rambam, Ramat Yishai, Israel",,"https://ClinicalTrials.gov/show/NCT04087317"
317,"NCT05362305","Essential Coaching for Every Mother in Tanzania","ECEMTZ","Not yet recruiting","No Results Available","Self Efficacy|Postpartum Depression|Postpartum Anxiety|Breastfeeding","Behavioral: Essential Coaching for Every Mother","Recruitment Effectiveness|Implementation Dose|Implementation Engagement|Implementation Quality|Newborn Care Knowledge|Maternal Self-Efficacy|Breastfeeding Self-Efficacy|Postpartum Depression|Postpartum Anxiety|Newborn morbidity|Newborn mortality|Need for readmission|Postnatal Clinic Attendance","IWK Health Centre","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","180","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Care Provider)|Primary Purpose: Supportive Care","ECEMTZ","May 2024","September 2024","January 2025","May 5, 2022",,"March 5, 2024",,,"https://ClinicalTrials.gov/show/NCT05362305"
318,"NCT06053515","Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication",,"Recruiting","No Results Available","Pregnancy|Postpartum Depression|Infant Development|Infant Conditions","Behavioral: Rosie the Chatbot","Maternal postpartum depression|Number of emergency room visits|Attendance of well-baby visits (preventive healthcare visits)","University of Maryland, College Park|National Institutes of Health (NIH)|National Institute on Minority Health and Health Disparities (NIMHD)","Female","14 Years to 99 Years   (Child, Adult, Older Adult)","Not Applicable","400","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","5R01MD016037-03|3R01MD016037-03S1","October 9, 2023","May 20, 2025","June 30, 2026","September 25, 2023",,"November 28, 2023","University of Maryland, College Park, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT06053515"
319,"NCT03965572","Factors and Outcomes Associated With Postpartum Cabergoline Use",,"Unknown status","No Results Available","Lactation Suppressed|Cabergoline Adverse Reaction|Postpartum DVT|Postpartum Depression",,"Demographics of women requesting cabergoline|Number of participants experiencing immediate treatment-related adverse events|Number of participants experiencing early treatment-related adverse events|Number of participants experiencing late treatment-related adverse events|Motivations conducting participants to ask for a lactation suppression drug immediatly after giving birth","Laniado Hospital","Female","16 Years to 65 Years   (Child, Adult, Older Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","0017-19-LND","June 7, 2019","December 31, 2022","May 12, 2023","May 29, 2019",,"September 28, 2021","Laniado Hospital, The Betty Retter Mother & Baby Medical Center, Netanya, Israel",,"https://ClinicalTrials.gov/show/NCT03965572"
320,"NCT05268588","mHealth India Postnatal Health Intervention Effectiveness","Kushal Maa","Not yet recruiting","No Results Available","Health Knowledge, Attitudes, Practice|Post Partum Depression|Breastfeeding|Nutrition, Healthy","Behavioral: MESSSSAGE intervention","Exclusive breastfeeding|Postpartum depression|Postpartum family planning adoption|Maternal and neonatal danger sign knowledge|Maternal and neonatal health care use|Neonatal preventive health care use|Infant vaccination","University of California, San Francisco|Post Graduate Institute of Medical Education and Research, Chandigarh|Indraprastha Institute of Information Technology|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Sangath","Female","18 Years to 49 Years   (Adult)","Not Applicable","2100","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","P0555059|R01HD108510","July 1, 2024","June 30, 2027","June 30, 2027","March 7, 2022",,"April 3, 2024","Indraprastha Institute for Information Technology, New Delhi, Delhi, India|Post-Graduate Institute for Medical Education and Research, Chandigarh, Haryana, India|Sangath, Bhopal, Madhya Pradesh, India",,"https://ClinicalTrials.gov/show/NCT05268588"
321,"NCT04051320","Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model",,"Completed","Has Results","Perinatal Depression|Post Partum Depression|Depression, Postpartum|Depression","Drug: Leuprolide Acetate 3.75 MG/ML|Drug: Estradiol 2 Mg tablet|Drug: Micronized progesterone","Mean Threat Processing Bias During Visual Dot-probe Paradigm Over Time|Mean Right Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time|Mean Left Amygdala-medial Prefrontal Cortex BOLD Connectivity During Implicit Emotion Face Processing Task Over Time|Mean Reactive Aggression During Hormone Addback Over Time|Mean BOLD Activation of the Right Amygdala During the Affective Posner Task Over Time|Mean BOLD Activation of the Left Amygdala During the Affective Posner Task Over Time|Mean BOLD Activation of the Right Caudate During the Affective Posner Task Over Time|Mean BOLD Activation of the Left Caudate During the Affective Posner Task Over Time|Mean BOLD Activation of the Right Putamen During the Affective Posner Task Over Time|Mean BOLD Activation of the Left Putamen During the Affective Posner Task Over Time|Mean BOLD Activation of the Right Nucleus Accumbens During the Affective Posner Task Over Time|Mean BOLD Activation of the Left Nucleus Accumbens During the Affective Posner Task Over Time|Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill -0.8Scale and Threat Attention Bias|Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Right Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.|Correlation Between the Inventory of Depressive and Anxiety Symptoms (IDAS) Ill Temper Scale and Left Amygdala-medial Prefrontal Cortex (PFC) BOLD Connectivity.|Correlation Between Irritability and Reactive Aggression During Hormone Addback|Correlation Between Irritability Subcortical Activation in HS+ During Hormone Addback","University of North Carolina, Chapel Hill|National Institute of Mental Health (NIMH)","Female","22 Years to 45 Years   (Adult)","Phase 2","23","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Basic Science","19-0401|R21MH119615-01","January 2, 2020","July 15, 2022","July 19, 2022","August 9, 2019","August 25, 2023","August 25, 2023","University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/20/NCT04051320/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/20/NCT04051320/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04051320"
322,"NCT03837392","Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Anxiety",,"Completed","No Results Available","Post Partum Depression|Perinatal Depression|Post Partum Anxiety|Perinatal Anxiety","Diagnostic Test: Baseline Assessment (18-26 weeks pregnant)|Behavioral: Online Intervention and Phone Coaching Interventions|Diagnostic Test: Follow Up Assessments: 34-36 weeks pregnant and 4-week postpartum|Diagnostic Test: Follow Up Assessments: 8 weeks postpartum","Change in Inventory of Mood and Anxiety Symptoms (IMAS-R) scores from Baseline|Change in Five Facet Mindfulness Questionnaire|Change in Acceptance and Action Questionnaire (AAQ-2) from Baseline","University of Iowa","Female","18 Years to 45 Years   (Adult)","Not Applicable","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","202002658","June 1, 2020","January 31, 2023","June 30, 2023","February 12, 2019",,"July 12, 2023","University of Iowa, Iowa City, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT03837392"
323,"NCT04285437","The Effects of Massage Therapy on Term Neonates Development and on Maternal Bonding",,"Unknown status","No Results Available","Infant Development|Breastfeeding|Postnatal Depression","Behavioral: infant massage","The rate of pairs that have Edinburgh Postnatal Depression Scale scored > 12|Change of the number of crying times over 15 minutes at 2 month - old - infant|The rate of pairs that have breastfeeding|The mean of Edinburgh Postnatal Depression Scale|Change of the number of defecation times at 2 month - old - infant|Change of the number of spitting up at 2 month - old - infant|Change of weight at 2 month - old - infant|Change of height at 2 month - old - infant|Change of head circle at 2 month - old - infant","University of Medicine and Pharmacy at Ho Chi Minh City","All","1 Day to 15 Days   (Child)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","414A/ĐHYD-HĐĐĐ","January 31, 2020","December 1, 2020","December 30, 2020","February 26, 2020",,"February 26, 2020","University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam",,"https://ClinicalTrials.gov/show/NCT04285437"
324,"NCT03615794","A Study of Pregnant and Postpartum Women With and Without Mood Disorders",,"Recruiting","No Results Available","Bipolar Disorder|Major Depressive Disorder|Postpartum Depression|Postpartum Psychosis",,"Major depressive episode|Postpartum depression as assessed by Whole blood analysis|Postpartum depression risk as assessed by serum analysis","Johns Hopkins University|University of Virginia","All","18 Years to 50 Years   (Adult)",,"400","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","IRB00027369","October 1, 2017","July 2024","October 2024","August 6, 2018",,"June 1, 2023","550 North Broadway, Baltimore, Maryland, United States|University of Virginia, Charlottesville, Virginia, United States",,"https://ClinicalTrials.gov/show/NCT03615794"
325,"NCT05764213","Improving Maternal Mental Health & SUD Screening and Treatment",,"Enrolling by invitation","No Results Available","Mental Health Issue|Substance Use Disorders|Postpartum Depression|Postpartum Anxiety","Behavioral: Listening to Women & Pregnant and Postpartum People","Change in Treatment Attendance|Change in Retention in Treatment|Change in depressive symptoms|Change in Substance Use|Change in Maternal Functioning and Wellbeing","Medical University of South Carolina|Patient-Centered Outcomes Research Institute","Female","18 Years to 45 Years   (Adult)","Not Applicable","9444","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Screening","00123833","April 3, 2023","July 31, 2025","October 1, 2025","March 10, 2023",,"July 13, 2023","Medical University of South Carolina, Charleston, South Carolina, United States",,"https://ClinicalTrials.gov/show/NCT05764213"
326,"NCT04636398","Postnatal mHealth Intervention Development","MESSAGE","Completed","Has Results","Health Attitude|Knowledge, Attitudes, Practice|Postpartum Depression|Acceptability of Health Care","Behavioral: MESSAGE - mHealth intervention","Satisfied or Very Satisfied About Their Overall Intervention Experience","University of California, San Francisco|University of California, Los Angeles|Post Graduate Institute of Medical Education and Research, Chandigarh|Indraprastha Institute of Information Technology Delhi|Survival for Women and Children Foundation|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years to 50 Years   (Adult)","Not Applicable","30","Other|NIH","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R21HD101786","December 1, 2020","January 30, 2021","January 30, 2021","November 19, 2020","August 19, 2022","August 19, 2022","Post Graduate Institute for Medical Education and Research (PGIMER), Chandigarh, India","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/98/NCT04636398/Prot_000.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/98/NCT04636398/SAP_001.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/98/NCT04636398/ICF_002.pdf","https://ClinicalTrials.gov/show/NCT04636398"
327,"NCT04693585","Development and Pilot Test of a Postnatal mHealth Intervention - Phase 2","MESSAGE","Completed","No Results Available","Health Attitude|Knowledge, Attitudes, Practice|Post Partum Depression|Acceptability of Health Care","Behavioral: MESSSSAGE - live|Behavioral: MESSSSAGE - asynchronous","Satisfied or very satisfied about their overall intervention experience|Participation rate|Knowledge on maternal and neonatal danger signs, best practices for infant care, family planning.|Exclusive breastfeeding|Postpartum depression|Postpartum family planning adoption","University of California, San Francisco|University of California, Los Angeles|Post Graduate Institute of Medical Education and Research, Chandigarh|Indraprastha Institute of Information Technology Delhi|Survival for Women and Children Foundation|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years to 50 Years   (Adult)","Not Applicable","201","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R21HD101786-A|R21HD101786","July 30, 2021","November 15, 2022","November 15, 2022","January 5, 2021",,"August 29, 2023","Post Graduate Institute for Medical Education and Research, Chandigarh, India",,"https://ClinicalTrials.gov/show/NCT04693585"
328,"NCT05664529","Mother-Child Interactions During Feeding",,"Enrolling by invitation","No Results Available","Feeding Disorders|Mother-Child Relations|Feeding; Disorder, Nonorganic Origin, in (Very Young) Child|Postpartum Depression","Diagnostic Test: Chatoor Feeding Scale","Feeding Scale scores|Generalized Anxiety Disorder questionnaire-7 scores of mothers|Edinburgh postnatal depression scale (EPDS) scores of mothers|The Postpartum Bonding Questionnaire|Parental report of infant sleep patterns using the Brief Infant Sleep Questionnaire","Marmara University","All","6 Months to 36 Months   (Child)",,"120","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","09.2022.585","August 1, 2022","September 1, 2023","December 1, 2023","December 23, 2022",,"December 23, 2022","Marmara University School of Medicine, Istanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05664529"
329,"NCT05520580","Effect of Mother's Push at Cesarean Delivery Mother's PUSHING AT CS A RANDOMIZED CONTROLLED TRIAL",,"Completed","No Results Available","Caesarean Section|Mother-Child Relations|Post Operative Pain|Postpartum Depression","Procedure: Mother's push during CS","Change in postoperative pain of the mother|Incidence and quality of Breastfeeding|Incidence of Postpartum Depression|senses of participation and control|Different in the operation duration between the two groups|Intensity of intraoperative fundal pressure|Quantity of the Intraoperative maternal blood loss|Rate of birth asphyxia","Hannover Medical School","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Screening","Rklapdor","May 1, 2020","March 20, 2021","March 20, 2021","August 30, 2022",,"August 30, 2022","Hanover medical school, Hanover, Lower Saxony, Germany","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/80/NCT05520580/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT05520580"
330,"NCT01909167","Keeping Well:Online Cognitive Behavioral Therapy (CBT) for Pregnant Women With Depressive Symptoms","OnCBTDep","Withdrawn","No Results Available","Anxiety|Mental Disorders|Postpartum Depression|Depressive Symptoms","Behavioral: Online Cognitive Behavioral Therapy (CBT)|Other: Treatment as usual","Changes in the Edinburgh Postnatal Depression Scale (EPDS)scores from 20 weeks antenatal to 10 weeks postnatal|Compliance and dropout rates from 20 weeks antenatal to 4 weeks postnatal|Changes in anxiety scores from 20 weeks antenatal to 10 weeks postnatal|Changes in bonding scores at 10 weeks postnatal","Imperial College London","Female","18 Years to 40 Years   (Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","13IC0475","June 1, 2020","June 1, 2021","July 1, 2021","July 26, 2013",,"June 27, 2022","Queen Charlotte's and Chelsea Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT01909167"
331,"NCT03856931","Behaviours and Emotions in Preschoolers","BeEPS","Unknown status","No Results Available","Mental Health Wellness|Emotional Problem|Behavioural Problem|Post Partum Depression",,"Total difficulties score","TARGetKids!|The Hospital for Sick Children|Unity Health Toronto","All","2 Years to 4 Years   (Child)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","1000056960","February 20, 2019","March 31, 2022","September 30, 2022","February 27, 2019",,"October 14, 2021","The Hospital for Sick Children, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT03856931"
332,"NCT00360204","Improving Health Outcomes for New Mothers and Babies",,"Completed","No Results Available","Hyperbilirubinemia|Jaundice|Dehydration|Postpartum Depression","Behavioral: Home Nurse Visit","Use of unplanned maternal and child healthcare services (inpatient, Emergency Department (ED), urgent/acute care, primary care, and mental health) in the first 14 days after delivery|Adherence to continuity of care guidelines|Postpartum anxiety|Breastfeeding duration|Maternal satisfaction with post-discharge healthcare|Parenting sense of competence|Cost of care","Milton S. Hershey Medical Center|Department of Health and Human Services|Health Resources and Services Administration (HRSA)|HRSA/Maternal and Child Health Bureau","All","1 Day to 7 Months   (Child)","Phase 3","1154","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","22163|R40 MC 06630-01","September 2006","August 2009","February 2010","August 4, 2006",,"July 28, 2017","Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States|Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00360204"
333,"NCT02221895","The Effect of Early Versus Traditional Follow-Up on Breastfeeding Rates at 6 Months",,"Completed","No Results Available","Pregnancy|Breastfeeding|Contraception|Cervical Cancer|Postpartum Depression","Other: Postpartum follow up appointment 2-3 weeks after delivery|Other: Postpartum follow up 6-8wk after delivery","breastfeeding|Contraception|Depression screen|Appointment utilization|BAPT|Cervical cancer screening","Madigan Army Medical Center","Female","18 Years to 50 Years   (Adult)","Not Applicable","344","U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","214030","March 2014","May 2017","May 2017","August 21, 2014",,"September 21, 2020","Madigan Army Medical Center, Tacoma, Washington, United States",,"https://ClinicalTrials.gov/show/NCT02221895"
334,"NCT01842542","Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset",,"Terminated","No Results Available","Depression, Postpartum","Device: NeuroStar Transcranial Magnetic Stimulation (TMS)","Evaluate the antidepressant effectiveness of acute treatment with NeuroStar TMS Therapy in patients with MDD with postpartum onset|Determine the safety of NeuroStar TMS Therapy.","Neuronetics","Female","18 Years to 50 Years   (Adult)","Not Applicable","25","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","44-03014-000","December 2013","July 2015","August 2015","April 29, 2013",,"October 13, 2021","Hartford Hospital Institute of Living, Hartford, Connecticut, United States|UF Health Adult Psychiatry - Springhill, Gainesville, Florida, United States|Harmonex Neuroscience and Research of Pensacola, Pensacola, Florida, United States|Rush University Medical Center, Chicago, Illinois, United States|Integrative Psychiatry, Louisville, Kentucky, United States|TMS Medical Associates of NY, New York, New York, United States|TMS Center of Lehigh Valley, Allentown, Pennsylvania, United States|University of Utah - Neuropsychiatric Institute, Salt Lake City, Utah, United States",,"https://ClinicalTrials.gov/show/NCT01842542"
335,"NCT05225987","Effects of Postpartum Nurse Navigation Program",,"Completed","No Results Available","Nursing Caries|Nurse's Role|Postpartum Depression|Postpartum Anxiety|Quality of Life|Postpartum Disorder","Behavioral: Postpartum Nurse Navigation Program based care","Self-Care Power Scale Score|Postpartum Quality of Life Scale Score|Postpartum Specific Anxiety Scale Score|Edinburgh Postpartum Depression Scale Score|Physical Symptom Severity Scale Score","Hacettepe University","Female","18 Years to 45 Years   (Adult)","Not Applicable","61","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","2020/12","June 1, 2021","December 24, 2021","December 24, 2021","February 7, 2022",,"February 23, 2022","University of Health Sciences Etlik Zübeyde Hanim Gyn Diseases Education and Research Hospital, Ankara, Turkey",,"https://ClinicalTrials.gov/show/NCT05225987"
336,"NCT05322161","Yoga in the NICU for Parents Study","YiN","Recruiting","No Results Available","Postpartum Depression|Anxiety|Depression|Stress Disorder|Prematurity","Behavioral: yoga classes","Change in parental depression, anxiety and stress score over time|Measure of NICU parent stress|Measure of parent-child bonding|Infant Length of Stay|Length of assisted ventilation (days)|Breastfeeding at discharge|Yoga class participation|Duration of participation in yoga classes|Postpartum Depression|Parent Satisfaction with Yoga Intervention","Seattle Children's Hospital|University of Washington","All","Child, Adult, Older Adult","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Other","STUDY00003325|SITE00001252","September 29, 2021","September 29, 2023","November 10, 2023","April 11, 2022",,"June 22, 2023","Seattle Children's Hospital, Seattle, Washington, United States|University of Washington, Seattle, Washington, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/61/NCT05322161/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT05322161"
337,"NCT04068662","Intervention for IPV-exposed Pregnant Women",,"Recruiting","No Results Available","Postpartum Depression|Posttraumatic Stress Disorder|Infant Behavior|Violence|Parenting","Behavioral: Pregnant Moms' Empowerment Program|Behavioral: Nondirective Support Group","Change in posttraumatic stress symptoms from baseline to post-treatment|Change in posttraumatic stress symptoms from baseline to 3-months postpartum|Change in posttraumatic stress symptoms from baseline to 12-months postpartum|Change in depressed mood from baseline to posttreatment|Change in depressed mood from baseline to 3-months postpartum|Change in depressed mood from baseline to 12-months postpartum|Change in resilience from baseline to posttreatment|Change in resilience from baseline to 3-months postpartum|Change in resilience from baseline to 12-months postpartum|Maternal Sensitivity at infant age 3 months|Maternal Sensitivity at infant age 12 months|Intimate Partner Violence at posttreatment|Intimate Partner Violence at 3-months postpartum|Intimate Partner Violence at 12-months postpartum|Infant Development at 3 months of age|Infant Development at 12 months of age|Infant Regulation at 3 months of age|Infant Regulation at 12 months of age|Change in social support from baseline to posttreatment|Change in social support from baseline to 3-months postpartum|Change in social support from baseline to 12-months postpartum|Change in empowerment from baseline to posttreatment|Change in empowerment from baseline to 3-months postpartum|Change in empowerment from baseline to 12-months postpartum","University of Notre Dame|University of Memphis","Female","3 Months to 55 Years   (Child, Adult)","Not Applicable","460","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","19-03-5260","July 10, 2019","December 20, 2024","December 20, 2024","August 28, 2019",,"April 2, 2024","University of Notre Dame, Notre Dame, Indiana, United States|University of Memphis, Memphis, Tennessee, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/62/NCT04068662/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT04068662"
338,"NCT03791749","Mother and Late Preterm Lactation Study","MAPLeS","Completed","No Results Available","Breastfeeding|Postnatal Depression|Stress, Psychological|Preterm Infant","Other: Breastfeeding Support","Maternal stress change at 6 weeks from 2 weeks post-delivery.|Infant weight change at 6 weeks from 2 weeks post-delivery.|Breast milk composition (macronutrients) change at 6 weeks from 2 weeks post-delivery.|Breast milk hormones change at 6 weeks from 2 weeks post-delivery.|Breast milk volume change at 6 weeks from 2 weeks post-delivery.|Infant behaviour change at 6 weeks from 2 weeks post-delivery.|Infant appetite change at 6 weeks from 2 weeks post-delivery.|Mother-infant attachment change at 6 weeks from 2 weeks post-delivery.|Exclusive Breastfeeding Status","University College, London","Female","18 Years to 45 Years   (Adult)","Not Applicable","72","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Participant)|Primary Purpose: Treatment","IRAS: 252031","January 25, 2019","January 13, 2021","March 13, 2021","January 3, 2019",,"July 19, 2022","Royal Free Hospital, London, United Kingdom",,"https://ClinicalTrials.gov/show/NCT03791749"
339,"NCT03120208","Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage","PSYCHE","Unknown status","No Results Available","Postpartum Hemorrhage|Postpartum Women|Postpartum Depression|Postpartum Stress|Postpartum Anxiety","Behavioral: • The Edinburgh postnatal depression scale (EPDS), validated in French, with a discrimination threshold ≥ 11.|Behavioral: The GAD-7 with a discrimination threshold ≥10.|Behavioral: • Spielberger's State-Trait anxiety inventory, Form Y (validated in French), with a STAI (form Y-A) discrimination threshold ≥ 46|Behavioral: The IES-R, validated in French, with a discrimination threshold ≥ 30.|Behavioral: EPDS, MINI, STAI-A and B, IES-R and QEVA (experience)","prevalence of depression|prevalence of depression among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)|The prevalence of depression among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention|severity of depression among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)|severity of depression among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention|prevalence of anxiety and post-traumatic stress among women after an immediate PPH|prevalence of anxiety and post-traumatic stress among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)|prevalence of anxiety and post-traumatic stress among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention|severity of anxiety and post-traumatic stress among women with PPH between 500-1000 mL compared with those with severe PPH (≥ 1000 mL)|severity of anxiety and post-traumatic stress among women with a PPH requiring a so-called second-order medical intervention (transfusion, vascular embolization, etc.) compared with women who had a PPH without such a second-order intervention|prevalence of depression, post-traumatic stress, and anxiety, the experience of delivery, in partners of women with an immediate postpartum hemorrhage (< 24 hours)","University Hospital, Clermont-Ferrand","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","1968","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Diagnostic","CHU-314|2016-A00092-49","April 27, 2017","August 2019","February 2020","April 19, 2017",,"December 31, 2018","CHU Clermont-Ferrand, Clermont-Ferrand, France",,"https://ClinicalTrials.gov/show/NCT03120208"
340,"NCT03880032","Happy Mother-Healthy Baby: An Anxiety-focused Early Prenatal Intervention","HMHB","Completed","Has Results","Postpartum Depression|Small for Gestational Age at Delivery|Preterm Birth|Anxiety|Birth Weight","Behavioral: Cognitive Behavioral Therapy Intervention for Anxiety","Number of Participants With Combined Common Mental Disorders (CMDs, i.e. Anxiety and Depression).|Number of Preterm Births|Small-for-gestational Age Birth|Low Birthweight","Johns Hopkins Bloomberg School of Public Health|Human Development Research Foundation, Pakistan","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","1200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","R01MH111859-01","April 16, 2019","October 7, 2022","October 7, 2022","March 19, 2019","February 15, 2024","February 15, 2024","Holy Family Hospital, Rawalpindi, Pakistan","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/32/NCT03880032/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/32/NCT03880032/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT03880032"
341,"NCT04815044","Experiences From Pregnancy and Post-partum Period in Women With a History of Eating Disorders.","PREG_PED-t","Enrolling by invitation","No Results Available","Pregnancy Related|Eating Disorders|Bulimia Nervosa|Binge-Eating Disorder|Post Partum Depression","Other: Pregnancy|Other: Post-Partum","Experiences of bodily changes in pregnancy and post-partum period|Experiences with pregnancy health care- and post-partum service|Quality of prenatal care|Current symptoms of eating disorders|Current symptoms of depression|Planning of pregnancy|Help in becoming pregnant|Supplementation and drugs during pregnancy|Body weight during pregnancy|Blood pressure in pregnancy|Fetus heart rate|Symphysis measure|Frequency and type of pregnancy complication|Birth delivery method","Ostfold University College|Norwegian School of Sport Sciences|University of Tromso","Female","18 Years to 50 Years   (Adult)",,"32","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","120532","December 1, 2020","December 31, 2026","December 31, 2026","March 24, 2021",,"April 2, 2024","Therese Fostervold Mathisen, Fredrikstad, Norway",,"https://ClinicalTrials.gov/show/NCT04815044"
342,"NCT04964206","Neuraxial Labor Analgesia and Offspring Neurodevelopment",,"Recruiting","No Results Available","Offspring, Adult|Labor Pain|Maternal Anesthesia and Analgesia Affecting Fetus or Newborn|Neurodevelopmental Delay|Postpartum Depression","Procedure: Neuraxial labor analgesia|Procedure: No neuraxial labor analgesia","Incidence of developmental delay in offspring at 24 months of age|Incidence of developmental delay in offspring at 6 and 12 months of age|Maternal intrapartum fever|Neonatal Apgar score <8 at 1 and 5 minutes after delivery|Histologic chorioamnionitis|Neonatal infection|Depression score of mothers","Dong-Xin Wang|Beijing Obstetrics and Gynecology Hospital|Ningxia Women and Children's Hospital|Taiyuan central hospital|Peking University First Hospital","Female","18 Years to 35 Years   (Adult)",,"5580","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","2021-026","October 14, 2022","May 2024","May 2026","July 16, 2021",,"April 4, 2023","Beijing University First Hospital, Beijing, Beijing, China|Beijing Gynecological and obstetrical hospital, Beijing, Beijing, China|Ningxia Women and Children's Hospital, Yinchuan, Ningxia, China|Taiyuan Central Hospital, Taiyuan, Shanxi, China",,"https://ClinicalTrials.gov/show/NCT04964206"
343,"NCT05949190","Improving Cognition and Gestational Duration With Targeted Nutrition","COGENT","Recruiting","No Results Available","Malnutrition in Pregnancy|Preterm Birth|Child Development|Postpartum Depression|Antepartum Depression","Dietary Supplement: M-RUSF+ (Maternal Ready-to-Use Supplementary Food + DHA/EPA/choline)|Dietary Supplement: M-RUSF (Maternal Ready-to-Use Supplementary Food)|Drug: Azithromycin|Drug: Albendazole|Drug: Sulfadoxine pyrimethamine|Behavioral: Cognitive behavioral therapy|Other: Insecticide-treated mosquito net","Gestational duration|Malawi Developmental Assessment Tool (MDAT) global z-score|Adapted Patient Health Questionnaire-9 (PHQ-9) score|Early preterm birth|Birth weight|Birth length|Low birth weight|Malawi Developmental Assessment Test sub-domain z-scores|Preterm birth|Neonatal mortality|Infant mortality|Depressive symptoms|Maternal and infant DHA status|Maternal and infant choline status|Maternal weight gain|Post-term delivery|Depression incidence|Birth chest circumference|Birth thigh circumference|Birth head circumference|Infant weight at 6 weeks, 3 months, 6 months, 9 months|Infant length at 6 weeks, 3 months, 6 months, 9 months|Infant length-for-age z-score at 6 weeks, 3 months, 6 months, 9 months|Placental weight|Small for gestational age (SGA)","Washington University School of Medicine|Project Peanut Butter|Open Philanthropy|United States Department of Agriculture (USDA)|Ministry of Health and Sanitation, Sierra Leone","All","13 Years and older   (Child, Adult, Older Adult)","Not Applicable","1600","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Triple (Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","202305139","August 18, 2023","February 2026","February 2026","July 17, 2023",,"March 13, 2024","Bandajuma, Bandajuma, Southern, Sierra Leone|Bendu Malen, Bendu, Southern, Sierra Leone|Blama Massaquoi, Blama Massaquoi, Southern, Sierra Leone|Futa Peje, Futa Peje, Southern, Sierra Leone|Gbondapi, Gbondapi, Southern, Sierra Leone|Nyandehun Malen, Nyandehun, Southern, Sierra Leone|Potoru, Potoru, Southern, Sierra Leone|Pujehun Static, Pujehun, Southern, Sierra Leone|Sahn Malen, Sahn, Southern, Sierra Leone|Zimmi, Zimmi, Southern, Sierra Leone",,"https://ClinicalTrials.gov/show/NCT05949190"
344,"NCT05595486","Baby2Home (B2H) Mobile Health Application",,"Recruiting","No Results Available","COVID-19 Pandemic|Health Knowledge, Attitudes, Practice|Perinatal Depression|Mental Health Wellness|Post Partum Depression","Other: Baby2Home Mobile Application","Concentration of preventive health services utilization for all family members (birthing, non-birthing, and infant)|Number of participants who attend comprehensive postpartum visit (birthing parent)|Completion of postpartum depression screening and treatment (birthing parent)|Number of participants who received contraception (birthing and non-birthing parent)|Number of participants who received the recommended vaccinations (non-birthing parent)|Completion of postnatal depression screening for non-birthing parent|Number of participants who attended well-child visits for the infant|Number of participants who received the recommended vaccinations for infant|Continued breastfeeding for infants until 6 months.|Duration of breastfeeding (birthing parent)|Stress symptoms (for birthing and non-birthing parent)|Depressive symptoms (for birthing and non-birthing parent)|Anxiety symptoms (for birthing and non-birthing parent)|Global health status (for birthing and non-birthing parent)|Relationship assessment (for birthing and non-birthing parent)|Self-efficacy (for birthing and non-birthing parent)|Parenting self-efficacy (for birthing and non-birthing parent)|Breastfeeding self-efficacy (for birthing parent)|COVID-19 related impact (for birthing and non-birthing parent)","Women and Infants Hospital of Rhode Island|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","All","18 Years and older   (Adult, Older Adult)","Not Applicable","640","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","STU00216659|1R01HD105499-01","November 9, 2022","December 1, 2024","March 1, 2025","October 27, 2022",,"July 21, 2023","Northwestern Medicine Prentice Women's Hospital, Chicago, Illinois, United States|Women and Infant's Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT05595486"
345,"NCT02148965","Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial","PAMELA","Completed","No Results Available","Gestational Hypertension|Prematurity|Maternal Post-partum Depression|Maternal Post-partum Weight Retention|Child's Development","Behavioral: Physical Exercise / Physical Activity","Prematurity|Maternal post-partum depression|Child's development","Federal University of Pelotas","Female","Child, Adult, Older Adult","Not Applicable","639","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","PAMELA-649.244|Wellcome Trust - 522.064","September 2014","June 2016","September 2016","May 29, 2014",,"September 29, 2021","Physical Education School, Pelotas, Rio Grande Do Sul, Brazil",,"https://ClinicalTrials.gov/show/NCT02148965"
346,"NCT05137925","Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum",,"Recruiting","No Results Available","Psychological Distress|Pregnancy Related|Postpartum Blues|Postpartum Depression|Postpartum Anxiety|Postpartum Sadness","Behavioral: Mindfulness-Based Cognitive Therapy (MBCT)|Behavioral: Treatment as Usual (TAU)","Change in presence and severity of depressive symptoms from baseline to 8 weeks|Change in presence and severity of depressive symptoms from 8 weeks to 3 months|Change in perceptions of daily life stress from baseline to 8 weeks|Change in perceptions of daily life stress from 8 weeks to 3 months|Change in anxiety symptoms from baseline to 8 weeks|Change in anxiety symptoms from 8 weeks to 3 months|Change in rumination from baseline to 8 weeks|Change in rumination from 8 weeks to 3 months|Change in mindfulness from baseline to 8 weeks|Change in mindfulness from 8 weeks to 3 months|Change in rates of psychiatric diagnoses from baseline to 3 months|Change in disinhibition from baseline to 8 weeks|Change in disinhibition from 8 weeks to 3 months|Change in attention from baseline to 8 weeks|Change in attention from 8 weeks to 3 months|Change in cognitive inflexibility from baseline to 8 weeks|Change in cognitive inflexibility from 8 weeks to 3 months|Change in emotion regulation from baseline to 8 weeks|Change in emotion regulation from 8 weeks to 3 months","University of Pittsburgh|American Psychological Foundation|The Pittsburgh Foundation","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","STUDY21060191","September 1, 2023","January 2025","June 2025","November 30, 2021",,"January 24, 2024","Western Psychiatric Institute & Clinic, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT05137925"
347,"NCT00380419","Effects of Interpersonal Psychotherapy on Depression During and After Pregnancy",,"Completed","No Results Available","Depression|Anxiety Disorders","Behavioral: Interpersonal Psychotherapy (IPT)","Mothers' depression symptom severity, as determined by the 17-item Hamilton Rating Scale for Depression (HAM-D 17)|Infant birth outcomes|Biologic measures related to depression in both mothers and infants","University of Michigan|National Institute of Mental Health (NIMH)","Female","21 Years to 45 Years   (Adult)","Not Applicable","120","Other|NIH","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","HUM00007344|R21MH072673|DSIR 83-ATAS","October 2006","August 2009","August 2009","September 26, 2006",,"May 30, 2013","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT00380419"
348,"NCT05399784","Postpartum Visit Timing and the Effect on Visit Attendance",,"Completed","No Results Available","Postpartum Disorder|Postpartum Depression|Postpartum Weight Retention|Breastfeeding|Satisfaction, Patient|Trust","Behavioral: Early postpartum visit|Behavioral: Standard postpartum visit","Number of postpartum visits attended|Number of recommended items covered during postpartum care|Trust in physician scale|Short Assessment of Patient Satisfaction|Number of emergency room visits","Women and Infants Hospital of Rhode Island","Female","13 Years to 50 Years   (Child, Adult)","Not Applicable","162","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","Kole_ConstanceHowesGrant_2020","February 1, 2021","April 1, 2023","June 1, 2023","June 1, 2022",,"August 2, 2023","Women & Infants Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT05399784"
349,"NCT02661789","Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression","GnRHa","Completed","No Results Available","Postpartum Depression|Major Depressive Disorder|Postpartum Psychosis|Menopause|Neurodegeneration|Schizophrenia","Drug: Goserelin 3.6 mg implant|Drug: Placebo","Changes from baseline in symptoms of depression|Changes from baseline in serotonin transporter binding in volumes of interest (VOIs)|Changes from baseline in fMRI response to emotional faces|Changes from baseline in fMRI response to gambling paradigm|Changes from baseline in rsfMRI changes in functional connectivity|Changes from baseline in affective cognition (VAMT-24 test)|Changes from baseline in reaction time|Serial mood fluctuations (SD of total mood disturbance (TMD) score of daily POMS across intervention period)|Changes from baseline in hippocampal volume|Changes in pre-pulse-inhibition (PPI) from baseline|Changes in a set of markers of immunoactivity across study period|Changes in epigenetic markers of estrogen sensitivity|Changes in HPA-axis dynamics (the cortisol awakening response)|Changes in sensorimotor gating (P50 suppression) from baseline|Changes from baseline in hippocampal microstructure|Changes from baseline in fMRI responses to emotional memory paradigm|Changes from baseline in Cohens perceived stress score|Changes in Pittsburg Sleep Quality Inventory (PSQI)|Side effects scores (project specific 15 items questionnaire)|Changes in SCL-R (Symptom check-list revised)|Major Depression Inventory (MDI)|Changes in profile of mood states (POMS TMD score)","Gitte Moos Knudsen|Center for Integrated Molecular Brain Imaging, Copenhagen, Denmak|Fertility Clinic Rigshospitalet|CNSR, Glostrup Psychiatric Center|Danish Multiple Sclerosis Center Rigshospitalet|Dept. of Clinical Immunology, Rigshospitalet|Rigshospitalet, Denmark","Female","18 Years to 40 Years   (Adult)","Not Applicable","63","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","GnRHa|H-2-2010-108","January 2011","December 2012","December 2012","January 22, 2016",,"January 22, 2016","Neurobiology Research Unit, Rigshospitalet, Copenhagen, Denmark",,"https://ClinicalTrials.gov/show/NCT02661789"
350,"NCT04364646","Personalized Integrated Chronotherapy for Perinatal Depression",,"Recruiting","No Results Available","Depression|Postpartum Depression|Prenatal Disorder|Circadian Dysregulation|Pregnancy Related|Sleep Disturbance","Behavioral: Personalized Integrated Chronotherapy","Change in Depressive Symptoms|Change in Circadian Phase|Change in Sleep Timing|Infant sleep behavior|Melatonin levels and timing of onset in breastmilk","Rhode Island Hospital|Northwell Health|University of North Carolina, Chapel Hill","Female","18 Years to 45 Years   (Adult)","Not Applicable","220","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","18-0913","November 2, 2020","June 2024","June 2024","April 28, 2020",,"July 5, 2023","Feinstein Institute For Medical Research, Glen Oaks, New York, United States|University of North Carolina, Chapel Hill, North Carolina, United States|Rhode Island Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT04364646"
351,"NCT05821569","Cerebral Synchronization Between Mothers and Their Newborns During Breastfeeding",,"Recruiting","No Results Available","Depression, Postpartum","Other: Standard approach|Other: Biological nurturing","To compare the frontal cerebral cortex functional synchronization in mother-newborn dyads adopting biological nurturing vs standard position to breastfeed|To compare the presence of postpartum depressive symptoms in women adopting biological nurturing vs standard position to breastfeed|To compare the oxytocin level of mothers adopting different position during breastfeeding (standard position vs biological nursing)|To evaluate the oxytocin level of newborns according to different position adopted during breastfeeding (standard position vs biological nursing)","IRCCS Burlo Garofolo","All","1 Day to 7 Days   (Child)",,"60","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","RC 53/22","January 9, 2024","September 15, 2024","September 15, 2024","April 20, 2023",,"January 18, 2024","IRCCS Burlo Garofolo, Trieste, Italy",,"https://ClinicalTrials.gov/show/NCT05821569"
352,"NCT00601757","Depression Prevention for Pregnant Women on Public Assistance",,"Completed","No Results Available","Depression, Postpartum|Depression","Behavioral: The Postpartum Prevention Program (PPP)|Behavioral: Enhanced care as usual (ECU)","Longitudinal Interval Follow-up Examination (LIFE)|Adjustment disorder or depression not otherwise specified (NOS) as measured by the Structured Clinical Interview for DSM Disorders (SCID)","Women and Infants Hospital of Rhode Island|National Institute of Mental Health (NIMH)","Female","18 Years to 40 Years   (Adult)","Phase 2","207","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R01MH071766|DSIR 83-ATP","January 2006","December 2012","December 2012","January 28, 2008",,"January 31, 2014","Womens' Care Inc., Providence, Rhode Island, United States|Women and Infants Hospital, Providence, Rhode Island, United States|Thundermist Health Center, Woonsocket, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00601757"
353,"NCT03438071","Impact of Videoconference Updates in Neonatal Intensive Care Unit on Parental Stress of Preterm Infants (VISIO-NEONAT)",,"Completed","No Results Available","Preterm Infants|Parent-Child Relations|Parental Stress|Post Partum Depression|Neonatal Intensive Care Units|Videoconferencing","Other: Videoconferencing","Level of stress of the mothers|Level of stress of the fathers|Parental stress evolution|Post-partum depression rate of the mothers|Quality of the relationship between the parents and their child","Poitiers University Hospital","All","Child, Adult, Older Adult",,"28","Other","Observational","Observational Model: Other|Time Perspective: Prospective","VISIO-NEONAT","February 21, 2018","August 18, 2018","September 7, 2018","February 19, 2018",,"June 1, 2020","CHU DE Poitiers, Poitiers, France",,"https://ClinicalTrials.gov/show/NCT03438071"
354,"NCT05806463","Efficacy of Mother's Time in Ethiopia",,"Completed","No Results Available","Depression, Postpartum|Anxiety, Postpartum|Contraceptive Usage","Behavioral: Mother's Time","Change in postpartum depression|Change in postpartum anxiety|Change in postpartum family planning","Johns Hopkins Bloomberg School of Public Health|United States Agency for International Development (USAID)|Johns Hopkins Center for Communication Programs|Camber Collective|DeepDive Consulting","Female","16 Years to 24 Years   (Child, Adult)","Not Applicable","328","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Health Services Research","23020","May 4, 2023","October 30, 2023","December 31, 2023","April 10, 2023",,"January 9, 2024","Health centers/clusters in selected woredas, West Gojjam, Amhara, Ethiopia",,"https://ClinicalTrials.gov/show/NCT05806463"
355,"NCT03416010","Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women","A-RCT","Active, not recruiting","No Results Available","Emotional Disturbances|Depression|Pregnancy Late|Post-Partum Depression|Anxiety|Nutritional Deficiency","Behavioral: COPE-P","Change is being assessed for an increase or decrease in self-reported healthy lifestyle beliefs|Change is being assessed for an increase or decrease in self-reported Anxiety level|Change is being assessed for an increase or decrease in self-reported stress|Change is being assessed for an Increase or decrease in self-reported healthy lifestyle behaviors|Change is being assessed for an increase or decrease in self-reported depressive symptoms|birth weight|Mode of Delivery: C-section, forceps/vacuum, vaginal|Breastfeeding initiation time|breastfeeding duration|Mode of Delivery|COPE-P Acceptability|Nutritional intake|Level of Exercise|Gestational age at birth|Participant weight|Participant Body Mass Index (BMI)|Participant height|Group Prenatal Care Acceptability|Program Evaluation","Ohio State University|National Institutes of Health (NIH)|New York University|Jacobi Medical Center|Boston College|University of Arizona|Drexel University|National Institute on Minority Health and Health Disparities (NIMHD)|University of South Florida","Female","18 Years to 40 Years   (Adult)","Not Applicable","299","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","2017B0425|1R01MD012770-01A1","March 5, 2018","April 20, 2023","April 20, 2024","January 30, 2018",,"August 4, 2023","Jacobi Medical Center, Bronx, New York, United States|OSU Total Health and Wellness, Columbus, Ohio, United States|OSUWMC OB/GYN Clinic, Columbus, Ohio, United States",,"https://ClinicalTrials.gov/show/NCT03416010"
356,"NCT02953626","Mother Matters Online Postpartum Support",,"Completed","No Results Available","Depression","Behavioral: Mother Matters Online Postpartum Support Group","Recruitment Feasibility (Eligibility)|Edinburgh Postnatal Depressive Scale (EPDS)|State-Trait Anxiety Inventory (STAI)|The Change in Eating Disorder Symptoms Scale (CHEDS)|Parenting Stress Index, Short Form (PSI)|Intervention Acceptability (Qualitative)|Intervention Acceptability (Website Usage)|Trial Protocol Adherence (Study Measure Completion)|Recruitment Feasibility (Recruitment)|Trial Protocol Adherence (Weekly Posting)|Trial Protocol Adherence (Posting Drop-Off)","Women's College Hospital|Centre for Addiction and Mental Health|Sunnybrook Health Sciences Centre|University of Toronto","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","96","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2016-0032-B","May 2016","March 2017","May 2017","November 3, 2016",,"May 12, 2017","Women's College Research Institute, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT02953626"
357,"NCT06242717","Postpartum Screening for Anxiety and Comorbid Conditions","PPA","Recruiting","No Results Available","Postpartum Anxiety|Postpartum Depression|Postpartum Disorder|Postoperative Pain|Sleep Wake Disorders|Quality of Life|Anger",,"Percentage of participants who completed surveys|Proportion of participants who consider usability of online surveys as being excellent (>85) with a System Usability Scale (SUS)|Number of participants with postpartum-related anxiety as assessed by the State-Trait Anxiety Inventory (STAI-S) and related predictors.|Number of participants with high postpartum-related anxiety and/or high risk for depression as assessed by validated questionnaires.|Number of participants with high postpartum-related anxiety and/or low social support as assessed by validated questionnaires.|Number of participants with high postpartum-related anxiety and/or high anger levels as assessed by validated questionnaires.|Number of participants with high postpartum-related anxiety and/or high levels of pain as assessed by validated questionnaires.|Number of participants with high postpartum-related anxiety and/or low quality of life as assessed by validated questionnaires.|Number of participants with high postpartum-related anxiety and/or poor sleep quality as assessed by validated questionnaires.|Number of participants with two or more comorbid comorbidities as described on outcome measures 4 to 9.","University of British Columbia|Ministry of Health, British Columbia|Providence Healthcare|St. Paul's Hospital, Canada|University of Victoria|Stanford University","Female","19 Years and older   (Adult, Older Adult)",,"550","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","H22-03298","November 9, 2023","December 31, 2024","December 31, 2024","February 5, 2024",,"February 23, 2024","BC Women's Hospital & Health Centre, Vancouver, British Columbia, Canada",,"https://ClinicalTrials.gov/show/NCT06242717"
358,"NCT06310720","Postpartum Video Education in High Risk Populations",,"Not yet recruiting","No Results Available","Postpartum Hemorrhage|Postpartum Depression|Postpartum Sepsis|Postpartum Preeclampsia|Patient Empowerment|Patient Education|Postpartum Care","Other: Video Education","Change in baseline and post-education questionnaire score|Change in post-education and post-discharge questionnaire score|Number of participants who attended 6 week postpartum visit|Healthcare utilization: Number of clinic visits|Healthcare utilization: Number of phone calls|Healthcare utilization: Number of urgent care/emergency room visits|Mean difference in patient satisfaction rating","Weill Medical College of Cornell University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","23-10026618","March 2024","December 2024","December 2024","March 15, 2024",,"March 15, 2024","Alexandra Cohen Hospital for Women and Newborns, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT06310720"
359,"NCT05159726","Postpartum Video Education",,"Completed","No Results Available","Postpartum Hemorrhage|Postpartum Preeclampsia|Postpartum Sepsis|Postpartum Depression|Patient Empowerment|Patient Education|Postpartum Care","Other: Video Education","Change in baseline and post-education questionnaire score|Change in post-education and post-discharge questionnaire score|Compliance with Postpartum Care|Healthcare utilization|Patient satisfaction","Yale University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","200","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2000031817","July 5, 2022","August 20, 2022","December 31, 2022","December 16, 2021",,"February 1, 2023","Yale New Haven Hospital, New Haven, Connecticut, United States",,"https://ClinicalTrials.gov/show/NCT05159726"
360,"NCT04037085","Ketamine to Improve Recovery After Cesarean Delivery - Part 1","KINETIC","Completed","Has Results","Obstetric Pain|Postpartum Depression|Breastfeeding|Pain, Acute|Pain, Chronic|Obstetric Anesthesia Problems|Drug Effect|Opioid Use","Drug: Ketamine","Ketamine (AUC)|Steady State (Css)|Elimination Half Life (T1/2) for Ketamine|Volume of Distribution Steady State (Vdss)|Ketamine Milk to Plasma Ratio (M:P)|Nor-ketamine Milk to Plasma Ratio|Hydroxynorketamine M:P Ratio|Relative Infant Dose of Ketamine (RID KET)|Relative Infant Dose of Ketamine Equivalent (Ketamine, Norketamine, Dehydro-norketamine)","Grace Lim, MD, MS|University of Pittsburgh","Female","18 Years to 99 Years   (Adult, Older Adult)","Phase 2","8","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","STUDY18120046","October 9, 2019","August 1, 2021","August 1, 2021","July 30, 2019","December 20, 2022","December 20, 2022","UPMC Montefiore Hospital CTRC, Pittsburgh, Pennsylvania, United States|Minhnoi C Wroble Biglan, Pittsburgh, Pennsylvania, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/85/NCT04037085/Prot_003.pdf|""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/85/NCT04037085/SAP_004.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/85/NCT04037085/ICF_005.pdf","https://ClinicalTrials.gov/show/NCT04037085"
361,"NCT04845230","Fresh RX: NHS 2020",,"Recruiting","No Results Available","Premature Birth|Birth Weight|Post Partum Depression|Health Care Utilization|Nutrition Deficiency Due to Insufficient Food|Housing Problems|Fetal Complications|Food Deprivation","Behavioral: FreshRx Nourishing Healthy Starts","Change in food insecurity|Gestational Age at Birth|Birthweight|Change in food spending|Change in self reported physical and mental health|Number of Prenatal Appointments|Maternal Immunizations Received|Change in Maternal Platelet Count|Change in Maternal White Blood Cell Count|Change in Maternal Hematocrit Count|Change in Maternal Hemoglobin Count|Change in Maternal Red Blood Cell Count|Maternal Anemia Diagnosis|Fetal Complications Diagnosis|Hypertensive Disorder Diagnosis|Spontaneous Preterm Labor|Preeclampsia Diagnosis|Difficulty paying bills|Post-partum depression|Intrauterine Fetal Demise (IUFD)|Spontaneous Abortion|Postpartum Complications|Adverse Post-Partum Mental Health Diagnoses|Maternal Mortality|Infant mortality|Change in food quality|Emergency liquidity|Public program participation|Maternal Hospital Admissions|Maternal Emergency Room Visits|Maternal Wellness Visits|Pediatric Visits|Infant Adverse Health Diagnoses|Days in Neonatal Intensive Care Unit (NICU)|Admission to Special Care Nursery|Birth Defects|Child Weight|Child Height|Child Hospital Admissions|Neonatal death|Child Emergency Department Admissions","Washington University School of Medicine|Operation Food Search Inc.","Female","14 Years to 55 Years   (Child, Adult)","Not Applicable","750","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","202011018","August 9, 2021","September 15, 2025","September 15, 2026","April 14, 2021",,"November 29, 2022","Operation Food Search Inc., Saint Louis, Missouri, United States",,"https://ClinicalTrials.gov/show/NCT04845230"
362,"NCT05763537","Understanding the Role of Doulas in Supporting People With PMADs",,"Not yet recruiting","No Results Available","Maternal Health|Pregnancy|Delivery, Obstetric|Self Efficacy|Social Support|Mental Health|Substance-Related Disorders|Postpartum Depression|Depression|Mental Health Services","Behavioral: Standard Doula Care Plus PMAD Intervention|Behavioral: Standard Doula Care","The Childbirth Self-Efficacy Inventory (CBSEI)|Change in the Childbirth Self-Efficacy Inventory (CBSEI) at 1 month postpartum|Change in the Childbirth Self-Efficacy Inventory (CBSEI) at 3 months postpartum|Change in the Childbirth Self-Efficacy Inventory (CBSEI) at 6 months postpartum|The General Self-Efficacy Scale (SGSE)|Change in the General Self-Efficacy Scale (SGSE) at 1-month postpartum|Change in the General Self-Efficacy Scale (SGSE) at 3-months postpartum|Change in the General Self-Efficacy Scale (SGSE) at 6-months postpartum|Edinburgh Depression Scale|Change in the Edinburgh Depression Scale at 1-month postpartum|Change in the Edinburgh Depression Scale at 3-months postpartum|Change in Edinburgh Depression Scale at 6-months postpartum|Patient Health Questionnaire (PHQ)-9|Change in Patient Health Questionnaire at 1-month postpartum (PHQ)-9|Change in Patient Health Questionnaire at 3-months postpartum (PHQ)-9|Change in Patient Health Questionnaire at 6-months postpartum (PHQ)-9|Generalized Anxiety Disorder (GAD)-7|Change in Generalized Anxiety Disorder (GAD)-7 at 1-month postpartum|Change in Generalized Anxiety Disorder (GAD)-7 at 3-months postpartum|Change in Generalized Anxiety Disorder (GAD)-7 at 6 months postpartum|Multi-Dimensional Scale of Perceived Social Support (MSPSS)|Change in Multi-Dimensional Scale of Perceived Social Support (MSPSS) at 1-month postpartum|Change in Multi-Dimensional Scale of Perceived Social Support (MSPSS) at 3-months postpartum|Change in Multi-Dimensional Scale of Perceived Social Support (MSPSS) at 6-months postpartum|Social Support Questionnaire (SSQ)- Short Form|Change in Social Support Questionnaire (SSQ)- Short Form at 1-month postpartum|Change in Social Support Questionnaire (SSQ)- Short Form at 3-months postpartum|Change in Social Support Questionnaire (SSQ)- Short Form at 6-months postpartum|Birth Companion Support Questionnaire|Change in Birth Companion Support Questionnaire at 3-months postpartum|Change in Birth Companion Support Questionnaire at 6-months postpartum|The Perceived Wellness Scale|Change in the Perceived Wellness Scale at 1-month postpartum|Change in the Perceived Wellness Scale at 3-months postpartum|Change in the Perceived Wellness Scale at 6-months postpartum|City Birth Trauma Scale City Birth Trauma Scale|Change in the City Birth Trauma Scale at 3-months postpartum City Birth Trauma Scale|Change in the City Birth Trauma Scale at 6-months postpartum City Birth Trauma Scale|Alcohol Use Disorders Identification Test (AUDIT) Alcohol Use Disorders Identification Test (AUDIT)|Change in the Alcohol Use Disorders Identification Test (AUDIT) at 1-month postpartum Alcohol Use Disorders Identification Test (AUDIT)|Change in the Alcohol Use Disorders Identification Test (AUDIT) at 3-months postpartum Alcohol Use Disorders Identification Test (AUDIT)|Change in the Alcohol Use Disorders Identification Test (AUDIT) at 6-months postpartum Alcohol Use Disorders Identification Test (AUDIT)|Drug Abuse Screening Test (DAST)|Change in the Drug Abuse Screening Test (DAST) at 1-month postpartum|Change in the Drug Abuse Screening Test (DAST) at 3-months postpartum|Change in the Drug Abuse Screening Test (DAST) at 6-months postpartum|CDC Health-Related Quality of Life (HRQOL)- 4 scale|Change in the CDC Health-Related Quality of Life (HRQOL)- 4 scale at 1-month postpartum|Change in the CDC Health-Related Quality of Life (HRQOL)- 4 scale at 3-months postpartum|Change in the CDC Health-Related Quality of Life (HRQOL)- 4 scale at 6-months postpartum|Pregnancy Risk Assessment Monitoring (PRAMS)","University of Montana","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","75","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Health Services Research","162-22","March 1, 2024","February 2025","February 2025","March 10, 2023",,"March 10, 2023",,,"https://ClinicalTrials.gov/show/NCT05763537"
363,"NCT04706442","Effectiveness of 'Supportive Parenting App' on Parental and Newborn Outcomes",,"Completed","No Results Available","Postnatal Depression|Self Efficacy|Parent-Child Relations|Development, Child|Anxiety|Parenting Satisfaction","Other: Supportive Parenting Application","Maternal postpartum depression|Infant physical, social, and emotional development|Paternal depression|Parental Anxiety|Parenting self-efficacy|Perceived social support|Parent-Infant bonding|Parenting satisfaction","National University of Singapore","All","21 Years to 65 Years   (Adult, Older Adult)","Not Applicable","398","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","NHG DSRB 2019/00875","March 1, 2020","March 22, 2022","March 22, 2022","January 12, 2021",,"April 12, 2022","Alice Lee Centre for Nursing Studies, Singapore, Singapore",,"https://ClinicalTrials.gov/show/NCT04706442"
364,"NCT01298778","High Pain Intervention in Cesarean Sections",,"Completed","Has Results","Other Chronic Postoperative Pain","Drug: Duramorph 150|Drug: Acetaminophen|Drug: Duramorph 300","Severity of Acute Pain|Incidence of Persistent Pain|Pain|Analgesic Consumption|Incidence of Depression|Average Pain Over 24 Hours","Wake Forest University Health Sciences","Female","18 Years to 45 Years   (Adult)","Not Applicable","69","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","IRB00012376","August 2010","July 2011","July 2011","February 18, 2011","June 9, 2017","September 10, 2018","Forsyth Medical Center-Sara Lee Center for Women's Health, Winston-Salem, North Carolina, United States",,"https://ClinicalTrials.gov/show/NCT01298778"
365,"NCT06207916","International Survey of Childbirth-Related Trauma - Swedish Part","SwIntersect","Completed","No Results Available","Childbirth-related PTSD|PTSD|Postnatal Depression|Fear of Childbirth|Post Traumatic Stress Disorder|Postpartum Sadness",,"Prevalence of childbirth-related PTSD","Region Östergötland","Female","18 Years and older   (Adult, Older Adult)",,"619","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","SwIntersect","September 1, 2021","January 31, 2022","January 31, 2022","January 17, 2024",,"January 17, 2024","Vrinnevisjukhuset, Norrköping, Sweden",,"https://ClinicalTrials.gov/show/NCT06207916"
366,"NCT00602732","Interpersonal Treatment Program to Prevent Depression and Post-Traumatic Stress Disorder in Low-Income Pregnant Women With Partner Abuse",,"Completed","No Results Available","Depression, Postpartum|Depression","Behavioral: The Reach Out for a Safe Environment (ROSE) program|Behavioral: Enhanced care as usual (ECU)","Longitudinal Interval Follow-up Examination (LIFE)|Revised Conflict Tactic Scale (CTS2)|Edinburgh Postnatal Depression Scale|The Davidson Trauma Scale|The Arizona Social Support Interview Schedule|Parenting Stress Index","Butler Hospital|National Institute of Mental Health (NIMH)","Female","18 Years to 40 Years   (Adult)","Phase 1","60","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R34MH075013|DSIR 83-ATP","September 2005","December 2013","December 2013","January 28, 2008",,"March 28, 2014","Memorial Hospital, Providence, Rhode Island, United States",,"https://ClinicalTrials.gov/show/NCT00602732"
367,"NCT02121015","Online Collaborative Learning Intervention to Prevent Perinatal Depression",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Share|Behavioral: Self-Directed","Change in depression symptoms over time as measured by the Inventory of Depression and Anxiety Symptoms (IDAS)|Usability and satisfaction based on the USE measure|Diagnosis of Major Depressive Disorder based on the Mini International Neuropsychiatric Interview (MINI)|Site usage as measured by the number of logins to the site over the course of the intervention","University of Illinois at Chicago|Northwestern University|University of Iowa|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","210","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","2014-1181|1R34MH102478-01|7R34MH102478-02","May 2016","November 2017","November 2017","April 23, 2014",,"January 18, 2020","University of Illinois at Chicago, Chicago, Illinois, United States|Northwestern University, Chicago, Illinois, United States|University of Iowa, Iowa City, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT02121015"
368,"NCT02883686","Randomized Controlled Trial of the Alma Peer Mentoring Program for Pregnant Women Experiencing Depression",,"Completed","No Results Available","Depression|Depression, Postpartum","Behavioral: Alma","Change in Patient Health Questionnaire (PHQ-9) score|Change in Generalized Anxiety Disorder Questionnaire (GAD-7) score|Change in Perceived Stress Scale (PSS-10) score|Change in WHO Disability Assessment Schedule (WHODAS 2.0) score|Parenting Stress Index-Short Form (PSI-4/SF)|Change in Behavioral Activation for Depression Scale (BADS) score|Change in Reward-Probability Index (RPI) score|Change in Environmental Reward Observation Scale (EROS) score|Change in Attitudes Toward Motherhood (AToM) score|Working Alliance Inventory - Short Form (Intervention group only)|Change in Self- Compassion Scale (SCS) score|Mother Inventory of Reward Experiences (MIRE)|Change in Social Support Questionnaire - Short Form (SSQ-SF) score|Client Satisfaction Questionnaire (CSQ-8)|Change in Effort-Expenditure for Rewards Task (EEfRT) performance|Change in Experience Sampling Survey response|Change in Go/No-Go Task (GNAT) performance|Exit Interview","University of Colorado, Boulder|Kaiser Permanente|Emory University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","27","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","CO-16-2391","February 6, 2019","April 28, 2020","April 28, 2020","August 30, 2016",,"May 6, 2020","Kaiser Permanente of Colorado, Aurora, Colorado, United States|University of Colorado Boulder, Boulder, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT02883686"
369,"NCT05654987","Perinatal Mental Health for Refugee Women","PMH-RW","Recruiting","No Results Available","Perinatal Depression",,"Depression Symptoms|Generalized anxiety disorder screener GAD- 7|Impact of Event Stress-Revise|Ten-Item Personality Inventory|City Birth Questionnaire","Universidad Nacional de Educación a Distancia|University of Gdansk|Taras Shevchenko National University of Kyiv","Female","Child, Adult, Older Adult",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","21-PSI-2022","December 1, 2022","July 31, 2023","October 1, 2023","December 16, 2022",,"December 16, 2022","Magdalena Chrzan-Dętkoś, Gdańsk, Poland|Lyudmyla Krupelnytska, Kiev, Ukraine",,"https://ClinicalTrials.gov/show/NCT05654987"
370,"NCT06231602","The Relationship Between Maternal Perinatal Depression and Feeding Behavior Among Primiparas",,"Not yet recruiting","No Results Available","Perinatal Depression|Breastfeeding|Complementary Feeding",,"maternal variables|infant variables|perinatal depression|breastfeeding situation|complementary feeding situation","National Taiwan University Hospital","Female","18 Years and older   (Adult, Older Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","202310157RINC","February 1, 2024","December 31, 2024","December 31, 2024","January 30, 2024",,"February 5, 2024",,,"https://ClinicalTrials.gov/show/NCT06231602"
371,"NCT00633178","Effectiveness of Group Interpersonal Psychotherapy in Treating Women With Prenatal Depression",,"Completed","No Results Available","Depression","Behavioral: Group interpersonal therapy (IPT)|Behavioral: Treatment as usual (TAU)","Improved prenatal mood|Postpartum depression","New York State Psychiatric Institute|National Institute of Mental Health (NIMH)","Female","18 Years to 40 Years   (Adult)","Not Applicable","116","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R34MH072838, #4914|R34MH072838","January 2005","March 2009","March 2009","March 11, 2008",,"July 1, 2021","Columbia University Medical Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT00633178"
372,"NCT06014892","The 4th Trimester Initiative: The Impact of Parental Support on Pregnant Trainee Wellbeing",,"Recruiting","No Results Available","Pregnancy Related|Burnout, Professional|Wellness, Psychological","Device: Snoo smart bassinet|Device: Willow wearable breast pump|Behavioral: Maven Clinic on-demand perinatal consultation|Behavioral: Faculty mentor","Burnout measured by emotional exhaustion and Interpersonal Disengagement components of the Stanford Professional Fulfillment Index|Professional Fulfillment measured by the Stanford Professional Fulfillment Index|Self reported medical error resulting in patient harm|Self reported medical error resulting in near miss for patient harm|Organizational and Personal Values Alignment|Negative Impact of Work on Personal Relationships|Postpartum Depression Screening|Ability to Meet Breastfeeding Goals|Duration of Breastfeeding|Serious thoughts of quitting training program|Regret for a Medical Career|Regret for a Chosen Specialty|Nightly wakenings|Nightly sleep duration|Fatigue","Massachusetts General Hospital|Brigham and Women's Hospital|Boston Children's Hospital|Beth Israel Deaconess Medical Center","Female","Child, Adult, Older Adult","Not Applicable","152","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","2022P001157","May 25, 2023","December 2025","June 2026","August 28, 2023",,"August 28, 2023","Massachusetts General Hospital, Boston, Massachusetts, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Boston Children's Hospital, Boston, Massachusetts, United States|Brigham and Women's Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT06014892"
373,"NCT05662423","Preventing Childbirth-Related PTSD With Expressive Writing","CARES","Recruiting","No Results Available","PTSD (Childbirth-Related)","Behavioral: Expressive Writing about Childbirth|Behavioral: Neutral Writing","Change from baseline in the PTSD Checklist for DSM-5 (PCL-5) total score|Physiological reactivity as determined from psychophysiologic responses during script-driven traumatic memory recollection of recent childbirth|Clinician-Administered PTSD-5 Scale for DSM 5 (CAPS-5)|Change from baseline in the Mother-to-Infant Bonding Scale (MIBS) total score|Maternal Attachment Inventory (MAI) total score|Change from baseline in the Edinburgh Postnatal Depression Scale (EPDS) total score|Change from baseline in the posttraumatic growth inventory (PTG) total score|Behavioral mother-infant bonding as determined by a quantitative observational assessment of mother-infant interaction using the Coding Interactive Behavior (CIB)","Massachusetts General Hospital","Female","18 Years to 50 Years   (Adult)","Not Applicable","136","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","2022P003320","November 8, 2023","January 31, 2025","January 31, 2025","December 22, 2022",,"March 26, 2024","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT05662423"
374,"NCT04657107","The Efficacy and Safety of S-ketamine in Elective Cesarean Section","ES-CS","Unknown status","No Results Available","Anesthesia|Analgesia|Depression|Cesarean Section|Parturition","Drug: S-ketamine|Other: normal saline","Intraoperative anesthesia effect|Ramsay Sedation Scale score|Clock-in-the-Box(CIB)|PHQ-9|Edinburgh Postnatal Depression Scale(EPDS)|Apgar score|placental transfer of S-ketamine|blood gas|umbilical arterial (UA)/umbilical venous (UV) ratio","Beijing Obstetrics and Gynecology Hospital|China Health Promotion Foundation|Beijing Haidian Maternal and Child Health Hospital|Obstetrics & Gynecology Hospital of Fudan University|Fourth Hospital of Shijiazhuang City|Changzhi Maternal and Child Health Hospital|Linfen Maternity&Child Healthcare Hospital|Maternal and Child Health Hospital, Jiading District|Tongzhou Maternal and Child Healthcare Hospital of Beijing|Beijing Chaoyang District Maternal and Child Health Care Hospital","Female","18 Years to 40 Years   (Adult)","Not Applicable","402","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Prevention","BeijingOGH","December 1, 2020","December 15, 2021","July 1, 2022","December 8, 2020",,"December 8, 2020",,,"https://ClinicalTrials.gov/show/NCT04657107"
375,"NCT00402389","Use of Omega-3 Fatty Acids for Perinatal Depression",,"Completed","No Results Available","Depression|Depression, Postpartum","Drug: Omega-3 Fatty Acids (EPA plus DHA)|Behavioral: Supportive psychotherapy|Drug: Placebo","Reduction of initial Edinburgh Postnatal Depression Scale (EPDS) score by 50% or more|Reduction of EPDS score to less than or equal to 9|CGI change score achievement of ""very much improved"" or ""much improved""|Significant reductions in outcome measures of functional status and reduction of SIGH-ADS score of 50%|Changes in the level of omega-3 fatty acid composition of red blood cell membranes","University of Arizona|National Institute of Mental Health (NIMH)","Female","18 Years to 45 Years   (Adult)","Phase 2","50","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Treatment","K23MH066265|DATR AK-TNAI2","June 2004","January 2006","January 2006","November 22, 2006",,"March 29, 2013","Women's Mental Health Program; University of Arizona; Department of Psychiatry, Tucson, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT00402389"
376,"NCT04730570","Essential Coaching for Every Mother, a Postpartum Text Message Program for Canadian Mothers","ECEM","Completed","No Results Available","Maternal Distress","Behavioral: Essential Coaching for Every Mother","Self Efficacy|Social support|Postpartum anxiety|Postpartum depression|Self-Efficacy|Social Support","IWK Health Centre|Dalhousie University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Care Provider, Outcomes Assessor)|Primary Purpose: Prevention","1024984","January 5, 2021","July 13, 2021","January 21, 2022","January 29, 2021",,"September 25, 2023","IWK Health, Halifax, Nova Scotia, Canada",,"https://ClinicalTrials.gov/show/NCT04730570"
377,"NCT01280474","Effects of Maternal Depressive Symptomatology on Pregnancy Outcomes and Newborn Development --- How is Paternal Psychopathology Involved?",,"Unknown status","No Results Available","Depression|Pregnancy",,,"Taipei Medical University WanFang Hospital","All","20 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Time Perspective: Prospective","99071","August 2010",,"August 2013","January 20, 2011",,"January 20, 2011","Taipei Medical University, Taipei, Taiwan",,"https://ClinicalTrials.gov/show/NCT01280474"
378,"NCT05453734","The Effect of Progressive Muscle Relaxation Exercises",,"Completed","No Results Available","Preterm|Mothers","Procedure: Progressive Muscle Relaxation Exercises","Breastfeeding Self-Efficacy Scale Score (BSES)|Edinburgh Postpartum Depression Scale Score (EDPS)|Edinburgh Postpartum Depression Scale (EDPS) Scores Change in Experimental and Control Group|Edinburgh Postpartum Depression Scale Scores Differences (EDPS) of the Groups","Istanbul University - Cerrahpasa (IUC)","Female","Child, Adult, Older Adult","Not Applicable","70","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Health Services Research","SHN503434","November 20, 2018","June 30, 2019","June 30, 2019","July 12, 2022",,"July 12, 2022","Kadriye Şahin, Istanbul, Şişli, Turkey",,"https://ClinicalTrials.gov/show/NCT05453734"
379,"NCT04472065","Study of Probiotic Use After Childbirth in Relation to Emotional Well-Being","PACE","Completed","No Results Available","Mental Health Wellness","Dietary Supplement: Lactobacillus reuteri|Other: Placebo","Coding Interactive Behavior (CIB) Negative Scale Score (range: 1-5; direction: Higher values indicate worse maternal responses) in the probiotic versus placebo group|Change in Toronto Alexithymia Scale (TAS-20) Total Score (range: 20-100; direction: lower scores indicate better socioemotional functioning) in the probiotic versus placebo group|Change in relative abundance of microbial taxa (operational taxonomic units) in fecal samples in the probiotic versus placebo group","Elizabeth Austen Lawson|Massachusetts General Hospital","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","46","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Other","2020P000562","March 10, 2021","October 16, 2023","October 16, 2023","July 15, 2020",,"October 25, 2023","Massachusetts General Hospital, Boston, Massachusetts, United States",,"https://ClinicalTrials.gov/show/NCT04472065"
380,"NCT01087112","Mother-Infant Psychoanalysis Project of Stockholm (MIPPS)- Follow-up at 4½ Years","MIPPS-02","Unknown status","No Results Available","Mother-child Relationship Disturbances","Behavioral: Mother-Infant Psychoanalytic tmt|Behavioral: Child Health Centre care","Child functioning: Children's Global Assessment Scale|Maternal depression: Edinburgh Postnatal Depression Scale|Maternal distress: Symptom Check List - 90|Maternal stress: Swedish Parental Stress Questionnaire|Child functioning: Ages and Stages Questionnaire:Social Emotional|Child functioning: Strengths and Difficulties Questionnaire|Child cognitive functioning: Wechsler's Preschool and Primary Scales of Intelligence|Child's social and emotional functioning: Story Stem Attachment Profile|Child's social and emotional functioning: Machover Draw-a-Person test","Karolinska Institutet","All","54 Months to 54 Months   (Child)","Early Phase 1","71","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","MIPPS-02","December 2009","June 2012","June 2013","March 16, 2010",,"March 16, 2010","Department of Women's and Children's Health, Child and Adolescent Psychiatry Unit, Karolinska Institutet, Stockholm, Sweden",,"https://ClinicalTrials.gov/show/NCT01087112"
381,"NCT04285684","The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women","KRF-LAC","Completed","Has Results","Ketamine|Lactation","Drug: ketamine in lactation","Ketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine|Ketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of 1mg/kg Ketamine|Norketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine|Norketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of 1mg/kg Ketamine|Dehydronorketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine|Dehydronorketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of 1mg/kg Ketamine|Hydroxynorketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of .5mg/kg Ketamine|Hydroxynorketamine Concentration in Breast Milk, up to 12 Hours at 3 Hour Intervals, Following an IM Administration of 1mg/kg Ketamine|Ketamine Concentration in Breast Milk at 24 and 30 Hours After an IM Administration of 1mg/kg Ketamine|Norketamine Concentration in Breast Milk at 24 and 30 Hours After an IM Administration of 1mg/kg Ketamine|Dehydronorketamine Concentration in Breast Milk at 24 and 30 Hours After an IM Administration of 1mg/kg Ketamine|Hydroxynorketamine Concentration in Breast Milk at 24 and 30 Hours After an IM Administration of 1mg/kg Ketamine","The Ketamine Research Foundation","Female","21 Years to 45 Years   (Adult)","Early Phase 1","4","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Basic Science","KetamineResearch","December 20, 2019","January 5, 2021","January 5, 2021","February 26, 2020","December 13, 2021","December 13, 2021","Ketamine Research Foundation, San Anselmo, California, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/84/NCT04285684/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT04285684"
382,"NCT01660165","Nutritional Status and Mental Health During Pregnancy and Postpartum: a Cohort Study in Rio de Janeiro, Brazil",,"Completed","No Results Available","Pregnancy",,"Major depressive episode|Gestational weight gain|Birth weight","Universidade Federal do Rio de Janeiro","Female","20 Years to 40 Years   (Adult)",,"299","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CAAE 0139.0.314.000-09","November 2009","November 2011","July 2012","August 8, 2012",,"January 17, 2014","Centro Municipal de Saúde Heitor Beltrão, Rio de Janeiro, Brazil",,"https://ClinicalTrials.gov/show/NCT01660165"
383,"NCT05655104","Effects of the Couplet Care in Neonatal Intensive Care Unit",,"Not yet recruiting","No Results Available","Early Skin-to-skin Contact|Psychological Distress|Parenting|Preterm Infant","Other: Couplet Care","Time from the birth to the first skin-to-skin contact|Time from the birth to the first holding|Average daily duration of parents' presence in the hospital room|Average duration of skin-to-skin contact|Average duration of holding|Parental postpartum depressive symptoms|Parental anxiety symptoms|Parent-infant bonding|Quality of family centered care as reported by parents|Breastmilk feeding|Breastfeeding","Turku University Hospital","All","Child, Adult, Older Adult",,"30","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","CoupletCareStudy/2022","January 2023","June 2023","December 2023","December 19, 2022",,"December 19, 2022",,,"https://ClinicalTrials.gov/show/NCT05655104"
384,"NCT03004872","Relationship Between Postpartum Mood Disorders and Delivery Experience",,"Completed","No Results Available","Postpartum Period|Depression|Stress Disorders, Post-Traumatic",,"Association of poor birth experiences with development of postpartum posttraumatic stress disorder (PTSD).|Association of poor birth experience with development of postpartum depression.","University of Michigan","Female","18 Years and older   (Adult, Older Adult)",,"600","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","HUM00119428","October 31, 2016","December 17, 2018","December 17, 2018","December 29, 2016",,"February 12, 2019","University of Michigan, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT03004872"
385,"NCT02692404","Labor Pain and Postpartum Behavioral Health Outcomes Study","LPPD","Completed","No Results Available","Depression, Postpartum|Pregnancy|Child Development|Pain|Labor Pain",,"Edinburgh Postnatal Depression Score (EPDS)|Perceived Stress|Brief Pain Inventory|Maternal-Infant Attachment|Parenting Self-Efficacy|Child Development","University of Pittsburgh","Female","18 Years and older   (Adult, Older Adult)",,"199","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","PRO15030338","January 2016","August 8, 2017","September 18, 2017","February 26, 2016",,"January 18, 2020","Magee Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States|The Midwife Center for Birth and Womens Health, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02692404"
386,"NCT03464630","Reducing Maternal Depression and Promoting Infant Social-Emotional Health & Development","MBN","Completed","No Results Available","Maternal Depression and Parent Practices, Postpartum|Infant Social-Emotional and Social Communication Competency Development","Behavioral: Mom & Baby Net|Behavioral: Depression & Developmental Awareness System","PHQ9|Landry Parent Child Interaction Rating Scales|Indicator of Parent Child Interaction (IPCI)","Georgia State University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Oregon Research Institute|The University of Texas Health Science Center, Houston","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","184","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Treatment","1R01HD086894|R01HD086894-01A1","February 15, 2018","June 1, 2022","July 1, 2022","March 14, 2018",,"July 13, 2022","Georgia State University, Atlanta, Georgia, United States","""Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/30/NCT03464630/SAP_001.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/30/NCT03464630/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03464630"
387,"NCT04852757","Estimating the Prevalence of Postpartum Anxiety and Depression in the Context of the Coronavirus Disease (COVID-19) Pandemic","PsyCOVIDUM","Completed","No Results Available","Depression, Postpartum",,"Follow the evolution of the prevalence of women in immediate postpartum presenting a depressive and/or anxious symptomatology in the population of 3 maternity units in the Paris area|Estimate the prevalence, in the context of a COVID-19 pandemic, of women in the immediate postpartum period presenting depressive and/or anxious symptoms (EPDS) in the population of women giving birth (in the 3 hospitals)|Estimate, in the context of a COVID-19 pandemic, the prevalence of women in the immediate postpartum period presenting depressive and/or anxious symptoms (STAI-S) in the population of women giving birth (in the 3 hospitals)|Estimate, in the context of a COVID-19 pandemic, the prevalence of women in the immediate postpartum period presenting depressive and/or anxious symptoms (PDEQ) in the population of women giving birth (in the 3 hospitals)|Estimate, in the context of a COVID-19 pandemic, the prevalence of women in the immediate postpartum period presenting depressive and/or anxious symptoms (PDI) in the population of women giving birth (in the 3 hospitals)|Estimate in the context of a COVID-19 pandemic the prevalence of women at 2 months postpartum with depressive and/or anxious symptoms (EPDS) in the population of women giving birth at the GhPSJ maternity hospital|Estimate in the context of a COVID-19 pandemic the prevalence of women at 2 months postpartum with depressive and/or anxious symptoms (STAI-S) in the population of women giving birth at the GhPSJ maternity hospital|Estimate in the context of a COVID-19 pandemic the prevalence of women at 2 months postpartum with depressive and/or anxious symptoms (PDEQ) in the population of women giving birth at the GhPSJ maternity hospital|Estimate in the context of a COVID-19 pandemic the prevalence of women at 2 months postpartum with depressive and/or anxious symptoms (IES-R) in the population of women giving birth at the GhPSJ maternity hospital|Investigate factors associated with the risk of developing depressive and/or anxiety symptomatology in the COVID-19 pandemic context|Comparison of the prevalence of anxiety and depressive disorders among women not infected with SARS-CoV2 in PsyCOVIDUM with those infected in the COROPREG study (COVID-19 and pregnancy: a population-based cohort of women and newborns)","Fondation Hôpital Saint-Joseph","Female","18 Years and older   (Adult, Older Adult)",,"2580","Other","Observational","Observational Model: Cohort|Time Perspective: Cross-Sectional","PsyCOVIDUM","May 25, 2021","October 31, 2022","April 30, 2023","April 21, 2021",,"September 13, 2023","Groupe Hospitalier Paris Saint Joseph, Paris, Ile-de-France, France",,"https://ClinicalTrials.gov/show/NCT04852757"
388,"NCT00183547","Depression Prevention Program for American Indian Adolescents During and After Pregnancy",,"Completed","No Results Available","Depression|Pregnancy","Behavioral: ""Living in Harmony"" depression prevention program|Behavioral: Depression-prevention education and support","Postpartum depression","Johns Hopkins University|National Institute of Mental Health (NIMH)","Female","15 Years to 19 Years   (Child, Adult)","Not Applicable","45","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","R34MH071300|DSIR 84-CTP","January 2005","March 2007","September 2007","September 16, 2005",,"May 29, 2013","Johns Hopkins Center for American Indian Health, Whiteriver, Arizona, United States|Johns Hopkins Center for American Indian Health, Baltimore, Maryland, United States",,"https://ClinicalTrials.gov/show/NCT00183547"
389,"NCT03381495","The Association Between Epidural Labor Analgesia and Pregnancy Outcomes",,"Unknown status","No Results Available","Labor Pain|Pregnancy Outcomes|Psychological Disorder","Drug: Ropivacaine Hydrochloride, Sufentanil","Labor duration|1 minute Apgar index|5 minute Apgar index|Visual Analogue Scores(VAS)|Modified Bromage scores|Postpartum depression|The mode of delivery","Deng Dongrui|Tongji Hospital","Female","15 Years to 50 Years   (Child, Adult)","Not Applicable","200","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","TJ-C20171201","May 16, 2018","September 1, 2018","December 31, 2019","December 22, 2017",,"July 13, 2018","Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China",,"https://ClinicalTrials.gov/show/NCT03381495"
390,"NCT00392847","Promoting Parental Skills and Enhancing Attachment in Early Childhood","CAPEDP","Completed","No Results Available","Behavioral Disorders","Behavioral: Promoting Parental Skills and Enhancing Attachment|Behavioral: had home visits by community workers during pregnancy","Mothers' scores on a postnatal depression scale (baseline, and when the child is 3, 6 and 12 months old)|Parental competencies (when the child is 3, 12 and 18 months old)|Child mental health (when the child is 18 and 24 months old)|Child attachment (when the child is 18 months old)|Family use of medical and social services (baseline, and when the child is 3, 6, 12 and 24 months old)|Family social support (baseline, and when the child is 3, 12 and 24 months old)|Mother's self-esteem as a parent (when the child is 3, 12 and 24 months old)|Child psychomotor development (when the child is 6, 12 and 24 months old)|Mother's knowledge about child development (baseline, and when the child is 3 and 24 months old)|Mother's attachment (at baseline)|Mother's mental health (baseline, and when the child is 3 and 24 months old)|Mother's working alliance with home visitor (not for control group) (when the child is 3, 6, 12 and 24 months old)|Social-demographic data (all follow-up points: baseline, and when the child is 3, 6, 12, 18 and 24 months old)","Assistance Publique - Hôpitaux de Paris|Ministry of Health, France","Female","up to 26 Years   (Child, Adult)","Not Applicable","440","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)","P051045","December 2006","August 2011","January 2012","October 26, 2006",,"July 10, 2012","Bichat-Claude Bernard Hospital, Paris, France",,"https://ClinicalTrials.gov/show/NCT00392847"
391,"NCT05345834","The DC Mother-Infant Behavioral Wellness Program",,"Recruiting","No Results Available","Perinatal Depression|Perinatal Anxiety|Prenatal Stress","Behavioral: Patient Navigation|Behavioral: Adapted Cognitive-Behavioral Therapy","Change in Stress at 24 weeks of pregnancy to 12 months postpartum|Change in Depression at 24 weeks of pregnancy to 12 months postpartum|Change in Anxiety at 24 weeks of pregnancy to 12 months postpartum","Children's National Research Institute|George Washington University|Patient-Centered Outcomes Research Institute","Female","18 Years to 45 Years   (Adult)","Not Applicable","700","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","Pro00015379","August 22, 2022","April 2024","August 2024","April 26, 2022",,"February 8, 2023","Unity Healthcare - Brentwood, Washington, District of Columbia, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/34/NCT05345834/Prot_SAP_000.pdf|""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/34/NCT05345834/ICF_001.pdf","https://ClinicalTrials.gov/show/NCT05345834"
392,"NCT05762133","African-American Social Support Effectiveness Treatment","ASSET-PPD","Active, not recruiting","No Results Available","Maternal Perinatal Depression","Behavioral: African-American Social Support Effectiveness Treatment-Partners alleviating Perinatal Depression (ASSET-PPD)","Maternal depression|Maternal anxiety|Breastfeeding|Infant affect and mood regulation|Parent-infant interaction quality","Northwestern University","All","18 Years and older   (Adult, Older Adult)","Not Applicable","100","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Supportive Care","1R21MD014798-01A1","August 27, 2020","October 31, 2024","October 31, 2024","March 9, 2023",,"March 15, 2024","Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT05762133"
393,"NCT02566980","Biological Triggers of Depression in Pregnancy",,"Completed","No Results Available","Depression and Suicide|Mood Disorders|Other Perinatal Conditions",,"Change in activity of the enzyme aminocarboxymuconate semialdehyde decarboxylase ACMSD in blood during pregnancy|Activity of the enzyme aminocarboxymuconate semialdehyde decarboxylase ACMSD in placenta|Increase in depressive symptoms|Suicidal symptoms|Change in blood inflammation|Placenta inflammation","Michigan State University|Pine Rest Christian Mental Health Services|Van Andel Research Institute|Spectrum Health Hospitals|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)",,"209","Other|NIH","Observational","Observational Model: Cohort|Time Perspective: Prospective","14-458M|1R01MH104622-01","October 23, 2014","February 28, 2017","February 28, 2017","October 2, 2015",,"June 28, 2018","Spectrum Health System, Grand Rapids, Michigan, United States|Van Andel Research Institute, Grand Rapids, Michigan, United States|Pine Rest Christian Mental Health Services, Grand Rapids, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT02566980"
394,"NCT02094092","Role of ProTectis on Infant Colic and Its Effect on Infant Crying Time and Maternal Mental Health","PRIC-SMM","Unknown status","No Results Available","Infantile Colic|Infant Sleeping Habits|Maternal Mental Health.","Other: ProTectis drops (five drops per day) for 21 days|Other: Placebo drops (five drops per day) for 21 days","The treatment success (defined as the percentage of children achieving a reduction in the daily average crying time 50% during the study)|Change in the duration of crying (minutes per day).|A reduction in the daily average crying time, to <3 h/d.|Change in Infant sleep duration in (minutes/day)|Change in Maternal mental health scores.","Ferozsons Laboratories Ltd.","All","up to 3 Months   (Child)","Not Applicable","60","Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment","FZSPBT001","May 2014","March 2016","March 2016","March 21, 2014",,"March 21, 2014","Fauji Foundation Hospital, Rawalpindi, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT02094092"
395,"NCT05815433","Comparing Impacts of Donor Human Milk to Formula Supplementation on the Gut Microbiome of Full-term Infants","PPDHM","Recruiting","No Results Available","Microbial Colonization","Other: Donor Human Milk - Nutritional Replacement","Infant gut microbiome - shallow shotgun metagenomics (RA)|Infant gut microbiome - shallow shotgun metagenomics (alpha diversity)|Infant gut microbiome - shallow shotgun metagenomics (beta diversity)|Infant Sleep|Infant Growth - weight|Infant Growth - length|Infant Growth - BMI|Infant Growth - head|Infant Growth- length|Infant feeding|Maternal Depression|Maternal Anger|Maternal Breastfeeding Self-efficacy|Maternal Anxiety","University of Calgary|University of British Columbia|University of Victoria|NorthernStar Mothers Milk Bank","All","37 Weeks and older   (Child, Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","RMS23-99633743","July 1, 2023","March 31, 2024","December 31, 2024","April 18, 2023",,"July 5, 2023","Rockyview General Hospital, Calgary, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT05815433"
396,"NCT04012580","Examining the Effectiveness of Transdiagnostic, Internet-Delivered Cognitive Behaviour Therapy in New Mothers Experiencing Anxiety and Depression",,"Completed","No Results Available","Depression, Postpartum|Anxiety","Behavioral: Therapist-assisted ICBT","Change in postpartum depression|Change in anxiety|Change in depression|Change in depression, anxiety, stress|Mother-infant bonding|Relationship satisfaction|Treatment credibility|Therapeutic alliance|Treatment satisfaction|Adverse effects|Service utilization","University of Regina","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","2019-077","September 30, 2019","November 27, 2020","November 27, 2020","July 9, 2019",,"April 29, 2021","Online Therapy Unit, University of Regina, Regina, Saskatchewan, Canada",,"https://ClinicalTrials.gov/show/NCT04012580"
397,"NCT05893485","Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus","WOMB","Recruiting","No Results Available","Music Therapy|Preterm Premature Rupture of Membrane (PPROM)","Behavioral: Music Therapy Intervention","Measure the length of time from when the membranes prematurely rupture to delivery|Change in anxiety levels in relation to the length of hospital stay|Music therapy in relation to maternal tachycardia due to stress|Edinburgh Postnatal Depression Scale score before and after music therapy|Visual analogue scale for anxiety before and after music therapy|Music therapy in relation to infant bonding|Change in the time interval between delivery and newborn receiving their mother's breastmilk|Change in blood pressure before and after music therapy","Christina Chianis Reed|The Methodist Hospital Research Institute|Baylor College of Medicine","Female","18 Years to 64 Years   (Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Prevention","H-52059","May 15, 2023","March 1, 2026","March 1, 2026","June 8, 2023",,"June 8, 2023","Texas Children's Pavilion for Women, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT05893485"
398,"NCT03212547","The Effect of a Neonatologist's Standardized Guidance Intervention on Preterm Infants With Relational Withdrawal.",,"Unknown status","No Results Available","Social Withdrawal of Childhood or Adolescence|Preterm Infant","Behavioral: Verbal Intervention","Sustained social withdrawal|Post-partum depression|Post-traumatic stress symptoms|Premature infant pain|Painful invasive procedures|Parental visiting time|Breastfeeding time|Skin to skin contact time","Clinica Alemana de Santiago","All","1 Day to 3 Days   (Child)","Not Applicable","140","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","ADBB Chile","September 19, 2017","May 19, 2020","July 19, 2020","July 11, 2017",,"January 29, 2019","Clinica Alemana de Santiago, Santiago, Region Metropolitana, Chile",,"https://ClinicalTrials.gov/show/NCT03212547"
399,"NCT03267043","Family Nurture Intervention in the NICU at The Valley Hospital",,"Completed","No Results Available","Premature Birth|Obstetric Labor, Premature","Behavioral: Family Nurture Intervention (FNI)|Behavioral: Standard Care","EEG Power in the frontal polar region|EEG Coherence in the left frontal polar to right frontal polar region|CES-D Score|State-Trait Anxiety Inventory (STAI) Score|Neurobehavioral Assessments of Infants - Bayley Scales or Infant and Toddler Development, Bayley III","Columbia University","All","26 Weeks to 34 Weeks   (Child)","Not Applicable","150","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","AAAR4899","October 20, 2017","March 19, 2020","July 1, 2020","August 30, 2017",,"February 15, 2023","The Valley Hospital, Ridgewood, New Jersey, United States|Morgan Stanley Children's Hospital of New York (MSCHONY), New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT03267043"
400,"NCT02710474","Family Nurture Intervention in the NICU",,"Completed","No Results Available","Premature Birth|Obstetric Labor, Premature","Behavioral: Family Nurture Intervention|Behavioral: Standard Care","EEG Power in the frontal polar region|EEG Coherence in the left frontal polar to right frontal polar region|CES-D Score|STAI Score|Neurobehavioral Assessment of Infants - Bayley Scales of Infant and Toddler Development, Bayley III","Columbia University|Einhorn Family Charitable Trust","All","26 Weeks to 34 Weeks   (Child)","Not Applicable","461","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","AAAQ7504","January 24, 2017","February 7, 2020","December 31, 2022","March 16, 2016",,"February 15, 2023","Morgan Stanley Children's Hospital of New York (MSCHONY), New York, New York, United States|University Texas Health Science Center San Antonio (UTHSCSA), San Antonio, Texas, United States",,"https://ClinicalTrials.gov/show/NCT02710474"
401,"NCT02352142","Family Nurture Intervention in the CHoNJ NICU",,"Terminated","No Results Available","Premature Birth","Other: Full Term EEG|Behavioral: Facilitated Infant Care","EEG measures of power and coherence|Maternal measures of anxiety, depression and care-giving|Measure of mother time spent with infant in unit and in skin to skin|Neurobehavioral Assessments of Infants- Bayley Scales of Infant and Toddler Development, Bayley III|Physiological Assessments- salivary cortisol|Physiological Assessments- breast milk|Physiological Assessments- infant stool collection|Physiological Assessments- infant blood samples|Mother-Infant Interactions Assessments: Evaluating the qualities of the mother's interaction with her infant during diaper change|Mother-Infant Interaction Assessments: Mother-infant face-to-face communicative competence, sensitivity of maternal caregiving and mother and infant physiological capacity to cope with a stressor","Columbia University|Newark Beth Israel Medical Center","All","26 Weeks to 42 Weeks   (Child)","Not Applicable","54","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","AAAN6850","January 2015","May 2016","May 2016","February 2, 2015",,"September 26, 2016","Children's Hospital of New Jersey, Newark, New Jersey, United States|Columbia University Data Coordinating Center, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT02352142"
402,"NCT04169334","Look - Your Baby is Talking to You.",,"Completed","No Results Available","Depression, Postpartum","Behavioral: Prolonged planned program for the stay at the obstetric department","Change in maternal depressive symptoms from baseline to three month postpartum|Parental Stress scale|Parental reflective function|Family function|Infant self-regulations|Process evaluation","Copenhagen University Hospital, Hvidovre","Female","Child, Adult, Older Adult","Not Applicable","121","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","H-18021300","September 19, 2019","January 21, 2022","January 21, 2022","November 19, 2019",,"July 20, 2022","COpenhagen University Hospital Hvidovre, Hvidovre, Danmark, Denmark",,"https://ClinicalTrials.gov/show/NCT04169334"
403,"NCT01439269","Family Nurture Intervention (FNI) in Neonatal Intensive Care Unit (NICU)",,"Completed","No Results Available","Premature Birth","Behavioral: Family Nurture Intervention","Length of Stay|Safety and Practicability of Intervention|Psychological Assessments: Mothers in both groups are given a wide-range of psychological questionnaires. These include indices of anxiety, depression, temperament, personality, attachment, stress, and social support.|Neurobehavioral Assessments of Infants: The use of the NICU Network Neurobehavioral Scale (NNNS) to assess infant's neurodevelopmental status|Neurobehavioral Assessments of Infants: Mothers provide a wide range of information about infant's development through questionnaires|Neurobehavioral Assessments of Infants- Bayley Scales of Infant and Toddler Development, Bayley III|Physiological Assessments: A one hour recording of high density electroencephalogram (EEG) (128 leads), electrocardiogram (ECG), and respiration during sleep.|Physiological Assessments- Cortisol Levels, breast milk, saliva, infant blood samples, and infant stool collection|Mother-Infant Interactions Assessments: Evaluating the qualities of the mother's interaction with her infant during diaper change|Mother-Infant Interaction Assessments: Mother-infant face-to-face communicative competence, sensitivity of maternal caregiving and mother and infant physiological capacity to cope with a stressor|Mother-Infant Interaction Assessments- Yale Inventory of Parental Thoughts and Actions (YIPTA)|Assessments of Neonatal Intensive Care Unit Activities: Ascertainment of attendance and the frequency and/or time spent engaged in key aspects of the Family Nurture Intervention using maternal self-report forms.","Columbia University|Williams College|New York State Psychiatric Institute","All","26 Weeks to 34 Weeks   (Child)","Not Applicable","394","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","AAAD0389","June 2008","July 3, 2012","January 9, 2018","September 23, 2011",,"February 15, 2023","Morgan Stanley Children's Hospital, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT01439269"
404,"NCT03990389","Tracking Depression Symptoms With a Health Chatbot",,"Completed","Has Results","Depression, Postpartum|Depression, Unipolar","Device: Chatbot Intervention","Longitudinal Change in Depression Severity|Change in Depression Severity|Change in Side-effect Burden|Change in Maternal Function|Change in Maternal Confidence|Medication Adherence","University of Chicago|NorthShore University HealthSystem","All","18 Years and older   (Adult, Older Adult)","Not Applicable","31","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","IRB16-1802","February 20, 2019","February 29, 2020","February 29, 2020","June 19, 2019","May 12, 2022","May 12, 2022","University of Chicago, Chicago, Illinois, United States|NorthShore University HealthSystem, Skokie, Illinois, United States","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/89/NCT03990389/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT03990389"
405,"NCT04680585","MOVIN Pilot Randomized Controlled Trial","MOVIN","Completed","No Results Available","Depression, Postpartum","Other: Enhanced Usual Care|Other: MOVIN Care Platform","Feasibility of the trial protocol: Recruitment|Feasibility of the trial protocol: Acceptability|Feasibility of the trial protocol: Compliance|Maternal clinical outcomes - depression symptoms|Maternal clinical outcomes - anxiety symptoms|Maternal clinical outcomes - quality of life|Health service use: participant time|Health service use: participant cost|Health service use: health system costs|Care coordinator time|Care coordinator cost|Dyadic relationship|Maternal child relationship|Infant temperament","Women's College Hospital","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","81","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Investigator)|Primary Purpose: Health Services Research","2020-0054-B","April 12, 2021","June 30, 2022","December 30, 2022","December 23, 2020",,"April 26, 2023","Women's College Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04680585"
406,"NCT03027037","Perinatal Emotion and Relationships Longitudinal Study","PEARLS","Completed","No Results Available","Depression, Postpartum",,"Occurrence of mood episodes and anxiety disorders|Mood and anxiety symptoms|Emotion reactivity and regulation|Empathic accuracy|Prosocial behavior|Well-being and social support|Parenting sensitivity, efficacy, stress, bond with infant","University of Colorado, Boulder|John Templeton Foundation|Emory University|University of Michigan|Columbia University|Queen's University","Female","18 Years and older   (Adult, Older Adult)",,"150","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","49683","November 2015","January 2018","January 2018","January 20, 2017",,"March 31, 2020","University of Colorado Boulder, Boulder, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT03027037"
407,"NCT02454322","The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience",,"Completed","No Results Available","Depression, Postpartum","Drug: Magnesium Sulfate","Frequency of Postpartum Depression|Cognitive Function (measured using the Salthouse Digit Comparison and Size Judgment Span tests)|Pain (Self-reported)","Northwestern University","Female","18 Years and older   (Adult, Older Adult)",,"300","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","IRB #200388","May 2015","November 2020","December 2021","May 27, 2015",,"May 5, 2022","Northwestern Memorial Hospital, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT02454322"
408,"NCT01587729","IMI PROTECT(WP2): Antidepressants & Fractures",,"Completed","No Results Available","Depression, Postpartum","Drug: Tricyclic AD (TCAs) and selective serotonin re-uptake inhibitors (SSRIs) antidepressants","First fracture of hip or femur during the study period","GlaxoSmithKline","All","18 Years and older   (Adult, Older Adult)",,"1","Industry","Observational","Time Perspective: Retrospective","115734|WEUKBRE5556","November 2011","July 2014","July 2014","April 30, 2012",,"March 27, 2015",,,"https://ClinicalTrials.gov/show/NCT01587729"
409,"NCT06246214","From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health",,"Active, not recruiting","No Results Available","Depression, Postpartum|Anxiety State","Device: Blue Light Therapy|Device: ControlLT","Depressive symptoms|Anxiety symptoms","Hospital de Clinicas de Porto Alegre|Federal University of Rio Grande do Sul","Female","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","150","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","2022-0584","January 4, 2024","May 2027","May 2027","February 7, 2024",,"February 7, 2024","Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil",,"https://ClinicalTrials.gov/show/NCT06246214"
410,"NCT02790905","Validating the Patient Health Questionnaire in Pregnant and Post-partum Migrant Women",,"Completed","No Results Available","Depression",,"Validity of Patient Health Questionnaire-9 (PHQ-9)|Validity of Refugee Health Screener-15 (RHS-15) questionnaire|Reliability of Patient Health Questionnaire-9 (PHQ-9)|Reliability of Refugee Health Screener-15 (RHS-15) questionnaire|Sensitivity of Patient Health Questionnaire-9 (PHQ-9)|Sensitivity of Refugee Health Screener-15 (RHS-15) questionnaire|Specificity of Patient Health Questionnaire-9 (PHQ-9)|Specificity of Refugee Health Screener-15 (RHS-15) questionnaire|Positive predictive value for each of Patient Health Questionnaire-9 (PHQ-9)|Positive predictive value for each of Refugee Health Screener-15 (RHS-15) questionnaire|Negative predictive value for each of Patient Health Questionnaire-9 (PHQ-9)|Negative predictive value for each of Refugee Health Screener-15 (RHS-15) questionnaire","University of Oxford","Female","18 Years and older   (Adult, Older Adult)",,"370","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","SMRU1503","September 2015","September 30, 2016","September 30, 2016","June 6, 2016",,"October 6, 2017","Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand",,"https://ClinicalTrials.gov/show/NCT02790905"
411,"NCT04836585","eMBC for Perinatal Depression and Anxiety","eMBC","Active, not recruiting","No Results Available","Depression, Postpartum|Anxiety","Other: eMBC Intervention","Feasibility of the trial protocol: Recruitment|Feasibility of the trial protocol: Participant Acceptability|Feasibility of the trial protocol: Provider Acceptability|Feasibility of the trial protocol: Adherence|Clinical outcomes - clinician-assessed depression symptoms|Clinical outcomes - self-report depression symptoms|Clinical outcomes - anxiety symptoms|Clinical outcomes - functional capacity|Clinical outcomes - social functioning|Clinical outcomes - antidepressant side effects","Women's College Hospital","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","42","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Health Services Research","2020-0090-B","January 4, 2022","October 27, 2023","June 2024","April 8, 2021",,"October 31, 2023","Women's College Hospital, Toronto, Ontario, Canada",,"https://ClinicalTrials.gov/show/NCT04836585"
412,"NCT00745537","T- BOOM Teens--Building Options and Opportunities for Moms","T-BOOM","Completed","No Results Available","Postpartum Major Depression","Other: repeated mood measures and phone depression care management","Severity of PPD will be assessed with the Children's Depression Rating Scale (CDRS).|Edinburgh Postnatal Depression Scale|Center for Epidemiologic Studies of Depression instrument (CES-D)|A specific measure of functioning at school or work and with peers, the Children's Global Assessment of Functioning (C-GAS) will be obtained.|The Social Function-12 (SF-12; Ware et al., 1993) is the most widely used measure of health-related functioning.|The Inventory of Functional Status after Birth (IFSAC) was used in studies of postpartum women to measure the woman's readiness to assume infant care and resume usual activities (Fawcett et al., 1988).|To assess the mother-infant relational quality, the Gratification in the Maternal Role (GRAT) is a 14-item checklist in which women rate each item on a 5 point scale (Mercer, 1985).","University of Pittsburgh","Female","10 Years to 17 Years   (Child)","Not Applicable","23","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","B7473","April 2008","December 2010","December 2010","September 3, 2008",,"May 28, 2015","University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT00745537"
413,"NCT03573713","Decreasing Stunting by Reducing Maternal Depression in Uganda: A Cluster Randomized Controlled Trial (CRCT) for Improved Nutrition Outcomes",,"Completed","No Results Available","Depression, Postpartum|Malnutrition, Child","Other: Care Groups|Behavioral: IPT-G","Change in scores of KPC Survey of maternal and child health and nutrition behaviors|Score of survey on home management, referral and care seeking for children|Score of survey on infant and young child feeding practices|Score of survey on water usage, sanitation and hygiene practices|Score of survey on knowledge and utility of preventive services available at local health facilities|Score of survey on family planning practices","Food for the Hungry|Teachers College, Columbia University|Johns Hopkins University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","1248","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","FHU-ECF","September 11, 2017","April 15, 2019","April 15, 2019","June 29, 2018",,"February 7, 2020","FH Uganda - Kitgum, Kitgum, Uganda",,"https://ClinicalTrials.gov/show/NCT03573713"
414,"NCT00711971","Does Fish Oil Prevent Depression in Pregnancy and Postpartum?",,"Completed","Has Results","Depression","Drug: EPA-rich fish oil supplement|Drug: DHA-rich fish oil supplement|Drug: placebo","Beck Depression Inventory","University of Michigan|National Center for Complementary and Integrative Health (NCCIH)","Female","18 Years and older   (Adult, Older Adult)","Phase 2|Phase 3","126","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Prevention","HUM00004684|R21AT004166-01A1","September 2008","August 2012","January 2013","July 9, 2008","April 28, 2017","April 28, 2017","University of Michigan Hospital, Ann Arbor, Michigan, United States",,"https://ClinicalTrials.gov/show/NCT00711971"
415,"NCT05353491","Thinking Healthy Program-Technology Assisted (THP-TA)","THP-TA","Active, not recruiting","No Results Available","Perinatal Depression|Depression, Postpartum","Behavioral: Technology assisted Thinking Healthy Program (THP-TA)|Behavioral: Standard Thinking Healthy Program","Remission rates of perinatal depression|Sustained remission rates of perinatal depression|Change in severity of perinatal depressive symptoms|Change in severity of perinatal anxiety symptoms|Change in maternal Quality of Life|Change in disability using the World Health Organization Disability Assessment Schedule 2.0|Service use and costs|Infant nutrition/breastfeeding|Family planning practices|Infant Immunization Status|Maternal Social support|Parental time spent in play with the infant|Diarrheal episodes among infants|Acute upper respiratory tract infections among infants","Human Development Research Foundation, Pakistan|Shifa Tameer-e-Millat University|University of Liverpool","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","980","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","UoL001668|NIHR200817","June 13, 2022","May 1, 2024","September 30, 2024","April 29, 2022",,"March 22, 2024","Human Development Research Foundation, Rawalpindi, Punjab, Pakistan","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/91/NCT05353491/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT05353491"
416,"NCT05820958","Intensified Tactile Contact With a Newborn Andt Emotional Transformation of the Mother",,"Completed","No Results Available","Parturition|Depression, Postpartum","Other: Shantali massage","Change in Edinburgh Postnatal Depression Scale|Change in The Hospital Anxiety and Depression Scale|Change in Positive and Negative Affect Schedule questionnaire|Change in Parenting Sense of Competence questionnaire","The Jerzy Kukuczka Academy of Physical Education in Katowice","Female","18 Years to 40 Years   (Adult)","Not Applicable","43","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Supportive Care","8/2017","January 10, 2021","February 14, 2022","April 10, 2022","April 20, 2023",,"April 20, 2023","The Jerzy Kukuczka Academy of Physical Education, Katowice, Poland",,"https://ClinicalTrials.gov/show/NCT05820958"
417,"NCT01602913","Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine",,"Completed","No Results Available","Depression, Postpartum","Drug: Pravastatin alone|Drug: Paroxetine alone|Drug: Pravastatin and paroxetine combined","Incidence of T2DM defined as having at least 2 diagnostic codes indicating T2DM after the index date, or 1 diagnostic code and 1 prescription of oral anti-diabetic medications or insulin (or Byetta and Victoza) after the index date","GlaxoSmithKline","All","18 Years and older   (Adult, Older Adult)",,"1","Industry","Observational","Observational Model: Cohort|Time Perspective: Retrospective","116554|WEUSKOP5966","December 2011","May 2012","May 2012","May 21, 2012",,"July 2, 2014",,,"https://ClinicalTrials.gov/show/NCT01602913"
418,"NCT02516982","mHealth for Antenatal Mental Health","AMHS","Completed","Has Results","Depression|Pregnancy","Other: Whooley Questions|Other: Edinburgh Postnatal Depression Scale|Other: Momentary questions|Other: Contextual questions","Number of Participants Responding Affirmatively to at Least One Whooley Question According to Survey Layout|Median EPDS Scores According to Survey Layout|Number of Participants at Each EPDS Scoring Interval According to Survey Layout|Number of Participants According to Their Score on Question 10 of the EPDS According to Survey Layout|Adherence With a 6-month Follow-up Protocol|Time Needed to Complete the Whooley Questions and the EPDS According to Survey Layout|Proportion of Participants Requesting Technical Assistance According to Survey Layout|Number of Requests for Technical Assistance by Type of Request and According to Survey Layout","Imperial College London","Female","18 Years and older   (Adult, Older Adult)",,"946","Other","Observational","Observational Model: Other|Time Perspective: Prospective","15IC2687","October 2015","February 2018","August 2018","August 6, 2015","September 23, 2019","September 23, 2019","East Lancashire, Blackburn, United Kingdom|Royal Bolton Hospital, Bolton, United Kingdom|Burton Hospitals, Burton, United Kingdom|The Pennine Acute Hospitals, Crumpsall, United Kingdom|Hinchinbrooke Hospital, Huntingdon, United Kingdom|East Midlands CRN, Lincoln, United Kingdom|Chelsea & Westminster Hospital, London, United Kingdom|Hillingdon Hospitals, London, United Kingdom|Northwick Park Hospital, London, United Kingdom|West Middlesex Hospital, London, United Kingdom|North of England, Newcastle, United Kingdom|Shrewsburty & Telford Hospital, Shrewsbury, United Kingdom|University Hospitals of North Midlands, Stoke-on-Trent, United Kingdom|Wrightington, Wigan and Leigh NHS, Wigan, United Kingdom","""Study Protocol and Statistical Analysis Plan"", https://classic.clinicaltrials.gov/ProvidedDocs/82/NCT02516982/Prot_SAP_000.pdf","https://ClinicalTrials.gov/show/NCT02516982"
419,"NCT06258655","The Effect of the Close Collaboration With Parents Intervention - Estonian Study",,"Recruiting","No Results Available","Depression, Postpartum|Anxiety","Other: Close Collaboration with Parents","Depression|Anxiety","University of Turku|University of Tartu","All","Child, Adult, Older Adult","Not Applicable","500","Other","Interventional","Allocation: Non-Randomized|Intervention Model: Sequential Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","SA332962","March 16, 2021","December 30, 2023","February 12, 2024","February 14, 2024",,"February 14, 2024","Sari Ahlqvist-Björkroth, Turku, Finland",,"https://ClinicalTrials.gov/show/NCT06258655"
420,"NCT04847076","Feasibility of M-health Version of ""What Were We Thinking"" Intervention to Promote Maternal Postpartum Mental Health",,"Unknown status","No Results Available","Depression, Postpartum|Anxiety Disorders and Symptoms|Maternal Behavior","Behavioral: m-health version of WWWT intervention|Other: Treatment as usual","Eligibility rate as feasibility indicator|Recruitment rate as feasibility indicator|Percentage of EG participants who receive the 12 psychoeducational modules, who attend the virtual meeting and who -at least- once established contact with the program facilitator|Percentage of participants who finished intervention by group as acceptability indicator|Percentage of participant retention at follow-up by group as acceptability indicator|Changes in maternal postnatal symptoms of depression, according to mean scores obtained with the Edinburgh Postnatal Depression Scale (EPDS)|Change in maternal postnatal symptoms of anxiety according to mean scores obtained with the Perinatal Anxiety Screening Scale (PASS)|Changes on perceived social support according to mean scores obtained with the multidimensional perceived social support scale (MSPSS)|Change in maternal self-efficacy according to mean scores obtained with the Parental Evaluation Scale (PEE)","Universidad del Desarrollo|Instituto Milenio para Investigación en Depresión y Personalidad|Peñalolén County Corporation, Chile","Female","18 Years to 64 Years   (Adult)","Not Applicable","90","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","MIDAP2020FIP1","May 3, 2021","December 2021","December 2021","April 15, 2021",,"October 7, 2021","Primary Health Center San Luis, Santiago, RMN, Chile|Primary Health Center Cardenal Silva Henríquez, Santiago, RM, Chile",,"https://ClinicalTrials.gov/show/NCT04847076"
421,"NCT04998721","A Dyadic Approach to Perinatal Depression in Primary Care: Maternal Infant and Dyadic Care","MInD","Recruiting","No Results Available","Depression, Postpartum|Efficacy, Self|Anxiety","Behavioral: Promoting First Relationships-Brief|Behavioral: Perinatal Collaborative Care","Change from Baseline in Perinatal Depression Symptomology on the Edinburgh Postnatal Depression Scale (EPDS)|Change from Baseline in Parental Self-Efficacy on the Self-Efficacy in a Nurturing Role (SENR)|Change from Postpartum Baseline in Dyadic Interaction|Change from Baseline in Disability on the World Health Organization Disability Assessment Schedule 2.0 (WHODAS)|Change from Postpartum Baseline in Maternal Functioning on the Barkin Index of Maternal Functioning (BIMF)|Relative utilization of MInD vs usual CC|Perceived match of treatment to patient need using Working Alliance Inventory (WAI-SR)","University of Washington|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Phase 2","60","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","STUDY00011405|1R34MH124798-01","November 1, 2022","March 1, 2025","June 1, 2025","August 10, 2021",,"December 22, 2023","Amritha Bhat, Seattle, Washington, United States",,"https://ClinicalTrials.gov/show/NCT04998721"
422,"NCT06252155","The Effect of Music Played to Newborn Mothers on Postpartum Blues",,"Completed","No Results Available","Postpartum Blues|Birth Depression|Mothers","Other: Music","Postpartum blues evaluated using the Edinburgh Postpartum Depression Scale|Depression evaluated using the Stein Blues Scale","Trakya University","Female","18 Years to 49 Years   (Adult)","Not Applicable","82","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Outcomes Assessor)|Primary Purpose: Supportive Care","2023-03","May 2, 2023","May 4, 2023","January 18, 2024","February 9, 2024",,"February 12, 2024","Bartın University, Bartın, Turkey",,"https://ClinicalTrials.gov/show/NCT06252155"
423,"NCT03247491","Effectiveness of a Mindfulness and Compassion Intervention for Pregnant Women and Their Partners for the Prevention of Stress and Depression During Pregnancy and Breastfeeding",,"Completed","No Results Available","Pregnancy, Childbirth and Postpartum","Behavioral: Mindfulness","Edinburgh postnatal depression scale (EPDS)|Sociodemographic data Gender, age, marital status, education, occupation, economical level|M.I.N.I. International Neuropsychiatric Interview|Client service receipt inventory (CSRI)|Medical data regarding delivery and breastfeeding|Perceived Stress Scale (PSS)|Positive and negative affect (PANAS)|Five Facets and factors of mindfulness (FFMQ)|Self Compassion Scale (SCS)|Self Compassion Scale(SCS)|Parental Evaluation Scale (EEP)","Javier Garcia Campayo|Universidad Nacional de Educación a Distancia|Hospital Miguel Servet","Female","18 Years to 45 Years   (Adult)","Not Applicable","122","Other","Interventional","Allocation: Randomized|Intervention Model: Factorial Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","50/2014/04","October 1, 2017","October 2, 2019","December 1, 2019","August 11, 2017",,"December 3, 2019","Universidad Nacional de Educacion a Distancia, Valladolid, Spain",,"https://ClinicalTrials.gov/show/NCT03247491"
424,"NCT00043602","Clinician Managed Interpersonal Psychotherapy",,"Completed","No Results Available","Depression|Depression, Postpartum","Behavioral: Standard interpersonal psychotherapy (IPT)|Behavioral: Clinician managed interpersonal psychotherapy (CM-IPT)","Hamilton Rating Scale for Depression","University of Iowa|National Institute of Mental Health (NIMH)","Female","18 Years and older   (Adult, Older Adult)","Early Phase 1","140","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","R01MH059668|DSIR 83-ATAS","September 2001","December 2007","December 2007","August 13, 2002",,"September 26, 2013","University of Iowa, Iowa City, Iowa, United States",,"https://ClinicalTrials.gov/show/NCT00043602"
425,"NCT02791932","Effect of Exercise on Perinatal Depression",,"Completed","No Results Available","Pregnancy|Postpartum Period|Depression","Behavioral: Exercise","Edinburgh Postnatal Depression Scale|Postpartum Weight Retention","University of Minnesota","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","111","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R40MC29454","February 23, 2017","June 15, 2020","June 15, 2020","June 7, 2016",,"January 13, 2021","Beth Lewis, Minneapolis, Minnesota, United States",,"https://ClinicalTrials.gov/show/NCT02791932"
426,"NCT05044546","A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers",,"Recruiting","No Results Available","Depression|Tobacco Use Disorder","Behavioral: Behavioral Activation Therapy|Procedure: Discussion|Behavioral: Health Education|Other: Questionnaire Administration|Other: Tobacco Cessation Counseling","Focus group","M.D. Anderson Cancer Center","All","18 Years and older   (Adult, Older Adult)","Not Applicable","99","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Prevention","2020-0972|NCI-2021-07469","October 19, 2021","March 31, 2024","April 30, 2024","September 14, 2021",,"September 13, 2023","M D Anderson Cancer Center, Houston, Texas, United States",,"https://ClinicalTrials.gov/show/NCT05044546"
427,"NCT00929409","Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia",,"Terminated","No Results Available","Anemia, Iron-Deficiency|Puerperal Disorders|Depression, Postpartum","Drug: Ferric carboxymaltose|Drug: Ferrous sulfate tablets","Haemoglobin concentration|Ferritin|Fatigue|Quality of life|Post partum depression","Norwegian University of Science and Technology|St. Olavs Hospital|Sykehuset Innlandet HF|Sykehuset Buskerud HF","Female","18 Years to 45 Years   (Adult)","Phase 2|Phase 3","30","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","4.2009.373|21830|09/03045-4|2008-008526-79","June 2009","July 2010","July 2010","June 29, 2009",,"February 17, 2012","Department of Obstetrics, Vestre Viken Hospital Trust, Drammen, Norway|Sykehuset Innlandet HF, Lillehammer, Norway|St Olavs Hospital, Trondheim, Norway",,"https://ClinicalTrials.gov/show/NCT00929409"
428,"NCT01899534","Mental Health E-screening in Pregnant and Postpartum Women",,"Completed","No Results Available","Depression|Anxiety","Other: E-screening","The primary outcome is feasibility/acceptability of the process of e-screening (vs 'usual' screening).|Proportion of pregnant and postpartum women with clinical depression and anxiety.|Depression and anxiety|Cost-effectiveness of e-screening","University of Calgary|Canadian Institutes of Health Research (CIHR)","Female","16 Years and older   (Child, Adult, Older Adult)","Not Applicable","566","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Screening","00039130","July 2013","December 2014","December 2014","July 15, 2013",,"October 26, 2016","Dickensfield Primary Care Maternity Clinic, Edmonton, Alberta, Canada|Royal Alexandra Hospital: Lois Hole Hospital for Women, Edmonton, Alberta, Canada|Sturgeon Primary Care Maternity Clinic, St. Albert, Alberta, Canada",,"https://ClinicalTrials.gov/show/NCT01899534"
429,"NCT06056609","Mother and Baby Yoga Study - Early Postnatal Yoga and Mental Health","MABY","Recruiting","No Results Available","Mental Health Issue|Depression, Postpartum|Anxiety","Other: Yoga","Maternal subjective experience of their mental health during and post online yoga programme|Maternal subjective feelings and experience towards the body and bond with infant post partum, during and post online yoga programme","York Teaching Hospitals NHS Foundation Trust|University of York","Female","18 Years to 50 Years   (Adult)","Not Applicable","40","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Other","294028YNP","August 15, 2022","August 2024","August 2024","September 28, 2023",,"September 28, 2023","York & Scarborough Teaching Hospitals NHS Foundation Trust, York, N. Yorks, United Kingdom",,"https://ClinicalTrials.gov/show/NCT06056609"
430,"NCT03351465","CALM for Pregnant and Post-Partum Women",,"Withdrawn","No Results Available","Anxiety|Depression|Depression, Postpartum|Pregnancy Related|CBT","Behavioral: Coordinated Anxiety Learning and Management","Change in Pregnancy Related Anxiety (composite will be created with anxiety and depression measures)|Change in General Anxiety (composite will be created with anxiety and depression measures)|Change in Depression (composite will be created with anxiety and depression measures)|Change in Functional Impairment|Treatment Satisfaction","University of California, Los Angeles|University of California, San Francisco","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","0","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Treatment","CALM RCT","January 1, 2020","June 30, 2020","June 30, 2020","November 22, 2017",,"September 26, 2019","University of California, San Francisco, Oakland, California, United States",,"https://ClinicalTrials.gov/show/NCT03351465"
431,"NCT01925664","Doula Support for Young Mothers: A Randomized Trial",,"Completed","No Results Available","Parenting|Breastfeeding|Depression, Postpartum","Behavioral: Doula","Breastfeeding Initiation|Positive parenting behavior (Parent Child Observation Guide)|Breastfeeding duration|Positive parenting behaviors (Parent Child Observation Guide)|Use of labor anesthesia|Labour Agentry Scale|Adult Adolescent Parenting Inventory (AAPI)|Maternal Self-Efficacy Scale|Parenting Stress Index (PSI)|Center for Epidemiologic Studies Depression Scale (CES-D)|Timing of solid food introduction to infant|The Brief Infant Toddler Social Emotional Assessment (BITSEA)|Mullen Scales of Early Learning","University of Chicago|HRSA/Maternal and Child Health Bureau","Female","14 Years to 21 Years   (Child, Adult)","Not Applicable","248","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","R40 MC 00203","January 2001","August 2006","August 2006","August 20, 2013",,"September 5, 2013","University of Chicago, Chicago, Illinois, United States",,"https://ClinicalTrials.gov/show/NCT01925664"
432,"NCT05573009","The Effect of Stress Reduction Program on Pregnancy Process and Mental Health in High Risk Pregnant Women",,"Completed","No Results Available","Pregnancy, High Risk|Depression, Postpartum|Anxiety in Pregnancy|Stress Disorder","Behavioral: cognitive behavioral approach-based stress reduction program","Information Form|Depression, Anxiety and Stress Scale (DASS-21)|Psychological Well-Being Scale :|Intolerance of uncertainty scale|Edinburgh Postnatal Depression Scale (EPDS)|Program Evaluation and Satisfaction Survey","Istanbul University|Istanbul University - Cerrahpasa (IUC)","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Care Provider)|Primary Purpose: Other","IstanbulU-NKALYONCU-001","March 1, 2022","March 31, 2023","July 31, 2023","October 10, 2022",,"October 5, 2023","Istanbul University Istanbul Faculty of Medicine, İstanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT05573009"
433,"NCT01908959","Madres Para la Salud (Mothers for Health)",,"Completed","No Results Available","Overweight and Obesity|Depression, Postpartum|Mother (Person)","Behavioral: Madres para la Salud","Change from Baseline Body Fat Percentage at 6 months|Change from Baseline Body Fat Percentage at 12 months|Change from Baseline Systemic and fat tissue inflammation at 12 months|Change from Baseline in Edinburgh Postnatal Depression Scale at 6 months|Change from Baseline in Edinburgh Postnatal Depression Scale at 12 months|Change from baseline in Medical Outcomes Study (MOS) Social Support Survey at 6 months|Change from baseline in Medical Outcomes Study (MOS) Social Support Survey at 12 months|Change from baseline in Neighborhood Health Questionnaire at 6 months|Change from baseline in Neighborhood Health Questionnaire at 12 months","Arizona State University","Female","18 Years to 40 Years   (Adult)","Not Applicable","177","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Basic Science","1R01NR010356-01A2","February 2010","February 2012","March 2012","July 26, 2013",,"July 26, 2013","Maricopa Integrated Health System, Phoenix, Arizona, United States",,"https://ClinicalTrials.gov/show/NCT01908959"
434,"NCT04853693","Pregnancy Without Psychosocial Stress",,"Unknown status","No Results Available","Depressive Symptoms|Anxiety Disorders and Symptoms|Depression, Postpartum","Behavioral: Mom´s Supporting Mom|Behavioral: Enhanced Treatment As Usual","Treatment gap for postpartum mental disorders|Pregnancy depressive symptoms|Postpartum depressive symptoms|Pregnancy anxiety symptoms|Postpartum anxiety symptoms","National Institute of Mental Health, Czech Republic","Female","18 Years to 45 Years   (Adult)","Not Applicable","120","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Prevention","ZD-ZDOVA1-018","April 1, 2021","March 31, 2023","March 31, 2023","April 21, 2021",,"April 11, 2022","National Institute of Mental Health, Klecany, Czechia",,"https://ClinicalTrials.gov/show/NCT04853693"
435,"NCT04384887","""Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women""",,"Completed","No Results Available","COVID|Anxiety|Depression, Postpartum","Behavioral: covid-19 positive pregnant women","Evaluation of depression and anxiety score changes of covid-19 positive pregnants","Kanuni Sultan Suleyman Training and Research Hospital|Ayşegül Bestel|İbrahim Polat|Merve Aldıkaçtıoğlu Talmaç","Female","18 Years to 45 Years   (Adult)",,"100","Other","Observational","Observational Model: Case-Control|Time Perspective: Prospective","beckcovid","April 25, 2020","August 25, 2020","August 26, 2020","May 12, 2020",,"September 2, 2020","Pinar Yalcin Bahat, Istanbul, İ̇stanbul, Turkey",,"https://ClinicalTrials.gov/show/NCT04384887"
436,"NCT03210155","Efficacy of CES in New Mothers During the Post Partum Period",,"Terminated","Has Results","Anxiety|Depression|Insomnia|Sleep Quality","Device: Alpha-Stim AID CES (Active Comparator)|Device: Alpha-Stim AID CES (Sham Comparator)","Hamilton Anxiety Rating Scale Scores Over Time|Hamilton Depression Rating Scale Scores Over Time|Pittsburgh Sleep Quality Index Scale Scores Over Time|Insomnia Severity Index Scores Over Time|Barkin Index of Maternal Functioning Scores Over Time","Christina Murphey, RN, PhD|Murphey, Christina, RN, PhD","Female","18 Years to 45 Years   (Adult)","Not Applicable","1","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Treatment","HSRP #36-17","July 24, 2017","August 1, 2019","August 1, 2019","July 6, 2017","August 17, 2020","August 17, 2020","Primay care; OB-GYN Clinic, Austin, Texas, United States|Primary care; OB-GYN Clinic, Corpus Christi, Texas, United States","""Study Protocol"", https://classic.clinicaltrials.gov/ProvidedDocs/55/NCT03210155/Prot_000.pdf","https://ClinicalTrials.gov/show/NCT03210155"
437,"NCT06316193","The Use of the Diary in Neonatal Pathology: a Mixed-method Study for Collecting and Analyzing the Experience of Parents and Health Care Personnel.","DiaPaNeo","Not yet recruiting","No Results Available","Experience, Life|Stress|Depression, Postpartum|Support, Family","Other: Diary","The objective of the qualitative phase is to provide a description of the experience of the parents of infants admitted to Neonatal Pathology and the healthcare personnel who participated in the compilation of the diary.|The quantitative phase includes as data collection tools a set of instruments validated in the Italian context and selected in relation to the variables to be measured. The instruments will be administered by one of the appropriately trained nurses.|The quantitative phase includes as data collection tools a set of instruments validated in the Italian context and selected in relation to the variables to be measured. Stressor Scale (PSS).|The quantitative phase includes as data collection tools a set of instruments validated in the Italian context and selected in relation to the variables to be measured. Edinburgh Postnatal Depression Scale (EPDS).|The quantitative phase includes as data collection tools a set of instruments validated in the Italian context and selected in relation to the variables to be measured. The Nurse Parental Support Tool (NPST).","IRCCS Ospedale San Raffaele","All","Child, Adult, Older Adult",,"15","Other","Observational","Observational Model: Other|Time Perspective: Cross-Sectional","DiaPaNeo","April 15, 2024","April 15, 2025","October 15, 2025","March 18, 2024",,"March 18, 2024","IRCCS Ospedale San Raffaele, Milano, MI, Italy",,"https://ClinicalTrials.gov/show/NCT06316193"
438,"NCT02059863","SPRING Cluster Randomised Controlled Trial","SPRING","Unknown status","No Results Available","Growth; Stunting, Nutritional|Child Development|Depression, Postpartum|Death","Behavioral: SPRING","infant mortality|stunting|child development|maternal psychosocial distress/depression|% adopting key promoted behaviours|wasting|underweight|age-specific infant mortality","London School of Hygiene and Tropical Medicine|University of Liverpool|University College, London|Human Development Research Foundation, Pakistan|Sangath","All","1 Day to 24 Months   (Child)","Not Applicable","12000","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","EPNPBE2610|093615","March 2014","October 2017","October 2017","February 11, 2014",,"August 24, 2017","Sangath: Haryana field site, Porvorim, Goa, India|Human Development Research Foundation: Rawalpindi field site, Islamabad, Punjab, Pakistan",,"https://ClinicalTrials.gov/show/NCT02059863"
439,"NCT01947244","Doula Home Visiting Randomized Trial",,"Completed","No Results Available","Breast Feeding|Parenting|Child Development|Depression, Postpartum","Behavioral: Doula Home Visiting|Behavioral: Case management","National Institute of Child Health and Human Development (NICHD) mother-child interaction measures|Breastfeeding initiation|Breastfeeding duration|Maternal Antenatal Attachment Scale (MAAS)|Center for Epidemiologic Studies Depression Scale (CES-D)|Labour Agentry Scale|Use of labor analgesia|Maternal Postnatal Attachment Scale (MPAS)|Parenting Stress Inventory (PSI)|Timing of solid food introduction|Knowledge of Infant Development Inventory (KIDI)|Infant/child ER visits|Infant/child immunizations|Infant/child hospitalizations|Adult Adolescent Parenting Inventory (AAPI)|Preschool Language Scales-5 (PLS-5)|Mullen Scales of Early Learning - Visual Reception|Infant Toddler Social and Emotional Assessment (ITSEA)|Subsequent pregnancy|Parent-Child Conflict Tactics Scales (CTS PC)|National Institute of Child Health and Human Development (NICHD) mother-child interaction measures.|Woodcock-Johnson III Tests of Achievement","University of Chicago|Health Resources and Services Administration (HRSA)|Illinois Department of Human Services","Female","14 Years to 24 Years   (Child, Adult)","Not Applicable","312","Other|U.S. Fed","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","D89MC23146","November 2011","October 2019","October 2019","September 20, 2013",,"November 6, 2020",,,"https://ClinicalTrials.gov/show/NCT01947244"
440,"NCT03593473","Inhaled Oxytocin and HPA Axis Reactivity",,"Completed","No Results Available","Depression, Postpartum|Anxiety Disorders|Stress, Psychological","Drug: Intranasal Oxytocin|Drug: Placebo","Changes in Cortisol (CRT) during Trier Social Stress Test (TSST)|Changes in Adrenocorticotropic hormone (ACTH ) during TSST|Changes in the lagged association between ACTH and CRT during the TSST|Changes in high frequency heart rate variability, an index of parasympathetic activity, during the TSST|Changes in pre-ejection period, an index of sympathetic activity, during the TSST","University of North Carolina, Chapel Hill|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","Female","18 Years and older   (Adult, Older Adult)","Phase 2","105","Other|NIH","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|Primary Purpose: Basic Science","12-2061|R01HD093901-01A1","February 7, 2019","July 25, 2023","July 25, 2023","July 20, 2018",,"January 25, 2024","University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States","""Informed Consent Form"", https://classic.clinicaltrials.gov/ProvidedDocs/73/NCT03593473/ICF_000.pdf","https://ClinicalTrials.gov/show/NCT03593473"
441,"NCT04844138","Evaluating Overcoming Anxiety in Pregnancy and Postpartum as an Online Self-Directed Program",,"Completed","No Results Available","Perinatal Anxiety|Perinatal Depression","Behavioral: Overcoming Anxiety in Pregnancy and Postpartum Online Self-Directed Program","Change in Perinatal Anxiety Symptoms from Baseline|Change in Perinatal Depression Symptoms from Baseline|Change in COVID-19 Stress from Baseline|Change in Non-Specific Psychological Distress from Baseline|Change in Life Stress from Baseline|Change in Maternal Antenatal Attachment from Baseline|Change in Maternal Postnatal Attachment from Baseline|Change in Maternal Efficacy from Baseline|Acceptability of the Online Self-Directed Program|Participant Satisfaction with the Online Self-Directed Program|Participant Experiences in the Online Self-Directed Program","University of Manitoba","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","95","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Investigator, Outcomes Assessor)|Primary Purpose: Treatment","P2020:104|53294","April 30, 2021","June 29, 2022","June 29, 2022","April 14, 2021",,"July 7, 2022","University of Manitoba, Winnipeg, Manitoba, Canada",,"https://ClinicalTrials.gov/show/NCT04844138"
442,"NCT04211467","A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Depression",,"Unknown status","No Results Available","Depression|Clinical Depression|Depression, Anxiety|Depression, Postpartum|Depression, Endogenous|Depression in Remission|Depression Chronic|Depression Moderate|Depression Severe","Other: No Intervention","Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing","ProgenaBiome","All","Child, Adult, Older Adult",,"100","Other","Observational","Observational Model: Case-Only|Time Perspective: Prospective","PRG-027","March 2, 2020","March 2023","July 2023","December 26, 2019",,"September 5, 2021","ProgenaBiome, Ventura, California, United States",,"https://ClinicalTrials.gov/show/NCT04211467"
443,"NCT02370576","The Effect of Traumatic Childbirth on the Incidence of PTSD and Other Major Postpartum Psychopathology",,"Unknown status","No Results Available","Stress Disorders, Post-Traumatic|Depressive Disorder, Major","Other: rating scale application","Presence or absence of PTSD (Questionnaire/ rating scale application)|Presence or absence of major depression (Questionnaire/ rating scale application)|Presence or absence of anxiety disorders (Questionnaire/ rating scale application)","Rambam Health Care Campus","Female","18 Years to 45 Years   (Adult)",,"500","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","rambam001","March 2015","March 2017","March 2018","February 25, 2015",,"February 25, 2015","Rambam Medical Center, Haifa, Israel",,"https://ClinicalTrials.gov/show/NCT02370576"
444,"NCT03300713","MOther-Child Interaction Assessment TRAINING for Pediatricians","MOCITRAINING","Recruiting","No Results Available","Child Behavior Disorders|Mother-child Relations|Depression, Postpartum","Other: MOCITRAINING program|Other: usual follow-up","Frequency of pathological Alarm Distress BaBy (ADBB) scores|Frequency of digestive disorders|Number of daytime sleep hours|Number of nighttime awakenings|Scores on maternal self-evaluation scales (Likert scales)|Frequency of dyads referred for psychiatric or perinatal psychiatric consultations|Frequency of maternal psychotropic medication","University Hospital, Lille|Ministry of Health, France","All","23 Days to 37 Days   (Child)","Not Applicable","3504","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","2015_04|2016-A00540-51","December 2, 2017","December 2026","December 2026","October 3, 2017",,"October 3, 2022","CHU, Lille, France",,"https://ClinicalTrials.gov/show/NCT03300713"
445,"NCT05000879","How Does Mindful Mood Balance for Moms Work?",,"Completed","No Results Available","Depression|Pregnancy Related|Antenatal Depression|Depression, Postpartum","Behavioral: MMB for Moms","Rate of change in depression symptoms|Rate of change in decentering|Rate of change in self-compassion|Depressive Relapse Status|Rate of change in anxiety symptoms","University of Colorado, Boulder","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","60","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Other","18-0402","November 16, 2018","August 20, 2019","August 20, 2019","August 11, 2021",,"August 11, 2021","University of Colorado Boulder, Boulder, Colorado, United States",,"https://ClinicalTrials.gov/show/NCT05000879"
446,"NCT05897619","Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum Individuals",,"Recruiting","No Results Available","Perinatal Anxiety|Perinatal Depression","Behavioral: Experimental: Maya Perinatal Cognitive Behavioral Skills App","User Version of the Mobile Application Rating Scale (uMARS) at midpoint|User Version of the Mobile Application Rating Scale (uMARS) at post-intervention|User Version of the Mobile Application Rating Scale (uMARS) at follow-up|Quantitative Feedback Survey of App Feasibility and Acceptability|Qualitative Feedback of App Feasibility and Acceptability at midpoint|Qualitative Feedback of App Feasibility and Acceptability at post-intervention|Qualitative Feedback of App Feasibility and Acceptability at follow-up|Changes in postnatal depression measures scores from baseline to midpoint as measured by the Edinburgh Postnatal Depression Scale (EPDS).|Changes in postnatal depression measures scores from baseline to post-intervention as measured by the Edinburgh Postnatal Depression Scale (EPDS).|Changes in postnatal depression measures scores from midpoint to post-intervention as measured by the Edinburgh Postnatal Depression Scale (EPDS).|Changes in postnatal depression measures scores from post-intervention to follow-up as measured by the Edinburgh Postnatal Depression Scale (EPDS).|Changes in postnatal anxiety measures scores from baseline to midpoint as measured by the Edinburgh Postnatal Depression Scale-Anxiety Subscale (EPDS 3A).|Changes in postnatal anxiety measures scores from baseline to post-intervention as measured by the Edinburgh Postnatal Depression Scale-Anxiety Subscale (EPDS 3A).|Changes in postnatal anxiety measures scores from midpoint to post-intervention as measured by the Edinburgh Postnatal Depression Scale-Anxiety Subscale (EPDS 3A).|Changes in postnatal anxiety measures scores from post-intervention to follow-up as measured by the Edinburgh Postnatal Depression Scale-Anxiety Subscale (EPDS 3A).|Changes in anxiety measures scores from baseline to midpoint as measured by the Generalized Anxiety Disorder-7 (GAD-7)|Changes in anxiety measures scores from baseline to post-intervention as measured by the Generalized Anxiety Disorder-7 (GAD-7)|Changes in anxiety measures scores from midpoint to post-intervention as measured by the Generalized Anxiety Disorder-7 (GAD-7)|Changes in anxiety measures scores from post-intervention to follow-up as measured by the Generalized Anxiety Disorder-7 (GAD-7)|Change in depression measures scores from baseline to midpoint as measured by the Patient Health Questionnaire-9 (PHQ-9)|Change in depression measures scores from baseline to post-intervention as measured by the Patient Health Questionnaire-9 (PHQ-9)|Change in depression measures scores from midpoint to post-intervention as measured by the Patient Health Questionnaire-9 (PHQ-9)|Change in depression measures scores from post-intervention to follow-up as measured by the Patient Health Questionnaire-9 (PHQ-9)|Changes in perinatal trauma measure scores from baseline to post-intervention as measured by Perinatal-Post Traumatic Stress Disorder Questionnaire-II (PPQ-II)|Changes in perinatal trauma measure scores from post-intervention to follow-up as measured by Perinatal-Post Traumatic Stress Disorder Questionnaire-II (PPQ-II)","Weill Medical College of Cornell University","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","50","Other","Interventional","Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment","22-10025299","September 19, 2023","May 2025","May 2025","June 9, 2023",,"October 3, 2023","Weill Cornell Medical College, New York, New York, United States",,"https://ClinicalTrials.gov/show/NCT05897619"
447,"NCT02441595","Mindfulness Based Childbirth and Parenting Education - RCT of Effects on Parent and Child Health","MBCP","Completed","No Results Available","Parent-Child Relations|Depression, Postpartum|Stress, Physiological|Stress, Psychological","Behavioral: MBCP|Behavioral: Psychoprophylaxis","Change in Perceived Stress Scale 14-item|Parent Child Early Relational Assessment|Change in Maternal heart rate variability|Change in Maternal serum levels of cytokines interleukin-6 and interleukin-10|Change in Maternal serum levels of Brain Derived Neurotrophic Factor-s|Change in Maternal serum levels of Corticotrophin Releasing Hormone|Change in Edinburgh Postnatal Depression Scale|Change in Positive States of Minds|Change in Five Facets of Mindfulness|Labour records|Infant serum levels of the cytokines interleukin-6 and interleukin-10|Infant serum levels of Brain Derived Neurotrophic Factor-S|Infant serum levels of Corticotrophin Releasing Hormone|Infant Heart Rate Variability|Pregnancy Interveiw","Karolinska Institutet","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","193","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","K63103043a","January 2015","January 2017","August 2018","May 12, 2015",,"August 8, 2018",,,"https://ClinicalTrials.gov/show/NCT02441595"
448,"NCT04093791","MAMA NO STRESS Project. The Effects of the ""HAPPY MAMA"" Intervention",,"Unknown status","No Results Available","Depression, Postpartum|Stress, Psychological|Postpartum Sadness|Self Efficacy|Mother-Infant Relations","Behavioral: Collective Intervention ""G""|Behavioral: Individual Intervention ""I""","Assessing a change of the Parental Stress Scale (PSS): The main outcome measures are the Parental Stress Scale (PSS) for change between the baseline and the follow-up (four time points).|Assessing a change of the Karitane Parenting Confidence Scale (KPCS). The secondary outcome measures are theKaritane Parenting Confidence Scale (KPCS) for change between the baseline and the follow-up (four time points).|Assessing a change of the Edinburgh Postnatal Depression Scale (EPDS). The secondary outcome measures are the Edinburgh Postnatal Depression Scale (EPDS) for change between the baseline and the follow-up (four time points).","University of Roma La Sapienza","Female","18 Years and older   (Adult, Older Adult)","Not Applicable","66","Other","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Supportive Care","80209930587","November 2019","December 2019","September 2020","September 18, 2019",,"September 20, 2019",,,"https://ClinicalTrials.gov/show/NCT04093791"
449,"NCT02867631","Postpartum Weight Retention",,"Completed","No Results Available","Obesity|Hypertension|Depression","Behavioral: 6 week challenge with 1 year of home visits: health texting, in home exercise supports, social support, healthy eating and feeding classes","Postpartum weight change|Depression|Dietary quality|Infant growth|Nutrition knowledge score change|Waist circumference as continuous measure, in inches|Back to prepregnancy weight|Back to pregnancy weight, continuous","University of Pennsylvania|Robert Wood Johnson Foundation|Aetna, Inc.","Female","Child, Adult, Older Adult","Not Applicable","175","Other|Industry","Interventional","Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Single (Outcomes Assessor)|Primary Purpose: Prevention","815827","January 2014","December 2016","December 2017","August 16, 2016",,"May 30, 2019","Maternity Care Coalition, Philadelphia, Pennsylvania, United States",,"https://ClinicalTrials.gov/show/NCT02867631"
450,"NCT03357965","Familiy Medicine Perspective to Maternal-infant Bonding",,"Completed","No Results Available","Maternal-Fetal Relations|Depression|Anxiety","Other: Questionnaire","Maternal Attachment Inventory","Yildiz Atadag|Umraniye Education and Research Hospital","Female","Child, Adult, Older Adult",,"73","Other","Observational","Observational Model: Cohort|Time Perspective: Prospective","18517","December 1, 2016","February 1, 2017","February 1, 2017","November 30, 2017",,"November 30, 2017","Gaziantep Sahinbey Baglarbasi Family Health Center, Gaziantep, Turkey",,"https://ClinicalTrials.gov/show/NCT03357965"
